Please wait...
| ID | PMID | YEAR | Sequence | MAP | Name | C-ter MOD | N-ter MOD | Linear/Cyclic | Stereo-Chemistry | Modified | Length | Fuction | Activity | RBCs Source | Origin | Experimental structure | Non-Hemolytic |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10660589 | 2000 | ALWMTLLKKVLKAAAKAALNAVLVGANA | S4 | Free | Free | Linear | L | None | 28 | Antimicrobial | LC50 =1.4±0.2μM | Human | Dermaseptin S4 (skin of tree frogs) | α-helix | NA | ||
| 10660589 | 2000 | ALWMTLLKKVLKAAAKAALDAVLVGANA | D20-S4 | Free | Free | Linear | L | None | 28 | Antimicrobial | LC50 =1.2±0.1μM | Human | Dermaseptin S4 analog (skin of tree frogs) | α-helix | NA | ||
| 10660589 | 2000 | ALWDTLLKKVLKAAAKAALNAVLVGANA | D4-S4 | Free | Free | Linear | L | None | 28 | Antimicrobial | LC50 =2.3±0.3μM | Human | Dermaseptin S4 analog (skin of tree frogs) | α-helix | NA | ||
| 10660589 | 2000 | ALWDTLLKKVLKAAAKAALDAVLVGANA | D4D20-S4 | Free | Free | Linear | L | None | 28 | Antimicrobial | LC50 =5±1μM | Human | Dermaseptin S4 analog (skin of tree frogs) | α-helix | NA | ||
| 10660589 | 2000 | ALWMTLLKKVLKAAAKAALKAVLVGANA | K20-S4 | Free | Free | Linear | L | None | 28 | Antimicrobial | LC50 =1.2±0.4μM | Human | Dermaseptin S4 analog (skin of tree frogs) | α-helix | NA | ||
| 10660589 | 2000 | ALWKTLLKKVLKAAAKAALNAVLVGANA | K4-S4 | Free | Free | Linear | L | None | 28 | Antimicrobial | LC50 =2±0.1μM | Human | Dermaseptin S4 analog (skin of tree frogs) | α-helix | NA | ||
| 10660589 | 2000 | ALWKTLLKKVLKAAAKAALKAVLVGANA | K4K20-S4 | Free | Free | Linear | L | None | 28 | Antimicrobial | LC50 =0.5±0.1μM | Human | Dermaseptin S4 analog (skin of tree frogs) | α-helix | NA | ||
| 10660589 | 2000 | TLLKKVLKAAAKAALNAVLVGANA | S4-(5-28) | Free | Free | Linear | L | None | 24 | Antimicrobial | LC50 =16.5±0.5μM | Human | Dermaseptin S4 analog (skin of tree frogs) | α-helix | NA | ||
| 18081258 | 2008 | GLPVCGETCVGGTCNTPGCTCSWPVCTRN{cyc:N-C} | Katala B1 | Free | Free | Cyclic | L | None | 29 | Anti-HIV | HD50 =11.7μM | Human | Cyclotides (Chinese herb from the Violaceae family Viola yedoensis) | NA | NA | ||
| 18081258 | 2008 | GVPCGESCVFIPCITGVIGCSCSSNVCYLN{cyc:N-C} | Cycloviolacin Y4 | Free | Free | Cyclic | L | None | 30 | Anti-HIV | HD50 =9.3μM | Human | Cyclotides (Chinese herb from the Violaceae family Viola yedoensis) | NA | NA | ||
| 18081258 | 2008 | GIPCAESCVWIPCTVTALVGCSCSDKVCYN{cyc:N-C} | Cycloviolacin Y5 | Free | Free | Cyclic | L | None | 30 | Anti-HIV | HD50 = 8.7μM | Human | Cyclotides (Chinese herb from the Violaceae family Viola yedoensis) | NA | NA | ||
| 11467858 | 2001 | RGLRRLGRKIAHGVKKYGPTVLRIIRIA{ct:Amid} | SMAP-29 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 60.8% hemolysis at 100μM | Human | Cathelecidin derivative SMAP-29 (sheep myeloid mRNA) | NA | NA | ||
| 11467858 | 2001 | RGLRRLGRKIAHGVKKYGPTVKRIKRKA{ct:Amid} | [K22,25,27]-SMAP-29 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 0% hemolysis at 100μM (non-hemolytic) | Human | Cathelecidin derivative SMAP-29 derivative (sheep myeloid mRNA) | NA | Non-hemolytic | ||
| 11467858 | 2001 | RGLRRLGRKIAHGVKKYGATVLRIIRIA{ct:Amid} | [A19]-SMAP-29 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 50.40% hemolysis at 100μM | Human | Cathelecidin derivative SMAP-29 derivative (sheep myeloid mRNA) | NA | NA | ||
| 11689009 | 2001 | GLNALKKVFQGIHEAIKLINNHVQ | Pseudin-2 | Free | Free | Linear | L | None | 24 | Antimicrobial | 50% hemolysis at >300μM | Human | Pseudin-2 (extract of the skin of the paradoxical frog Pseudis paradoxa (Pseudidae)) | NA | NA | ||
| 15544856 | 2005 | GVVDILKGAAKDIAGHLASKVMNKL{ct:Amid} | Fallaxin | Amidation | Free | Linear | L | None | 25 | Antimicrobial | HC50 >200μM | Human | Fallaxin (skin secretions of the mountain chicken frog Leptodactylus fallax) | NA | NA | ||
| 16236555 | 2005 | GLLDTLKGAAKNVVGSLASKVMEKL{ct:Amid} | Pentadactylin | Amidation | Free | Linear | L | None | 25 | Antimicrobial | LD50 >400μM | Human | Pentadactylin (skin secetion of south American bullfrog Leptodactylus pentadactylus) | NA | NA | ||
| 16413829 | 2006 | FLGSIVGALASALPSLISKIRN{ct:Amid} | Brevinin-1TSa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | LD50 =12μM | Human | Brevinin (skin of the Tsushima brown frog Rana tsushimensis) | NA | NA | ||
| 20044030 | 2010 | GLMDTVKNAAKNLAGQMLDKLKCKITGSC | Ranatuerin-2ONa | Free | Free | Linear | L | None | 29 | Antimicrobial | LD50 =90μM | Human | Ranatuerin-2ONa (leopard frog Lithobates onca) | NA | NA | ||
| 20044030 | 2010 | FLPVIAGAANFLPKLFCAISKKC | Brevinin-1Ya | Free | Free | Linear | L | None | 23 | Antimicrobial | LD50 =14μM | Human | Brevinin analog (leopard frog Lithobates onca) | NA | NA | ||
| 20044030 | 2010 | FLPIIAGAAAKVVQKIFCAISKKC | Brevinin-1Yb | Free | Free | Linear | L | None | 24 | Antimicrobial | LD50 =10μM | Human | Brevinin analog (leopard frog Lithobates onca) | NA | NA | ||
| 17114219 | 2007 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Hemolytic | 100% hemolysis at 2μM | Rat | Melittin (venom of the european honey bee, Apis mellifera) | Random coil and α Helical | NA | ||
| 17158938 | 2007 | KWKSFLKTFKSAKKTVLHTALKAISS{nt:Acet}{ct:Amid} | V13KL | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | MHC =250μg/ml | Human | Synthetic peptide | α-helix | NA | ||
| 17158938 | 2007 | KWKSFAKTFKSAKKTVLHTAAKAISS{nt:Acet}{ct:Amid} | L6A/L21A | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | MHC =1000 μg/ml | Human | Synthetic peptide | α-helix | NA | ||
| 17158938 | 2007 | KWKSFAKTFKSAKKTVLHTALKAISS{nt:Acet}{ct:Amid} | L6A | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | MHC =1000μg/ml | Human | Synthetic peptide | α-helix | NA | ||
| 17158938 | 2007 | KWKSFLKTFKSAKKTVLHTALKLISS{nt:Acet}{ct:Amid} | A23L | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | MHC =62.5μg/ml | Human | Synthetic peptide | α-helix | NA | ||
| 17158938 | 2007 | KWKSFLKTFKSLKKTVLHTALKAISS{nt:Acet}{ct:Amid} | A12L | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | MHC =31.3μg/ml | Human | Synthetic peptide | α-helix | NA | ||
| 17158938 | 2007 | KWKSFLKTFKSAKKTVLHTLLKAISS{nt:Acet}{ct:Amid} | A20L | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | MHC =31.3μg/ml | Human | Synthetic peptide | α-helix | NA | ||
| 17158938 | 2007 | KWKSFLKTFKSLKKTVLHTALKLISS{nt:Acet}{ct:Amid} | A12L/A23L | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | MHC =15.6μg/ml | Human | Synthetic peptide | α-helix | NA | ||
| 17158938 | 2007 | KWKSFLKTFKSLKKTVLHTLLKAISS{nt:Acet}{ct:Amid} | A12L/A20L | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | MHC =8μg/ml | Human | Synthetic peptide | α-helix | NA | ||
| 17158938 | 2007 | KWKSFLKTFKSLKKTVLHTLLKLISS{nt:Acet}{ct:Amid} | A12L/A20L/A23L | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | MHC =4μg/ml | Human | Synthetic peptide | α-helix | NA | ||
| 17328560 | 2007 | FFHHIFRGIVHVGKTIHRLVTG | Piscidin 1 (Pis-1) | Free | Free | Linear | L | None | 22 | Cytotoxic | HC50 =11μM | Human | Piscidin 1 (mast cells of hybrid striped bass (Morone saxatilis x M.chrysops ) | α-helix | NA | ||
| 17328560 | 2007 | FFHHIFRAIVHVGKTIHRLVTG | Pis-1 AG | Free | Free | Linear | L | None | 22 | Cytotoxic | HC50 =4μM | Human | Piscidin 1 analogs (mast cells of hybrid striped bass (Morone saxatilis x M.chrysops ) | α-helix | NA | ||
| 17328560 | 2007 | FFHHIFRGIVHVAKTIHRLVTG | Pis-1 GA | Free | Free | Linear | L | None | 22 | Cytotoxic | HC50 =4μM | Human | Piscidin 1 analogs (mast cells of hybrid striped bass (Morone saxatilis x M.chrysops ) | α-helix | NA | ||
| 17328560 | 2007 | FFHHIFRAIVHVAKTIHRLVTG | Pis-1 AA | Free | Free | Linear | L | None | 22 | Cytotoxic | HC50 =6μM | Human | Piscidin 1 analogs (mast cells of hybrid striped bass (Morone saxatilis x M.chrysops ) | α-helix | NA | ||
| 17328560 | 2007 | FFHHIFRPIVHVGKTIHRLVTG | Pis-1 PG | Free | Free | Linear | L | None | 22 | Cytotoxic | HC50 >200μM | Human | Piscidin 1 analogs (mast cells of hybrid striped bass (Morone saxatilis x M.chrysops ) | α-helix | NA | ||
| 17328560 | 2007 | FFHHIFRGIVHVPKTIHRLVTG | Pis-1 GP | Free | Free | Linear | L | None | 22 | Cytotoxic | HC50 >200μM | Human | Piscidin 1 analogs (mast cells of hybrid striped bass (Morone saxatilis x M.chrysops ) | α-helix | NA | ||
| 17328560 | 2007 | FFHHIFRPIVHVPKTIHRLVTG | Pis-1 PP | Free | Free | Linear | L | None | 22 | Cytotoxic | HC50 >200μM | Human | Piscidin 1 analogs (mast cells of hybrid striped bass (Morone saxatilis x M.chrysops ) | α-helix | NA | ||
| 17328560 | 2007 | FFHHIFRAIVHVPKTIHRLVTG | Pis-1 AP | Free | Free | Linear | L | None | 22 | Cytotoxic | HC50 =75μM | Human | Piscidin 1 analogs (mast cells of hybrid striped bass (Morone saxatilis x M.chrysops ) | α-helix | NA | ||
| 17328560 | 2007 | FFHHIFRPIVHVAKTIHRLVTG | Pis-1 PA | Free | Free | Linear | L | None | 22 | Cytotoxic | HC50 =32μM | Human | Piscidin 1 analogs (mast cells of hybrid striped bass (Morone saxatilis x M.chrysops ) | α-helix | NA | ||
| 17328560 | 2007 | FFHHIFRA{d}IVHVA{d}KTIHRLVTG | Pis-1 aa | Free | Free | Linear | Mix | None | 22 | Cytotoxic | HC50 =8μM | Human | Piscidin 1 analogs (mast cells of hybrid striped bass (Morone saxatilis x M.chrysops ) | α-helix | NA | ||
| 17389605 | 2007 | KILRGVCKKIMRTFLRRISKDILTGKK{ct:Amid} | NK-2 | Amidation | Free | Linear | L | None | 27 | Antimicrobial and Cytotoxic | ~50% hemolysis at 100μg/ml | Human | Synthetic peptide variants based on the NK-2 lysin | α-helix | NA | ||
| 17389605 | 2007 | KILRGVSKKIMRTFLRRISKDILTGKK{ct:Amid} | NK27 | Amidation | Free | Linear | L | None | 27 | Antimicrobial and Cytotoxic | >20% hemolysis at 100μg/ml | Human | Synthetic peptide variants based on the NK-2 lysin | α-helix | NA | ||
| 17389605 | 2007 | KILRGVSKKIMRTFLRRILTGKK{ct:Amid} | NK23c | Amidation | Free | Linear | L | None | 23 | Antimicrobial and Cytotoxic | ~20% hemolysis at 100μg/ml | Human | Synthetic peptide variants based on the NK-2 lysin | α-helix | NA | ||
| 17451843 | 2007 | FLPILAGLAAKIVPKLFCLATKKC | Brevinin-1CSa | Free | Free | Linear | L | None | 24 | Antimicrobial | LD50 =5μM | Human | Brevinin-1analog (skin secretions of Rana cascadae) | NA | NA | ||
| 18098173 | 2007 | EWESFLETFESAKETVLHTALEAISS{nt:Acet}{ct:Amid} | -5 Peptide | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | MHC >1000.0μg/ml | Human | Amphipathic α-helical antimicrobial peptide L-V13K analogs | α-helix | NA | ||
| 18098173 | 2007 | KWKEFLKEFKEAKKEVLHEALKAISE{nt:Acet}{ct:Amid} | 1 Peptide | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | MHC >1000.0μg/ml | Human | Amphipathic α-helical antimicrobial peptide L-V13K analogs | α-helix | NA | ||
| 18098173 | 2007 | KWKEFLKTFKEAKKEVLHTALKAISS{nt:Acet}{ct:Amid} | +4E Peptide | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | MHC =250.0μg/ml | Human | Amphipathic α-helical antimicrobial peptide L-V13K analogs | α-helix | NA | ||
| 18098173 | 2007 | SWKSFLKTFSSAKSTVLHTALKAISS{nt:Acet}{ct:Amid} | +4S Peptide | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | MHC =125.0μg/ml | Human | Amphipathic α-helical antimicrobial peptide L-V13K analogs | α-helix | NA | ||
| 18098173 | 2007 | KWKSFLKTFKSAKKTVLHTALKAISS{nt:Acet}{ct:Amid} | V13K Peptide | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | MHC =250.0μg/ml | Human | Amphipathic α-helical antimicrobial peptide L-V13K | α-helix | NA | ||
| 18098173 | 2007 | KWKSFLKTFKSAKKKVLHTALKAISS{nt:Acet}{ct:Amid} | 8 Peptide | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | MHC =250.0μg/ml | Human | Amphipathic α-helical antimicrobial peptide L-V13K analogs | α-helix | NA | ||
| 18098173 | 2007 | KWKSFLKTFKSAKKKVLHKALKAISS{nt:Acet}{ct:Amid} | 9 Peptide | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | MHC <7.8μg/ml | Human | Amphipathic α-helical antimicrobial peptide L-V13K analogs | α-helix | NA | ||
| 18098173 | 2007 | KWKSFLKTFKSAKKKVLHKALKAISK{nt:Acet}{ct:Amid} | 10 Peptide | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | MHC <7.8μg/ml | Human | Amphipathic α-helical antimicrobial peptide L-V13K analogs | α-helix | NA | ||
| 18779649 | 2008 | GWGSFFKKAAHVGKHVGKAALTHYL{ct:Amid} | L-Pleurocidin | Amidation | Free | Linear | L | None | 25 | Antibacterial | 77% hemolysis at 100 μM | Human | Skin mucous of the winter flounder (Pleuronectes americanus ) | α-helix | NA | ||
| 18779649 | 2008 | GWGSFFKKAAHVGKHVGKAALTHYL{ct:Amid} | L-Pleurocidin | Amidation | Free | Linear | L | None | 25 | Antibacterial | 29% hemolysis at 50 μM | Human | Skin mucous of the winter flounder (Pleuronectes americanus ) | α-helix | NA | ||
| 18779649 | 2008 | GWGSFFKKAAHVGKHVGKAALTHYL{ct:Amid} | L-Pleurocidin | Amidation | Free | Linear | L | None | 25 | Antibacterial | 0% hemolysis at 3.13-25 μM | Human | Skin mucous of the winter flounder (Pleuronectes americanus ) | α-helix | NA | ||
| 18779649 | 2008 | G{d}W{d}G{d}S{d}F{d}F{d}K{d}K{d}A{d}A{d}H{d}V{d}G{d}K{d}H{d}V{d}G{d}K{d}A{d}A{d}L{d}T{d}H{d}Y{d}L{d}{ct:Amid} | D-Pleurocidin | Amidation | Free | Linear | D | None | 25 | Antibacterial | 19% hemolysis at 100 μM | Human | Skin mucous of the winter flounder (Pleuronectes americanus ) | α-helix | NA | ||
| 18779649 | 2008 | G{d}W{d}G{d}S{d}F{d}F{d}K{d}K{d}A{d}A{d}H{d}V{d}G{d}K{d}H{d}V{d}G{d}K{d}A{d}A{d}L{d}T{d}H{d}Y{d}L{d}{ct:Amid} | D-Pleurocidin | Amidation | Free | Linear | D | None | 25 | Antibacterial | 0% hemolysis at 3.13-50 μM | Human | Skin mucous of the winter flounder (Pleuronectes americanus ) | α-helix | NA | ||
| 18795096 | 2008 | KFFRKLKKSVKKRAKEFFKKPRVIGVSIPF | Cathelicidin-BF | Free | Free | Linear | L | None | 30 | Antimicrobial | Little hemolysis up to 400 mg/ml (non-hemolytic) | Human | Snake venoms of Bungarus fasciatus | random-coil | Non-hemolytic | ||
| 18827353 | 2008 | FFHHIFRGIVHVGKTIHRLVTG{ct:Amid} | Piscidin 1 (P1) | Amidation | Free | Linear | L | None | 22 | Antifungal | 100% hemolysis at 25μM | Human | Mast cells of hybrid striped bass | α-helix | NA | ||
| 18827353 | 2008 | FFHHIFRGIVHVGKTIHRLVTG{ct:Amid} | Piscidin 1 (P1) | Amidation | Free | Linear | L | None | 22 | Antifungal | 96% hemolysis at 12.5μM | Human | Mast cells of hybrid striped bass | α-helix | NA | ||
| 18827353 | 2008 | FFHHIFRGIVHVGKTIHRLVTG{ct:Amid} | Piscidin 1 (P1) | Amidation | Free | Linear | L | None | 22 | Antifungal | 92% hemolysis at 6.25μM | Human | Mast cells of hybrid striped bass | α-helix | NA | ||
| 18827353 | 2008 | FFHHIFRGIVHVGKTIHRLVTG{ct:Amid} | Piscidin 1 (P1) | Amidation | Free | Linear | L | None | 22 | Antifungal | 45% hemolysis at 3.125μM | Human | Mast cells of hybrid striped bass | α-helix | NA | ||
| 18827353 | 2008 | FFHHIFRGIVHVGKTIHRLVTG{ct:Amid} | Piscidin 1 (P1) | Amidation | Free | Linear | L | None | 22 | Antifungal | 9% hemolysis at 1.56μM | Human | Mast cells of hybrid striped bass | α-helix | NA | ||
| 18827353 | 2008 | FFHHIFRGIVHVGKTIHRLVTG{ct:Amid} | Piscidin 1 (P1) | Amidation | Free | Linear | L | None | 22 | Antifungal | 0% hemolysis at 0.78μM | Human | Mast cells of hybrid striped bass | α-helix | NA | ||
| 18827353 | 2008 | FIHHIFRGIVHAGRSIGRFLTG{ct:Amid} | Piscidin 3 (P3) | Amidation | Free | Linear | L | None | 22 | Antifungal | 25% hemolysis at 25μM | Human | Mast cells of hybrid striped bass | α-helix | NA | ||
| 18827353 | 2008 | FIHHIFRGIVHAGRSIGRFLTG{ct:Amid} | Piscidin 3 (P3) | Amidation | Free | Linear | L | None | 22 | Antifungal | 4% hemolysis at 12.5μM | Human | Mast cells of hybrid striped bass | α-helix | NA | ||
| 18827353 | 2008 | FIHHIFRGIVHAGRSIGRFLTG{ct:Amid} | Piscidin 3 (P3) | Amidation | Free | Linear | L | None | 22 | Antifungal | 0% hemolysis at 0.78 - 6.25μM | Human | Mast cells of hybrid striped bass | α-helix | NA | ||
| 18972522 | 2008 | PICTRNGLPVCGETCFGGTCNTPGCTCTW{cyc:N-C} | K1 (B2) | Free | Free | Cyclic | L | None | 29 | Uteroactive and antimicrobial | 100% hemolysis at >0.5 mg/ml | Human | Kalata (Oldenlandia affinis DC) | β-strands | NA | ||
| 18972522 | 2008 | PVCTRNGLPVCGETCVGGTCNTPGCTCSW{cyc:N-C} | K2 (B1) | Free | Free | Cyclic | L | None | 29 | Uteroactive and antimicrobial | 100% hemolysis at >0.5 mg/ml | Human | Kalata (Oldenlandia affinis DC) | β-strands | NA | ||
| 18972522 | 2008 | PICKRNGLPVCGETCTLGTCYTQGCTCSW{cyc:N-C} | K3 (B7) | Free | Free | Cyclic | L | None | 29 | Uteroactive and antimicrobial | 100% hemolysis at >0.5 mg/ml | Human | Kalata (Oldenlandia affinis DC) | β-strands | NA | ||
| 19104020 | 2009 | GIGKFIHAVKKWGKTFIGEIAKS{ct:Amid} | MK5E | Amidation | Free | Linear | L | None | 23 | Antimicrobial | EC50 =33.4μM | Human | Magainin-derived synthetic peptide | α-helix | NA | ||
| 19104020 | 2009 | GIGKFIHAVKKWGKTFIGEIAKS{nt:Acet}{ct:Amid} | Ac-MK5E | Amidation | Acetylation | Linear | L | None | 23 | Antimicrobial | EC50 >400μM | Human | Magainin-derived synthetic peptide | α-helix | NA | ||
| 19111524 | 2009 | TQTVYEWCGVATQLLAAYILL | Hemolysin E (HlyE) | Free | Free | Linear | L | None | 21 | Cytotoxic | ~90% hemolysis at 0.8μM | Human | Synthetic peptide | Helical | NA | ||
| 19111524 | 2009 | TQTVYEWCGDATQLLAAYILL | Mu1-HlyE | Free | Free | Linear | L | None | 21 | Cytotoxic | ~2% hemolysis at 0.8μM | Human | Synthetic peptide | Helical | NA | ||
| 19111524 | 2009 | TQTVYEWCDDATQLLAAYILL | Mu2-HlyE | Free | Free | Linear | L | None | 21 | Cytotoxic | 0% hemolysis at 0.8μM (non-hemolytic) | Human | Synthetic peptide | Helical | Non-hemolytic | ||
| 20033827 | 2011 | FWGALAKGALKLIPSLFSSFSKKD | Pin2 | Free | Free | Linear | L | None | 24 | Antimicrobial | IC50 =3.3μM | Human | Venom of the African scorpion Pandinus imperator | α-helix | NA | ||
| 20033827 | 2011 | FWGALAKGALKLIVSLFSSFSKKD | Pin2 [P14V] | Free | Free | Linear | L | None | 24 | Antimicrobial | IC50 =6.4μM | Human | Venom of the African scorpion Pandinus imperator | α-helix | NA | ||
| 20033827 | 2011 | FWGALAKGALKLIGVSLFSSFSKKD | Pin2 [P14GV] | Free | Free | Linear | L | None | 25 | Antimicrobial | IC50 =9.3μM | Human | Venom of the African scorpion Pandinus imperator | α-helix | NA | ||
| 20033827 | 2011 | FWGALAKGALKLIVGSLFSSFSKKD | Pin2 [P14VG] | Free | Free | Linear | L | None | 25 | Antimicrobial | IC50 =8.8μM | Human | Venom of the African scorpion Pandinus imperator | α-helix | NA | ||
| 20033827 | 2011 | FWGALAKGALKLIGVGSLFSSFSKKD | Pin2 [P14GVG] | Free | Free | Linear | L | None | 26 | Antimicrobial | IC50 =11.5μM | Human | Venom of the African scorpion Pandinus imperator | α-helix | NA | ||
| 19524300 | 2009 | RFGRFLRKIRRFRPKVTITIQGSARFG | C1-27 | Free | Free | Linear | L | None | 27 | Immunomodulatory and antimicrobial | 50% hemolysis at 40μM | Chicken | Host defense peptide cathelicidin-2 (CATH-2) analog (Chicken ) | Helical | NA | ||
| 19524300 | 2009 | RFGRFLRKIRRFRPKVTITIQGSARF{ct:Amid} | C1-26 | Amidation | Free | Linear | L | None | 26 | Immunomodulatory and antimicrobial | 60% hemolysis at 40μM | Chicken | Host defense peptide cathelicidin-2 (CATH-2) analog (Chicken ) | Helical | NA | ||
| 19524300 | 2009 | RFGRFLRKIRRFRPKVTITIQ | C1-21 | Free | Free | Linear | L | None | 21 | Immunomodulatory and antimicrobial | 40% hemolysis at 40μM | Chicken | Host defense peptide cathelicidin-2 (CATH-2) analog (Chicken ) | Helical | NA | ||
| 19563807 | 2009 | GLFGKLIKKFGRKAISYAVKKARGKH | Ltc2a (native) | Free | Free | Linear | L | None | 26 | Antimicrobial and Cytotoxic | EC50 =6μM | Human | Lachesana tarabaevi Spider venom | α-helix | NA | ||
| 19563807 | 2009 | GLFGKLQKKFGRKAISYAVKKARGKH | Ltc2a_I7Q | Free | Free | Linear | L | None | 26 | Antimicrobial and Cytotoxic | EC50 >36μM | Human | Lachesana tarabaevi Spider venom | α-helix | NA | ||
| 19563807 | 2009 | GLFGKLIKKKGRKAISYAVKKARGKH | Ltc2a_F10K | Free | Free | Linear | L | None | 26 | Antimicrobial and Cytotoxic | EC50 >36μM | Human | Lachesana tarabaevi Spider venom | α-helix | NA | ||
| 19563807 | 2009 | GLFGKLIKKFLRKAISYAVKKARGKH | Ltc2a_G11L | Free | Free | Linear | L | None | 26 | Antimicrobial and Cytotoxic | EC50 =3μM | Human | Lachesana tarabaevi Spider venom | α-helix | NA | ||
| 19563807 | 2009 | GKLIKKFGRKAISYAVKKARGKH | Ltc2a_N-trim | Free | Free | Linear | L | None | 23 | Antimicrobial and Cytotoxic | EC50 >36μM | Human | Lachesana tarabaevi Spider venom | α-helix | NA | ||
| 19563807 | 2009 | GFFGKMKEYFKKFGASFKRRFANLKKRL{ct:Amid} | Ltc5 (native) | Amidation | Free | Linear | L | None | 28 | Antimicrobial and Cytotoxic | EC50 =12μM | Human | Lachesana tarabaevi Spider venom | α-helix | NA | ||
| 19563807 | 2009 | GFFGKRKEYFKKFGASFKRRFANLKKRL{ct:Amid} | Ltc5_M6R | Amidation | Free | Linear | L | None | 28 | Antimicrobial and Cytotoxic | EC50 >36μM | Human | Lachesana tarabaevi Spider venom | α-helix | NA | ||
| 19563807 | 2009 | GKMKEYFKKFGASFKRRFANLKKRL{ct:Amid} | Ltc5_N-trim | Amidation | Free | Linear | L | None | 25 | Antimicrobial and Cytotoxic | EC50 >36μM | Human | Lachesana tarabaevi Spider venom | α-helix | NA | ||
| 19804724 | 2009 | MQFITDLIKKAVDFFKGLFGNK | Warnericin RK | Free | Free | Linear | L | None | 22 | Antimicrobial | 100% hemolysis at 200μM | Human | Warnericin RK (Staphylococcus warneri RK strain) | α-helix | NA | ||
| 20564013 | 2010 | GTPCGESCVYIPCISGVIGCSCTDKVCYLN{cyc:N-C} | Kalata B5 | Free | Free | Cyclic | L | None | 30 | Pesticidal | HD50 =27.4±1.2μM | Human | Cyclotides (Oldenlandia affinis) | typical bracelet cyclotide fold | NA | ||
| 20728940 | 2010 | NPVLVKDATGSTQFGPVQALGAQYSMWKLK | CP2 | Free | Free | Linear | L | None | 30 | Inhibitor of complement pathway | 100% hemolysis at 0.77mM | Sheep | Coat protein derivative (human astrovirus type 1) | NA | NA | ||
| 20728940 | 2010 | PAICQRATATLGTVGSNTSGTTEIEACILL | CP1 | Free | Free | Linear | L | None | 30 | Inhibitor of complement pathway | 100% hemolysis at 0.77mM | Sheep | Coat protein derivative (human astrovirus type 1) | NA | NA | ||
| 20728940 | 2010 | PAIAQRATATLGTVGSNTSGTTEIEACILL | C04A | Free | Free | Linear | L | None | 30 | Inhibitor of complement pathway | 100% hemolysis at 0.77mM | Sheep | Coat protein derivative (human astrovirus type 1) | NA | NA | ||
| 20728940 | 2010 | PAICQRATATLGTVGSNTSGTTEIEAAILL | C27A | Free | Free | Linear | L | None | 30 | Inhibitor of complement pathway | 90% hemolysis at 0.77mM | Sheep | Coat protein derivative (human astrovirus type 1) | NA | NA | ||
| 20728940 | 2010 | PAICQRATATLGTVGSNTSGTTAIEACILL | E23A | Free | Free | Linear | L | None | 30 | Inhibitor of complement pathway | 80% hemolysis at 0.77mM | Sheep | Coat protein derivative (human astrovirus type 1) | Helix+Sheet+Loop | NA | ||
| 20728940 | 2010 | PAICQRATATLGTVGSNTSGTTEIAACILL | E25A | Free | Free | Linear | L | None | 30 | Inhibitor of complement pathway | 95% hemolysis at 0.77mM | Sheep | Coat protein derivative (human astrovirus type 1) | NA | NA | ||
| 20955730 | 2011 | RIKRFWPVVIRTVVAGYNLYRAIKKK | Pc-CATH1 | Free | Free | Linear | L | None | 26 | Antimicrobial | 3.6% hemolysis at 3.15μM | Human | Cathelicidin (ring necked pheasant Phasianus colchicus) | NA | NA | ||
| 20955730 | 2011 | RIKRFWPVVIRTVVAGYNLYRAIKKK | Pc-CATH1 | Free | Free | Linear | L | None | 26 | Antimicrobial | 6.3% hemolysis at 6.30μM | Human | Cathelicidin (ring necked pheasant Phasianus colchicus) | NA | NA | ||
| 20955730 | 2011 | RIKRFWPVVIRTVVAGYNLYRAIKKK | Pc-CATH1 | Free | Free | Linear | L | None | 26 | Antimicrobial | 9.1% hemolysis at 15.7μM | Human | Cathelicidin (ring necked pheasant Phasianus colchicus) | NA | NA | ||
| 20955730 | 2011 | RIKRFWPVVIRTVVAGYNLYRAIKKK | Pc-CATH1 | Free | Free | Linear | L | None | 26 | Antimicrobial | 13.2% hemolysis at 31.5μM | Human | Cathelicidin (ring necked pheasant Phasianus colchicus) | NA | NA | ||
| 15232222 | 2004 | VIPFVASVAAEMMHHVYCAASKRC | Brevinin-1Ed | Free | Free | Linear | L | None | 24 | Antimicrobial | 0.19% hemolysis at 10µg/ml | Human | Brevinin-1 family (skin of the Rana esculenta) | α-helical | NA | ||
| 15232222 | 2004 | FLPLLAGLAANFLPKIFCKITRKC | Brevinin-1E | Free | Free | Linear | L | None | 24 | Antimicrobial | 25.8% hemolysis at 10µg/ml | Human | Brevinin-1 family (skin of the Rana esculenta) | α-helical | NA | ||
| 15232222 | 2004 | VIPFVASVAAEMMQHVYCAASRKC | Brevinin-1Eb | Free | Free | Linear | L | None | 24 | Antimicrobial | 0.02% hemolysis at 10µg/ml | Human | Brevinin-1 family (skin of the Rana esculenta) | α-helical | NA | ||
| 15232222 | 2004 | VIPFVASVAAEMMHHVYCAASKRC | Brevinin-1Ed | Free | Free | Linear | L | None | 24 | Antimicrobial | 0.32% hemolysis at 100µg/ml | Human | Brevinin-1 family (skin of the Rana esculenta) | α-helical | NA | ||
| 15232222 | 2004 | FLPLLAGLAANFLPKIFCKITRKC | Brevinin-1E | Free | Free | Linear | L | None | 24 | Antimicrobial | 189.2% hemolysis at 100µg/ml | Human | Brevinin-1 family (skin of the Rana esculenta) | α-helical | NA | ||
| 15232222 | 2004 | VIPFVASVAAEMMQHVYCAASRKC | Brevinin-1Eb | Free | Free | Linear | L | None | 24 | Antimicrobial | 0.08% hemolysis at 100µg/ml | Human | Brevinin-1 family (skin of the Rana esculenta) | α-helical | NA | ||
| 15298176 | 2004 | GLFGVLAKVAAHVVPAIAEHF{ct:Amid} | Mac | Amidation | Free | Linear | L | None | 21 | Antibacterial | 100% hemolysis at 100µM | Rabbit | Maculatin 1.1 from dorsal glands of the tree frog Litoria genimaculata | α-helical | NA | ||
| 15298176 | 2004 | GLFGVLAKVAAHVVPAIAKHF{ct:Amid} | [K19]Mac | Amidation | Free | Linear | L | None | 21 | Antibacterial | 100% hemolysis at 100µM | Rabbit | Analog of Maculatin 1.1 (dorsal glands of the tree frog Litoria genimaculata) | α-helical | NA | ||
| 15298176 | 2004 | GLFGVLAKVAAKVVPAIAKHF{ct:Amid} | [K12,19]Mac | Amidation | Free | Linear | L | None | 21 | Antibacterial | 100% hemolysis at 100µM | Rabbit | Analog of Maculatin 1.1 (dorsal glands of the tree frog Litoria genimaculata) | α-helical | NA | ||
| 15298176 | 2004 | GLFGVLAKVAAHVVAAIAEHF{ct:Amid} | [A15]Mac | Amidation | Free | Linear | L | None | 21 | Antibacterial | 100% hemolysis at 100µM | Rabbit | Analog of Maculatin 1.1 (dorsal glands of the tree frog Litoria genimaculata) | α-helical | NA | ||
| 15328050 | 2004 | FWGALAKGALKLIPSLFSSFSKKD | Pin2 | Free | Free | Linear | L | None | 24 | Hemolytic | ~60% hemolysis at 25µM | Pig | Pandinin 2 (Pandinus imperator) | α-helical | NA | ||
| 15325526 | 2005 | FLPILAGLAAKLVPKVFCSITKKC | Brevinin-1AUa | Free | Free | Linear | L | None | 24 | Antimicrobial | HC50 =5µM | Human | Brevinin-1 from skin secretions of the Northern red-legged frog Rana aurora aurora | NA | NA | ||
| 15325526 | 2005 | FLPILAGLAANILPKVFCSITKKC | Brevinin-1AUb | Free | Free | Linear | L | None | 24 | Antimicrobial | HC50 =7µM | Human | Brevinin-1 from skin secretions of the Northern red-legged frog Rana aurora aurora | NA | NA | ||
| 15616319 | 2005 | QRSVSNAATRVCRTGRSRWRDVCRNFMRR | G8 | Free | Free | Linear | L | None | 29 | Antibiotic | >80% hemolysis 100µM | Rabbit | Granulysin-Derived Peptides | α-helical | NA | ||
| 15616319 | 2005 | GRSRWRDVCRNFMRRYQSRVIQGLV | G20 | Free | Free | Linear | L | None | 25 | Antibiotic | >80% hemolysis 100µM | Rabbit | Granulysin-Derived Peptides | α-helical | NA | ||
| 15629533 | 2005 | MAQDIISTIGDLVKWIIDTVNKFTKK{nt:Formylation} | Peptide f-26 | Free | Formylation | Linear | L | None | 26 | Antibiotic | ~90% hemolysis at 30µM | Guinea-pig | Analog of delta-lysin from staphylococcus aureus (synthetic peptide) | α-helical | NA | ||
| 15629533 | 2005 | MAQDIISTIGDLVKWIIDTVNKFTKK | Peptide n-26 | Free | Free | Linear | L | None | 26 | Hemolytic | ~95% hemolysis at 30µM | Guinea-pig | Analog of delta-lysin from staphylococcus aureus (synthetic peptide) | α-helical | NA | ||
| 15629533 | 2005 | AQDIISTIGDLVKWIIDTVNKFTKK | Peptide n-25 | Free | Free | Linear | L | None | 25 | Hemolytic | >75% hemolysis at 30µM | Guinea-pig | Analog of delta-lysin from staphylococcus aureus (synthetic peptide) | α-helical | NA | ||
| 15629533 | 2005 | IISTIGDLVKWIIDTVNKFTKK | Peptide n-22 | Free | Free | Linear | L | None | 22 | Hemolytic | 100% hemolysis at 5µM | Guinea-pig | Analog of delta-lysin from staphylococcus aureus (synthetic peptide) | α-helical | NA | ||
| 16137634 | 2005 | AGYLLGKINLKALAALAKKIL{ct:Amid} | Transportan 10 | Amidation | Free | Linear | L | None | 21 | CPP | 29.0±4.9% hemolysis at 50µM | Bovine | Galanin and Mastoparan fragments | NA | NA | ||
| 16460023 | 2006 | VSAVAKVAMKKGAALLKKMGVKISPLK | P1 | Free | Free | Linear | L | None | 27 | Hemolytic | 50% hemolysis at >900µM | Human | Peptides derived from Trialysin protein found in the saliva of Triatoma infestans | NA | NA | ||
| 16460023 | 2006 | KQLKKVSAVAKVAMKKGAALLKKMGVK | P2 | Free | Free | Linear | L | None | 27 | Hemolytic | 50% hemolysis at 450µM | Human | Peptides derived from Trialysin protein found in the saliva of Triatoma infestans | NA | NA | ||
| 16460023 | 2006 | VGKVLKQLKKVSAVAKVAMKKGAALLK | P3 | Free | Free | Linear | L | None | 27 | Hemolytic | 50% hemolysis at >900µM | Human | Peptides derived from Trialysin protein found in the saliva of Triatoma infestans | NA | NA | ||
| 16460023 | 2006 | KFGKIVGKVLKQLKKVSAVAKVAMKKG | P4 | Free | Free | Linear | L | None | 27 | Hemolytic | 50% hemolysis at 274µM | Human | Peptides derived from Trialysin protein found in the saliva of Triatoma infestans | NA | NA | ||
| 16460023 | 2006 | GKVLDKFGKIVGKVLKQLKKVSAVAKV | P5 | Free | Free | Linear | L | None | 27 | Hemolytic | 50% hemolysis at 117µM | Human | Peptides derived from Trialysin protein found in the saliva of Triatoma infestans | NA | NA | ||
| 16460023 | 2006 | FKIKPGKVLDKFGKIVGKVLKQLKKVS | P7 | Free | Free | Linear | L | None | 27 | Hemolytic | 50% hemolysis at 296µM | Human | Peptides derived from Trialysin protein found in the saliva of Triatoma infestans | NA | NA | ||
| 16621155 | 2006 | GLFGKILGVGKKVLCGLSGMC | Nigrocin-2GRb | Free | Free | Linear | L | None | 21 | Antimicrobial | LC50 = 40µM | Human | Nigrocin isolated from an extract of the skin of the Yunnanfu Kunming frog Rana grahami | NA | NA | ||
| 16621155 | 2006 | GLLSGILGAGKHIVCGLSGLC | Nigrocin-2GRa | Free | Free | Linear | L | None | 21 | Antimicrobial | LC50 = 295µM | Human | Nigrocin isolated from an extract of the skin of the Yunnanfu Kunming frog Rana grahami | NA | NA | ||
| 16621155 | 2006 | GLLSGILGAGKNIVCGLSGLC | Nigrocin-2GRc | Free | Free | Linear | L | None | 21 | Antimicrobial | LC50 = 500µM | Human | Nigrocin isolated from an extract of the skin of the Yunnanfu Kunming frog Rana grahami | NA | NA | ||
| 16848415 | 2006 | GIGAVLKVLTTGLPALISWIKRKRQQ | M0 | Free | Free | Linear | L | None | 26 | Hemolytic | HL50 = 1.5 μM at pH 7.4 | Mouse | Analog of Melittin | NA | NA | ||
| 16848415 | 2006 | GIGAVLKVLTTGLPALISWIKRKRQQ | M0 | Free | Free | Linear | L | None | 26 | Hemolytic | HL50 = 6 μM at pH 4.5 | Mouse | Analog of Melittin | NA | NA | ||
| 16848415 | 2006 | CIGAVLKVLTTGLPALISWIKRKRQQC | M1 | Free | Free | Linear | L | None | 27 | Hemolytic | HL50 = 3.0 at pH 7.4 | Mouse | Analog of Melittin | NA | NA | ||
| 16848415 | 2006 | CIGAVLKVLTTGLPALISWIKRKRQQC | M1 | Free | Free | Linear | L | None | 27 | Hemolytic | HL50 = 1 μM at pH 4.5 | Mouse | Analog of Melittin | NA | NA | ||
| 16848415 | 2006 | CKKIGAVLKVLTTGLPALISWIKRKRQQKKC | M6 | Free | Free | Linear | L | None | 30 | Hemolytic | HL50 = 2.5 μM at pH 7.4 | Mouse | Analog of Melittin | NA | NA | ||
| 16889633 | 2006 | KWKKLLKKLLKLLKKLLKKLKKLLK{ct:Amid} | M25 | Amidation | Free | Linear | L | None | 25 | Antimicrobial | ~80% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 16889633 | 2006 | KWKKLLKKLLKLPKKLLKKLKKLLK{ct:Amid} | M25P | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 11% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 16889633 | 2006 | KWKKLLKKLLKLLKKLLKKLK{ct:Amid} | M21 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 65% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 16889633 | 2006 | KWKKLLKKLLPLLKKLLKKLK{ct:Amid} | M21P | Amidation | Free | Linear | L | None | 21 | Antimicrobial | ~40% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 16889633 | 2006 | KWKKLLKKLLKLLKKLLKKLKKLLK{ct:Amid} | M25 | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 75% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 16889633 | 2006 | KWKKLLKKLLKLPKKLLKKLKKLLK{ct:Amid} | M25P | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 11% hemolysis at 100µM | Human | Synthetic peptide | NA | NA | ||
| 16889633 | 2006 | KWKKLLKKLLKLLKKLLKKLK{ct:Amid} | M21 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 65% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 16889633 | 2006 | KWKKLLKKLLPLLKKLLKKLK{ct:Amid} | M21P | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 21% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 17000029 | 2006 | FLPLAVSLAANFLPKLFCKITKKC | Brevinins-ALb | Free | Free | Linear | L | None | 24 | Antimicrobial | 96% hemolysis at 20 µg/ml | Rabbit | Brevinins derivative (Amolops loloensis) | NA | NA | ||
| 17065623 | 2006 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antifungal | 115.7 ±2.5% hemolysis at 100µM | Human | Melittin analog | NA | NA | ||
| 17065623 | 2006 | GIGAVLIVLTTGLPALISWIKRKRQQ | Mel.subK7I | Free | Free | Linear | L | None | 26 | Antifungal | 30.2±2.8% hemolysis at 100µM | Human | Melittin analog | NA | NA | ||
| 17067722 | 2006 | VKRALSALKPKNKRFIGGIISFFKRLFG | Pp 2b | Free | Free | Linear | L | None | 28 | Antibacterial | 63 HU/mg | Horse | Grammistins (Pogonoperca punctata) | NA | NA | ||
| 17547385 | 2007 | GKGL{nnr:Tic}{nnr:Oic}GR{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GR{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GR{nnr:Tic}{nnr:Oic}GKR{ct:Amid} | Peptide-2 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 29 | Antibiotic | 100% hemolysis at100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GKGL{nnr:Tic}{nnr:Oic}GR{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GR{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GR{nnr:Tic}{nnr:Oic}GKR{ct:Amid} | Peptide-2 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 29 | Antibiotic | 100% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GKGL{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GLR{ct:Amid} | Peptide-3 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 29 | Antibiotic | 100% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GKGL{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GLR{ct:Amid} | Peptide-3 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 29 | Antibiotic | 100% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GKGL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GKR{ct:Amid} | Peptide-4 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 29 | Antibiotic | 100% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GKGL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GKR{ct:Amid} | Peptide-4 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 29 | Antibiotic | 100% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GKGL{nnr:Tic}{nnr:Oic}FK{nnr:Tic}{nnr:Oic}KF{nnr:Tic}{nnr:Oic}FK{nnr:Tic}{nnr:Oic}KF{nnr:Tic}{nnr:Oic}FK{nnr:Tic}{nnr:Oic}FKR{ct:Amid} | Peptide-5 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 29 | Antibiotic | 100% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GKGL{nnr:Tic}{nnr:Oic}FK{nnr:Tic}{nnr:Oic}KF{nnr:Tic}{nnr:Oic}FK{nnr:Tic}{nnr:Oic}KF{nnr:Tic}{nnr:Oic}FK{nnr:Tic}{nnr:Oic}FKR{ct:Amid} | Peptide-5 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 29 | Antibiotic | 100% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GKGL{nnr:Tic}{nnr:Oic}GR{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GR{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}ELMNS{ct:Amid} | Peptide-6 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 27 | Antibiotic | 70% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GKGL{nnr:Tic}{nnr:Oic}GR{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GR{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}ELMNS{ct:Amid} | Peptide-6 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 27 | Antibiotic | 70% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | ELMNS{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}ELMNS{ct:Amid} | Peptide-7 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 28 | Antibiotic | 3% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | ELMNS{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}ELMNS{ct:Amid} | Peptide-7 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 28 | Antibiotic | 3% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GKGL{nnr:Tic}{nnr:Oic}{nnr:βAla}K{nnr:Tic}{nnr:Oic}{nnr:βAla}F{nnr:Tic}{nnr:Oic}{nnr:βAla}K{nnr:Tic}{nnr:Oic}{nnr:βAla}F{nnr:Tic}{nnr:Oic}ELMNS{ct:Amid} | Peptide-20 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid, βAla = β-alanine{nnr:Bala} – β-Alanine | 27 | Antibiotic | 55% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | GKGL{nnr:Tic}{nnr:Oic}{nnr:βAla}K{nnr:Tic}{nnr:Oic}{nnr:βAla}F{nnr:Tic}{nnr:Oic}{nnr:βAla}K{nnr:Tic}{nnr:Oic}{nnr:βAla}F{nnr:Tic}{nnr:Oic}ELMNS{ct:Amid} | Peptide-20 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid, βAla = β-alanine{nnr:Bala} – β-Alanine | 27 | Antibiotic | 55% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | EGKGLG{nnr:βAla}{nnr:βAla}K{nnr:Tic}{nnr:Oic}{nnr:βAla}F{nnr:Tic}{nnr:Oic}{nnr:βAla}E{nnr:Tic}{nnr:Oic}{nnr:βAla}F{nnr:Tic}{nnr:Oic}ELMNS{ct:Amid} | Peptide-21 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid, βAla = β-alanine{nnr:Bala} – β-Alanine | 28 | Antibiotic | 27% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | EGKGLG{nnr:βAla}{nnr:βAla}K{nnr:Tic}{nnr:Oic}{nnr:βAla}F{nnr:Tic}{nnr:Oic}{nnr:βAla}E{nnr:Tic}{nnr:Oic}{nnr:βAla}F{nnr:Tic}{nnr:Oic}ELMNS{ct:Amid} | Peptide-21 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid, βAla = β-alanine{nnr:Bala} – β-Alanine | 28 | Antibiotic | 27% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | KL{nnr:Tic}{nnr:Oic}K{nnr:Tic}{nnr:Oic}F{nnr:Tic}{nnr:Oic}K{nnr:Tic}{nnr:Oic}F{nnr:Tic}{nnr:Oic}K{nnr:Tic}{nnr:Oic}KR{ct:Amid} | Peptide-22 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 21 | Antibiotic | 63% hemolysis at 100µM | Mouse | Synthetic peptide | NA | NA | ||
| 17547385 | 2007 | KL{nnr:Tic}{nnr:Oic}K{nnr:Tic}{nnr:Oic}F{nnr:Tic}{nnr:Oic}K{nnr:Tic}{nnr:Oic}F{nnr:Tic}{nnr:Oic}K{nnr:Tic}{nnr:Oic}KR{ct:Amid} | Peptide-22 | Amidation | Free | Linear | L | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid | 21 | Antibiotic | 63% hemolysis at 25µM | Mouse | Synthetic peptide | NA | NA | ||
| 17826814 | 2007 | ELAGTIIDGASLTFEVLDKVLGELGKVSRK | St I 2–31 | Free | Free | Linear | L | None | 30 | Hemolytic | Hemolytic activity expresssed as the initial rate (∆A/∆t, min- 1) i.e. at above 100 µM activity is less than 0.002 min-1 | Human | Sticholysin (Stichodactyla helianthus) | NA | NA | ||
| 17826814 | 2007 | ALAGTIIAGASLTFQVLDKVLEELGKVSRK | St II 1–30 | Free | Free | Linear | L | None | 30 | Hemolytic | Hemolytic activity expresssed as the initial rate (∆A/∆t, min- 1) i.e. at above 100 µM activity is above 0.010 min-1 | Human | Sticholysin (Stichodactyla helianthus) | NA | NA | ||
| 17927208 | 2007 | FHPSLWVLIPQYIQLIRKILKSG | Conolysin-Mt | Free | Free | Linear | L | None | 23 | Hemolytic | 40% hemolysis at 1 µM | Human | Conolysin-Mt (Conus mustelinus) | NA | NA | ||
| 17927208 | 2007 | FHPSLWVLIPQYIQLIRKILKSG | Conolysin-Mt | Free | Free | Linear | L | None | 23 | Hemolytic | 90% hemolysis at 10 µM | Human | Conolysin-Mt (Conus mustelinus) | NA | NA | ||
| 18052076 | 2007 | FFGWLIKGAIHAGKAIHGLIHRRRH | Chrysophsin | Free | Free | Linear | L | None | 25 | Antimicrobial | EC50 = 1 µM | Human | Chrysophsin-1 (Chrysophrys major) | NA | NA | ||
| 15196144 | 2004 | DSHEKRHHGYKRKFHEKHHSHRGY | Histatin-5 | Free | Free | Linear | L | None | 24 | Fungicidal | 0% hemolysis at 100µM (non-hemolytic) | Human | Histatin | NA | Non-hemolytic | ||
| 15304333 | 2004 | ACGILHDNCVYVPAQNPCCRGLQCRYGKCLVQV | Psalmopeotoxin I (PcFK1) | Free | Free | Linear | L | None | 28 | Antimalarial | No hemolysis at 10µM (non-hemolytic) | Human | Venom of the tarantula Psalmopoeus cambridgei | NA | Non-hemolytic | ||
| 15616319 | 2005 | QRSVSNAATRVSRTGRSRWRDVSRNFMRR | G9 | Free | Free | Linear | L | None | 29 | Antimicrobial | No hemolysis at 10µM (non-hemolytic) | Rabbit | Granulysin-Derived Peptides | NA | Non-hemolytic | ||
| 16460028 | 2006 | GASLSFKILKTVLEALGNVKRK | EqTII11-32 | Free | Free | Linear | L | None | 22 | Antimicrobial | Non-hemolytic | Human | Actinoporin (Actinia equina L) | NA | Non-hemolytic | ||
| 16730859 | 2006 | VTLASHLPSDFTPAVHASLDKFLANVSTVL | a107–136 | Free | Free | Linear | L | None | 30 | Antibacterial | Non-hemolytic | Bovine | Bovine hemoglobin | NA | Non-hemolytic | ||
| 16963159 | 2006 | GLWSTIKNVGKEAAIAAGKAALGAL{ct:Amid} | DPh-1 | Amidation | Free | Linear | L | None | 25 | Antimicrobial | No hemolysis at 6µM (non-hemolytic) | Human | Dermaseptins (Phyllomedusa hypochondrialis) | NA | Non-hemolytic | ||
| 17888907 | 2008 | VFQFLGKIIHHVGNFVHGFSHVF | Clavanin-A | Free | Free | Linear | L | None | 23 | Antimicrobial | 20% hemolysis 100 µM | Human | Synthetic peptide | NA | NA | ||
| 17888907 | 2008 | GIGKFLKKAKKFGKAFVKMKK{ct:Amid} | MSI-94 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 45-50% hemolysis 100 µM | Human | Synthetic peptide | NA | NA | ||
| 11242518 | 2001 | AVGIGALFLGFLGAAGSTMGARS{ct:Amid} | FP-1 | Amidation | Free | Linear | L | None | 23 | Hemolytic | 50% hemolysis at 40 µM | Human | Synthetic peptides derived from the gp41 domain | NA | NA | ||
| 11242518 | 2001 | AVGIGALFLGFLGAAGSTMGARS{ct:Amid} | FP-1 | Amidation | Free | Linear | L | None | 23 | Hemolytic | 90% hemolysis at 100 µM | Human | Synthetic peptides derived from the gp41 domain | NA | NA | ||
| 11242518 | 2001 | AAGLAMLFLGILSAAGSTMGARA{ct:Amid} | FP-IVAU | Amidation | Free | Linear | L | None | 23 | Hemolytic | 50-55% hemolysis at 40 µM | Human | Synthetic peptides derived from the gp41 domain | NA | NA | ||
| 11242518 | 2001 | AAGLAMLFLGILSAAGSTMGARA{ct:Amid} | FP-IVAU | Amidation | Free | Linear | L | None | 23 | Hemolytic | 55-60% hemolysis at 80 µM | Human | Synthetic peptides derived from the gp41 domain | NA | NA | ||
| 11532323 | 2001 | WEAKLAKALAKALAKHLAKALAKALKACEA | KALA | Free | Free | Linear | L | None | 30 | Cytotoxic | 65-70% hemolysis at 10 µg/ml | Human | Synthetic peptide | NA | NA | ||
| 11532323 | 2001 | WEAKLAKALAKALAKHLAKALAKALKACEA | KALA | Free | Free | Linear | L | None | 30 | Cytotoxic | 80-85% hemolysis at 100 µg/ml | Human | Synthetic peptide | NA | NA | ||
| 11532323 | 2001 | WEAKLAKALAKALAKHLAKALAKALKACEA | PEG-KALA | Free | Free | Linear | L | None | 30 | Hemolytic | 50-60% hemolysis at 10 µg/ml | Human | Synthetic peptide | NA | NA | ||
| 11532323 | 2001 | WEAKLAKALAKALAKHLAKALAKALKACEA | PEG-KALA | Free | Free | Linear | L | None | 30 | Hemolytic | 90-95% hemolysis at 100 µg/ml | Human | Synthetic peptide | NA | NA | ||
| 15003829 | 2004 | GLMDVFKGAAKNLLASALDKIRCKVTKC | Ranatuerin-2PRa | Free | Free | Linear | L | None | 28 | Antimicrobial | HC50 = 150µM | Human | Rana pirica (brevinin-2) | NA | NA | ||
| 21928440 | 2011 | CGETCVGGTCNTPGCTCSWPVCTRNGLPV{cyc:N-C} | Kalata B1 | Free | Free | Cyclic | L | None | 29 | Anticancer and Anti-HIV | IC50 = 26 µM | Human | Kalata (Oldenlandia affinis) | NA | NA | ||
| 21928440 | 2011 | C{d}G{d}E{d}T{d}C{d}V{d}G{d}G{d}T{d}C{d}N{d}T{d}P{d}G{d}C{d}T{d}C{d}S{d}W{d}P{d}V{d}C{d}T{d}R{d}N{d}G{d}L{d}N{d}P{d}V{d}{cyc:N-C} | D-Kalata B1 | Free | Free | Cyclic | D | None | 29 | Anticancer and Anti-HIV | IC50 = 77 µM | Human | Kalata analog (Oldenlandia affinis) | NA | NA | ||
| 22123629 | 2012 | GFGSFLGKALKAGLKLGANLLGGAPQQ | CPF-PG1 | Free | Free | Linear | L | None | 27 | Antimicrobial | LC50 = 145 µM | Human | Skin secretions of the tetraploid frogs Xenopus pygmaeus | NA | NA | ||
| 10817697 | 2000 | DSHAKRHHGYKRKFHEKHHSHRGY{ct:Amid} | Hsn-5 | Amidation | Free | Linear | L | None | 24 | Antifungal | <10% hemolysis at 200µM | Human | Human salivary histatin-5 (Hsn-5) | NA | NA | ||
| 10817697 | 2000 | DSHAKRHHGYKIKFHENHHSHRGY{ct:Amid} | R12I/K17N | Amidation | Free | Linear | L | None | 24 | Antifungal | <10% hemolysis at 200µM | Human | Histatin-6 variants | NA | NA | ||
| 10817697 | 2000 | DSHAKRHHGYKIKFHEKHHSLRGY{ct:Amid} | R12I/H21L | Amidation | Free | Linear | L | None | 24 | Antifungal | <10% hemolysis at 200µM | Human | Histatin-7 variants | NA | NA | ||
| 20798581 | 2010 | GWGSFFKKAAHVGKHVGKAALTHYL{ct:Amid} | Ple | Amidation | Free | Linear | L | None | 25 | Antifungal | 7% hemolysis at 100µM | Human | Pleurocidin (Pleuronectes americanus) | NA | NA | ||
| 20798581 | 2010 | SFFKKAAHVGKHVGKAALTHYL{ct:Amid} | Ple (4-25) | Amidation | Free | Linear | L | None | 22 | Antifungal | 0% hemolysis at 100µM (non-hemolytic) | Human | Pleurocidin analogs (Pleuronectes americanus) | NA | Non-hemolytic | ||
| 20798581 | 2010 | GWGSFFKKAAHVGKHVGKAALT{ct:Amid} | Ple (1-22) | Amidation | Free | Linear | L | None | 22 | Antifungal | 0% hemolysis at 100µM (non-hemolytic) | Human | Pleurocidin analogs (Pleuronectes americanus) | NA | Non-hemolytic | ||
| 23430306 | 2013 | LRRLWLRANRLLRRLWLRANRL | LRR-2 | Free | Free | Linear | L | None | 22 | Antibacterial | ~70% hemolysis at 128µM | Human | Synthetic peptide | NA | NA | ||
| 23594231 | 2013 | RKCNFLCKLKEKLRTVITSHIDKVLRPQG | Cathelicidin-PY | Free | Free | Linear | L | None | 29 | Antimicrobial | 2.5% hemolysis at 12.5µg/ml | Human | Cathelicidin-PY from the skin secretions of the frog Paa yunnanensis | NA | NA | ||
| 23594231 | 2013 | RKCNFLCKLKEKLRTVITSHIDKVLRPQG | Cathelicidin-PY | Free | Free | Linear | L | None | 29 | Antimicrobial | 3.5% hemolysis at 25µg/ml | Human | Cathelicidin-PY from the skin secretions of the frog Paa yunnanensis | NA | NA | ||
| 23594231 | 2013 | RKCNFLCKLKEKLRTVITSHIDKVLRPQG | Cathelicidin-PY | Free | Free | Linear | L | None | 29 | Antimicrobial | 5.5% hemolysis at 50µg/ml | Human | Cathelicidin-PY from the skin secretions of the frog Paa yunnanensis | NA | NA | ||
| 16730966 | 2006 | QPTRRPRPGTGPGRRPRPRPRP | QPT22 | Free | Free | Linear | L | None | 22 | Antimicrobial | ~4% hemolysis at 60µM | Human | Synthetic peptide | NA | NA | ||
| 22497805 | 2012 | IKLSPETKDNLKKVLKGAIKGAIAVAKMV{ct:Amid} | Hymenochirin-1B | Amidation | Free | Linear | L | None | 29 | Antimicrobial | LC50 = 225µM | Human | Hymenochirins from norepinephrine-stimulated skin secretions Hymenochirus boettgeri | NA | NA | ||
| 22497805 | 2012 | LKIPGFVKDTLKKVAKGIFSAVAGAMTPS | Hymenochirin-2B | Free | Free | Linear | L | None | 29 | Antimicrobial | LC50 > 300µM | Human | Hymenochirins from norepinephrine-stimulated skin secretions Hymenochirus boettgeri | NA | NA | ||
| 22497805 | 2012 | IKIPAVVKDTLKKVAKGVLSAVAGALTQ | Hymenochirin-3B | Free | Free | Linear | L | None | 28 | Antimicrobial | LC50 > 300µM | Human | Hymenochirins from norepinephrine-stimulated skin secretions Hymenochirus boettgeri | NA | NA | ||
| 22497805 | 2012 | IKIPAFVKDTLKKVAKGVISAVAGALTQ | Hymenochirin-4B | Free | Free | Linear | L | None | 28 | Antimicrobial | LC50 = 160µM | Human | Hymenochirins from norepinephrine-stimulated skin secretions Hymenochirus boettgeri | NA | NA | ||
| 22497805 | 2012 | IKIPPIVKDTLKKVAKGVLSTIAGALST | Hymenochirin-5B | Free | Free | Linear | L | None | 28 | Antimicrobial | Non-hemolytic | Human | Hymenochirins from norepinephrine-stimulated skin secretions Hymenochirus boettgeri | NA | Non-hemolytic | ||
| 11168895 | 2000 | GWGSFFKKAAHVGKHVGKAALTHYL | Pleurocidin | Free | Free | Linear | L | None | 25 | Antibacterial | 6% hemolysis at 100µM | Rabbit | Pleurocidin isolated from the skin mucous secretions of the winter flounder(Pleuronectes americanus) | NA | NA | ||
| 11168895 | 2000 | GWGSFFKKAAHVGKHVGKAALTHYL | Pleurocidin | Free | Free | Linear | L | None | 25 | Antibacterial | 15% hemolysis at 100µM | Human | Pleurocidin isolated from the skin mucous secretions of the winter flounder(Pleuronectes americanus) | NA | NA | ||
| 11168895 | 2000 | AWASFFKKAAHVGKHVGKAALTHYL | [A1,3]Ple | Free | Free | Linear | L | None | 25 | Antibacterial | 4% hemolysis at 100µM | Rabbit | Pleurocidin analogs (Pleuronectes americanus) | NA | NA | ||
| 11168895 | 2000 | AWASFFKKAAHVGKHVGKAALTHYL | [A1,3]Ple | Free | Free | Linear | L | None | 25 | Antibacterial | 8% hemolysis at 100µM | Human | Pleurocidin analogs (Pleuronectes americanus) | NA | NA | ||
| 11168895 | 2000 | GWGSFFKKAAHVAKHVAKAALTHYL | [A13,17]Ple | Free | Free | Linear | L | None | 25 | Antibacterial | 50% hemolysis at 100µM | Rabbit | Pleurocidin analogs (Pleuronectes americanus) | NA | NA | ||
| 11168895 | 2000 | GWGSFFKKAAHVAKHVAKAALTHYL | [A13,17]Ple | Free | Free | Linear | L | None | 25 | Antibacterial | 93% hemolysis at 100µM | Human | Pleurocidin analogs (Pleuronectes americanus) | NA | NA | ||
| 11168895 | 2000 | AWASFFKKAAHVAKHVAKAALTHYL | [A1,3,13,17]Ple | Free | Free | Linear | L | None | 25 | Antibacterial | 45% hemolysis at 100µM | Rabbit | Pleurocidin analogs (Pleuronectes americanus) | NA | NA | ||
| 11168895 | 2000 | AWASFFKKAAHVAKHVAKAALTHYL | [A1,3,13,17]Ple | Free | Free | Linear | L | None | 25 | Antibacterial | 90% hemolysis at 100µM | Human | Pleurocidin analogs (Pleuronectes americanus) | NA | NA | ||
| 11168895 | 2000 | GWGSFFKKAAAVGKAVGKAALTAYL | [A11,15,23]Ple | Free | Free | Linear | L | None | 25 | Antibacterial | 15% hemolysis at 100µM | Rabbit | Pleurocidin analogs (Pleuronectes americanus) | NA | NA | ||
| 11168895 | 2000 | GWGSFFKKAAAVGKAVGKAALTAYL | [A11,15,23]Ple | Free | Free | Linear | L | None | 25 | Antibacterial | 45% hemolysis at 100µM | Human | Pleurocidin analogs (Pleuronectes americanus) | NA | NA | ||
| 11226440 | 2001 | VLSAADKGNVKAAWGKVGGHAAE | α 1-23 peptide | Free | Free | Linear | L | None | 23 | Antibacterial | 0% hemolysis upto 2.013 mM (non-hemolytic) | Bovine | Peptic bovine hemoglobin hydrolysate | NA | Non-hemolytic | ||
| 11279030 | 2001 | WLGSALKIGAKLLPSVVGLFKKKKQ | Ponericin-W1 | Free | Free | Linear | L | None | 25 | Antimicrobial and Insecticidal | zone of inhibition (2 mm) at 0.4-0.5mM | Horse | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | WLGSALKIGAKLLPSVVGLFKKKKQ | Ponericin-W1 | Free | Free | Linear | L | None | 25 | Antimicrobial and Insecticidal | zone of inhibition (1 mm) at 0.4-0.5mM | Sheep | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | GIWGTLAKIGIKAVPRVISMLKKKKQ | Ponericin-W3 | Free | Free | Linear | L | None | 26 | Antimicrobial and Insecticidal | zone of inhibition (1 mm) at 0.4-0.5mM | Horse | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | GIWGTLAKIGIKAVPRVISMLKKKKQ | Ponericin-W3 | Free | Free | Linear | L | None | 26 | Antimicrobial and Insecticidal | zone of inhibition not detected at 0.4-0.5mM | Sheep | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | GIWGTALKWGVKLLPKLVGMAQTKKQ | Ponericin-W4 | Free | Free | Linear | L | None | 26 | Antimicrobial and Insecticidal | zone of inhibition (2 mm) at 0.4-0.5mM | Horse | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | GIWGTALKWGVKLLPKLVGMAQTKKQ | Ponericin-W4 | Free | Free | Linear | L | None | 26 | Antimicrobial and Insecticidal | zone of inhibition not detected at 0.4-0.5mM | Sheep | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | FWGALIKGAAKLIPSVVGLFKKKQ | Ponericin-W5 | Free | Free | Linear | L | None | 24 | Antimicrobial and Insecticidal | zone of inhibition (4 mm) at 0.4-0.5mM | Horse | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | FWGALIKGAAKLIPSVVGLFKKKQ | Ponericin-W5 | Free | Free | Linear | L | None | 24 | Antimicrobial and Insecticidal | zone of inhibition (1.5 mm) at 0.4-0.5mM | Sheep | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | GWKDWAKKAGGWLKKKGPGMAKAALKAAMQ | Ponericin-G1 | Free | Free | Linear | L | None | 30 | Antimicrobial and Insecticidal | zone of inhibition not detected at 0.4-0.5mM | Horse | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | GWKDWAKKAGGWLKKKGPGMAKAALKAAMQ | Ponericin-G1 | Free | Free | Linear | L | None | 30 | Antimicrobial and Insecticidal | zone of inhibition not detected at 0.4-0.5mM | Sheep | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | GWKDWLNKGKEWLKKKGPGIMKAALKAATQ | Ponericin-G3 | Free | Free | Linear | L | None | 30 | Antimicrobial and Insecticidal | zone of inhibition not detected at 0.4-0.5mM | Horse | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | GWKDWLNKGKEWLKKKGPGIMKAALKAATQ | Ponericin-G3 | Free | Free | Linear | L | None | 30 | Antimicrobial and Insecticidal | zone of inhibition not detected at 0.4-0.5mM | Sheep | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | DFKDWMKTAGEWLKKKGPGILKAAMAAAT | Ponericin-G4 | Free | Free | Linear | L | None | 29 | Antimicrobial and Insecticidal | zone of inhibition not detected at 0.4-0.5mM | Horse | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | DFKDWMKTAGEWLKKKGPGILKAAMAAAT | Ponericin-G4 | Free | Free | Linear | L | None | 29 | Antimicrobial and Insecticidal | zone of inhibition not detected at 0.4-0.5mM | Sheep | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | LLKELWTKIKGAGKAVLGKIKGLL{ct:Amid} | Ponericin-L2 | Amidation | Free | Linear | L | None | 24 | Antimicrobial and Insecticidal | zone of inhibition not detected at 0.4-0.5mM | Horse | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | LLKELWTKIKGAGKAVLGKIKGLL{ct:Amid} | Ponericin-L2 | Amidation | Free | Linear | L | None | 24 | Antimicrobial and Insecticidal | zone of inhibition not detected at 0.4-0.5mM | Sheep | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11892852 | 2001 | FLPLLAGLAANFLPKIFCKITRKC{cyc:N-C} | Brevinin 1E (B) | Free | Free | Cyclic | L | None | 24 | Antibacterial | 100% hemolysis at 0.7μM | Rat | Brevinin 1E from the skin secretions of Rana esculenta | NA | NA | ||
| 11892852 | 2001 | FLPLLAGLAANFLPKIFC-{nnr:Acm}-KITRKC-{nnr:Acm} | Brevinin1E linear (BL) | Free | Free | Linear | L | Acm = acetamidomethyl | 26 | Antibacterial | 100% hemolysis at 5μM | Rat | Synthetic brevinin 1E variants (Rana esculenta) | NA | NA | ||
| 11892852 | 2001 | FLPLLAGLCKITRKCAANFLPKIF{cyc:N-C} | Analog of brevinin 1E (BA) | Free | Free | Cyclic | L | None | 24 | Antibacterial | 100% hemolysis at 7μM | Rat | Synthetic brevinin 1E variants (Rana esculenta) | NA | NA | ||
| 11892852 | 2001 | FLPLLAGLC-{nnr:Acm}-KITRKC-{nnr:Acm}-AANFLPKIF | Linear analog of brevinin 1E (BAL) | Free | Free | Linear | L | Acm = acetamidomethyl | 26 | Antibacterial | Non-hemolytic | Rat | Synthetic brevinin 1E variants (Rana esculenta) | NA | Non-hemolytic | ||
| 11976325 | 2002 | FWGALAKGALKLIPSLFSSFSKKD | Pandinin 2 | Free | Free | Linear | L | None | 24 | Antimicrobial and Insecticidal | ~100% hemolysis at 50μM | Pig | Pandinins (Extracted from the venom of the scorpion Pandinus imperator) | NA | NA | ||
| 11976325 | 2002 | FWGALAKGALKLIPSLFSSFSKKD | Pandinin 2 | Free | Free | Linear | L | None | 24 | Antimicrobial and Insecticidal | ~100% hemolysis at 50μM | Guinea-pig | Pandinins (Extracted from the venom of the scorpion Pandinus imperator) | NA | NA | ||
| 11976325 | 2002 | FWGALAKGALKLIPSLFSSFSKKD | Pandinin 2 | Free | Free | Linear | L | None | 24 | Antimicrobial and Insecticidal | ~100% hemolysis at 50μM | Sheep | Pandinins (Extracted from the venom of the scorpion Pandinus imperator) | NA | NA | ||
| 12297012 | 2002 | GSKKPVPIIYCNRRTGKCQRM | Thanatin | Free | Free | Linear | L | None | 21 | Antibacterial | 0% hemolysis at 20.8µM (non-hemolytic) | Human | Thanatin (Podisus maculiventris) | NA | Non-hemolytic | ||
| 12297012 | 2002 | GSKKPVPIIYCNRRATGKCQRM | Th4 | Free | Free | Linear | L | None | 22 | Antibacterial | 0% hemolysis at 20.8µM (non-hemolytic) | Human | Thanatin analogs (Podisus maculiventris) | NA | Non-hemolytic | ||
| 12297012 | 2002 | GSKKPVPIIYCNRRAATGKCQRM | Th5 | Free | Free | Linear | L | None | 23 | Antibacterial | 0% hemolysis at 20.8µM (non-hemolytic) | Human | Thanatin analogs (Podisus maculiventris) | NA | Non-hemolytic | ||
| 12297012 | 2002 | GSKKPVPIIYANRRTGKAQRM | Th6 | Free | Free | Linear | L | None | 21 | Antibacterial | 0% hemolysis at 20.8µM (non-hemolytic) | Human | Thanatin analogs (Podisus maculiventris) | NA | Non-hemolytic | ||
| 12384369 | 2002 | KKAAAFAAAAAFAAWAAFAAAKKKK{ct:Amid} | F25 | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 4% hemolysis at 200µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKAAAFAAAAAFAAWAAFAAAKKKK{ct:Amid} | F25 | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 0% hemolysis at 50µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKAAAFAAAAAFAAWAAFAAAKKKK{ct:Amid} | F25 | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 1% hemolysis at 200µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKAAAFAAAAAFAAWAAFAAAKKKK{ct:Amid} | F25 | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 0% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAAFAAAAAFAAWAAFAAA{ct:Amid} | F25-6K | Amidation | Free | Linear | L | None | 25 | Antimicrobial | Not detected hemolysis at 200µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAAFAAAAAFAAWAAFAAA{ct:Amid} | F25-6K | Amidation | Free | Linear | L | None | 25 | Antimicrobial | Not detected hemolysis at 50µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAAFAAAAAFAAWAAFAAA{ct:Amid} | F25-6K | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 17% hemolysis at 200µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKKKKKAAAFAAAAAFAAWAAFAAA{ct:Amid} | F25-6K | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 11% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKAAAAF{d}AAF{d}AAW{d}F{d}AAF{d}AAAAKKKK{ct:Amid} | 4F | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 34% hemolysis at 200µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKAAAAFAAFAAWFAAFAAAAKKKK{ct:Amid} | 4F | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 14% hemolysis at 50µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKAAAAFAAFAAWFAAFAAAAKKKK{ct:Amid} | 4F | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 42% hemolysis at 200µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKAAAAFAAFAAWFAAFAAAAKKKK{ct:Amid} | 4F | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 17% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKAFAAAAAFAAWAAFAKKKK{ct:Amid} | F21 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 3% hemolysis at 200µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKAFAAAAAFAAWAAFAKKKK{ct:Amid} | F21 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 1% hemolysis at 50µM | Rabbit | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKAFAAAAAFAAWAAFAKKKK{ct:Amid} | F21 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 0% hemolysis at 200µM | Human | Synthetic peptide | NA | NA | ||
| 12384369 | 2002 | KKAFAAAAAFAAWAAFAKKKK{ct:Amid} | F21 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 0% hemolysis at 50µM | Human | Synthetic peptide | NA | NA | ||
| 12581207 | 2003 | FFGWLIKGAIHAGKAIHGLIHRRRH{ct:Amid} | Chrysophsin-1 | Amidation | Free | Linear | L | None | 25 | Antibacterial | 100% hemolysis at 1μM | Human | Synthetic peptide | NA | NA | ||
| 12581207 | 2003 | FFGWLIRGAIHAGKAIHGLIHRRRH{ct:Amid} | Chrysophsin-2 | Amidation | Free | Linear | L | None | 25 | Antibacterial | 100% hemolysis at 1 μM | Human | Synthetic peptide | NA | NA | ||
| 12963031 | 2003 | HVDKKVADKVLLLKQLRIMRLLTRL | Spinigerin | Free | Free | Linear | L | None | 25 | Antibacterial | 0% hemolysis at 100µM (non-hemolytic) | Human | Spinigerin isolated from the fungus-growing termite Pseudacanthotermes spiniger | NA | Non-hemolytic | ||
| 14531844 | 2003 | FLPILASLAAKFGPKLFCLVTKKC | Brevinin-1BYa | Free | Free | Linear | L | None | 24 | Antibacterial | HC50 = 4µM | Human | Brevinin-1B analog | NA | NA | ||
| 14531844 | 2003 | FLPILASLAAKLGPKLFCLVTKKC | Brevinin-1BYb | Free | Free | Linear | L | None | 24 | Antibacterial | HC50 = 4µM | Human | Brevinin-1B analog | NA | NA | ||
| 14531844 | 2003 | FLPILASLAATLGPKLLCLITKKC | Brevinin-1BYc | Free | Free | Linear | L | None | 24 | Antibacterial | Non-hemolytic | Human | Brevinin-1B analog(Rana boylii) | α-helix | Non-hemolytic | ||
| 14531844 | 2003 | GIMDSVKGLAKNLAGKLLDSLKCKITGC | Ranatuerin-2BYb | Free | Free | Linear | L | None | 28 | Antibacterial | HC50 >200µM | Human | Ranatuerin-2B analog | NA | NA | ||
| 14637016 | 2003 | FWGALAKGALKLIPSLFSSFSKKD | Pin2 | Free | Free | Linear | L | None | 24 | Antimicrobial | >80% hemolysis at 50μM | Sheep | Pandinins analog (Pandinus imperator) | NA | NA | ||
| 14637016 | 2003 | FWGALAKGALKLIPSLFSSFSKKD | Pin2 | Free | Free | Linear | L | None | 24 | Antimicrobial | 100% hemolysis at 50μM | Pig | Pandinins analog (Pandinus imperator) | NA | NA | ||
| 14637016 | 2003 | FWGALAKGALKLIPSLFSSFSKKD | Pin2 | Free | Free | Linear | L | None | 24 | Antimicrobial | 100% hemolysis at 50μM | Guinea-pig | Pandinins analog (Pandinus imperator) | NA | NA | ||
| 14596922 | 2003 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antibacterial | HC10 = 1.78 μg/ml | Human | Melittin | NA | NA | ||
| 15581850 | 2004 | SIGSALKKALPVAKKIGKIALPIAKAALP | CtxA1–29 | Free | Free | Linear | L | None | 29 | Antibacterial | Hemolytic at 960µM | Human | Ceratotoxins are α-helical cationic peptides isolated from the medfly Ceratitis capitata | NA | NA | ||
| 15546886 | 2005 | GCRFCCNCCPNMSGCGVCCRF | Bass Hepcidin | Free | Free | Linear | L | None | 21 | Antibacterial and Antifungal | 0% hemolysis at 100 µg/ml (non-hemolytic) | Rat | Bass hepcidin (Morone chrysops x Morone saxatilis) | NA | Non-hemolytic | ||
| 10795591 | 2000 | CYCRIPACIAGERRYGTCIYQGRLWAFCC | HNP-2 | Free | Free | Linear | L | None | 29 | Antimicrobial | 0.9% hemolysis at 80µg/ml | Human | Human neutrophils | NA | NA | ||
| 10795591 | 2000 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 94.6% hemolysis at 80µg/ml | Human | Bee venom | NA | NA | ||
| 10795591 | 2000 | GIGKFLHSAGKFGKAFVGEIMKS | Magainin 1 | Free | Free | Linear | L | None | 23 | Antimicrobial | 0% hemolysis at 80µg/ml | Human | Frog skin | NA | NA | ||
| 10795591 | 2000 | GIGKFLKKAKKFGKAFVKILKK | MSI-78 | Free | Free | Linear | L | None | 22 | Antimicrobial | 11.4% hemolysis at 80µg/ml | Human | Magainin-1 analog | NA | NA | ||
| 10795591 | 2000 | VFQFLGKIIHHVGNFVHGFSHVF{ct:Amid} | Clavanin A amide | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 3.7% hemolysis at 80µg/ml | Human | Tunicate hemocytes | NA | NA | ||
| 10795591 | 2000 | VFQFLGKIIHHVGNFVHGFSHVF | Clavanin A acid | Free | Free | Linear | L | None | 23 | Antimicrobial | 0% hemolysis at 80µg/ml | Human | Clavanin A analog | NA | NA | ||
| 10795591 | 2000 | VFQFLGKIIKKVGNFVKGFSKVF | Clavanin AK acid | Free | Free | Linear | L | None | 23 | Antimicrobial | 30.6% hemolysis at 80µg/ml | Human | Clavanin A analog | NA | NA | ||
| 10795591 | 2000 | FLPVLAGIAAKVVPALFCKITKKC | Brevinin-1 | Free | Free | Linear | L | None | 24 | Antimicrobial | 89% hemolysis at 80µg/ml | Human | Frog skin | NA | NA | ||
| 10795591 | 2000 | FLPVLAGIAAKVVPALFCKITKKC | CAM-brevinin | Free | Free | Linear | L | None | 24 | Antimicrobial | 0.5% hemolysis at 80µg/ml | Human | Brevinin-1analog | NA | NA | ||
| 10879468 | 2000 | KNWKGIAGMAKKLLGKNWKLM | Mast 21 | Free | Free | Linear | L | None | 21 | Antimicrobial | 5.4% hemolysis at 10µM | Human | Synthetic peptide | NA | NA | ||
| 10879468 | 2000 | KNWKGIAGMAKKLLGENWELM | Mast 21(+2) | Free | Free | Linear | L | None | 21 | Antimicrobial | 5.3% hemolysis at 10µM | Human | Synthetic peptide | NA | NA | ||
| 10879468 | 2000 | KNWKGIAGMAKKLLGENWKLM | Mast 21(+4) | Free | Free | Linear | L | None | 21 | Antimicrobial | 7.1% hemolysis at 10µM | Human | Synthetic peptide | NA | NA | ||
| 10879468 | 2000 | KNWKKIAGMAKKLLKKNWKLM | Mast 21(+8) | Free | Free | Linear | L | None | 21 | Antimicrobial | 6.3% hemolysis at 10µM | Human | Synthetic peptide | NA | NA | ||
| 10879468 | 2000 | KNWKGIAGMAKKLLGKNWELMEK | Mast 23(+4) | Free | Free | Linear | L | None | 23 | Antimicrobial | 6.3% hemolysis at 10µM | Human | Synthetic peptide | NA | NA | ||
| 10879468 | 2000 | KNWKGIAGMAKKLLGKNWELMKK | Mast 23(+6) | Free | Free | Linear | L | None | 23 | Antimicrobial | 7.2% hemolysis at 10µM | Human | Synthetic peptide | NA | NA | ||
| 10879468 | 2000 | KNWKGIAGMAKKLLGKNWKLMKK | Mast 23(+8) | Free | Free | Linear | L | None | 23 | Antimicrobial | 7.2% hemolysis at 10µM | Human | Synthetic peptide | NA | NA | ||
| 10879468 | 2000 | KNWKGIAGMAKKLLGKNWKLM{ct:Amid} | Mast 21N | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 12.3% hemolysis at 10µM | Human | Synthetic peptide | NA | NA | ||
| 10879468 | 2000 | GIGKFLHSAKKFGKAFVGEIMNS | Magainin 2 | Free | Free | Linear | L | None | 23 | Antimicrobial | 4.5% hemolysis at 10µM | Human | Synthetic peptide | NA | NA | ||
| 11779154 | 2002 | RIIDLLWRVRRPQKPKFVTVWVR | PMAP-23 | Free | Free | Linear | L | None | 23 | Antibacterial | 0% hemolysis at 100µM (non-hemolytic) | Human | Porcine myeloid antibacterial peptide | NA | Non-hemolytic | ||
| 12168695 | 2002 | GIGAVLKVLTTGLP{d}ALISWIKRKRQQ{ct:Amid} | Melittin-1 | Amidation | Free | Linear | Mix | None | 26 | Antibacterial | 50% hemolysis at >200µg/ml | Human | Melittin analogs | NA | NA | ||
| 12168695 | 2002 | GIGAVLKVLTTGLP{d}ALISWIKFKRQQ{ct:Amid} | Melittin-2 | Amidation | Free | Linear | Mix | None | 26 | Antibacterial | 50% hemolysis at >80µg/ml | Human | Melittin analogs | NA | NA | ||
| 12168695 | 2002 | GIGAVLKVLTTGLP{d}ALISWIKXXKRQQ{ct:Amid} | Melittin-1P | Amidation | Free | Linear | Mix | None | 27 | Antibacterial | 50% hemolysis at >18µg/ml | Human | Melittin analogs | NA | NA | ||
| 12168695 | 2002 | GIGAVLKVLTTGLP{d}ALISWIKXKRQQ{nt:Acet}{ct:Amid} | Melittin-A1P | Amidation | Acetylation | Linear | Mix | None | 26 | Antibacterial | 50% hemolysis at >200µg/ml | Human | Melittin analogs | NA | NA | ||
| 12168695 | 2002 | GIGAVLKVLTTGLP{d}ALISWIKRKRQQ{nt:Acet}{ct:Amid} | Melittin-A1 | Amidation | Acetylation | Linear | Mix | None | 26 | Antibacterial | 50% hemolysis at >200µg/ml | Human | Melittin analogs | NA | NA | ||
| 12429503 | 2002 | GLMDTVKNAAKNLAGQLLDTIKCKMTGC | Ranatuerin-2ARa | Free | Free | Linear | L | None | 28 | Antibacterial | HC50 = 100µM | Human | Ranatuerin-2 analog (Rana areolata) | NA | NA | ||
| 12429503 | 2002 | GILDTIKNAAKTVAVGLLEKIKCKMTGC | Ranatuerin-2ARb | Free | Free | Linear | L | None | 28 | Antibacterial | HC50 = 150µM | Human | Ranatuerin-2 analog (Rana areolata) | NA | NA | ||
| 12429503 | 2002 | GFISTVKNLATNVAGTVIDTIKCKVTGGC | Palustrin-2AR | Free | Free | Linear | L | None | 29 | Antibacterial | HC50 > 300µM | Human | Palustrin-2 analog (Rana areolata) | NA | NA | ||
| 10747913 | 2000 | CGETCVGGTCNTPGCTCSWPVCTRNGLPV{cyc:N-C} | Kalata B1 | Free | Free | Cyclic | L | None | 29 | Anti-HIV | 50% hemolytic at 50μM | Human | Macrocyclic peptides | NA | NA | ||
| 15222751 | 2004 | GLVTSLIKGAGKLLGGLFGSVTGGQS | DRP-PBN2 | Free | Free | Linear | L | None | 26 | Cytotoxic | 42% hemolytic at 50μM | Rat | Dermaseptins (Frog skin) | NA | NA | ||
| 15222751 | 2004 | GLVTSLIKGAGKLLGGLFGSVTGGQS | DRP-PBN2 | Free | Free | Linear | L | None | 26 | Cytotoxic | 75% hemolytic at 100μM | Rat | Dermaseptins (Frog skin) | NA | NA | ||
| 15222751 | 2004 | GVVTDLLNTAGGLLGNLVGSLSG{ct:Amid} | DRP-PD 3-6 | Amidation | Free | Linear | L | None | 23 | Cytotoxic | 43% hemolytic at 50μM | Rat | Dermaseptins (Frog skin) | NA | NA | ||
| 15222751 | 2004 | GVVTDLLNTAGGLLGNLVGSLSG{ct:Amid} | DRP-PD 3-6 | Amidation | Free | Linear | L | None | 23 | Cytotoxic | 65% hemolytic at 100μM | Rat | Dermaseptins (Frog skin) | NA | NA | ||
| 15222751 | 2004 | GLVTGLLKTAGKLLGDLFGSLSG{ct:Amid} | ANC [K8,12] - ANC | Amidation | Free | Linear | L | None | 23 | Cytotoxic | 22% hemolytic at 50μM | Rat | Dermaseptins (Frog skin) | NA | NA | ||
| 15222751 | 2004 | GLVTGLLKTAGKLLGDLFGSLSG{ct:Amid} | ANC [K8,12] - ANC | Amidation | Free | Linear | L | None | 23 | Cytotoxic | 48% hemolytic at 100μM | Rat | Dermaseptins (Frog skin) | NA | NA | ||
| 15222751 | 2004 | GVVTDLLKTAGKLLGNLVGSLSG{ct:Amid} | [K8,12] - DRP-PD 3-6 | Amidation | Free | Linear | L | None | 23 | Cytotoxic | 35% hemolytic at 50μM | Rat | Dermaseptins (Frog skin) | NA | NA | ||
| 15222751 | 2004 | GVVTDLLKTAGKLLGNLVGSLSG{ct:Amid} | [K8,12] – DRP-PD 3-6 | Amidation | Free | Linear | L | None | 23 | Cytotoxic | 71% hemolytic at 100μM | Rat | Dermaseptins (Frog skin) | NA | NA | ||
| 14965277 | 2004 | GWGSFFKKAAHVGKHVGKAALTHYL | Ple | Free | Free | Linear | L | None | 25 | Antimicrobial | 2.5% hemolytic at 100μM | Human | Pleurocidin | NA | NA | ||
| 14965277 | 2004 | GWGSFFKKAAHVAKHVGKAALTHYL | Ple-AG | Free | Free | Linear | L | None | 25 | Antimicrobial | 16.6% hemolytic at 100μM | Human | Pleurocidin | NA | NA | ||
| 14965277 | 2004 | GWGSFFKKAAHVGKHVAKAALTHYL | Ple-GA | Free | Free | Linear | L | None | 25 | Antimicrobial | 15.4% hemolytic at 100μM | Human | Pleurocidin | NA | NA | ||
| 14965277 | 2004 | GWGSFFKKAAHVAKHVAKAALTHYL | Ple-AA | Free | Free | Linear | L | None | 25 | Antimicrobial | 37.4% hemolytic at 100μM | Human | Pleurocidin | NA | NA | ||
| 12071741 | 2002 | GIGKFLHAAKKFAKAFVAEIMNS{ct:Amid} | Ala8,13,18-magainin II | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 100% hemolytic at 100μg/ml | Human | Magainin analog | NA | NA | ||
| 11738090 | 2001 | GFLGPLLKLAAKGVAKVIPHLIPSRQQ | XT-1 | Free | Free | Linear | L | None | 27 | Antimicrobial | HC50 = 90μM | Human | Isolated from norepinephrine-stimulated skin secretions of the diploid clawed frog, Xenopus tropicalis | NA | NA | ||
| 11738090 | 2001 | GVFLDALKKFAKGGMNAVLNPK | XT-4 | Free | Free | Linear | L | None | 22 | Antimicrobial | HC50 > 150μM | Human | Isolated from norepinephrine-stimulated skin secretions of the diploid clawed frog, Xenopus tropicalis | NA | NA | ||
| 11738090 | 2001 | GMATKAGTALGKVAKAVIGAAL{ct:Amid} | XT-5 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | HC50 > 150μM | Human | Isolated from norepinephrine-stimulated skin secretions of the diploid clawed frog, Xenopus tropicalis | NA | NA | ||
| 10879468 | 2000 | GIGKFLHSAKKFGKAFVGEIMNS | Magainin 2 | Free | Free | Linear | L | None | 23 | Antimicrobial and Hemolytic | 4.5% hemolytic at 10μM | Human | Magainin-2 (Xenopus laevis) | NA | NA | ||
| 10879468 | 2000 | KNWKGIAGMAKKLLGENWELM | Mast 21(+2) | Free | Free | Linear | L | None | 21 | Antimicrobial and Hemolytic | 5.3% hemolytic at 10μM | Human | Mastoparan X derived peptides | NA | NA | ||
| 10879468 | 2000 | KNWKGIAGMAKKLLGENWKLM | Mast 21(+4) | Free | Free | Linear | L | None | 21 | Antimicrobial and Hemolytic | 7.1% hemolytic at 10μM | Human | Mastoparan X derived peptides | NA | NA | ||
| 10879468 | 2000 | KNWKKIAGMAKKLLKKNWKLM | Mast 21(+8) | Free | Free | Linear | L | None | 21 | Antimicrobial and Hemolytic | 6.3% hemolytic at 10μM | Human | Mastoparan X derived peptides | NA | NA | ||
| 10879468 | 2000 | KNWKGIAGMAKKLLGKNWELMEK | Mast 23(+4) | Free | Free | Linear | L | None | 23 | Antimicrobial and Hemolytic | 6.3% hemolytic at 10μM | Human | Mastoparan X derived peptides | NA | NA | ||
| 10879468 | 2000 | KNWKGIAGMAKKLLGKNWELMKK | Mast 23(+6) | Free | Free | Linear | L | None | 23 | Antimicrobial and Hemolytic | 7.2% hemolytic at 10μM | Human | Mastoparan X derived peptides | NA | NA | ||
| 10879468 | 2000 | KNWKGIAGMAKKLLGKNWKLMKK | Mast 23(+8) | Free | Free | Linear | L | None | 23 | Antimicrobial and Hemolytic | 7.2% hemolytic at 10μM | Human | Mastoparan X derived peptides | NA | NA | ||
| 10879468 | 2000 | KNWKGIAGMAKKLLGKNWKLM{ct:Amid} | Mast 21N | Amidation | Free | Linear | L | None | 21 | Antimicrobial and Hemolytic | 12.3% hemolytic at 10μM | Human | Mastoparan X derived peptides | NA | NA | ||
| 10669014 | 1999 | LFGFLIKLIPSLFGALSNIGRNRNQ | Gs1 | Free | Free | Linear | L | None | 25 | Hemolytic and Ichthyotoxic | LC50 =1.9μM | Horse | Grammistins peptide (Grammistes sexlineatus) | NA | NA | ||
| 10669014 | 1999 | LFGFLIPLLPHIIGAIPQVIGAIR | Gs2 | Free | Free | Linear | L | None | 24 | Hemolytic and Ichthyotoxic | LC50 = 0.19μM | Horse | Grammistins peptide (Grammistes sexlineatus) | NA | NA | ||
| 18501981 | 2008 | GVIIDTLKGAAKTVAAELLRKAHCKLTNSC{ct:Amid} | Brevinin-2GUb | Amidation | Free | Linear | L | None | 30 | Cytolytic | LC50 = 700μM | Human | Insulin-releasing peptide (Hylarana guntheri) | NA | NA | ||
| 18325325 | 2008 | GWGSFFKKAAHVGKHVGKAALTHYL{ct:Amid} | Ple | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 77% hemolysis at 100μM | Human | Pleurocidin (Winter flounder) | NA | NA | ||
| 18325325 | 2008 | GWGSFFKKAAHVGKHVGKAALTHYL{ct:Amid} | Ple | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 29% hemolysis at 50μM | Human | Pleurocidin (Winter flounder) | NA | NA | ||
| 18325325 | 2008 | GWGSFFKKAAHVGKHVGKAALTHYL{ct:Amid} | Ple | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 6% hemolysis at 25μM | Human | Pleurocidin (Winter flounder) | NA | NA | ||
| 18325325 | 2008 | GWGSFFKKAAHVGKHVGKAALTHYL{ct:Amid} | Ple | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 0% hemolytic at 12.5μM | Human | Pleurocidin (Winter flounder) | NA | NA | ||
| 18325325 | 2008 | RWRSFFKKAAHRGKHVGKRARTHYL{ct:Amid} | Anal-R | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 0% hemolytic at 100μM (non-hemolytic) | Human | Pleurocidin (Winter flounder) | NA | Non-hemolytic | ||
| 18325325 | 2008 | SWSSFFKKAAHSGKHVGKSASTHYL{ct:Amid} | Anal-S | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 0% hemolytic at 100μM (non-hemolytic) | Human | Pleurocidin (Winter flounder) | NA | Non-hemolytic | ||
| 23519707 | 2013 | FSEAIKKIIDFLGEGLFDIIKKIAESF | E(AU)2 | Free | Free | Linear | L | None | 27 | Antimicrobial | ~5% hemolytic at 128μmol/L | Human | N-terminal dimer of aurein | NA | NA | ||
| 23519707 | 2013 | FSEAIKKIIDFLGEGLFDIIKKIAESF | E(AU)2 | Free | Free | Linear | L | None | 27 | Antimicrobial | 0% hemolytic at 4 -32μmol/L | Human | N-terminal dimer of aurein | NA | NA | ||
| 23519707 | 2013 | GLFDIIKKIAESFKFSEAIKKIIDFLG | (AU)2K | Free | Free | Linear | L | None | 27 | Antimicrobial | ~30% hemolytic at 32μmol/L | Human | C-terminal dimer of aurein | NA | NA | ||
| 23519707 | 2013 | GLFDIIKKIAESFKFSEAIKKIIDFLG | (AU)2K | Free | Free | Linear | L | None | 27 | Antimicrobial | 10% hemolytic at 4μmol/L | Human | C-terminal dimer of aurein | NA | NA | ||
| 23226256 | 2013 | GECIWDAIFHGAKHFLHRLVNP | TP2 | Free | Free | Linear | L | None | 22 | Antimicrobial | 60% hemolytic at 40µg/ml | Fish | Derivative of Piscidin (Nile tilapia, Oreochromis niloticus) | NA | NA | ||
| 23226256 | 2013 | FIHHIIGGLFSVGKHIHSLIHGH | TP3 | Free | Free | Linear | L | None | 23 | Antimicrobial | 42% hemolytic at 100 µg/ml | Fish | Derivative of Piscidin (Nile tilapia, Oreochromis niloticus) | NA | NA | ||
| 23226256 | 2013 | FIHHIIGGLFSAGKAIHRLIRRRRR | TP4 | Free | Free | Linear | L | None | 25 | Antimicrobial | 100% hemolytic at 100 µg/ml | Fish | Derivative of Piscidin (Nile tilapia, Oreochromis niloticus) | NA | NA | ||
| 23226256 | 2013 | QLQGKQVSGEVVQKVLQELIQSVAKP | TP5 | Free | Free | Linear | L | None | 26 | Antimicrobial | 0% hemolytic at 100μg/ml (non-hemolytic) | Fish | Derivative of Piscidin (Nile tilapia, Oreochromis niloticus) | NA | Non-hemolytic | ||
| 23093034 | 2013 | FFGSLLSLGSKLLPSVFKLFQRKKE | Css54 | Free | Free | Linear | L | None | 25 | Antimicrobial | 83% hemolytic at 25mM | Human | Analogs of antimicrobial peptides La47 (From venom of Lachesana sp.) | NA | NA | ||
| 22869378 | 2013 | K{d}K{d}L{d}A{d}L{d}L{d}A{d}L{d}K{d}K{d}W{d}L{d}L{d}A{d}L{d}K{d}K{d}L{d}A{d}L{d}L{d}A{d}L{d}K{d}K{d}{ct:Amid} | D-LAK120 | Amidation | Free | Linear | D | None | 25 | Antimicrobial, Antiplasmodial and Anticancer | HC50 = 4.06±1.30μM | Human | Synthetic peptide | NA | NA | ||
| 22869378 | 2013 | K{d}K{d}L{d}A{d}L{d}L{d}A{d}L{d}K{d}K{d}W{d}L{d}P{d}A{d}L{d}K{d}K{d}L{d}A{d}L{d}L{d}A{d}L{d}K{d}K{d}{ct:Amid} | D-LAK120-P13 | Amidation | Free | Linear | D | None | 25 | Antimicrobial, Antiplasmodial and Anticancer | HC50 = 11.66±0.03μM | Human | Synthetic peptide | NA | NA | ||
| 22869378 | 2013 | K{d}K{d}L{d}A{d}L{d}A{d}L{d}A{d}K{d}K{d}W{d}L{d}A{d}L{d}A{d}K{d}K{d}L{d}A{d}L{d}A{d}L{d}A{d}K{d}K{d}{ct:Amid} | D-LAK120-A | Amidation | Free | Linear | D | None | 25 | Antimicrobial, Antiplasmodial and Anticancer | HC50 = 17.42±2.17μM | Human | Synthetic peptide | NA | NA | ||
| 22869378 | 2013 | K{d}K{d}L{d}A{d}L{d}A{d}L{d}A{d}K{d}K{d}W{d}L{d}P{d}L{d}A{d}K{d}K{d}L{d}A{d}L{d}A{d}L{d}A{d}K{d}K{d}{ct:Amid} | D-LAK120-AP13 | Amidation | Free | Linear | D | None | 25 | Antimicrobial, Antiplasmodial and Anticancer | HC50 = 58.61±10.41μMc | Human | Synthetic peptide | NA | NA | ||
| 22869378 | 2013 | K{d}K{d}L{d}A{d}L{d}H{d}A{d}L{d}K{d}K{d}W{d}L{d}H{d}A{d}L{d}K{d}K{d}L{d}A{d}H{d}L{d}A{d}L{d}K{d}K{d}{ct:Amid} | D-LAK120-H | Amidation | Free | Linear | D | None | 25 | Antimicrobial, Antiplasmodial and Anticancer | HC50 = 20.29±2.42μM | Human | Synthetic peptide | NA | NA | ||
| 22869378 | 2013 | K{d}K{d}A{d}L{d}A{d}H{d}A{d}L{d}K{d}K{d}W{d}L{d}P{d}A{d}L{d}K{d}K{d}L{d}A{d}H{d}A{d}L{d}A{d}K{d}K{d}{ct:Amid} | D-LAK120-HP13 | Amidation | Free | Linear | D | None | 25 | Antimicrobial, Antiplasmodial and Anticancer | HC50 = 79.61±2.80μM | Human | Synthetic peptide | NA | NA | ||
| 22869378 | 2013 | K{d}K{d}A{d}L{d}A{d}K{d}A{d}L{d}K{d}H{d}W{d}L{d}P{d}A{d}L{d}H{d}K{d}L{d}A{d}K{d}A{d}L{d}A{d}K{d}K{d}{ct:Amid} | D-LAK80-HP13 | Amidation | Free | Linear | D | None | 25 | Antimicrobial, Antiplasmodial and Anticancer | HC50 = 8.61±0.35μM | Human | Synthetic peptide | NA | NA | ||
| 22869378 | 2013 | K{d}K{d}A{d}L{d}K{d}H{d}A{d}L{d}A{d}K{d}W{d}L{d}P{d}A{d}L{d}K{d}A{d}L{d}A{d}H{d}K{d}L{d}A{d}K{d}K{d}{ct:Amid} | D-LAK160-HP13 | Amidation | Free | Linear | D | None | 25 | Antimicrobial, Antiplasmodial and Anticancer | HC50 = 185.0±18.65μM | Human | Synthetic peptide | NA | NA | ||
| 22837667 | 2013 | KWKSFLKTFKSLKKTVLHTLLKAISS{nt:Acet}{ct:Amid} | P | Amidation | Acetylation | Linear | Mix | None | 26 | Anticancer | MHC = 5.20 ± 0.02μmol/L | Human | Synthetic α-helical cationic anticancer peptides | NA | NA | ||
| 22837667 | 2013 | KWKSFLK{d}TFKSLKKTVLHTLLKAISS{nt:Acet}{ct:Amid} | K7D | Amidation | Acetylation | Linear | Mix | None | 26 | Anticancer | MHC = 10.4 ± 0.04μmol/L | Human | Synthetic α-helical cationic anticancer peptides | NA | NA | ||
| 22837667 | 2013 | KWKSFLKTFKSLKK{d}TVLHTLLKAISS{nt:Acet}{ct:Amid} | K14D | Amidation | Acetylation | Linear | Mix | None | 26 | Anticancer | MHC = 5.20 ± 0.02μmol/L | Human | Synthetic α-helical cationic anticancer peptides | NA | NA | ||
| 22837667 | 2013 | KWKSFLKTFKSLKKTVLHTLLK{d}AISS{nt:Acet}{ct:Amid} | K22D | Amidation | Acetylation | Linear | Mix | None | 26 | Anticancer | MHC = 20.81 ± 0.10 μmol/L | Human | Synthetic α-helical cationic anticancer peptides | NA | NA | ||
| 22837667 | 2013 | KWKSFLK{d}TFKSLKK{d}TVLHTLLKAISS{nt:Acet}{ct:Amid} | K7D/K14 D | Amidation | Acetylation | Linear | Mix | None | 26 | Anticancer | MHC = 20.81 ± 0.15μmol/L | Human | Synthetic α-helical cationic anticancer peptides | NA | NA | ||
| 22837667 | 2013 | KWKSFLKTFKSLKK{d}TVLHTLLK{d}AISS{nt:Acet}{ct:Amid} | K14D/K22D | Amidation | Acetylation | Linear | Mix | None | 26 | Anticancer | MHC = 20.81 ± 0.06μmol/L | Human | Synthetic α-helical cationic anticancer peptides | NA | NA | ||
| 22837667 | 2013 | KWKSFLK{d}TFKSLKK{d}TVLHTLLK{d}AISS{nt:Acet}{ct:Amid} | K7D/K14D/K22D | Amidation | Acetylation | Linear | Mix | None | 26 | Anticancer | MHC = 81.31 ± 0.17μmol/L | Human | Synthetic α-helical cationic anticancer peptides | NA | NA | ||
| 22837667 | 2013 | KWKSFLK{d}TFK{d}SLKK{d}TVLHTLLK{d}AISS{nt:Acet}{ct:Amid} | K7D/K10D/K14D/K22D | Amidation | Acetylation | Linear | Mix | None | 26 | Anticancer | MHC = 325.20 ± 0.82μmol/L | Human | Synthetic α-helical cationic anticancer peptides | NA | NA | ||
| 22837667 | 2013 | KWK{d}SFLK{d}TFK{d}SLKK{d}TVLHTLLK{d}AISS{nt:Acet}{ct:Amid} | K3D/K7D/K10D/K14D/K22D | Amidation | Acetylation | Linear | Mix | None | 26 | Anticancer | MHC >325.20μmol/L | Human | Synthetic α-helical cationic anticancer peptides | NA | NA | ||
| 22837667 | 2013 | K{d}WK{d}SFLK{d}TFK{d}SLKK{d}TVLHTLLK{d}AISS{nt:Acet}{ct:Amid} | K1D/K3D/K7D/K10D/K14D/K22D | Amidation | Acetylation | Linear | Mix | None | 26 | Anticancer | MHC >325.20μmol/L | Human | Synthetic α-helical cationic anticancer peptides | NA | NA | ||
| 22837667 | 2013 | KWKSFL{d}KTFKSLKKTVLHTLLKAISS{nt:Acet}{ct:Amid} | L6D | Amidation | Acetylation | Linear | Mix | None | 26 | Anticancer | MHC =10.40 ± 0.08μmol/L | Human | Synthetic α-helical cationic anticancer peptides | NA | NA | ||
| 22837667 | 2013 | KWKSFLKTFKSL{d}KKTVLHTLLKAISS{nt:Acet}{ct:Amid} | L12D | Amidation | Acetylation | Linear | Mix | None | 26 | Anticancer | MHC =20.81 ± 0.03μmol/L | Human | Synthetic α-helical cationic anticancer peptides | NA | NA | ||
| 22837667 | 2013 | KWKSFLKTFKSLKKTVLHTL{d}LKAISS{nt:Acet}{ct:Amid} | L20D | Amidation | Acetylation | Linear | Mix | None | 26 | Anticancer | MHC =20.81 ± 0.13μmol/L | Human | Synthetic α-helical cationic anticancer peptides | NA | NA | ||
| 22837667 | 2013 | KWKSFL{d}KTFKSL{d}KKTVLHTLLKAISS{nt:Acet}{ct:Amid} | L6D/L12D | Amidation | Acetylation | Linear | Mix | None | 26 | Anticancer | MHC =20.81 ± 0.10 μmol/L | Human | Synthetic α-helical cationic anticancer peptides | NA | NA | ||
| 22837667 | 2013 | KWKSFLKTFKSL{d}KKTVLHTL{d}LKAISS{nt:Acet}{ct:Amid} | L12D/L20D | Amidation | Acetylation | Linear | Mix | None | 26 | Anticancer | MHC =81.31 ± 0.43μmol/L | Human | Synthetic α-helical cationic anticancer peptides | NA | NA | ||
| 22837667 | 2013 | KWKSFL{d}KTFKSL{d}KKTVLHTL{d}LKAISS{nt:Acet}{ct:Amid} | L6D/L12D/L20D | Amidation | Acetylation | Linear | Mix | None | 26 | Anticancer | MHC =162.61 ± 0.19μmol/L | Human | Synthetic α-helical cationic anticancer peptides | NA | NA | ||
| 22837667 | 2013 | KWKSFL{d}KTFKSL{d}KKTVLHTL{d}LKAISS{nt:Acet}{ct:Amid} | L6D/L12D/L17D/L20D | Amidation | Acetylation | Linear | Mix | None | 26 | Anticancer | MHC =81.31 ± 1.05μmol/L | Human | Synthetic α-helical cationic anticancer peptides | NA | NA | ||
| 22837667 | 2013 | KWKSFL{d}KTFKSL{d}KKTVLHTL{d}L{d}KAISS{nt:Acet}{ct:Amid} | L6D/L12D/L17D/L20D/L21D | Amidation | Acetylation | Linear | Mix | None | 26 | Anticancer | MHC >325.20μmol/L | Human | Synthetic α-helical cationic anticancer peptides | NA | NA | ||
| 22670762 | 2013 | KKFFLKVLTKIRCKVAGGCRT | OG2 | Free | Free | Linear | L | None | 21 | Antimicrobial | 10% hemolytic at 256 μg/mL | Porcine | Variant of OG1 | NA | NA | ||
| 22328546 | 2012 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | CPP | >80% hemolytic at 25μM at pH 8 | Human | Melittin (Apis mellifera) | NA | NA | ||
| 22328546 | 2012 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | CPP | <60% hemolytic at 25μM at pH 6 | Human | Melittin (Apis mellifera) | NA | NA | ||
| 22328546 | 2012 | GIGAILKVLATGLPTLISWIKNKRKQ | Florae | Free | Free | Linear | L | None | 26 | CPP | <70% hemolytic at 25μM at pH 6 | Human | Melittin analog | NA | NA | ||
| 22328546 | 2012 | GIGAILKVLATGLPTLISWIKNKRKQ | Florae | Free | Free | Linear | L | None | 26 | CPP | ~80% hemolytic at 25μM at pH 8 | Human | Melittin analog | NA | NA | ||
| 22371493 | 2012 | MGIIAGIIKVIKSLIEQFTGK | PSMα1 | Free | Free | Linear | L | None | 21 | Immunosuppressive and antimicrobial | 58% hemolytic at 10 μg/mL | Human | Phenol-soluble modulins derivative (Staphylococcus aureus) | NA | NA | ||
| 22391524 | 2012 | GWLDVAKKIGKAAFNVAKNFL{ct:Amid} | MON | Amidation | Free | Linear | L | None | 21 | Antimicrobial | HC50 = 37.3± 1.4 μmol/L | Human | Ctx-Ha ceratotoxin-like peptide (Hypsiboas albopunctatus) | NA | NA | ||
| 22038181 | 2012 | GLPRKILCAIAKKKGKCKGPLKLVCKC{cyc:N-C} | Lasiocepsin | Free | Free | Cyclic | L | None | 27 | Antimicrobial | <1% hemolytic at 200μM | Human | Lasiocepsin (From venom of eusocial bee, Lasioglossum laticeps) | NA | NA | ||
| 22038181 | 2012 | GLPRKILCAIAKKKGKCKGPLKLVCKC{cyc:N-C}{ct:Amid} | Lasiocepsin-NH2 | Amidation | Free | Cyclic | L | None | 27 | Antimicrobial | <1% hemolytic at 200μM | Human | Lasiocepsin analogs (From venom of eusocial bee, Lasioglossum laticeps) | NA | NA | ||
| 22038181 | 2012 | GLPRKILCAIAKKKGKCKGPLKLVCKC{cyc:N-C} | Las[C8-C27, C17-C25] | Free | Free | Cyclic | L | None | 27 | Antimicrobial | <1% hemolytic at 200μM | Human | Lasiocepsin analogs (From venom of eusocial bee, Lasioglossum laticeps) | NA | NA | ||
| 22038181 | 2012 | GLPRKILCAIAKKKGKCKGPLKLVCKC{cyc:N-C} | Las[C8-C17, C25-C27] | Free | Free | Cyclic | L | None | 27 | Antimicrobial | <1% hemolytic at 200μM | Human | Lasiocepsin analogs (From venom of eusocial bee, Lasioglossum laticeps) | NA | NA | ||
| 22038181 | 2012 | GLPRKILCAIAKKKGKAKGPLKLVCKA{cyc:N-C} | Las[C8-C25, Ala17,27] | Free | Free | Cyclic | L | None | 27 | Antimicrobial | <1% hemolytic at 200μM | Human | Lasiocepsin analogs (From venom of eusocial bee, Lasioglossum laticeps) | NA | NA | ||
| 22038181 | 2012 | GLPRKILAAIAKKKGKCKGPLKLVAKC{cyc:N-C} | Las[C17-C27, Ala8,25] | Free | Free | Cyclic | L | None | 27 | Antimicrobial | <1% hemolytic at 200μM | Human | Lasiocepsin analogs (From venom of eusocial bee, Lasioglossum laticeps) | NA | NA | ||
| 22038181 | 2012 | GLPRKILAAIAKKKGKAKGPLKLVAKA | Las[Ala8,17,25,27] | Free | Free | Linear | L | None | 27 | Antimicrobial | <1% hemolytic at 200μM | Human | Lasiocepsin analogs (From venom of eusocial bee, Lasioglossum laticeps) | NA | NA | ||
| 22038181 | 2012 | LCAIAKKKGKCKGPLKLVCKC{cyc:N-C}{ct:Amid} | Las[des1-6]-NH2 | Amidation | Free | Cyclic | L | None | 21 | Antimicrobial | <1% hemolytic at 200μM | Human | Lasiocepsin analogs (From venom of eusocial bee, Lasioglossum laticeps) | NA | NA | ||
| 19635451 | 2010 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100% hemolytic at 0.4μM & 23μM | Human | Melittin (Honey bee) | NA | NA | ||
| 20798581 | 2010 | GWGSFFKKAAHVGKHVGKAALTHYL{ct:Amid} | Ple | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 7% hemolytic at 100μM | Human | Pleurocidin (Pleuronectes americanus) | NA | NA | ||
| 20798581 | 2010 | SFFKKAAHVGKHVGKAALTHYL{ct:Amid} | Ple (4-25) | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 0% hemolytoc at 100μM (non-hemolytic) | Human | Pleurocidin (Pleuronectes americanus) | NA | Non-hemolytic | ||
| 20798581 | 2010 | GWGSFFKKAAHVGKHVGKAALT{ct:Amid} | Ple (1-22) | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 0% hemolysis at 100μM (non-hemolytic) | Human | Pleurocidin (Pleuronectes americanus) | NA | Non-hemolytic | ||
| 20858205 | 2011 | K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}K{d}S{d}A{d}K{d}K{d}T{d}V{d}L{d}H{d}T{d}A{d}L{d}K{d}A{d}I{d}S{d}S{d}{nt:Acet}{ct:Amid} | D1 | Amidation | Acetylation | Linear | D | None | 26 | Antimicrobial | HC50 = 421.5μg/ml | Human | Synthetic peptides | NA | NA | ||
| 20858205 | 2011 | K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}K{d}S{d}A{d}K{d}K{d}T{d}V{d}L{d}H{d}T{d}L{d}L{d}K{d}A{d}I{d}S{d}S{d}{nt:Acet}{ct:Amid} | D2 | Amidation | Acetylation | Linear | D | None | 26 | Antimicrobial | HC50 = 83μg/ml | Human | Synthetic peptides | NA | NA | ||
| 20858205 | 2011 | K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}K{d}S{d}L{d}K{d}K{d}T{d}V{d}L{d}H{d}T{d}L{d}L{d}K{d}A{d}I{d}S{d}S{d}{nt:Acet}{ct:Amid} | D3 | Amidation | Acetylation | Linear | D | None | 26 | Antimicrobial | HC50 = 14μg/ml | Human | Synthetic peptides | NA | NA | ||
| 20858205 | 2011 | K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}K{d}S{d}L{d}K{d}K{d}T{d}V{d}L{d}H{d}T{d}L{d}L{d}K{d}L{d}I{d}S{d}S{d}{nt:Acet}{ct:Amid} | D4 | Amidation | Acetylation | Linear | D | None | 26 | Antimicrobial | HC50 = 3.5μg/ml | Human | Synthetic peptides | NA | NA | ||
| 20858205 | 2011 | K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}K{d}S{d}L{d}K{d}K{d}T{d}K{d}L{d}H{d}T{d}L{d}L{d}K{d}L{d}I{d}S{d}S{d}{nt:Acet}{ct:Amid} | D5 | Amidation | Acetylation | Linear | D | None | 26 | Antimicrobial | HC50 = 47μg/ml | Human | Synthetic peptides | NA | NA | ||
| 20955730 | 2011 | RIKRFWPVVIRTVVAGYNLYRAIKKK | Pc-CATH1 | Free | Free | Linear | L | None | 26 | Antimicrobial | 13.2% hemolytic at 31.5μM | Human | Novel cathelicidin-derived myeloid antimicrobial peptide from Phasianus colchicus | NA | NA | ||
| 20955730 | 2011 | RIKRFWPVVIRTVVAGYNLYRAIKKK | Pc-CATH1 | Free | Free | Linear | L | None | 26 | Antimicrobial | 9.1% hemolytic at 15.7μM | Human | Novel cathelicidin-derived myeloid antimicrobial peptide from Phasianus colchicus | NA | NA | ||
| 20955730 | 2011 | RIKRFWPVVIRTVVAGYNLYRAIKKK | Pc-CATH1 | Free | Free | Linear | L | None | 26 | Antimicrobial | 6.3% hemolytic at 6.30μM | Human | Novel cathelicidin-derived myeloid antimicrobial peptide from Phasianus colchicus | NA | NA | ||
| 20955730 | 2011 | RIKRFWPVVIRTVVAGYNLYRAIKKK | Pc-CATH1 | Free | Free | Linear | L | None | 26 | Antimicrobial | 3.6% hemolytic at 3.15μM | Human | Novel cathelicidin-derived myeloid antimicrobial peptide from Phasianus colchicus | NA | NA | ||
| 21219588 | 2011 | K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}K{d}S{d}A{d}V{d}K{d}T{d}V{d}L{d}H{d}T{d}A{d}L{d}K{d}A{d}I{d}S{d}S{d}{nt:Acet}{ct:Amid} | D1 (V13) | Amidation | Acetylation | Linear | D | None | 26 | Antimicrobial | HC50 =1.8μM | Human | Synthetic peptides | NA | NA | ||
| 21219588 | 2011 | K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}K{d}S{d}A{d}K{d}K{d}T{d}V{d}L{d}H{d}T{d}A{d}L{d}K{d}A{d}I{d}S{d}S{d}{nt:Acet}{ct:Amid} | D1 (K13) | Amidation | Acetylation | Linear | D | None | 26 | Antimicrobial | HC50 = 140.9μM | Human | Synthetic peptides | NA | NA | ||
| 21219588 | 2011 | K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}S{d}K{d}A{d}K{d}K{d}K{d}V{d}L{d}K{d}T{d}A{d}L{d}K{d}A{d}I{d}S{d}K{d}{nt:Acet}{ct:Amid} | D11 | Amidation | Acetylation | Linear | D | None | 26 | Antimicrobial | HC50 = 254.1μM | Human | Synthetic peptides | NA | NA | ||
| 21219588 | 2011 | K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}S{d}K{d}A{d}K{d}K{d}K{d}A{d}L{d}K{d}T{d}L{d}L{d}K{d}A{d}I{d}S{d}K{d}{nt:Acet}{ct:Amid} | D22 | Amidation | Acetylation | Linear | D | None | 26 | Antimicrobial | HC50 =81.3μM | Human | Synthetic peptides | NA | NA | ||
| 21219588 | 2011 | K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}S{d}K{d}A{d}K{d}K{d}K{d}K{d}L{d}K{d}T{d}L{d}L{d}K{d}A{d}I{d}S{d}K{d}{nt:Acet}{ct:Amid} | D14 | Amidation | Acetylation | Linear | D | None | 26 | Antimicrobial | HC50 =351.5μM | Human | Synthetic peptides | NA | NA | ||
| 21219588 | 2011 | K{d}L{d}K{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}K{d}A{d}K{d}K{d}K{d}L{d}L{d}K{d}T{d}A{d}L{d}K{d}A{d}L{d}S{d}K{d}{nt:Acet}{ct:Amid} | D15 | Amidation | Acetylation | Linear | D | None | 26 | Antimicrobial | HC50 =169.6μM | Human | Synthetic peptides | NA | NA | ||
| 21219588 | 2011 | K{d}L{d}K{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}K{d}A{d}K{d}K{d}K{d}K{d}L{d}K{d}T{d}L{d}L{d}K{d}A{d}L{d}S{d}K{d}{nt:Acet}{ct:Amid} | D16 | Amidation | Acetylation | Linear | D | None | 26 | Antimicrobial | HC50 =1342.0μM | Human | Synthetic peptides | NA | NA | ||
| 21343499 | 2011 | EEEEAAAK{d}W{d}K{d}L{d}F{d}K{d}K{d}I{d}P{d}K{d}F{d}L{d}H{d}L{d}A{d}K{d}K{d}F{d}{nt:Acet}{ct:Amid} | Ac-E4-A3–D-P18 | Amidation | Acetylation | Linear | Mix | None | 24 | Antimcrobial and Hemolytic | ~3.5% hemolytic upto 500μM | Human | Host defense peptides analog (Rana temporaria) | NA | NA | ||
| 21607695 | 2011 | FKCRRWQWRMKKLGAPSITCVRRAF | LfcinB (C–C) | Free | Free | Linear | L | None | 25 | Antimicrobial | ~7% hemolytic at 256mg/ml | Pig | Synthetic peptide derived from bovine lactoferricin | NA | NA | ||
| 21607695 | 2011 | FKCRRWQWRMKKLGAPSITCVRRAF | LfcinB | Free | Free | Linear | L | None | 25 | Antimicrobial | <10% hemolytic at 256mg/ml | Pig | Synthetic peptide derived from bovine lactoferricin | NA | NA | ||
| 21729875 | 2011 | GKGRWLERIGKAGGIIIGGALDHL{ct:Amid} | NRC-01 | Amidation | Free | Linear | L | None | 24 | Anticancer | 50% hemolytic at >256 μg/ml | Human | Pleurocidin variant derived from gut and skin of pleuronectid flatfish | NA | NA | ||
| 21729875 | 2011 | GRRKRKWLRRIGKGVKIIGGAALDHL{ct:Amid} | NRC-03 | Amidation | Free | Linear | L | None | 26 | Anticancer | 50% hemolytic at >256 μg/ml | Human | Pleurocidin variant derived from gut and skin of pleuronectid flatfish | NA | NA | ||
| 21729875 | 2011 | GWGSFFKKAAHVGKHVGKAALTHYL{ct:Amid} | NRC-04 | Amidation | Free | Linear | L | None | 25 | Anticancer | 50% hemolytic at >256 μg/ml | Human | Pleurocidin variant derived from gut and skin of pleuronectid flatfish | NA | NA | ||
| 21729875 | 2011 | FLGALIKGAIHGGRFIHGMIQNHH{ct:Amid} | NRC-05 | Amidation | Free | Linear | L | None | 24 | Anticancer | 50% hemolytic at >256 μg/ml | Human | Pleurocidin variant derived from gut and skin of pleuronectid flatfish | NA | NA | ||
| 21729875 | 2011 | GWGSIFKHGRHAAKHIGHAAVNHYL{ct:Amid} | NRC-06 | Amidation | Free | Linear | L | None | 25 | Anticancer | 50% hemolytic at >256 μg/ml | Human | Pleurocidin variant derived from gut and skin of pleuronectid flatfish | NA | NA | ||
| 21729875 | 2011 | RWGKWFKKATHVGKHVGKAALTAYL{ct:Amid} | NRC-07 | Amidation | Free | Linear | L | None | 25 | Anticancer | 50% hemolytic at >256 μg/ml | Human | Pleurocidin variant derived from gut and skin of pleuronectid flatfish | NA | NA | ||
| 21729875 | 2011 | RSTEDIIKSISGGGFLNAMNA{ct:Amid} | NRC-08 | Amidation | Free | Linear | L | None | 21 | Anticancer | 50% hemolytic at >256 μg/ml | Human | Pleurocidin variant derived from gut and skin of pleuronectid flatfish | NA | NA | ||
| 21729875 | 2011 | GWKSVFRKAKKVGKTVGGLALDHYL{ct:Amid} | NRC-11 | Amidation | Free | Linear | L | None | 25 | Anticancer | 50% hemolytic at >256 μg/ml | Human | Pleurocidin variant derived from gut and skin of pleuronectid flatfish | NA | NA | ||
| 21729875 | 2011 | GWKKWFNRAKKVGKTVGGLAVDHYL{ct:Amid} | NRC-12 | Amidation | Free | Linear | L | None | 25 | Anticancer | 50% hemolytic at >256 μg/ml | Human | Pleurocidin variant derived from gut and skin of pleuronectid flatfish | NA | NA | ||
| 21729875 | 2011 | GWRTLLKKAEVKTVGKLALKHYL{ct:Amid} | NRC-13 | Amidation | Free | Linear | L | None | 23 | Anticancer | 50% hemolytic at >256 μg/ml | Human | Pleurocidin variant derived from gut and skin of pleuronectid flatfish | NA | NA | ||
| 21729875 | 2011 | AGWGSIFKHIFKAGKFIHGAIQAHND{ct:Amid} | NRC-14 | Amidation | Free | Linear | L | None | 26 | Anticancer | 50% hemolytic at >256 μg/ml | Human | Pleurocidin variant derived from gut and skin of pleuronectid flatfish | NA | NA | ||
| 21729875 | 2011 | GFWGKLFKLGLHGIGLLHLHL{ct:Amid} | NRC-15 | Amidation | Free | Linear | L | None | 21 | Anticancer | 50% hemolytic at 64μg/ml | Human | Pleurocidin variant derived from gut and skin of pleuronectid flatfish | NA | NA | ||
| 21729875 | 2011 | GWKKWLRKGAKHLGQAAIKGLAS | NRC-17 | Free | Free | Linear | L | None | 23 | Anticancer | 50% hemolytic at >256 μg/ml | Human | Pleurocidin variant derived from gut and skin of pleuronectid flatfish | NA | NA | ||
| 21729875 | 2011 | FLGLLFHGVHHVGKWIHGLIHGHH{ct:Amid} | NRC-19 | Amidation | Free | Linear | L | None | 24 | Anticancer | 50% hemolytic at 16μg/ml | Human | Pleurocidin variant derived from gut and skin of pleuronectid flatfish | NA | NA | ||
| 21729875 | 2011 | GFLGILFHGVHHGRKKALHMNSERRS | NRC-20 | Free | Free | Linear | L | None | 26 | Anticancer | 50% hemolytic at >256 μg/ml | Human | Pleurocidin variant derived from gut and skin of pleuronectid flatfish | NA | NA | ||
| 21729875 | 2011 | GWKDWFRKAKKVGKTVGGLALNHYL{ct:Amid} | NRC-123 | Amidation | Free | Linear | L | None | 25 | Anticancer | 50% hemolytic at >256 μg/ml | Human | Pleurocidin variant derived from gut and skin of pleuronectid flatfish | NA | NA | ||
| 21729875 | 2011 | GIRKWFKKAAHVGKEVGKVALNACL | NRC-124 | Free | Free | Linear | L | None | 25 | Anticancer | 50% hemolytic at >256 μg/ml | Human | Pleurocidin variant derived from gut and skin of pleuronectid flatfish | NA | NA | ||
| 21729875 | 2011 | GLKKWFKKAVHVGKKVGKVALNAYL{ct:Amid} | NRC-125 | Amidation | Free | Linear | L | None | 25 | Anticancer | 50% hemolytic at >256 μg/ml | Human | Pleurocidin variant derived from gut and skin of pleuronectid flatfish | NA | NA | ||
| 21729875 | 2011 | GWRKWIKKATHVGKHIGKAALDAYI{ct:Amid} | NRC-126 | Amidation | Free | Linear | L | None | 25 | Anticancer | 50% hemolytic at >256 μg/ml | Human | Pleurocidin variant derived from gut and skin of pleuronectid flatfish | NA | NA | ||
| 21729875 | 2011 | GCKKWFKKAAHVGKNVGKVALNAYL{ct:Amid} | NRC-127 | Amidation | Free | Linear | L | None | 25 | Anticancer | 50% hemolytic at >256 μg/ml | Human | Pleurocidin variant derived from gut and skin of pleuronectid flatfish | NA | NA | ||
| 21729875 | 2011 | GIRKWFKKAAHVGKKVGKVALNAYL{ct:Amid} | NRC-128 | Amidation | Free | Linear | L | None | 25 | Anticancer | 50% hemolytic at >256 μg/ml | Human | Pleurocidin variant derived from gut and skin of pleuronectid flatfish | NA | NA | ||
| 21729875 | 2011 | GR{d}R{d}K{d}R{d}K{d}WLR{d}R{d}IGK{d}GVK{d}IIGGAALDHL{ct:Amid} | NRC-03D | Amidation | Free | Linear | Mix | None | 26 | Anticancer | 50% hemolytic at >256 μg/ml | Human | Pleurocidin variant derived from gut and skin of pleuronectid flatfish | NA | NA | ||
| 21729875 | 2011 | GRRKRKWLRRIGKGVKIIGGAALDHL{nt:Biotin}{ct:Amid} | NRC-03B | Amidation | Biotin | Linear | L | None | 26 | Anticancer | 50% hemolytic at >256 μg/ml | Human | Pleurocidin variant derived from gut and skin of pleuronectid flatfish | NA | NA | ||
| 21729875 | 2011 | GIGKFLHSAKKFGKAFVGEIMNS{ct:Amid} | Mag2 | Amidation | Free | Linear | L | None | 23 | Anticancer | 50% hemolytic at >256 μg/ml | Human | Magainin-2 | NA | NA | ||
| 21576247 | 2011 | GLPVCGETCVGGTCNTPGCTCSWPVCTRN{cyc:N-C} | kB1 | Free | Free | Cyclic | L | None | 29 | Hemolytic and Anti-HIV | 41.2 ±1.5% hemolytic at 25μM | Human | Kalata B1 (Oldenlandia affinis) | NA | NA | ||
| 21576247 | 2011 | GLPKCGETCVGGTCNTPGCTCSWPVCTRN{cyc:N-C} | V4K | Free | Free | Cyclic | L | None | 29 | Hemolytic and Anti-HIV | 2.9±0.5% hemolytic at 25μM | Human | kalata B1 analog (Oldenlandia affinis) | NA | NA | ||
| 21576247 | 2011 | GLPVCGDTCVGGTCNTPGCTCSWPVCTRN{cyc:N-C} | E7D | Free | Free | Cyclic | L | None | 29 | Hemolytic and Anti-HIV | 3.8±0.4% hemolytic at 25μM | Human | kalata B1 analog (Oldenlandia affinis) | NA | NA | ||
| 21576247 | 2011 | GLPVCGEKCVGGTCNTPGCTCSWPVCTRN{cyc:N-C} | T8K | Free | Free | Cyclic | L | None | 29 | Hemolytic and Anti-HIV | 3.4±0.7% hemolytic at 25μM | Human | kalata B1 analog (Oldenlandia affinis) | NA | NA | ||
| 21576247 | 2011 | GLPVCGETCKGGTCNTPGCTCSWPVCTRN{cyc:N-C} | V10K | Free | Free | Cyclic | L | None | 29 | Hemolytic and Anti-HIV | 0±1.7% hemolytic at 25μM | Human | kalata B1 analog (Oldenlandia affinis) | NA | Non-hemolytic | ||
| 21576247 | 2011 | GLPVCGETCVGGTCKTPGCTCSWPVCTRN{cyc:N-C} | N15K | Free | Free | Cyclic | L | None | 29 | Hemolytic and Anti-HIV | 2.1±0.4% hemolytic at 25μM | Human | kalata B1 analog (Oldenlandia affinis) | NA | NA | ||
| 21576247 | 2011 | GLPVCGETCVGGTCNKPGCTCSWPVCTRN{cyc:N-C} | T16K | Free | Free | Cyclic | L | None | 29 | Hemolytic and Anti-HIV | 4.3±0.1% hemolytic at 25μM | Human | kalata B1 analog (Oldenlandia affinis) | NA | NA | ||
| 21576247 | 2011 | GLPVCGETCVGGTCNTPGCKCSWPVCTRN{cyc:N-C} | T20K | Free | Free | Cyclic | L | None | 29 | Hemolytic and Anti-HIV | 51.3±1.6% hemolytic at 25μM | Human | kalata B1 analog (Oldenlandia affinis) | NA | NA | ||
| 21576247 | 2011 | GLPVCGETCVGGTCNTPGCTCSWPKCTRN{cyc:N-C} | V25K | Free | Free | Cyclic | L | None | 29 | Hemolytic and Anti-HIV | 1.1±1.0% hemolytic at 25μM | Human | kalata B1 analog (Oldenlandia affinis) | NA | NA | ||
| 21576247 | 2011 | GLPVCGETCVGGTCNTPGCTCSWPVCTRK{cyc:N-C} | N29K | Free | Free | Cyclic | L | None | 29 | Hemolytic and Anti-HIV | 54.5±0.9% hemolytic at 25μM | Human | kalata B1 analog (Oldenlandia affinis) | NA | NA | ||
| 21576247 | 2011 | GLPVCGETCVGGTCNTPGCTCSKPVCTRN{cyc:N-C} | W23K | Free | Free | Cyclic | L | None | 29 | Hemolytic and Anti-HIV | 2.4±0.7% hemolytic at 25μM | Human | kalata B1 analog (Oldenlandia affinis) | NA | NA | ||
| 21576247 | 2011 | GLPVCGETCVGGTCNTPGCNCSWPVCTRK{cyc:N-C} | T20N29K | Free | Free | Cyclic | L | None | 29 | Hemolytic and Anti-HIV | 64.4±2.2% hemolytic at 25μM | Human | kalata B1 analog (Oldenlandia affinis) | NA | NA | ||
| 21576247 | 2011 | GLPVCGETCVGGTCNTPGCTCSWPVCTKN{cyc:N-C} | R28K | Free | Free | Cyclic | L | None | 29 | Hemolytic and Anti-HIV | 12.0±1.8% hemolytic at 25μM | Human | kalata B1 analog (Oldenlandia affinis) | NA | NA | ||
| 21576247 | 2011 | GLPVCGETCVGGTCNTPGCTCSWPVCTRN | acyclic | Free | Free | Linear | L | None | 29 | Hemolytic and Anti-HIV | 2.8±0.3% hemolytic at 25μM | Human | kalata B1 analog (Oldenlandia affinis) | NA | NA | ||
| 22029824 | 2012 | KEKLKLKCKAPKCYNDKLACT | Andersonin-G1 | Free | Free | Linear | L | None | 21 | Antimicrobial | Non-hemolytic upto 50 μg/mL | Human | Skin secretion of frog Odorrana andersonii | NA | Non-hemolytic | ||
| 22029824 | 2012 | ENAEEDIVLMENLFCSYIVGSADSFWT | Andersonin-R1 | Free | Free | Linear | L | None | 27 | Antimicrobial | Non-hemolytic upto 50 μg/mL | Human | Skin secretion of frog Odorrana andersonii | NA | Non-hemolytic | ||
| 22029824 | 2012 | DANVENGEDAEDLTDKFIGLMG | Andersonin-S1 | Free | Free | Linear | L | None | 22 | Antimicrobial | Non-hemolytic upto 50 μg/mL | Human | Skin secretion of frog Odorrana andersonii | NA | Non-hemolytic | ||
| 19961432 | 2010 | SVSNAATRVCRTGRSRWRDVCRNFMR | Gr-1L(25-50) | Free | Free | Linear | L | None | 26 | Antimicrobial | 20-30% hemolysis at 50μM | Human | Derivative of granulysin (Synthetic peptide) | NA | NA | ||
| 19961432 | 2010 | SVSNAATRVCRTGRSRWRDVCRNFMR{cyc:N-C} | Gr-1C(25-50) | Free | Free | Cyclic | L | None | 26 | Antimicrobial | 20-30% hemolysis at 50μM | Human | Derivative of granulysin (Synthetic peptide) | NA | NA | ||
| 19961432 | 2010 | SVSNAATRVARTGRSRWRDVARNFMR | Gr-2 (25-50) | Free | Free | Linear | L | None | 26 | Antimicrobial | 20-30% hemolysis at 50μM | Human | Derivative of granulysin (Synthetic peptide) | NA | NA | ||
| 19961432 | 2010 | SRWRDVARNFMRRYQSRVIQGLVA | Gr-3 (39-62) | Free | Free | Linear | L | None | 24 | Antimicrobial | 90% hemolysis at 50μM | Human | Derivative of granulysin (Synthetic peptide) | NA | NA | ||
| 19961432 | 2010 | SVSNAATRVCRTGRSRWRDVCRNFMR | Gr-1L(25-50) | Free | Free | Linear | L | None | 26 | Antimicrobial | 40-50% hemolysis at 100μM | Human | Derivative of granulysin (Synthetic peptide) | NA | NA | ||
| 19961432 | 2010 | SVSNAATRVCRTGRSRWRDVCRNFMR{cyc:N-C} | Gr-1C(25-50) | Free | Free | Cyclic | L | None | 26 | Antimicrobial | 40-50% hemolysis at 100μM | Human | Derivative of granulysin (Synthetic peptide) | NA | NA | ||
| 19961432 | 2010 | SVSNAATRVARTGRSRWRDVARNFMR | Gr-2 (25-50) | Free | Free | Linear | L | None | 26 | Antimicrobial | 40-50% hemolysis at 100μM | Human | Derivative of granulysin (Synthetic peptide) | NA | NA | ||
| 19961432 | 2010 | SRWRDVARNFMRRYQSRVIQGLVA | Gr-3 (39-62) | Free | Free | Linear | L | None | 24 | Antimicrobial | 100% hemolysis at 100μM | Human | Derivative of granulysin (Synthetic peptide) | NA | NA | ||
| 19961432 | 2010 | SVSNAATRVCRTGRSRWRDVCRNFMR | Gr-1L(25-50) | Free | Free | Linear | L | None | 26 | Antimicrobial | 80-85% hemolysis at 200μM | Human | Derivative of granulysin (Synthetic peptide) | NA | NA | ||
| 19961432 | 2010 | SVSNAATRVCRTGRSRWRDVCRNFMR{cyc:N-C} | Gr-1C(25-50) | Free | Free | Cyclic | L | None | 26 | Antimicrobial | 70% hemolysis at 200μM | Human | Derivative of granulysin (Synthetic peptide) | NA | NA | ||
| 19961432 | 2010 | SVSNAATRVARTGRSRWRDVARNFMR | Gr-2 (25-50) | Free | Free | Linear | L | None | 26 | Antimicrobial | 90% hemolysis at 200μM | Human | Derivative of granulysin (Synthetic peptide) | NA | NA | ||
| 19961432 | 2010 | SRWRDVARNFMRRYQSRVIQGLVA | Gr-3 (39-62) | Free | Free | Linear | L | None | 24 | Antimicrobial | 100% hemolysis at 200μM | Human | Derivative of granulysin (Synthetic peptide) | NA | NA | ||
| 20457198 | 2010 | DVNDLKNLCAKTHNLLPMCAMFGKK | DK25 | Free | Free | Linear | L | None | 25 | Antimicrobial | no hemolysis upto <400μM | Human | Rana tagoi okiensis | NA | Non-hemolytic | ||
| 20457198 | 2010 | DVNDLKNLCAKTHNLLPMCAMF{ct:Amid} | DF-22-amide | Amidation | Free | Linear | L | None | 22 | Antimicrobial | no hemolysis upto <400μM | Human | Rana tagoi okiensis | NA | Non-hemolytic | ||
| 20472009 | 2010 | GIGAVLKVLSTGLPALISWIKRKRQQ | melittin-S | Free | Free | Linear | L | None | 26 | Antimicrobial | 35% hemolysis at | Human | Melittin isoform | α-helical | NA | ||
| 20600431 | 2010 | GSKKPVPIIYCNRRSGKCQRM | S-thanatin | Free | Free | Linear | L | None | 21 | Antimicrobial | low hemolytic activity up to 400μg/ml | Human | Thanatin analog | β-sheet | Non-hemolytic | ||
| 20603168 | 2010 | GLKEIFKAGLGSLVKGIAAHVAS | Alyteserin-1c | Free | Free | Linear | L | None | 23 | Antimicrobial | LC50 =220μM | Human | Alytes obstetricans (Alyteserin-1c) | α-helical | NA | ||
| 20603168 | 2010 | GLKK{d}IFKAGLGSLVKGIAAHVAS | E4K | Free | Free | Linear | L | None | 23 | Antimicrobial | LC50 >400μM | Human | Alyteserin-1c analog | α-helical | NA | ||
| 20603168 | 2010 | GLKK{d}IFKAGLGSLVKGIAAHVAS | E4k | Free | Free | Linear | Mix | None | 23 | Antimicrobial | LC50 >400μM | Human | Alyteserin-1c analog | α-helical | NA | ||
| 20603168 | 2010 | GLKKIFKKGLGSLVKGIAAHVAS | E4K,A8K | Free | Free | Linear | L | None | 23 | Antimicrobial | LC50 >400μM | Human | Alyteserin-1c analog | α-helical | NA | ||
| 20603168 | 2010 | GLKK{d}IFKKGLGSLVKGIAAHVAS | E4k,A8K | Free | Free | Linear | Mix | None | 23 | Antimicrobial | LC50 >400μM | Human | Alyteserin-1c analog | α-helical | NA | ||
| 20603168 | 2010 | GLKK{d}IFKAGLGSLKKGIAAHVAS | E4K,V14K | Free | Free | Linear | L | None | 23 | Antimicrobial | LC50 >400μM | Human | Alyteserin-1c analog | α-helical | NA | ||
| 20603168 | 2010 | GLKK{d}IFKAGLGSLKKGIAAHVAS | E4k,V14K | Free | Free | Linear | Mix | None | 23 | Antimicrobial | LC50 >400μM | Human | Alyteserin-1c analog | α-helical | NA | ||
| 20603168 | 2010 | GLKK{d}IFKAGLGSLVKGIKAHVAS | E4K,A18K | Free | Free | Linear | L | None | 23 | Antimicrobial | LC50 >400μM | Human | Alyteserin-1c analog | α-helical | NA | ||
| 20603168 | 2010 | GLKK{d}IFKAGLGSLVKGIKAHVAS | E4k,A18K | Free | Free | Linear | Mix | None | 23 | Antimicrobial | LC50 >400μM | Human | Alyteserin-1c analog | α-helical | NA | ||
| 20603168 | 2010 | GLKEIFKAGLGSLVKGIAAHVAS{nt:palmitate(pal)} | N-Pal,E4K | Free | palmitate(pal) | Linear | L | None | 23 | Antimicrobial | LC50 =10μM | Human | Alyteserin-1c analog | α-helical | NA | ||
| 20603168 | 2010 | GLKKIFKAGLGSLVKGIK{nnr:*}AHVAS | E4K,Pal-A18K | Free | Free | Linear | L | * = palmitate(PAL) | 23 | Antimicrobial | LC50 =30μM | Human | Alyteserin-1c analog | α-helical | NA | ||
| 20656059 | 2010 | GIGKFLHSAGKFGKAFLGEVMKS | Magainin-B2 | Free | Free | Linear | L | None | 23 | Antimicrobial | 0% hemolysis at 200μM | Human | Xenopus borealis | NA | Non-hemolytic | ||
| 20656059 | 2010 | GMASKAGSIVGKIAKIALGAL{ct:Amid} | PGLa-B2 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 27% hemolysis at 200μM | Human | Xenopus borealis | NA | NA | ||
| 20656059 | 2010 | GLGSLLGKAFKIGLKTVGKMMGGAPREQ | CPF-B1 | Free | Free | Linear | L | None | 28 | Antimicrobial | 18% hemolysis at 200μM | Human | Xenopus borealis | NA | NA | ||
| 21241661 | 2011 | RWCVYAYVRVRGVLVRYRRCW | Arenicin-1 | Free | Free | Linear | L | None | 21 | Antimicrobial | 0% hemolysis at 12.5μM | Human | Derived from coelomocytes of the marine polychaeta lugworm(Arenicola marina) | β-sheet | NA | ||
| 21241661 | 2011 | RWCVYAYVRVRGVLVRYRRCW | Arenicin-1 | Free | Free | Linear | L | None | 21 | Antimicrobial | 12% hemolysis at 25μM | Human | Derived from coelomocytes of the marine polychaeta lugworm(Arenicola marina) | β-sheet | NA | ||
| 21241661 | 2011 | RWCVYAYVRVRGVLVRYRRCW | Arenicin-1 | Free | Free | Linear | L | None | 21 | Antimicrobial | 35% hemolysis at 50μM | Human | Derived from coelomocytes of the marine polychaeta lugworm(Arenicola marina) | β-sheet | NA | ||
| 21241661 | 2011 | RWCVYAYVRVRGVLVRYRRCW | Arenicin-1 | Free | Free | Linear | L | None | 21 | Antimicrobial | 51% hemolysis at 100μM | Human | Derived from coelomocytes of the marine polychaeta lugworm(Arenicola marina) | β-sheet | NA | ||
| 21241661 | 2011 | RWCVYAYVRVAGVLVRYRRCW | Arenicin-1(analog-2) | Free | Free | Linear | L | None | 21 | Antimicrobial | 0% hemolysis at 12.5μM | Human | Arenicin-1 analog | NA | NA | ||
| 21241661 | 2011 | RWCVYAYVRVAGVLVRYRRCW | Arenicin-1(analog-2) | Free | Free | Linear | L | None | 21 | Antimicrobial | 7% hemolysis at 25μM | Human | Arenicin-1 analog | NA | NA | ||
| 21241661 | 2011 | RWCVYAYVRVAGVLVRYRRCW | Arenicin-1(analog-2) | Free | Free | Linear | L | None | 21 | Antimicrobial | 32% hemolysis at 50μM | Human | Arenicin-1 analog | NA | NA | ||
| 21241661 | 2011 | RWCVYAYVRVAGVLVRYRRCW | Arenicin-1(analog-2) | Free | Free | Linear | L | None | 21 | Antimicrobial | 45% hemolysis at 100μM | Human | Arenicin-1 analog | NA | NA | ||
| 21497177 | 2011 | GRFKRFRKKFKKLFKKLSPVIPLLHL{ct:Amid} | BMAP -27 | Amidation | Free | Linear | L | None | 27 | Antimicrobial | 10% hemolysis at 6.2μM | Human | Bovine myeloid antimicrobial peptide 27 (BMAP 27) | α-helical | NA | ||
| 21664395 | 2011 | GIGKFLHSAGKFGKAFIGEIMKS | Magainin-M1 | Free | Free | Linear | L | None | 23 | Antibacterial | LC50 =180μM | Human | Derived from skin secretions of Xenopus muelleri | NA | NA | ||
| 21664395 | 2011 | GIGKFLHSAGKFGKAFLGEVMKS | Magainin-MW1 | Free | Free | Linear | L | None | 23 | Antibacterial | LC50 >200μM | Human | Derived from skin secretions of Xenopus muelleri West | NA | NA | ||
| 21664395 | 2011 | GMASKAGSVLGKITKIALGAL{ct:Amid} | PGLa-MW1 | Amidation | Free | Linear | L | None | 21 | Antibacterial | LC50 >200μM | Human | Derived from skin secretions of Xenopus muelleri West | NA | NA | ||
| 21664395 | 2011 | GLGSLLGKAFKFGLKTVGKMMGGAPREQ | CPF-MW1 | Free | Free | Linear | L | None | 28 | Antibacterial | LC50 =70μM | Human | Derived from skin secretions of Xenopus muelleri West | NA | NA | ||
| 21664395 | 2011 | GLGSLLGKAFKFGLKTVGKMMGGAPREE | CPF-MW2 | Free | Free | Linear | L | None | 28 | Antibacterial | LC50 =105μM | Human | Derived from skin secretions of Xenopus muelleri West | NA | NA | ||
| 22800690 | 2012 | GKLEVLHSTKKFAKGFITGLTGQ | Magainin-SE1 | Free | Free | Linear | L | None | 23 | Antimicrobial | LC50 >160μM | Human | Derived from skin secretions of Silurana epitropicalis (magainin) | NA | NA | ||
| 22800690 | 2012 | GMATKAGTALGKVAKAVIGAAL{ct:Amid} | PGLa-SE1 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | LC50 >160μM | Human | Derived from skin secretions of Silurana epitropicalis (magainin) | NA | NA | ||
| 22800690 | 2012 | GMATAAGTTLGKLAKFVIGAV{ct:Amid} | PGLa-SE2 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | LC50 >160μM | Human | Derived from skin secretions of Silurana epitropicalis (magainin) | NA | NA | ||
| 22800690 | 2012 | GLASTIGSLLGKFAKGGAQAFLQPK | XPF-SE2 | Free | Free | Linear | L | None | 25 | Antimicrobial | LC50 >160μM | Human | Derived from skin secretions of Silurana epitropicalis (magainin) | NA | NA | ||
| 22800690 | 2012 | GFWTTAAEGLKKFAKAGLASILNPK | XPF-SE3 | Free | Free | Linear | L | None | 25 | Antimicrobial | LC50 =105μM | Human | Derived from skin secretions of Silurana epitropicalis (magainin) | NA | NA | ||
| 22800690 | 2012 | GVWTTILGGLKKFAKGGLEALTNPK | XPF-SE4 | Free | Free | Linear | L | None | 25 | Antimicrobial | LC50 =60μM | Human | Derived from skin secretions of Silurana epitropicalis (magainin) | NA | NA | ||
| 22800690 | 2012 | GFLGPLLKLGLKGVAKVIPHLIPSRQQ | CPF-SE1 | Free | Free | Linear | L | None | 27 | Antimicrobial | LC50 =50μM | Human | Derived from skin secretions of Silurana epitropicalis (magainin) | NA | NA | ||
| 22800690 | 2012 | GFLGPLLKLGLKGAAKLLPQLLPSRQQ | CPF-SE2 | Free | Free | Linear | L | None | 27 | Antimicrobial | LC50 =50μM | Human | Derived from skin secretions of Silurana epitropicalis (magainin) | NA | NA | ||
| 22943778 | 2012 | GLADYWRTAFRANFANLGPGIRCKSARC | Ranatuerin-2ZHa | Free | Free | Linear | L | None | 28 | Antimicrobial | HC50 >64μM | Human | Derived from skin of Rana zhenhaiensis | NA | NA | ||
| 23403131 | 2013 | GILKTIKSIASKVANTVQKLKRKAKNAVA | Peptide | Free | Free | Linear | L | None | 29 | Antimicrobial | EC50 =46μM | Human | Derived from venom of hadrurin and vejovine(Synthetic peptide) | α-helical | NA | ||
| 23403131 | 2013 | GILKTIKSIASKVANTVQKLKRKAKNAV | Δ(Α29) | Free | Free | Linear | L | None | 28 | Antimicrobial | EC50 =47μM | Human | Derived from venom of hadrurin and vejovine(Synthetic peptide) | α-helical | NA | ||
| 23776609 | 2013 | RAGLQFPVGRLLRRLLRRLLR | BR3 | Free | Free | Linear | L | None | 21 | CPP | 5% hemolysis at 25μM | Human | buforin IIb | NA | NA | ||
| 23776609 | 2013 | RAGLQFPVGRLLRRLLRRLLR | BR3 | Free | Free | Linear | L | None | 21 | CPP | 34.3% hemolysis at 200μM | Human | buforin IIb | NA | NA | ||
| 9748603 | 1998 | FLPLLAGLAANFLPKIFCKITKRC{ct:Amid} | Brevinin 1E | Amidation | Free | Linear | L | None | 24 | Antimicrobial | HD50=1.1μg/ml | Mouse | Brevinin 1E analogs | α-helical | NA | ||
| 9748603 | 1998 | FLPLLAGLAANFLPKIFCKITKRC{ct:Amid} | Brevinin 1E (red) | Amidation | Free | Linear | L | None | 24 | Antimicrobial | HD50=1.6μg/ml | Mouse | Brevinin 1E analogs | α-helical | NA | ||
| 9748603 | 1998 | LLAGLAANFLPKIFCKITKRC{ct:Amid} | Brevinin 21 (oxi) | Amidation | Free | Linear | L | None | 21 | Antimicrobial | HD50=77μg/ml | Mouse | Brevinin 1E analogs | α-helical | NA | ||
| 9748603 | 1998 | LLAGLAANFLPKIFCKITKRC{ct:Amid} | Brevinin 21 (red) | Amidation | Free | Linear | L | None | 21 | Antimicrobial | HD50=110μg/ml | Mouse | Brevinin 1E analogs | α-helical | NA | ||
| 6325405 | 1984 | KFTIVFPHNQKGNWKNVPSNYHYCP | VSV G | Free | Free | Linear | L | None | 25 | Hemolysin | 400μg of peptide can totally lyse 7x108 erythrocytes in 10 min at pH 5.0 | Sheep | Synthetic peptide (Vesicular Stomatitis Virus) | NA | NA | ||
| 6325405 | 1984 | CKTRTSTNTDHLWIAKSKARLSET | Synthetic peptide-1 | Free | Free | Linear | L | None | 24 | Not mentioned | 0% hemolysis upto 500μg/ml (non hemolytic) | Sheep | Synthetic peptide | NA | Non-hemolytic | ||
| 8027544 | 1994 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Cytolytic | 100% hemolysis at 120μM | Mouse | Melttin (Honey bee venom) | NA | NA | ||
| 8027544 | 1994 | GIGAVLKVLTTGLPALISWIKRKRQQ{nt:Acet}{ct:Amid} | Ac-Melittin | Amidation | Acetylation | Linear | L | None | 26 | Cytolytic | 100% hemolysis at 120μM compared with melittin | Mouse | Melttin analog (Honey bee venom) | NA | NA | ||
| 8027544 | 1994 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Lac=p-amidophenyl-β-D-lactopyranoside} | Melittin-Lac | Lac=p-amidophenyl-β-D-lactopyranoside | Free | Linear | L | None | 26 | Cytolytic | 120% hemolysis at 120μM compared with melittin | Mouse | Melttin analog (Honey bee venom) | NA | NA | ||
| 8027544 | 1994 | GIGAVLKVLTTGLPALISWIKRKRQQ{nt:Lac=p-amidophenyl-β-D-lactopyranoside and Suc=Succinyl}{ct:Amid} | LacSuc-Melittin | Amidation | Lac=p-amidophenyl-β-D-lactopyranoside and Suc=Succinyl | Linear | L | None | 26 | Cytolytic | 43% hemolysis at 120μM compared with melittin | Mouse | Melttin analog (Honey bee venom) | NA | NA | ||
| 8027544 | 1994 | KRKRQQGIGAVLKVLTTGLPALISWI{ct:Amid} | Melittin-(21-26) (1-20) | Amidation | Free | Linear | L | None | 26 | Cytolytic | 20% hemolysis at 120μM compared with melittin | Mouse | Melttin analog (Honey bee venom) | NA | NA | ||
| 8027544 | 1994 | KRKRQQGIGAVLKVLTTGLPALISWI{nt:Acet}{ct:Amid} | Ac-Melttin-(21-26) (1-20) | Amidation | Acetylation | Linear | L | None | 26 | Cytolytic | 20% hemolysis at 120μM compared with melittin | Mouse | Melttin analog (Honey bee venom) | NA | NA | ||
| 8027544 | 1994 | QQRKRKGIGAVLKVLTTGLPALISWI{ct:Amid} | Melttin-(26-21) (1-20) | Amidation | Free | Linear | L | None | 26 | Cytolytic | 15% hemolysis at 120μM compared with melittin | Mouse | Melttin analog (Honey bee venom) | NA | NA | ||
| 8027544 | 1994 | QQRKRKGIGAVLKVLTTGLPALISWI{nt:Acet} | Ac-Melittin-(26-21) (1-20) | Free | Acetylation | Linear | L | None | 26 | Cytolytic | 15% hemolysis at 120μM compared with melittin | Mouse | Melttin analog (Honey bee venom) | NA | NA | ||
| 8163497 | 1994 | FLPLLAGLAANFLPKIFCKITRKC | Brevinin-1E | Free | Free | Linear | L | None | 24 | Antimicrobial | Lethal concentration = 0.5μM | Human | Derived from skin secretion of Rana esculenta | NA | NA | ||
| 2253768 | 1990 | G{d}I{d}G{d}K{d}F{d}L{d}H{d}S{d}A{d}K{d}K{d}F{d}G{d}K{d}A{d}F{d}V{d}G{d}E{d}I{d}M{d}N{d}S{d} | All-D-Magainin-2 | Free | Free | Linear | D | None | 23 | Antibacterial and Antifungal | 0% hemolysis upto 80μg/ml | Human | Derived from skin of Xenopus laevis | NA | NA | ||
| 2253768 | 1990 | G{d}I{d}G{d}K{d}F{d}L{d}H{d}S{d}A{d}K{d}K{d}F{d}G{d}K{d}A{d}F{d}V{d}G{d}E{d}I{d}M{d}N{d}S{d} | All-D-Magainin-2 | Free | Free | Linear | D | None | 23 | Antibacterial and Antifungal | 1% hemolysis at 100μg/ml | Human | Derived from skin of Xenopus laevis | NA | NA | ||
| 2253768 | 1990 | G{d}I{d}G{d}K{d}F{d}L{d}H{d}S{d}A{d}K{d}K{d}F{d}G{d}K{d}A{d}F{d}V{d}G{d}E{d}I{d}M{d}N{d}S{d} | All-D-Magainin-2 | Free | Free | Linear | D | None | 23 | Antibacterial and Antifungal | 2% hemolysis at 200μg/ml | Human | Derived from skin of Xenopus laevis | NA | NA | ||
| 2253768 | 1990 | GIGKFLHSAKKFGKAFVGEIMNS | All-L-Magainin-2 | Free | Free | Linear | L | None | 23 | Antibacterial and Antifungal | 0% hemolysis at 25μg/ml (non hemolytic) | Human | Derived from skin of Xenopus laevis | NA | Non-hemolytic | ||
| 2253768 | 1990 | GIGKFLHSAKKFGKAFVGEIMNS | All-L-Magainin-2 | Free | Free | Linear | L | None | 23 | Antibacterial and Antifungal | 1% hemolysis at 80μg/ml | Human | Derived from skin of Xenopus laevis | NA | NA | ||
| 2253768 | 1990 | GIGKFLHSAKKFGKAFVGEIMNS | All-L-Magainin-2 | Free | Free | Linear | L | None | 23 | Antibacterial and Antifungal | 2% hemolysis at 200μg/ml | Human | Derived from skin of Xenopus laevis | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-A | Free | Formylation | Linear | L | None | 26 | Cytolytic | 82% hemolysis at 25μg | Human | δ-toxin (Staphylococcus aurezis) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-A | Free | Formylation | Linear | L | None | 26 | Cytolytic | 100% hemolysis at 75μg | Human | δ-toxin (Staphylococcus aurezis) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-A | Free | Formylation | Linear | L | None | 26 | Cytolytic | 73% hemolysis at 25μg | Horse | δ-toxin (Staphylococcus aurezis) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-A | Free | Formylation | Linear | L | None | 26 | Cytolytic | 85% hemolysis at 75μg | Horse | δ-toxin (Staphylococcus aurezis) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-A | Free | Formylation | Linear | L | None | 26 | Cytolytic | 92% hemolysis at 25μg | Guinea-pig | δ-toxin (Staphylococcus aurezis) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-A | Free | Formylation | Linear | L | None | 26 | Cytolytic | 100% hemolysis at 75μg | Guinea-pig | δ-toxin (Staphylococcus aurezis) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-A | Free | Formylation | Linear | L | None | 26 | Cytolytic | 87% hemolysis at 25μg | Rabbit | δ-toxin (Staphylococcus aurezis) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-A | Free | Formylation | Linear | L | None | 26 | Cytolytic | 100% hemolysis at 75μg | Rabbit | δ-toxin (Staphylococcus aurezis) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-A | Free | Formylation | Linear | L | None | 26 | Cytolytic | 38% hemolysis at 25μg | Sheep | δ-toxin (Staphylococcus aurezis) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-A | Free | Formylation | Linear | L | None | 26 | Cytolytic | 80% hemolysis at 75μg | Sheep | δ-toxin (Staphylococcus aurezis) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-B | Free | Formylation | Linear | L | None | 26 | Cytolytic | 47% hemolysis at 25μg | Human | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-B | Free | Formylation | Linear | L | None | 26 | Cytolytic | 55% hemolysis at 75μg | Human | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-B | Free | Formylation | Linear | L | None | 26 | Cytolytic | 34% hemolysis at 25μg | Horse | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-B | Free | Formylation | Linear | L | None | 26 | Cytolytic | 43% hemolysis at 75μg | Horse | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-B | Free | Formylation | Linear | L | None | 26 | Cytolytic | 32% hemolysis at 25μg | Guinea-pig | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-B | Free | Formylation | Linear | L | None | 26 | Cytolytic | 55% hemolysis at 75μg | Guinea-pig | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-B | Free | Formylation | Linear | L | None | 26 | Cytolytic | 20% hemolysis at 25μg | Rabbit | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-B | Free | Formylation | Linear | L | None | 26 | Cytolytic | 22% hemolysis at 75μg | Rabbit | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-B | Free | Formylation | Linear | L | None | 26 | Cytolytic | 2% hemolysis at 75μg | Sheep | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK | Peptide-C | Free | Free | Linear | L | None | 26 | Cytolytic | 60% hemolysis at 75μg | Human | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK | Peptide-C | Free | Free | Linear | L | None | 26 | Cytolytic | 50% hemolysis at 75μg | Horse | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK | Peptide-C | Free | Free | Linear | L | None | 26 | Cytolytic | 58% hemolysis at 75μg | Guinea-pig | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK | Peptide-C | Free | Free | Linear | L | None | 26 | Cytolytic | 25% hemolysis at 75μg | Rabbit | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK | Peptide-C | Free | Free | Linear | L | None | 26 | Cytolytic | 8% hemolysis at 75μg | Sheep | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MLQDLLSSLGDLLKSWLDTLNKFTKK{nt:Formylation} | Peptide-F | Free | Formylation | Linear | L | None | 26 | Cytolytic | 4% hemolysis at 75μg | Human | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MLQDLLSSLGDLLKSWLDTLNKFTKK{nt:Formylation} | Peptide-F | Free | Formylation | Linear | L | None | 26 | Cytolytic | 12% hemolysis at 75μg | Horse | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MLQDLLSSLGDLLKSWLDTLNKFTKK{nt:Formylation} | Peptide-F | Free | Formylation | Linear | L | None | 26 | Cytolytic | 36% hemolysis at 75μg | Guinea-pig | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MLQDLLSSLGDLLKSWLDTLNKFTKK{nt:Formylation} | Peptide-F | Free | Formylation | Linear | L | None | 26 | Cytolytic | 0% hemolysis at 75μg (non hemolytic) | Rabbit | δ-toxin derivative (Synthetic peptide) | NA | Non-hemolytic | ||
| 2474443 | 1989 | MLQDLLSSLGDLLKSWLDTLNKFTKK{nt:Formylation} | Peptide-F | Free | Formylation | Linear | L | None | 26 | Cytolytic | 0% hemolysis at 75μg (non hemolytic) | Sheep | δ-toxin derivative (Synthetic peptide) | NA | Non-hemolytic | ||
| 2474443 | 1989 | MLQDLLSSLGDLLKSWLDTLNKFTKK | Peptide-G | Free | Free | Linear | L | None | 26 | Cytolytic | 13% hemolysis at 75μg | Human | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MLQDLLSSLGDLLKSWLDTLNKFTKK | Peptide-G | Free | Free | Linear | L | None | 26 | Cytolytic | 31% hemolysis at 75μg | Horse | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MLQDLLSSLGDLLKSWLDTLNKFTKK | Peptide-G | Free | Free | Linear | L | None | 26 | Cytolytic | 34% hemolysis at 75μg | Guinea-pig | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MLQDLLSSLGDLLKSWLDTLNKFTKK | Peptide-G | Free | Free | Linear | L | None | 26 | Cytolytic | 35% hemolysis at 75μg | Rabbit | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MLQDLLSSLGDLLKSWLDTLNKFTKK | Peptide-G | Free | Free | Linear | L | None | 26 | Cytolytic | 13% hemolysis at 75μg | Sheep | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MLQDWLSSLGDLLKSLLDTVNKFTKK{nt:Fmoc} | Peptide-H | Free | Fmoc | Linear | L | None | 26 | Cytolytic | 59% hemolysis at 75μg | Human | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MLQDWLSSLGDLLKSLLDTVNKFTKK{nt:Fmoc} | Peptide-H | Free | Fmoc | Linear | L | None | 26 | Cytolytic | 25% hemolysis at 75μg | Horse | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MLQDWLSSLGDLLKSLLDTVNKFTKK{nt:Fmoc} | Peptide-H | Free | Fmoc | Linear | L | None | 26 | Cytolytic | 91% hemolysis at 75μg | Guinea-pig | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MLQDWLSSLGDLLKSLLDTVNKFTKK{nt:Fmoc} | Peptide-H | Free | Fmoc | Linear | L | None | 26 | Cytolytic | 43% hemolysis at 75μg | Sheep | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MLQDWLSSLGDLLKSLLDTVNKFTKK | Peptide-I | Free | Free | Linear | L | None | 26 | Cytolytic | 40% hemolysis at 75μg | Human | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MLQDWLSSLGDLLKSLLDTVNKFTKK | Peptide-I | Free | Free | Linear | L | None | 26 | Cytolytic | 11% hemolysis at 75μg | Horse | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MLQDWLSSLGDLLKSLLDTVNKFTKK | Peptide-I | Free | Free | Linear | L | None | 26 | Cytolytic | 66% hemolysis at 75μg | Guinea-pig | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MLQDWLSSLGDLLKSLLDTVNKFTKK | Peptide-I | Free | Free | Linear | L | None | 26 | Cytolytic | 24% hemolysis at 75μg | Sheep | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 9022710 | 1996 | FIGSALKVLAGVLPSVISWVKQ{ct:Amid} | MLP | Amidation | Free | Linear | L | None | 22 | Antimicrobial | Lethal concentration =0.5μM | Human | Melittin like peptide | NA | NA | ||
| 9442044 | 1998 | IWLTALKFLGKHAAKHLAKQQLSKL{ct:Amid} | Lycotoxin I | Amidation | Free | Linear | L | None | 25 | Antimicrobial and Neuroactive | 55% hemolysis at 200μM | Rabbit | Lycotoxin (Lycosa carolinensis) | NA | NA | ||
| 9442044 | 1998 | GIGKFLHAAKKFAKAFVAEIMNS | Magainin-B | Free | Free | Linear | L | None | 23 | Antimicrobial | 35% hemolysis at 200μM | Rabbit | Synthetic peptide | NA | NA | ||
| 9784609 | 1998 | RQKDKRPYSERKNQYTGPQFLYPPERIPP | Lumbricin I(6-34) | Free | Free | Linear | L | None | 29 | Antimicrobial | 0.03% hemolysis at 5μg/ml | Human | Lumbricin I (Lumbricus rubellus) | NA | NA | ||
| 9784609 | 1998 | RQKDKRPYSERKNQYTGPQFLYPPERIPP | Lumbricin I(6-34) | Free | Free | Linear | L | None | 29 | Antimicrobial | 0.07% hemolysis at 10μg/ml | Human | Lumbricin I (Lumbricus rubellus) | NA | NA | ||
| 9784609 | 1998 | RQKDKRPYSERKNQYTGPQFLYPPERIPP | Lumbricin I(6-34) | Free | Free | Linear | L | None | 29 | Antimicrobial | 0.13% hemolysis at 25μg/ml | Human | Lumbricin I (Lumbricus rubellus) | NA | NA | ||
| 9784609 | 1998 | RQKDKRPYSERKNQYTGPQFLYPPERIPP | Lumbricin I(6-34) | Free | Free | Linear | L | None | 29 | Antimicrobial | 0.17% hemolysis at 50μg/ml | Human | Lumbricin I (Lumbricus rubellus) | NA | NA | ||
| 9784609 | 1998 | RQKDKRPYSERKNQYTGPQFLYPPERIPP | Lumbricin I(6-34) | Free | Free | Linear | L | None | 29 | Antimicrobial | 0.21% hemolysis at 100μg/ml | Human | Lumbricin I (Lumbricus rubellus) | NA | NA | ||
| 10430870 | 1999 | CTCSWPVCTRNGLPVCGETCVGGTCNTPG{cyc:N-C} | Kalata B1 | Free | Free | Cyclic | L | None | 29 | Antimicrobial | 50% hemolysis at >400μM | Human | Kalata (Oldenlandia affinis) | NA | NA | ||
| 10430870 | 1999 | CSCKNKVCYRNGIPCGESCVWIPCISAALG{cyc:N-C} | Cir A | Free | Free | Cyclic | L | None | 30 | Antimicrobial | 50% hemolysis at >400μM | Human | Circulin A (Chassalia parvifolia) | NA | NA | ||
| 10430870 | 1999 | CSCKNKVCYRNGVIPCGESCVFIPCISTLLG{cyc:N-C} | Cir B | Free | Free | Cyclic | L | None | 30 | Antimicrobial | 50% hemolysis at >400μM | Human | Circulin B (Chassalia parvifolia) | NA | NA | ||
| 10430870 | 1999 | CSCKSKVCYKNSIPCGESCVFIPCTVTALLG{cyc:N-C} | CPT | Free | Free | Cyclic | L | None | 30 | Antimicrobial | 50% hemolysis at >400μM | Human | Cyclopsychotride (Psychotria longipes) | NA | NA | ||
| 11713517 | 2001 | FFHHIFRGIVHVGKTIHRLVTG | Piscidin 1 | Free | Free | Linear | L | None | 22 | Antimicrobial | 0% hemolysis at 10μg/ml | Human | Piscidin (aquacultured fish, hybrid striped bass Morone saxatilis x M. Chrysops) | α-helix | NA | ||
| 11713517 | 2001 | FFHHIFRGIVHVGKTIHRLVTG | Piscidin 1 | Free | Free | Linear | L | None | 22 | Antimicrobial | ~90% hemolysis at 100μg/ml | Human | Piscidin (aquacultured fish, hybrid striped bass Morone saxatilis x M. Chrysops) | α-helix | NA | ||
| 11713517 | 2001 | FFHHIFRGIVHVGKTIHKLVTG | Piscidin 2 | Free | Free | Linear | L | None | 22 | Antimicrobial | 0% hemolysis at 10μg/ml | Human | Piscidin (aquacultured fish, hybrid striped bass Morone saxatilis x M. Chrysops) | α-helix | NA | ||
| 11713517 | 2001 | FFHHIFRGIVHVGKTIHKLVTG | Piscidin 2 | Free | Free | Linear | L | None | 22 | Antimicrobial | ~90% hemolysis at 100μg/ml | Human | Piscidin (aquacultured fish, hybrid striped bass Morone saxatilis x M. Chrysops) | α-helix | NA | ||
| 11713517 | 2001 | FIHHIFRGIVHAGRSIGRFLTG | Piscidin 3 | Free | Free | Linear | L | None | 22 | Antimicrobial | 0% hemolysis at 10μg/ml | Human | Piscidin (aquacultured fish, hybrid striped bass Morone saxatilis x M. Chrysops) | α-helix | NA | ||
| 11713517 | 2001 | FIHHIFRGIVHAGRSIGRFLTG | Piscidin 3 | Free | Free | Linear | L | None | 22 | Antimicrobial | ~5% hemolysis at 100μg/ml | Human | Piscidin (aquacultured fish, hybrid striped bass Morone saxatilis x M. Chrysops) | α-helix | NA | ||
| 11739390 | 2002 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | Wb-moronecidin | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 0% hemolysis upto 1.25μM | Human | White bass (Morone chrysops) | α-helix | NA | ||
| 11739390 | 2002 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | Wb-moronecidin | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 1% hemolysis upto 2.5μM | Human | White bass (Morone chrysops) | α-helix | NA | ||
| 11739390 | 2002 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | Wb-moronecidin | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 0% hemolysis upto 5μM | Sheep | White bass (Morone chrysops) | α-helix | Non-hemolytic | ||
| 11739390 | 2002 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | Wb-moronecidin | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 19% hemolysis at 5μM | Human | White bass (Morone chrysops) | α-helix | NA | ||
| 11739390 | 2002 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | Wb-moronecidin | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 11% hemolysis at 10μM | Sheep | White bass (Morone chrysops) | α-helix | NA | ||
| 11739390 | 2002 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | Wb-moronecidin | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 55% hemolysis at 10μM | Human | White bass (Morone chrysops) | α-helix | NA | ||
| 11739390 | 2002 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | Wb-moronecidin | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 51% hemolysis at 20μM | Sheep | White bass (Morone chrysops) | α-helix | NA | ||
| 11739390 | 2002 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | Wb-moronecidin | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 100% hemolysis at 80μM | Human | White bass (Morone chrysops) | α-helix | NA | ||
| 11739390 | 2002 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | Wb-moronecidin | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 80% hemolysis at 40μM | Sheep | White bass (Morone chrysops) | α-helix | NA | ||
| 11739390 | 2002 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | Wb-moronecidin | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 100% hemolysis at 80μM | Sheep | White bass (Morone chrysops) | α-helix | NA | ||
| 1605597 | 1992 | GIGKFLHSAKKFGKAFVGEIMNS | Peptide-1 | Free | Free | Linear | L | None | 23 | Antibacterial | 0% hemolysis upto 100μg/ml | Human | Magainin-2 analog (Skin secretion of the african frog Xenopus laevis) | NA | NA | ||
| 1605597 | 1992 | GIGKFLHSAKKFGKAFVGEIMNS | Peptide-1 | Free | Free | Linear | L | None | 23 | Antibacterial | 1% hemolysis upto 200μg/ml | Human | Magainin-2 analog (Skin secretion of the african frog Xenopus laevis) | NA | NA | ||
| 1605597 | 1992 | KKFLHSAKKWLKAFVKLKKNW | Peptide-8 | Free | Free | Linear | L | None | 21 | Antibacterial | 3% hemolysis at 25μg/ml | Human | Magainin-2 analog (Skin secretion of the african frog Xenopus laevis) | NA | NA | ||
| 1605597 | 1992 | KKFLHSAKKWLKAFVKLKKNW | Peptide-8 | Free | Free | Linear | L | None | 21 | Antibacterial | 16% hemolysis at 50μg/ml | Human | Magainin-2 analog (Skin secretion of the african frog Xenopus laevis) | NA | NA | ||
| 1605597 | 1992 | KKFLHSAKKWLKAFVKLKKNW | Peptide-8 | Free | Free | Linear | L | None | 21 | Antibacterial | 29% hemolysis at 100μg/ml | Human | Magainin-2 analog (Skin secretion of the african frog Xenopus laevis) | NA | NA | ||
| 1605597 | 1992 | KKFLHSAKKWLKAFVKLKKNW | Peptide-8 | Free | Free | Linear | L | None | 21 | Antibacterial | 41% hemolysis at 200μg/ml | Human | Magainin-2 analog (Skin secretion of the african frog Xenopus laevis) | NA | NA | ||
| 1605597 | 1992 | GIGKLFLHAAKKFAKAFVAEKMNS | Peptide-9 | Free | Free | Linear | L | None | 24 | Antibacterial | 0% hemolysis upto 200μg/ml (non hemolytic) | Human | Magainin-2 analog (Skin secretion of the african frog Xenopus laevis) | NA | Non-hemolytic | ||
| 11738090 | 2001 | GFLGPLLKLAAKGVAKVIPHLIPSRQQ | XT-1 | Free | Free | Linear | L | None | 27 | Antimicrobial | HC50 =90μM | Human | XT (skin secretions of the diploid frog Xenopus tropicalis) | NA | NA | ||
| 11738090 | 2001 | GVFLDALKKFAKGGMNAVLNPK | XT-4 | Free | Free | Linear | L | None | 22 | Antimicrobial | HC50 >150μM | Human | XT (skin secretions of the diploid frog Xenopus tropicalis) | NA | NA | ||
| 11738090 | 2001 | GMATKAGTALGKVAKAVIGAAL{ct:Amid} | XT-5 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | HC50 >150μM | Human | XT (skin secretions of the diploid frog Xenopus tropicalis) | NA | NA | ||
| 19427345 | 2009 | GFMKYIGPLIPHAVKAISDLI{ct:Amid} | Kassinatuerin-1S | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 45-50% hemolysis at 120μM | Horse | Kassinatuerin 2 (skin secretion of the African hyperoliid frog Kassina maculata) | NA | NA | ||
| 9026036 | 1997 | CIGAVLKVLTTGLPALISWIKRKRQQ | Dioleoylmelittin | Free | Free | Linear | L | None | 26 | Membrane disturbing | ~20% hemolysis at 1μM | Dog | Synthetic peptide | NA | NA | ||
| 9026036 | 1997 | CIGAVLKVLTTGLPALISWIKRKRQQ | Dioleoylmelittin | Free | Free | Linear | L | None | 26 | Membrane disturbing | 100% hemolysis at 10μM | Dog | Synthetic peptide | NA | NA | ||
| 9166783 | 1997 | GLGKFLHSAKRFGKAFVGEAMNS{ct:Amid} | L2R11A20-M2a | Amidation | Free | Linear | L | None | 23 | Antibacterial | EC50 >1000μM | Human | Maginin-2 analog ( skin of the African clawed frog Xenopus laevis) | NA | NA | ||
| 9166783 | 1997 | GLGKFLHSAKRFGKAFVGEAMNS{ct:Amid} | L2R11A20-M2a | Amidation | Free | Linear | L | None | 23 | Antibacterial | 12% hemolysis at 150μM | Human | Maginin-2 analog ( skin of the African clawed frog Xenopus laevis) | NA | NA | ||
| 9166783 | 1997 | GIGKFLHSAKKFGKAFVGEIMNS{ct:Amid} | M2a | Amidation | Free | Linear | L | None | 23 | Antibacterial | EC50 =430μM | Human | Maginin-2 analog ( skin of the African clawed frog Xenopus laevis) | NA | NA | ||
| 9166783 | 1997 | GIGKFLHSAKKFGKAFVGEIMNS{ct:Amid} | M2a | Amidation | Free | Linear | L | None | 23 | Antibacterial | 30% hemolysis at 150μM | Human | Maginin-2 analog ( skin of the African clawed frog Xenopus laevis) | NA | NA | ||
| 9166783 | 1997 | GIGKFIHSAKKFGKLFVGEIMNS{ct:Amid} | I6L15-M2a | Amidation | Free | Linear | L | None | 23 | Antibacterial | EC50 =260μM | Human | Maginin-2 analog ( skin of the African clawed frog Xenopus laevis) | NA | NA | ||
| 9166783 | 1997 | GIGKFIHSAKKFGKLFVGEIMNS{ct:Amid} | I6L15-M2a | Amidation | Free | Linear | L | None | 23 | Antibacterial | 40% hemolysis at 150μM | Human | Maginin-2 analog ( skin of the African clawed frog Xenopus laevis) | NA | NA | ||
| 9166783 | 1997 | GIGKFIHAAKKFGKLFIGEIMNS{ct:Amid} | I6A8L15I17-M2a | Amidation | Free | Linear | L | None | 23 | Antibacterial | EC50 =32μM | Human | Maginin-2 analog ( skin of the African clawed frog Xenopus laevis) | NA | NA | ||
| 9166783 | 1997 | GIGKFIHAAKKFGKLFIGEIMNS{ct:Amid} | I6A8L15I17-M2a | Amidation | Free | Linear | L | None | 23 | Antibacterial | 98% hemolysis at 150μM | Human | Maginin-2 analog ( skin of the African clawed frog Xenopus laevis) | NA | NA | ||
| 11689009 | 2001 | GLNALKKVFQGIHEAIKLINNHVQ | Pseudin-2 | Free | Free | Linear | L | None | 24 | Antimicrobial | EC50 >300μM | Human | Pseudin (extract of the skin of the paradoxical frog Pseudis paradoxa) | NA | NA | ||
| 11479030 | 2001 | ILQKAVLDCLKAAGSSLSKAAITAIYNKIT | Dicynthaurin | Free | Free | Linear | L | None | 30 | Antimicrobial | 0% hemolysis at 25μg/ml | Human | Dicynthaurin (hemocytes of the solitary tunicate Halocynthia aurantium) | NA | NA | ||
| 11479030 | 2001 | ILQKAVLDCLKAAGSSLSKAAITAIYNKIT | Dicynthaurin | Free | Free | Linear | L | None | 30 | Antimicrobial | 10% hemolysis at 50μg/ml | Human | Dicynthaurin (hemocytes of the solitary tunicate Halocynthia aurantium) | NA | NA | ||
| 11479030 | 2001 | ILQKAVLDCLKAAGSSLSKAAITAIYNKIT | Dicynthaurin | Free | Free | Linear | L | None | 30 | Antimicrobial | 20% hemolysis at 100μg/ml | Human | Dicynthaurin (hemocytes of the solitary tunicate Halocynthia aurantium) | NA | NA | ||
| 11479030 | 2001 | QKAVLDCLKAAGSSLSKAAITAI | Cynthaurin | Free | Free | Linear | L | None | 23 | Antimicrobial | 0% hemolysis at 100μg/ml (non hemolytic) | Human | Synthetic peptide | NA | Non-hemolytic | ||
| 3299384 | 1987 | GIGKFLHSAKKFGKAFVGEIMNS | Magainin-2 | Free | Free | Linear | L | None | 23 | Antimicrobial | 0% hemolysis at 10μg/ml (non hemolytic) | Human | Magainin-2 (skin of the African clawed frog Xenopus laevis) | NA | Non-hemolytic | ||
| 12005415 | 2001 | FLRFIGSVIHGIGHLVHHIGVAL{ct:Amid} | Clavaspirin | Amidation | Free | Linear | L | None | 23 | Antimicrobial | ~70% hemolysis at 20μg/ml | Human | Clavaspirin pharyngeal tissues of the tunicate,Styela clava | NA | NA | ||
| 12005415 | 2001 | FLRFIGSVIHGIGHLVHHIGVAL{ct:Amid} | Clavaspirin | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 75% hemolysis at 80μg/ml | Human | Clavaspirin pharyngeal tissues of the tunicate,Styela clava | NA | NA | ||
| 12067731 | 2002 | ALLHHGLNCAKGVLAALLHHGLNCAKGVLA | 15 homodimer halocidin | Free | Free | Linear | L | None | 30 | Antimicrobial | 0% hemolysis at 100μg/ml (non hemolytic) | Human | Halocidin (hemocytes of the solitary tunicate Halocynthia aurantium) | NA | Non-hemolytic | ||
| 12581207 | 2003 | FFGWLIKGAIHAGKAIHGLIHRRRH{ct:Amid} | Chrysophsin-1 | Amidation | Free | Linear | L | None | 25 | Antibacterial | ~40% hemolysis at 1μM | Human | Chrysophsin (the gills of red sea bream Chrysophrys major) | NA | NA | ||
| 12581207 | 2003 | FFGWLIKGAIHAGKAIHGLIHRRRH{ct:Amid} | Chrysophsin-1 | Amidation | Free | Linear | L | None | 25 | Antibacterial | 100% hemolysis at 100μM | Human | Chrysophsin (the gills of red sea bream Chrysophrys major) | NA | NA | ||
| 12581207 | 2003 | FFGWLIRGAIHAGKAIHGLIHRRRH{ct:Amid} | Chrysophsin-2 | Amidation | Free | Linear | L | None | 25 | Antibacterial | >40% hemolysis at 1μM | Human | Chrysophsin (the gills of red sea bream Chrysophrys major) | NA | NA | ||
| 12581207 | 2003 | FFGWLIRGAIHAGKAIHGLIHRRRH{ct:Amid} | Chrysophsin-2 | Amidation | Free | Linear | L | None | 25 | Antibacterial | 100% hemolysis at 100μM | Human | Chrysophsin (the gills of red sea bream Chrysophrys major) | NA | NA | ||
| 11563967 | 2001 | FWGALAKGALKLIPSLFSSFSKKD | Pandinin 2 | Free | Free | Linear | L | None | 24 | Antimicrobial | 90.5±0.8% hemolysis at 44.5μM | Sheep | Pandinin (venom of the African scorpion Pandinus imperator) | NA | NA | ||
| 11563967 | 2001 | FWGALAKGALKLIPSLFSSFSKKD | Pandinin 2 | Free | Free | Linear | L | None | 24 | Antimicrobial | 51.4±0.5% hemolysis at 22.2μM | Sheep | Pandinin (venom of the African scorpion Pandinus imperator) | NA | NA | ||
| 11563967 | 2001 | FWGALAKGALKLIPSLFSSFSKKD | Pandinin 2 | Free | Free | Linear | L | None | 24 | Antimicrobial | 17.5±1.1% hemolysis at 11.1μM | Sheep | Pandinin (venom of the African scorpion Pandinus imperator) | NA | NA | ||
| 11563967 | 2001 | FWGALAKGALKLIPSLFSSFSKKD | Pandinin 2 | Free | Free | Linear | L | None | 24 | Antimicrobial | 3.7±0.1% hemolysis at 5.5μM | Sheep | Pandinin (venom of the African scorpion Pandinus imperator) | NA | NA | ||
| 11563967 | 2001 | FWGALAKGALKLIPSLFSSFSKKD | Pandinin 2 | Free | Free | Linear | L | None | 24 | Antimicrobial | 1.4±0.3% hemolysis at 2.7μM | Sheep | Pandinin (venom of the African scorpion Pandinus imperator) | NA | NA | ||
| 2689223 | 1989 | KWKLFKKIEKVGQGIGAVLKVLTTGL{ct:Amid} | CA(1-13)M(1-13) | Amidation | Free | Linear | L | None | 26 | Antibacterial and Antiparasitic | Lethal concentration calculated from zone of inhibition >200μM | Sheep | Cercropin-melittin hybrids | NA | NA | ||
| 2689223 | 1989 | AVAVVGQATQIAKKWKLFKKIEKVGQ{ct:Amid} | CA(25-37)CA(1-13) | Amidation | Free | Linear | L | None | 26 | Antibacterial and Antiparasitic | Lethal concentration calculated from zone of inhibition >300μM | Sheep | Cercropin-melittin hybrids | NA | NA | ||
| 2689223 | 1989 | GIGAVLKVLTTGLKWKLFKKIEKVGQ{ct:Amid} | M(1-13)CA(1-13) | Amidation | Free | Linear | L | None | 26 | Antibacterial and Antiparasitic | Lethal concentration calculated from zone of inhibition 80μM | Sheep | Cercropin-melittin hybrids | NA | NA | ||
| 2689223 | 1989 | LISWIKRKRQQGIGAVLKVLTTGL{ct:Amid} | M(16-26)M(1-13) | Amidation | Free | Linear | L | None | 24 | Antibacterial and Antiparasitic | Lethal concentration calculated from zone of inhibition >200μM | Sheep | Cercropin-melittin hybrids | NA | NA | ||
| 9395500 | 1997 | {nnr:X}ALWMTLLKKVLKAAAKAALNAVLVGANA | DS4 | Free | Free | Linear | L | X = H | 29 | Antimicrobial and Cytolytic | Hemolysis observed at >8.5μM | Human | Dermaseptins (skin of the tree frogs) | NA | NA | ||
| 15304333 | 2004 | RCLPAGKTCVRGPMRVPCCGSCSQNKCT | PcFK2 | Free | Free | Linear | L | None | 28 | Antiplasmodial | No hemolysis at 10μM (non hemolytic) | Human | Psalmopeotoxins (venom of the Trinidad chevron tarantula Psalmopoeus cambridgei) | NA | Non-hemolytic | ||
| 18519720 | 2008 | AGYLLGKINLKALAALAKKIL{ct:Amid} | TP10 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 5% hemolysis at 30μM | Human | Synthetic peptide | NA | NA | ||
| 18984589 | 2009 | KKALL{nnr:O}HALH{nnr:O}LALLA{nnr:O}HLAH{nnr:O}LKKA{ct:Amid} | HALO | Amidation | Free | Linear | L | O = L-Ornithine | 26 | Antimicrobial and Antiplasmodial | HC50 =179.2μM | Human | Synthetic peptide | NA | NA | ||
| 18984589 | 2009 | ALALL{nnr:O}HALH{nnr:O}LALLA{nnr:O}HLAH{nnr:O}LALA{ct:Amid} | HALO-2 | Amidation | Free | Linear | L | O = L-Ornithine | 26 | Antimicrobial and Antiplasmodial | HC50 <5.6μM | Human | Synthetic peptide | NA | NA | ||
| 18984589 | 2009 | FFKKL{nnr:O}HALH{nnr:O}LALLA{nnr:O}HLAH{nnr:O}LKKA{ct:Amid} | HALO-F | Amidation | Free | Linear | L | O = L-Ornithine | 26 | Antimicrobial and Antiplasmodial | HC50 <5.6μM | Human | Synthetic peptide | NA | NA | ||
| 18984589 | 2009 | KKALL{nnr:O}HPLH{nnr:O}LALLA{nnr:O}HLAH{nnr:O}LKKA{ct:Amid} | HALO-P8 | Amidation | Free | Linear | L | O = L-Ornithine | 26 | Antimicrobial and Antiplasmodial | HC50 =89.6μM | Human | Synthetic peptide | NA | NA | ||
| 18984589 | 2009 | A{d}K{d}K{d}L{d}{nnr:d-o}H{d}A{d}L{d}H{d}{nnr:d-o}A{d}L{d}L{d}A{d}L{d}{nnr:d-o}H{d}L{d}A{d}H{d}{nnr:d-o}L{d}L{d}A{d}K{d}K{d}{ct:Amid} | D-HALO-rev | Amidation | Free | Linear | D | o = D-Ornithine | 26 | Antimicrobial and Antiplasmodial | HC50 =716.8μM | Human | Synthetic peptide | NA | NA | ||
| 18984589 | 2009 | A{d}K{d}K{d}L{d}{nnr:d-o}H{d}A{d}L{d}H{d}{nnr:d-o}A{d}L{d}L{d}A{d}L{d}{nnr:d-o}H{d}L{d}P{d}H{d}{nnr:d-o}L{d}K{d}K{d}F{d}F{d}{ct:Amid} | D-HALO-P8Frev | Amidation | Free | Linear | D | o = D-Ornithine | 26 | Antimicrobial and Antiplasmodial | HC50 >65.2μM | Human | Synthetic peptide | NA | NA | ||
| 18332165 | 2008 | KILRGVCKKIMRTFLRRISKDILTGKK{ct:Amid} | NK-2 | Amidation | Free | Linear | L | None | 27 | Antiplasmodial | No hemolysis upto 10μM (non hemolytic) | Human | Synthetic shortened analog of the mammalian defense protein NK-lysin | NA | Non-hemolytic | ||
| 9048567 | 1997 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antibacterial | 100% hemolysis at 50μM | Human | Melittin ( venom of the honey bee Apis mellifera) | NA | NA | ||
| 9048567 | 1997 | GIGAV{d}LKV{d}LTTGLPALI{d}SWIK{d}RKRQQ{ct:Amid} | [D]-V5,8,I17,K21-melittin | Amidation | Free | Linear | Mix | None | 26 | Antibacterial | 0% hemolysis at 50μM | Human | Melittin diastereomers ( venom of the honey bee Apis mellifera) | NA | Non-hemolytic | ||
| 9048567 | 1997 | GIGAV{d}LKV{d}LTTGLPALI{d}SWIK{d}RKRQQ | [D]-V5,8,I17,K21-melittin | Free | Free | Linear | Mix | None | 26 | Antibacterial | ~1-2% hemolysis at 50μM | Human | Melittin diastereomers (Apis mellifera) | NA | NA | ||
| 9335545 | 1997 | GVAKFGKAAAHFGKGWIKEMLNS{ct:Amid} | 80°M2a | Amidation | Free | Linear | L | None | 23 | Antibacterial | EC25=307μM | Human | Synthetic peptide | NA | NA | ||
| 9335545 | 1997 | GIAKFGKAAAHFGKKWVGELMNS{ct:Amid} | 100°M2a | Amidation | Free | Linear | L | None | 23 | Antibacterial | EC25=159μM | Human | Synthetic peptide | NA | NA | ||
| 9335545 | 1997 | GIGKFLHSAKKFGKAWVGEIMNS{ct:Amid} | 120°M2a | Amidation | Free | Linear | L | None | 23 | Antibacterial | EC25=271μM | Human | Synthetic peptide | NA | NA | ||
| 9335545 | 1997 | GIGKFLHTLKTFGKKWVGEIMNS{ct:Amid} | 140°M2a | Amidation | Free | Linear | L | None | 23 | Antibacterial | EC25=15μM | Human | Synthetic peptide | NA | NA | ||
| 9335545 | 1997 | GIGKFLHKVKSFGKSWIGEIMNS{ct:Amid} | 160°M2a | Amidation | Free | Linear | L | None | 23 | Antibacterial | EC25=20μM | Human | Synthetic peptide | NA | NA | ||
| 9335545 | 1997 | GIGKFLHKVGSFIKSWKGEIMNS{ct:Amid} | 180°M2a | Amidation | Free | Linear | L | None | 23 | Antibacterial | EC25=24μM | Human | Synthetic peptide | NA | NA | ||
| 10387056 | 1999 | KWKSFIKKLTSAAKKVVTTAKPLISS | CP26p | Free | Free | Linear | L | None | 26 | Antimicrobial | MHC=8μg/ml | Human | Synthetic peptide | NA | NA | ||
| 10387056 | 1999 | KWKSFLKTFKSAVKTVLHTALKAISS | V681n | Free | Free | Linear | L | None | 26 | Antimicrobial | MHC >128μg/ml | Human | Synthetic peptide | NA | NA | ||
| 10387056 | 1999 | KWKSFLRTLKSPAKTVFHTALKAISS | V25p | Free | Free | Linear | L | None | 26 | Antimicrobial | MHC >128μg/ml | Human | Synthetic peptide | NA | NA | ||
| 10387056 | 1999 | KWKSFLKKLTSAAKKVLTTALKPISS | V26p | Free | Free | Linear | L | None | 26 | Antimicrobial | MHC=64μg/ml | Human | Synthetic peptide | NA | NA | ||
| 10387056 | 1999 | KWKSFLKTLKSPVKTVFYTALKPISS | V1pp | Free | Free | Linear | L | None | 26 | Antimicrobial | MHC >128μg/ml | Human | Synthetic peptide | NA | NA | ||
| 10387056 | 1999 | KWKSFLRTFKSPVRTVFHTALKPISS | V8pp | Free | Free | Linear | L | None | 26 | Antimicrobial | MHC=32μg/ml | Human | Synthetic peptide | NA | NA | ||
| 10387056 | 1999 | KWKSFLKTFKSPVKTVFYTALKPISS | V14pp | Free | Free | Linear | L | None | 26 | Antimicrobial | MHC >128μg/ml | Human | Synthetic peptide | NA | NA | ||
| 10387056 | 1999 | KWKSFLKTFKSPARTVLYTALKPISS | V68pp | Free | Free | Linear | L | None | 26 | Antimicrobial | MHC >128μg/ml | Human | Synthetic peptide | NA | NA | ||
| 10387056 | 1999 | KWKSFLKTFKSPARTVLHTALKPISS | V31pp | Free | Free | Linear | L | None | 26 | Antimicrobial | MHC >128μg/ml | Human | Synthetic peptide | NA | NA | ||
| 19085906 | 2008 | FWGHIWNAVKRVGANALHGAVTGALS | Halocyntin | Free | Free | Linear | L | None | 26 | Antimicrobial | 22% hemolysis at 50µM | Sheep | Halocyntin (Halocynthia papillosa) | NA | NA | ||
| 18000874 | 2007 | GLLNGLALRLGKRALKKIIKRLCR | Cryptonin | Free | Free | Linear | L | None | 24 | Antimicrobial | 5% hemolysis upto 200µg/ml | Rat | Cryptonin (Cryptotympana dubia) | NA | NA | ||
| 17927208 | 2007 | FHPSLWVLIPQYIQLIRKILKSG | Conolysin-Mt | Free | Free | Linear | L | None | 23 | Cytolytic | 40% hemolysis at 1µM | Human | Derived from venom of Conus mustelinus | NA | NA | ||
| 17927208 | 2007 | FHPSLWVLIPQYIQLIRKILKSG | Conolysin-Mt | Free | Free | Linear | L | None | 23 | Cytolytic | ~90% hemolysis at 10µM | Human | Derived from venom of Conus mustelinus | NA | NA | ||
| 17884127 | 2007 | GLLDFVTGVGKDIFAQLIKQI{ct:Amid} | Ocellatin 4 | Amidation | Free | Linear | L | None | 21 | Cytolytic | HC50 =14.3 mM | Human | Derived from skin secretion of Leptodactylus ocellatus | NA | NA | ||
| 17764786 | 2007 | SIITMTKEAKLPQLWKQIACRLYNTC{cyc:N-C} | Pleurain-A1 | Free | Free | Cyclic | L | None | 26 | Antimicrobial | Little hemolysis at 200mg/ml | Human | Derived from skin secretion of Rana pleuraden | NA | NA | ||
| 17764786 | 2007 | SIITMTKEAKLPQSWKQIACRLYNTC{cyc:N-C} | Pleurain-A2 | Free | Free | Cyclic | L | None | 26 | Antimicrobial | Little hemolysis at 200mg/ml | Human | Derived from skin secretion of Rana pleuraden | NA | NA | ||
| 17764786 | 2007 | SIITMTREAKLPQLWKQIACRLYNTC{cyc:N-C} | Pleurain-A3 | Free | Free | Cyclic | L | None | 26 | Antimicrobial | Little hemolysis at 200mg/ml | Human | Derived from skin secretion of Rana pleuraden | NA | NA | ||
| 17764786 | 2007 | SIITTTKEAKLPQLWKQIACRLYNTC{cyc:N-C} | Pleurain-A4 | Free | Free | Cyclic | L | None | 26 | Antimicrobial | Little hemolysis at 200mg/ml | Human | Derived from skin secretion of Rana pleuraden | NA | NA | ||
| 17698252 | 2007 | GLLRASSVWGRKYYVDLAGCAKA | Odorranin-HP | Free | Free | Linear | L | None | 23 | Antimicrobial | Little hemolysis at 100µg/ml | Rabbit | Derived from skin secretion of Odorrana grahami | NA | NA | ||
| 17272268 | 2007 | GFMDTAKNVAKNVAVTLLDNLKCKITKAC | Odorranain-F1 | Free | Free | Linear | L | None | 29 | Antimicrobial | 15.4±3.5% hemolysis at 50µg/ml | Human | Odorranain (Odorrana grahami) | NA | NA | ||
| 17272268 | 2007 | GLFGKSSVWGRKYYVDLAGCAKA | Odorranain-W1 | Free | Free | Linear | L | None | 23 | Antimicrobial | 17.6±2.2% hemolysis at 50µg/ml | Human | Odorranain (Odorrana grahami) | NA | NA | ||
| 17272268 | 2007 | GIFGKILGVGKKVLCGLSGVC | Odorranain-H1 | Free | Free | Linear | L | None | 21 | Antimicrobial | 21.6±7.3% hemolysis at 50µg/ml | Human | Odorranain (Odorrana grahami) | NA | NA | ||
| 17272268 | 2007 | GLLGKILGVEKKVLCGLSGMC | Nigrocin-OG2 | Free | Free | Linear | L | None | 21 | Antimicrobial | 60±7.1% hemolysis at 50µg/ml | Human | Nigrocin (Odorrana grahami) | NA | NA | ||
| 17272268 | 2007 | GLLSGILGAGKHIICGLSGLC | Nigrocin-OG4 | Free | Free | Linear | L | None | 21 | Antimicrobial | 65.5±7.7% hemolysis at 50µg/ml | Human | Nigrocin (Odorrana grahami) | NA | NA | ||
| 17272268 | 2007 | GLLSGILGAGKQKVCGLSGLC | Nigrocin-OG5 | Free | Free | Linear | L | None | 21 | Antimicrobial | 87.2±2.6% hemolysis at 50µg/ml | Human | Nigrocin (Odorrana grahami) | NA | NA | ||
| 17272268 | 2007 | GLLSGVLGVGKKVLCGLSGLC | Nigrocin-OG21 | Free | Free | Linear | L | None | 21 | Antimicrobial | 100% hemolysis at 50µg/ml | Human | Nigrocin (Odorrana grahami) | NA | NA | ||
| 8620888 | 1996 | GFFALIPKIISSPLFKTLLSAV | Des-(23-33)-pardaxin | Free | Free | Linear | L | None | 22 | Antibacterial | >100% hemolysis at 10µM | Human | Pardaxin analog (Pardachirus marmoratus) | NA | NA | ||
| 8620888 | 1996 | GFFALIPKIISSPLFKTLLSAV{ct:[NH(CH2)2NH2]2} | Des-(23-33)-pardaxin-[NH(CH2)2NH2]2 | [NH(CH2)2NH2]2 | Free | Linear | L | None | 22 | Antibacterial | <20% hemolysis at 50µM | Human | Pardaxin analog (Pardachirus marmoratus) | NA | NA | ||
| 8620888 | 1996 | KGFFALIPKIISSPLFKTLLSAV{ct:[NH(CH2)2NH2]2} | Lys-des-(23- 33)-pardaxin-[NH(CH2)2NH2]2 | [NH(CH2)2NH2]2 | Free | Linear | L | None | 23 | Antibacterial | No hemolysis (Non hemolytic) | Human | Pardaxin analog (Pardachirus marmoratus) | NA | Non-hemolytic | ||
| 8620888 | 1996 | ISSPLFKTLLSAVGSALSSSGGQE | Des-(I -9)-pardaxin | Free | Free | Linear | L | None | 24 | Antibacterial | No hemolysis (Non hemolytic) | Human | Pardaxin analog (Pardachirus marmoratus) | NA | Non-hemolytic | ||
| 8620888 | 1996 | ISSPLFKTLLSAVGSALSSSGGQE{ct:[NH(CH2)2NH2]2} | Des-(I -9)-pardaxin-[NH(CH2)2NH2]2 | [NH(CH2)2NH2]2 | Free | Linear | L | None | 24 | Antibacterial | No hemolysis (Non hemolytic) | Human | Pardaxin analog (Pardachirus marmoratus) | NA | Non-hemolytic | ||
| 8508915 | 1993 | FLPLLAGLAANFLPKIFCKITRKC | Brevinin-1 E | Free | Free | Linear | L | None | 24 | Antimicrobial | LC50 =5µM | Human | Derived from skin secretion of Rana esculenta | NA | NA | ||
| 8508915 | 1993 | FLPVLAGIAAKVVPALFCKITKKC | Brevinin-2 E | Free | Free | Linear | L | None | 24 | Antimicrobial | LC50 >100µM | Human | Derived from skin secretion of Rana esculenta | NA | NA | ||
| 7989335 | 1994 | ALWKNMLKGIGKLAGKAALGAVKKLVGAES | DS s3 | Free | Free | Linear | L | None | 30 | Antimicrobial | 100% hemolysis at 80µM | Human | Dermaseptin analog (Phyllomedusa sauvagii) | NA | NA | ||
| 7989335 | 1994 | ALWMTLLKKVLKAAAKAALNAVLVGANA | DS s4 | Free | Free | Linear | L | None | 28 | Antimicrobial | 100% hemolysis at 1µM | Human | Dermaseptin analog (Phyllomedusa sauvagii) | NA | NA | ||
| 7989335 | 1994 | GLWSKIKTAGKSVAKAAAKAAVKAVTNAV | DS s5 | Free | Free | Linear | L | None | 29 | Antimicrobial | 100% hemolysis at >90µM | Human | Dermaseptin analog (Phyllomedusa sauvagii) | NA | NA | ||
| 7999137 | 1994 | FLGALFKVASKVLPSVKCAITKKC | Gaegurin 5 | Free | Free | Linear | L | None | 24 | Antimicrobial | 1.01% hemolysis at 100µM | Human | Derived from skin of Rana rugosa | NA | NA | ||
| 7999137 | 1994 | FLPLLAGLAANFLPTIICKISYKC | Gaegurin 6 | Free | Free | Linear | L | None | 24 | Antimicrobial | 0.86% hemolysis at 100µM | Human | Derived from skin of Rana rugosa | NA | NA | ||
| 8353519 | 1993 | SIGSALKKALPVAKKIGKIALPIAKAALP | Ceratotoxin A | Free | Free | Linear | L | None | 29 | Antibacterial | Area of inhibition ~25mm2 at 5 nmol | Human | Derived from secretion of the female reproductive accessory glands of Ceratitis capitata | NA | NA | ||
| 19716842 | 2010 | FLPKMSTKLRVPYRRGTKDYH | Scolopin 1 | Free | Free | Linear | L | None | 21 | Antimicrobial | 25±2% hemolysis at 50µg/ml | Human | Derived from venom of Scolopendra subspinipes mutilans | NA | NA | ||
| 19716842 | 2010 | FLPKMSTKLRVPYRRGTKDYH | Scolopin 1 | Free | Free | Linear | L | None | 21 | Antimicrobial | 21±5% hemolysis at 50µg/ml | Rabbit | Derived from venom of Scolopendra subspinipes mutilans | NA | NA | ||
| 19716842 | 2010 | GILKKFMLHRGTKVYKMRTLSKRSH | Scolopin 2 | Free | Free | Linear | L | None | 25 | Antimicrobial | 32±7% hemolysis at 50µg/ml | Human | Derived from venom of Scolopendra subspinipes mutilans | NA | NA | ||
| 19716842 | 2010 | GILKKFMLHRGTKVYKMRTLSKRSH | Scolopin 2 | Free | Free | Linear | L | None | 25 | Antimicrobial | 37±6% hemolysis at 50µg/ml | Rabbit | Derived from venom of Scolopendra subspinipes mutilans | NA | NA | ||
| 23483218 | 2013 | LDVKKIICVACKIKPNPACKKICPK | PNG-K | Free | Free | Linear | L | None | 25 | Antimicrobial | LC50 >200µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LDVKKII-{nnr:Abu}-VA-{nnr:Abu}-KIKPNPA-{nnr:Abu}-KKI-{nnr:Abu}-PK | PNG-K/1 | Free | Free | Linear | L | Abu = 2-aminobutyric acid | 25 | Antimicrobial | LC50 >200µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LDVKKIICVACKIRPNPACKKICPK | PNG-R | Free | Free | Linear | L | None | 25 | Antimicrobial | LC50 >200µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 23483218 | 2013 | LDVKKII-{nnr:Abu}-VA-{nnr:Abu}-KIRPNPA-{nnr:Abu}-KKI-{nnr:Abu}-PK | PNG-R/1 | Free | Free | Linear | L | Abu = 2-aminobutyric acid | 25 | Antimicrobial | LC50 >200µM | Human | Panurgine analog (PNG-I) | NA | NA | ||
| 20656059 | 2010 | GLGSLLGKAFKIGLKTVGKMMGGAPREQ | CPF-B1 | Free | Free | Linear | L | None | 25 | Antimicrobial | 18% hemolysis at 200μM | Human | Caerulein-precursor fragments (Xenopus borealis) | NA | NA | ||
| 9009216 | 1997 | SLSRYAKLANRLANPKLLETFLSKWIG | SPLN | Free | Free | Linear | L | None | 27 | Antimicrobial | 5% hemolysis at 30μg/ml | Rat | Seminalplasmin (Bovine) | NA | NA | ||
| 9009216 | 1997 | SLSRYAKLANRLANPKLLETFLSKWIG | SPLN | Free | Free | Linear | L | None | 27 | Antimicrobial | 20% hemolysis at 45μg/ml | Rat | Seminalplasmin (Bovine) | NA | NA | ||
| 9009216 | 1997 | SLSRYAKLANRLANPKLLETFLSKWIG | SPLN | Free | Free | Linear | L | None | 27 | Antimicrobial | 30% hemolysis at 60μg/ml | Rat | Seminalplasmin (Bovine) | NA | NA | ||
| 9009216 | 1997 | SLSRYAKLANRLANPKLLETFLSKWIG | SPLN | Free | Free | Linear | L | None | 27 | Antimicrobial | 50% hemolysis at 75μg/ml | Rat | Seminalplasmin (Bovine) | NA | NA | ||
| 9009216 | 1997 | SLSRYAKLANRLANPKLLETFLSKWIG | SPLN | Free | Free | Linear | L | None | 27 | Antimicrobial | 85% hemolysis at 120μg/ml | Rat | Seminalplasmin (Bovine) | NA | NA | ||
| 9009216 | 1997 | SLSRYAKLANRLANPKLLETFLSKWIG | SPLN | Free | Free | Linear | L | None | 27 | Antimicrobial | 90% hemolysis at 150μg/ml | Rat | Seminalplasmin (Bovine) | NA | NA | ||
| 9009216 | 1997 | SLSRYAKLANRLANPKLLETFLSKWIG | SPLN | Free | Free | Linear | L | None | 27 | Antimicrobial | 100% hemolysis at 180μg/ml | Rat | Seminalplasmin (Bovine) | NA | NA | ||
| 9108731 | 1996 | GFFALIPKIISSPLFKTLLSAVGSAL | PX1–26 | Free | Free | Linear | L | None | 26 | Cytolytic | Conc. Required for hemolysis =1.1nmols | Human | Synthetic Peptide | NA | NA | ||
| 9271200 | 1997 | RQRVEELSKFSKKGAAARRRK | Misgurin | Free | Free | Linear | L | None | 21 | Antimicrobial | 0% hemolysis at 5μg/ml | Sheep | Misgurnus anguillicaudatus | NA | NA | ||
| 9271200 | 1997 | RQRVEELSKFSKKGAAARRRK | Misgurin | Free | Free | Linear | L | None | 21 | Antimicrobial | 0% hemolysis at 10μg/ml | Sheep | Misgurnus anguillicaudatus | NA | NA | ||
| 9271200 | 1997 | RQRVEELSKFSKKGAAARRRK | Misgurin | Free | Free | Linear | L | None | 21 | Antimicrobial | 0.23% hemolysis at 25μg/ml | Sheep | Misgurnus anguillicaudatus | NA | NA | ||
| 9271200 | 1997 | RQRVEELSKFSKKGAAARRRK | Misgurin | Free | Free | Linear | L | None | 21 | Antimicrobial | 0.23% hemolysis at 50μg/ml | Sheep | Misgurnus anguillicaudatus | NA | NA | ||
| 9271200 | 1997 | RQRVEELSKFSKKGAAARRRK | Misgurin | Free | Free | Linear | L | None | 21 | Antimicrobial | 0.46% hemolysis at 100μg/ml | Sheep | Misgurnus anguillicaudatus | NA | NA | ||
| 9395500 | 1997 | HALWMTLLKKVLKAAAKAALNAVLVGANA | DS4 | Free | Free | Linear | L | None | 29 | Cytotoxic | 2.6% hemolysis at 10μM | Human | Analog of Dermaseptin | NA | NA | ||
| 9639668 | 1998 | AVVKVPLKKFKSIRETMKEKGLLEDF | hPcAP | Free | Free | Linear | L | None | 26 | Antimicrobial | 0.49% hemolysis at 200μg/ml | Human | Isolated from the stomach of the bullfrog, Rana catesbeiana | NA | NA | ||
| 9784609 | 1998 | FSKYERQKDKRPYSERKNQYTG | Lumbricin I | Free | Free | Linear | L | None | 22 | Antimicrobial | 0.02% hemolysis at 5μg/ml | Human | Lumbricus rubellus | NA | NA | ||
| 9784609 | 1998 | FSKYERQKDKRPYSERKNQYTG | Lumbricin I | Free | Free | Linear | L | None | 22 | Antimicrobial | 0.06% hemolysis at 10μg/ml | Human | Lumbricus rubellus | NA | NA | ||
| 9784609 | 1998 | FSKYERQKDKRPYSERKNQYTG | Lumbricin I | Free | Free | Linear | L | None | 22 | Antimicrobial | 0.14% hemolysis at 25μg/ml | Human | Lumbricus rubellus | NA | NA | ||
| 9784609 | 1998 | FSKYERQKDKRPYSERKNQYTG | Lumbricin I | Free | Free | Linear | L | None | 22 | Antimicrobial | 0.19% hemolysis at 50μg/ml | Human | Lumbricus rubellus | NA | NA | ||
| 9784609 | 1998 | FSKYERQKDKRPYSERKNQYTG | Lumbricin I | Free | Free | Linear | L | None | 22 | Antimicrobial | 0.23% hemolysis at 100μg/ml | Human | Lumbricus rubellus | NA | NA | ||
| 9784609 | 1998 | RQKDKRPYSERKNQYTGPQFLYPPERIPP | Lumbricin I(6-34) | Free | Free | Linear | L | None | 29 | Antimicrobial | 0.03% hemolysis at 5μg/ml | Human | Lumbricus rubellus | NA | NA | ||
| 9784609 | 1998 | RQKDKRPYSERKNQYTGPQFLYPPERIPP | Lumbricin I(6-34) | Free | Free | Linear | L | None | 29 | Antimicrobial | 0.07% hemolysis at 10μg/ml | Human | Lumbricus rubellus | NA | NA | ||
| 9784609 | 1998 | RQKDKRPYSERKNQYTGPQFLYPPERIPP | Lumbricin I(6-34) | Free | Free | Linear | L | None | 29 | Antimicrobial | 0.13% hemolysis at 25μg/ml | Human | Lumbricus rubellus | NA | NA | ||
| 9784609 | 1998 | RQKDKRPYSERKNQYTGPQFLYPPERIPP | Lumbricin I(6-34) | Free | Free | Linear | L | None | 29 | Antimicrobial | 0.17% hemolysis at 50μg/ml | Human | Lumbricus rubellus | NA | NA | ||
| 9784609 | 1998 | RQKDKRPYSERKNQYTGPQFLYPPERIPP | Lumbricin I(6-34) | Free | Free | Linear | L | None | 29 | Antimicrobial | 0.21% hemolysis at 100μg/ml | Human | Lumbricus rubellus | NA | NA | ||
| 9889358 | 1998 | KLLKLLLKLLKLLLKLLLKLLK{nt:Dansylation} | DnsLK22 | Free | Dansylation | Linear | L | None | 22 | Cytotoxin | LD50 =0.3 μM | Human | Synthetic Peptide | α-Helix | NA | ||
| 9889358 | 1998 | KLLKLLLKLLKLLLKLLLKLLK{nt:Dansylation}{ct:Amid} | DnsLK22 | Amidation | Dansylation | Linear | L | None | 22 | Cytotoxin | LD50 =0.1 μM | Human | Synthetic Peptide | α-Helix | NA | ||
| 9914515 | 1999 | GFFALIPKIISSPLFKTLLSAV{ct:NH(CH2)2NH2} | Par[1-22] | NH(CH2)2NH2 | Free | Linear | L | None | 22 | Antimicrobial | 22% hemolysis at 50μM | Human | Synthetic Peptide | NA | NA | ||
| 9914515 | 1999 | GFFALIP{d}KIISSPLFKTL{d}L{d}SAV{ct:NH(CH2)2NH2} | [D]-P7L18,19-Par[1-22] | NH(CH2)2NH2 | Free | Linear | Mix | None | 22 | Antimicrobial | 1% hemolysis at 50μM | Human | Synthetic Peptide | NA | NA | ||
| 9914515 | 1999 | KGFFALIP{d}KIISSPLFKTL{d}L{d}SAV{ct:NH(CH2)2NH2} | K1[D]-P7L18,19-Par[1-22] | NH(CH2)2NH2 | Free | Linear | Mix | None | 23 | Antimicrobial | 0% hemolysis at 50μM | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 10421892 | 1999 | WNPFKELERAGQRIRDSIISAAP | Cecropin D1 | Free | Free | Linear | L | None | 23 | Antimicrobial | 0% hemolysis at 100μg/ml | Human | Cecropin D (Agrius convolvuli) | NA | Non-hemolytic | ||
| 10421892 | 1999 | WNPFKELERAGQRVRDAIISAAP | Cecropin D2 | Free | Free | Linear | L | None | 23 | Antimicrobial | 0% hemolysis at 100μg/ml | Human | Cecropin D (Agrius convolvuli) | NA | Non-hemolytic | ||
| 18568863 | 2008 | RWCVYAYVRVRGVLVRYRRCW | Arenicin-1 (AR-1) | Free | Free | Linear | L | None | 21 | Antimicrobial | MHC >1μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | RWSVYAYVRVRGVLVRYRRSW | AR-1-S | Free | Free | Linear | L | None | 21 | Antimicrobial | MHC >1μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | RVKRVWPLVIRTVIAGYNLYRAIKKK | Fowlicidin-1 | Free | Free | Linear | L | None | 26 | Antimicrobial | MHC =1->440μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | GVVDILKGAAKDLAGHLATKVMNKL | Laticeptin | Free | Free | Linear | L | None | 25 | Antimicrobial | MHC <400μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | KILRGVSKKIMRTFLRRILTGKK | NK23c | Free | Free | Linear | L | None | 23 | Antimicrobial | MHC <10μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | GLLSGILGAGKHIVCGLTGCAKA | Odorranain-NR | Free | Free | Linear | L | None | 23 | Antimicrobial | MHC >100μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | KKTWWKTWWTKWSQPKKKRKV | Pep-1-K | Free | Free | Linear | L | None | 21 | Antimicrobial | MHC >200μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | HNKQEGRDHDKSKGHFHRVVIHHKGGKAH | SgI-29 | Free | Free | Linear | L | None | 29 | Antimicrobial | MHC >200μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | SSLLEKGLDGAKKAVGGLGKLGK | SSL-23 | Free | Free | Linear | L | None | 22 | Antimicrobial | MHC >100μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | SSLLEKGLDGAKKAVGGLGKLGKDA | SSL-25 | Free | Free | Linear | L | None | 25 | Antimicrobial | MHC >100μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | SSLLEKGLDGAKKAVGGLGKLGKDAVEDL | SSL-29 | Free | Free | Linear | L | None | 29 | Antimicrobial | MHC >100μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | KWKSFLKTFKSAAKTVLHTALKAISS{nt:Acet}{ct:Amid} | V13AD | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | MHC =31.3μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | KWKSFLKTFKSAVKTVLHTALKAISS{nt:Acet}{ct:Amid} | V681 | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | MHC =7.8μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18568863 | 2008 | K{d}W{d}K{d}S{d}F{d}L{d}K{d}T{d}F{d}K{d}S{d}A{d}V{d}K{d}T{d}V{d}L{d}H{d}T{d}A{d}L{d}K{d}A{d}I{d}S{d}S{d}{nt:Acet}{ct:Amid} | DV681 | Amidation | Acetylation | Linear | D | None | 26 | Antimicrobial | MHC =7.8μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 8577744 | 1996 | GSKKPVPIIYCNRRTGKCQRM | Thanatin | Free | Free | Linear | L | None | 21 | Antimicrobial | 0% hemolysis at 40μM | Porcine | Synthetic Peptide | NA | Non-hemolytic | ||
| 8910461 | 1996 | GRFKRFRKKFKKLFKKLSPVIPLLHLG | BMAP-27 | Free | Free | Linear | L | None | 27 | Antimicrobial | 3% hemolysis at 10μM | Human | Cathelicidins (Zanetti, M., Gennaro, R., and Romeo,D.) | NA | NA | ||
| 8910461 | 1996 | GRFKRFRKKFKKLFKKLSPVIPLLHLG | BMAP-27 | Free | Free | Linear | L | None | 27 | Antimicrobial | 6% hemolysis at 30μM | Human | Cathelicidins (Zanetti, M., Gennaro, R., and Romeo,D.) | NA | NA | ||
| 8910461 | 1996 | GRFKRFRKKFKKLFKKLSPVIPLLHLG | BMAP-27 | Free | Free | Linear | L | None | 27 | Antimicrobial | 22% hemolysis at 100μM | Human | Cathelicidins (Zanetti, M., Gennaro, R., and Romeo,D.) | NA | NA | ||
| 8910461 | 1996 | GGLRSLGRKILRAWKKYGPIIVPIIRIG | BMAP-28 | Free | Free | Linear | L | None | 28 | Antimicrobial | 0% hemolysis at 100μM | Human | Cathelicidins (Zanetti, M., Gennaro, R., and Romeo,D.) | NA | Non-hemolytic | ||
| 9271200 | 1997 | RQRVQQLSKFSKKGAAARRRK | Misgurin | Free | Free | Linear | L | None | 21 | Antimicrobial | 0.46% hemolysis at 100μg/ml | Sheep | Misgurnus anguillicaudatus | NA | Non-hemolytic | ||
| 16441062 | 2005 | CAESCVWIPCTVTALLGCSCSNNVCYNGIP{cyc:N-C} | Cycloviolacin H4 | Free | Free | Cyclic | L | None | 30 | HIV inhibitory, Antimicrobial, Cytotoxic, Neurotensin antagonistic, Trypsin inhibitory, Insecticide | HD50 =5.5μM | Human | Viola hederaceae | NA | NA | ||
| 16488428 | 2006 | SAISCGETCFKFKCYTPRCSCSYPVCK{cyc:N-C} | Violacin A | Free | Free | Cyclic | L | None | 27 | Uterotonic, Insecticidal, Anti-HIV, Antimicrobial, Anti-neurotensive, Cytotoxic and Hemolytic | 30% hemolysis at 1.5μM | Human | Synthetic Peptide | NA | NA | ||
| 10600388 | 1999 | CAESCVYIPCTVTALLGCSCSNRVCYNGIP{cyc:N-C} | Cycloviolacin O1 | Free | Free | Cyclic | L | None | 30 | Anti-HIV | 50% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 10600388 | 1999 | CGESCVWIPCISSAIGCSCKSKVCYRNGIP{cyc:N-C} | Cycloviolacin O2 | Free | Free | Cyclic | L | None | 30 | Anti-HIV | 50% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 10600388 | 1999 | CGESCVWIPCLTSAIGCSCKSKVCYRNGIP{cyc:N-C} | Cycloviolacin O3 | Free | Free | Cyclic | L | None | 30 | Anti-HIV | 50% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 10600388 | 1999 | CGESCVWIPCISSAIGCSCKNKVCYRNGIP{cyc:N-C} | Cycloviolacin O4 | Free | Free | Cyclic | L | None | 30 | Anti-HIV | 50% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 10600388 | 1999 | CGESCVWIPCISSAVGCSCKNKVCYKNGTP{cyc:N-C} | Cycloviolacin O5 | Free | Free | Cyclic | L | None | 30 | Anti-HIV | 50% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 10600388 | 1999 | CGESCVWIPCTITALAGCKCKSKVCYNSIP{cyc:N-C} | Cycloviolacin O7 | Free | Free | Cyclic | L | None | 30 | Anti-HIV | 50% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 10600388 | 1999 | CESCVWIPCISSVVGCSCKSKVCYKNGTLP{cyc:N-C} | Cycloviolacin O8 | Free | Free | Cyclic | L | None | 30 | Anti-HIV | 50% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 10600388 | 1999 | CGESCVWIPCLTSAVGCSCKSKVCYRNGIP{cyc:N-C} | Cycloviolacin O9 | Free | Free | Cyclic | L | None | 30 | Anti-HIV | 50% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 10600388 | 1999 | CGESCVYIPCLTSAVGCSCKSKVCYRNGIP{cyc:N-C} | Cycloviolacin O10 | Free | Free | Cyclic | L | None | 30 | Anti-HIV | 50% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 10600388 | 1999 | CGESCVYIPCLTSAIGCSCKSKVCYRNGIP{cyc:N-C} | Cycloviolacin H1 | Free | Free | Cyclic | L | None | 30 | Anti-HIV | 50% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 10600388 | 1999 | CGESCVYIPCISGVIGCSCTDKVCYLNGTP{cyc:N-C} | Kalata B5 | Free | Free | Cyclic | L | None | 30 | Anti-HIV | 50% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 10600388 | 1999 | CGESCVWIPCISAALGCSCKNKVCYRNGIP{cyc:N-C} | Circulin A | Free | Free | Cyclic | L | None | 30 | Anti-HIV | 50% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 10600388 | 1999 | CGESCVFIPCVTALLGCSCKSKVCYKNSIP{cyc:N-C} | Cyclopsychotride A | Free | Free | Cyclic | L | None | 30 | Anti-HIV | 50% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 10600388 | 1999 | VCGETCVGGTCNTPGCSCSRPVCTRNGLP{cyc:N-C} | Violapeptide I | Free | Free | Cyclic | L | None | 29 | Anti-HIV | 50% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 10600388 | 1999 | ICGETCVGGTCNTPGCSCSWPVCTRNGLP{cyc:N-C} | Cycloviolacin O12 | Free | Free | Cyclic | L | None | 29 | Anti-HIV | 50% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 10600388 | 1999 | VCGETCFGGTCNTPGCSCTWPICTRDGLP{cyc:N-C} | Kalata B2 | Free | Free | Cyclic | L | None | 29 | Anti-HIV | 50% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 10600388 | 1999 | TCGETCFGGTCNTPGCTCDPWPICTDRGLP{cyc:N-C} | Kalata B3 | Free | Free | Cyclic | L | None | 30 | Anti-HIV | 50% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 10600388 | 1999 | VCGETCVGGTCNTPGCTCSWPVCTRDGLP{cyc:N-C} | Kalata B4 | Free | Free | Cyclic | L | None | 29 | Anti-HIV | 50% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 10600388 | 1999 | VCGETCEGGTCNTPGCSCSWPVCTRNGLP{cyc:N-C} | Kalata S | Free | Free | Cyclic | L | None | 29 | Anti-HIV | 51% hemolysis at ~20μM | Human | Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis) | NA | NA | ||
| 19778602 | 2010 | FLGPIIKIATGILPTAICKILKKC | Gaegurin-RN3 | Free | Free | Linear | L | None | 24 | Antimicrobial | 0% hemolysis at 100μg/ml | Rabbit | Skin secretions of Rana nigrovittata | NA | Non-hemolytic | ||
| 16735513 | 2006 | SMWSGMWRRKLKKLRNALKKKLKGE | Ltc1 | Free | Free | Linear | L | None | 25 | Antimicrobial | 20% hemolysis at 80μM | Rabbit | Venom of the spider Lachesana tarabaevi | NA | NA | ||
| 16735513 | 2006 | GLFGKLIKKFGRKAISYAVKKARGKH | Ltc2a | Free | Free | Linear | L | None | 26 | Antimicrobial | 20% hemolysis at 6.0μM | Rabbit | Venom of the spider Lachesana tarabaevi | NA | NA | ||
| 16735513 | 2006 | GLKDKFKSMGEKLKQYIQTWKAKF{ct:Amid} | Ltc4a | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 20% hemolysis at >120μM | Rabbit | Venom of the spider Lachesana tarabaevi | NA | NA | ||
| 16735513 | 2006 | SLKDKVKSMGEKLKQYIQTWKAKF{ct:Amid} | Ltc4b | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 20% hemolysis at >120μM | Rabbit | Venom of the spider Lachesana tarabaevi | NA | NA | ||
| 16735513 | 2006 | GFFGKMKEYFKKFGASFKRRFANLKKRL{ct:Amid} | Ltc5 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 20% hemolysis at 40μM | Rabbit | Venom of the spider Lachesana tarabaevi | NA | NA | ||
| 14531844 | 2003 | FLPILASLAAKFGPKLFCLVTKKC | Brevinin-1BYa | Free | Free | Linear | L | None | 24 | Antimicrobial | HC50 = 4μM | Human | Rana boylii | NA | NA | ||
| 14531844 | 2003 | FLPILASLAAKLGPKLFCLVTKKC | Brevinin-1BYb | Free | Free | Linear | L | None | 24 | Antimicrobial | HC50 = 4μM | Human | Rana boylii | NA | NA | ||
| 14531844 | 2003 | GIMDSVKGLAKNLAGKLLDSLKCKITGC | Ranatuerin-2BYb | Free | Free | Linear | L | None | 28 | Antimicrobial | HC50 >200μM | Human | Rana boylii | NA | NA | ||
| 15328050 | 2004 | FWGALAKGALKLIPSLFSSFSKKD | Pin2 | Free | Free | Linear | L | None | 24 | Antimicrobial | 7% hemolysis at 1μM | Guinea-pig | Pandinin 2 from venom of the scorpionid scorpion Pandinus imperator | NA | NA | ||
| 15328050 | 2004 | FWGALAKGALKLIPSLFSSFSKKD | Pin2 | Free | Free | Linear | L | None | 24 | Antimicrobial | 50% hemolysis at 6μM | Guinea-pig | Pandinin 2 from venom of the scorpionid scorpion Pandinus imperator | NA | NA | ||
| 15328050 | 2004 | FWGALAKGALKLIPSLFSSFSKKD | Pin2 | Free | Free | Linear | L | None | 24 | Antimicrobial | 85% hemolysis at 12.5μM | Guinea-pig | Pandinin 2 from venom of the scorpionid scorpion Pandinus imperator | NA | NA | ||
| 15328050 | 2004 | FWGALAKGALKLIPSLFSSFSKKD | Pin2 | Free | Free | Linear | L | None | 24 | Antimicrobial | 100% hemolysis at 25μM | Guinea-pig | Pandinin 2 from venom of the scorpionid scorpion Pandinus imperator | NA | NA | ||
| 15885852 | 2005 | GFMKYIGPLIPHAVKAISDLI{ct:Amid} | Kassinatuerin-1 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | LD50 =65μM | Human | Skin of the African frog Kassina senegalensis | NA | NA | ||
| 15885852 | 2005 | GFMKYIGPLIPHKVKAISDLI{ct:Amid} | Kassinatuerin-1 (Lys13) | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 32% hemolysis at 400μM | Human | Kassina senegalensis | NA | NA | ||
| 15885852 | 2005 | GFMKYIGPLIPHAVKAISKLI{ct:Amid} | Kassinatuerin-1 (Lys19) | Amidation | Free | Linear | L | None | 21 | Antimicrobial | LD50 =45μM | Human | Kassina senegalensis | NA | NA | ||
| 15885852 | 2005 | GFMKYIGPLIPHAVKAIKKLI{ct:Amid} | Kassinatuerin-1 (Lys18, Lys19) | Amidation | Free | Linear | L | None | 21 | Antimicrobial | LD50 =25μM | Human | Kassina senegalensis | NA | NA | ||
| 15885852 | 2005 | GFMKYIKPLIPHAVKAISKLI{ct:Amid} | Kassinatuerin-1 (Lys7, Lys19) | Amidation | Free | Linear | L | None | 21 | Antimicrobial | LD50 =55μM | Human | Kassina senegalensis | NA | NA | ||
| 15885852 | 2005 | GFMKYIKPLIPHAVKAIKKLI{ct:Amid} | Kassinatuerin-1 (Lys7, Lys18, Lys19) | Amidation | Free | Linear | L | None | 21 | Antimicrobial | LD50 =40μM | Human | Kassina senegalensis | NA | NA | ||
| 15885852 | 2005 | GFMKYIGPLIPHAVKAISDLI | Kassinatuerin-1 (COOH) | Free | Free | Linear | L | None | 21 | Antimicrobial | 39% hemolysis at 400μM | Human | Kassina senegalensis | NA | NA | ||
| 15885852 | 2005 | GFMKYIGPLIPHAVKAISKLI | Kassinatuerin-1 (Lys19)(COOH) | Free | Free | Linear | L | None | 21 | Antimicrobial | LD50 =120μM | Human | Kassina senegalensis | NA | NA | ||
| 15885852 | 2005 | GFMKYIKPLIPHAVKAISKLI | Kassinatuerin-1 (Lys7, Lys19)(COOH) | Free | Free | Linear | L | None | 21 | Antimicrobial | LD50 =135μM | Human | Kassina senegalensis | NA | NA | ||
| 15885852 | 2005 | GFMKYIKPLIPHAVKAIKKLI | Kassinatuerin-1 (Lys7, Lys18, Lys19) (COOH) | Free | Free | Linear | L | None | 21 | Antimicrobial | LD50 =200μM | Human | Kassina senegalensis | NA | NA | ||
| 3125066 | 1988 | GIGKFLHSAKKFGKAFVGEIMNS | Maganin 2 | Free | Free | Linear | L | None | 23 | Antiparasitic | 4% hemolysis at 50μg/ml | Human | Xenopus laevis | NA | NA | ||
| 3125066 | 1988 | GIGKFLHSAKKFGKAFVGEIMNS | Maganin 2 | Free | Free | Linear | L | None | 23 | Antiparasitic | 3% hemolysis at 100μg/ml | Human | Xenopus laevis | NA | NA | ||
| 3125066 | 1988 | GIGKFLHSAKKFGKAFVGEIMNS | Maganin 2 | Free | Free | Linear | L | None | 23 | Antiparasitic | 3% hemolysis at 200μg/ml | Human | Xenopus laevis | NA | NA | ||
| 3125066 | 1988 | GIGKFLHSAKKFGKAFVGEIMNS | Maganin 2 | Free | Free | Linear | L | None | 23 | Antiparasitic | 4% hemolysis at 500μg/ml | Human | Xenopus laevis | NA | NA | ||
| 3125066 | 1988 | GIGKFLHSAKKFGKAFVGEIMNS | Maganin 2 | Free | Free | Linear | L | None | 23 | Antiparasitic | 6% hemolysis at 1000μg/ml | Human | Xenopus laevis | NA | NA | ||
| 3125066 | 1988 | GWASKIGQTLGKIAKVGLKELIQPK | XPF | Free | Free | Linear | L | None | 24 | Antiparasitic | 1% hemolysis at 50μg/ml | Human | Xenopus laevis | NA | NA | ||
| 3125066 | 1988 | GWASKIGQTLGKIAKVGLKELIQPK | XPF | Free | Free | Linear | L | None | 24 | Antiparasitic | 1% hemolysis at 100μg/ml | Human | Xenopus laevis | NA | NA | ||
| 3125066 | 1988 | GWASKIGQTLGKIAKVGLKELIQPK | XPF | Free | Free | Linear | L | None | 24 | Antiparasitic | 2% hemolysis at 200μg/ml | Human | Xenopus laevis | NA | NA | ||
| 3125066 | 1988 | GWASKIGQTLGKIAKVGLKELIQPK | XPF | Free | Free | Linear | L | None | 24 | Antiparasitic | 5% hemolysis at 500μg/ml | Human | Xenopus laevis | NA | NA | ||
| 3125066 | 1988 | GWASKIGQTLGKIAKVGLKELIQPK | XPF | Free | Free | Linear | L | None | 24 | Antiparasitic | 6% hemolysis at 1000μg/ml | Human | Xenopus laevis | NA | NA | ||
| 3125066 | 1988 | GMASKAGAIAGKIAKVALKAL{ct:Amid} | PGLa | Amidation | Free | Linear | L | None | 21 | Antiparasitic | 4% hemolysis at 50μg/ml | Human | Xenopus laevis | NA | NA | ||
| 3125066 | 1988 | GMASKAGAIAGKIAKVALKAL{ct:Amid} | PGLa | Amidation | Free | Linear | L | None | 21 | Antiparasitic | 3% hemolysis at 100μg/ml | Human | Xenopus laevis | NA | NA | ||
| 3125066 | 1988 | GMASKAGAIAGKIAKVALKAL{ct:Amid} | PGLa | Amidation | Free | Linear | L | None | 21 | Antiparasitic | 4% hemolysis at 200μg/ml | Human | Xenopus laevis | NA | NA | ||
| 3125066 | 1988 | GMASKAGAIAGKIAKVALKAL{ct:Amid} | PGLa | Amidation | Free | Linear | L | None | 21 | Antiparasitic | 5% hemolysis at 500μg/ml | Human | Xenopus laevis | NA | NA | ||
| 3125066 | 1988 | GMASKAGAIAGKIAKVALKAL{ct:Amid} | PGLa | Amidation | Free | Linear | L | None | 21 | Antiparasitic | 7% hemolysis at 1000μg/ml | Human | Xenopus laevis | NA | NA | ||
| 12379643 | 2002 | GLWSTIKQKGKEAAIAAAKAAGQAALGAL{ct:Amid} | DS 01 | Amidation | Free | Linear | L | None | 29 | Antiparasitic | 0.41% hemolysis at 4μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 12379643 | 2002 | GLWSTIKQKGKEAAIAAAKAAGQAALGAL{ct:Amid} | DS 01 | Amidation | Free | Linear | L | None | 29 | Antiparasitic | 0.54% hemolysis at 8μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 12379643 | 2002 | GLWSTIKQKGKEAAIAAAKAAGQAALGAL{ct:Amid} | DS 01 | Amidation | Free | Linear | L | None | 29 | Antiparasitic | 0.81% hemolysis at 16μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 12379643 | 2002 | GLWSTIKQKGKEAAIAAAKAAGQAALGAL{ct:Amid} | DS 01 | Amidation | Free | Linear | L | None | 29 | Antiparasitic | 1.08% hemolysis at 32μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 12379643 | 2002 | GLWSTIKQKGKEAAIAAAKAAGQAALGAL{ct:Amid} | DS 01 | Amidation | Free | Linear | L | None | 29 | Antiparasitic | 1.36% hemolysis at 64μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 12379643 | 2002 | GLWSTIKQKGKEAAIAAAKAAGQAALGAL{ct:Amid} | DS 01 | Amidation | Free | Linear | L | None | 29 | Antiparasitic | 2.17% hemolysis at 128μg/ml | Human | Synthetic Peptide | NA | NA | ||
| 18984589 | 2009 | KKALL{nnr:O}HALH{nnr:O}LALLA{nnr:O}HLAH{nnr:O}LKKA{ct:Amid} | HALO | Amidation | Free | Linear | L | O = L-Ornithine | 26 | Antiparasitic | HC50 =179.2μM | Human | Synthetic Peptide | NA | NA | ||
| 18984589 | 2009 | ALALL{nnr:O}HALH{nnr:O}LALLA{nnr:O}HLAH{nnr:O}LALA{ct:Amid} | HALO-2 | Amidation | Free | Linear | L | O = L-Ornithine | 26 | Antiparasitic | HC50 <5.6μM | Human | Synthetic Peptide | NA | NA | ||
| 18984589 | 2009 | FFKKL{nnr:O}HALH{nnr:O}LALLA{nnr:O}HLAH{nnr:O}LKKA{ct:Amid} | HALO-F | Amidation | Free | Linear | L | O = L-Ornithine | 26 | Antiparasitic | HC50 <5.6μM | Human | Synthetic Peptide | NA | NA | ||
| 18984589 | 2009 | KKALL{nnr:O}HPLH{nnr:O}LALLA{nnr:O}HLAH{nnr:O}LKKA{ct:Amid} | HALO-P8 | Amidation | Free | Linear | L | O = L-Ornithine | 26 | Antiparasitic | HC50 =89.6μM | Human | Synthetic Peptide | NA | NA | ||
| 18984589 | 2009 | A{d}K{d}K{d}L{d}{nnr:d-o}H{d}A{d}L{d}H{d}{nnr:d-o}A{d}L{d}L{d}A{d}L{d}{nnr:d-o}H{d}L{d}A{d}H{d}{nnr:d-o}L{d}L{d}A{d}K{d}K{d}{ct:Amid} | D-HALO-rev | Amidation | Free | Linear | D | o = D-Ornithine | 26 | Antiparasitic | HC50 =716.8μM | Human | Synthetic Peptide | NA | NA | ||
| 18984589 | 2009 | A{d}K{d}K{d}L{d}{nnr:d-o}H{d}A{d}L{d}H{d}{nnr:d-o}A{d}L{d}L{d}A{d}L{d}{nnr:d-o}H{d}L{d}P{d}H{d}{nnr:d-o}L{d}K{d}K{d}F{d}F{d}{ct:Amid} | D-HALO-P8F-rev | Amidation | Free | Linear | D | o = D-Ornithine | 26 | Antiparasitic | HC50 >65.2μM | Human | Synthetic Peptide | NA | NA | ||
| 11279030 | 2001 | WLGSALKIGAKLLPSVVGLFKKKKQ | W1 | Free | Free | Linear | L | None | 25 | Antimicrobial, Insecticidal | Zone of inhibition 2mm at 0.4-0.5mM | Horse | Ponericin | NA | NA | ||
| 11279030 | 2001 | WLGSALKIGAKLLPSVVGLFKKKKQ | W1 | Free | Free | Linear | L | None | 25 | Antimicrobial, Insecticidal | Zone of inhibition 1mm at 0.4-0.5mM | Sheep | Ponericin | NA | NA | ||
| 11279030 | 2001 | WLGSALKIGAKLLPSVVGLFQKKKK | W2 | Free | Free | Linear | L | None | 25 | Antimicrobial, Insecticidal | Zone of inhibition 1mm at 0.4-0.5mM | Horse | Ponericin | NA | NA | ||
| 11279030 | 2001 | GIWGTALKWGVKLLPKLVGMAQTKKQ | W4 | Free | Free | Linear | L | None | 26 | Antimicrobial, Insecticidal | Zone of inhibition 2mm at 0.4-0.5mM | Horse | Ponericin | NA | NA | ||
| 11279030 | 2001 | FWGALIKGAAKLIPSVVGLFKKKQ | W5 | Free | Free | Linear | L | None | 24 | Antimicrobial, Insecticidal | Zone of inhibition 4mm at 0.4-0.5mM | Horse | Ponericin | NA | NA | ||
| 11279030 | 2001 | FWGALIKGAAKLIPSVVGLFKKKQ | W5 | Free | Free | Linear | L | None | 24 | Antimicrobial, Insecticidal | Zone of inhibition 1.5mm at 0.4-0.5mM | Sheep | Ponericin | NA | NA | ||
| 10441158 | 1999 | CGETCVGGTCNTPGCTCSWPVCTRNGLPV{cyc:N-C} | Kalata B1 | Free | Free | Cyclic | L | None | 29 | Uterotonic | HD50 =50μM | Human | O. affinis | NA | NA | ||
| 10441158 | 1999 | CGESCVFIPCISTLLGCSCKNKVCYRNGVIP{cyc:N-C} | Circulin B | Free | Free | Cyclic | L | None | 30 | Uterotonic | HD50 =30μM | Human | O. affinis | NA | NA | ||
| 20564013 | 2010 | GLPVCGETCVGGTCNTPGCTCSWPVCTRN{cyc:N-C} | Kalata B1 | Free | Free | Cyclic | L | None | 30 | Pesticidal | HD50 = 20.0±1.1μM | Human | Cyclotides (Oldenlandia affinis) | NA | NA | ||
| 20564013 | 2010 | GLPVCGETCTLGTVYTQGCTCSWPICKRN{cyc:N-C} | Kalata B7 | Free | Free | Cyclic | L | None | 30 | Pesticidal | HD50 = 55.2±1.3μM | Human | Cyclotides (Oldenlandia affinis) | NA | NA | ||
| 19111524 | 2009 | X-NH-GVATQLLAAYILLFDEYNEKKASAQKDILIKVL{nt:X=H, NBD, Rhodamine}{ct:Amid} | H-88 | Amidation | X=H, NBD, Rhodamine | Linear | L | None | 21 | Cytotoxic | 50% hemolysis at ~0.72μM | Human | Synthetic peptide | Helical | NA | ||
| 19111524 | 2009 | X-NH-GDATQLLAAYILLFDEYNEKKASAQKDILIKVL{nt:X=H, NBD, Rhodamine}{ct:Amid} | Mu1-H88 | Amidation | X=H, NBD, Rhodamine | Linear | L | None | 21 | Cytotoxic | 0% hemolysis at 0.8μM | Human | Synthetic peptide | Helical | Non-hemolytic | ||
| 23483218 | 2013 | LDVKKIICVACKIKPNPACKKICPK | PNG-K | Free | Free | Linear | L | None | 25 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LDVKKII{nnr:Abu}VA{nnr:Abu}KIKPNPA{nnr:Abu}KKI{nnr:Abu}PK{ct:Amid} | PNG-K/1 | Free | Free | Linear | L | Abu = 2-aminobutyric acid | 25 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LDVKKIICVACKIRPNPACKKICPK | PNG-R | Free | Free | Linear | L | None | 25 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23483218 | 2013 | LDVKKII{nnr:Abu}VA{nnr:Abu}KIRPNPA{nnr:Abu}KKI{nnr:Abu}PK{ct:Amid} | PNG-R/1 | Free | Free | Linear | L | Abu = 2-aminobutyric acid | 25 | Antimicrobial | 50 % Hemolysis at >200 µM | Human | Png-1 Analogs | α-Helix | NA | ||
| 23689723 | 2013 | FILFILFILGGKHKHKHKHKHK{ct:Amid} | R41 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | No Hemolysis at 100 µM | Human | Designed Peptide | NA | Non-hemolytic | ||
| 23689723 | 2013 | GPPRFPPRFPPRFPPRFPPRFP{ct:Amid} | R8 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | No Hemolysis at 100 µM | Human | Design Based On Sequence Of Pr-39 | NA | Non-hemolytic | ||
| 23689723 | 2013 | AGYLLGKINLKALAALAKKIL{ct:Amid} | TP10 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | <2 % Hemolysis at 100 µM | Human | Deletion Analogue Of Transportan, A Chimeric Peptide | NA | NA | ||
| 23689723 | 2013 | MVTVLFRRLRIRRASGPPRVRV{ct:Amid} | M918 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | No Hemolysis at 100 µM | Human | Tumor Suppressor Protein P14Arf | NA | Non-hemolytic | ||
| 24004075 | 2013 | RILTMTKRVKMPQLYKQIVCRLFKTC | pleuraina1-thel | Free | Free | Linear | L | None | 26 | Antimicrobial | 2.5 % Hemolysis at 100 µg/ml | Human | Tree Frog Theloderma Kwangsiensis | NA | NA | ||
| 24004075 | 2013 | RILTMTKRVKMPQLYKQIVCRLFKTC | pleuraina1-thel | Free | Free | Linear | L | None | 26 | Antimicrobial | 3.7 % Hemolysis at 200 µg/ml | Human | Tree Frog Theloderma Kwangsiensis | NA | NA | ||
| 24004075 | 2013 | RILTMTKRVKMPQLYKQIVCRLFKTC | pleuraina1-thel | Free | Free | Linear | L | None | 26 | Antimicrobial | 3.2 % Hemolysis at 100 µg/ml | Rabbit | Tree Frog Theloderma Kwangsiensis | NA | NA | ||
| 24004075 | 2013 | RILTMTKRVKMPQLYKQIVCRLFKTC | pleuraina1-thel | Free | Free | Linear | L | None | 26 | Antimicrobial | 3.5 % Hemolysis at 200 µg/ml | Rabbit | Tree Frog Theloderma Kwangsiensis | NA | NA | ||
| 23893605 | 2013 | KILRGVCKKIMRTFLRRISKDILTGKK{ct:Amid} | NK-2 | Amidation | Free | Linear | L | None | 27 | Antimicrobial | <20 % Hemolysis at 10 µM | Human | Porcine Nk-Lysin-Derived Peptide | α-Helix | NA | ||
| 23893605 | 2013 | KILRGVCKKIMRTFLRRISKDILTGKK{ct:Amid} | NK-2 | Amidation | Free | Linear | L | None | 27 | Antimicrobial | <40 % Hemolysis at 100 µM | Human | Porcine Nk-Lysin-Derived Peptide | α-Helix | NA | ||
| 23893605 | 2013 | KILRGVAKKIMRTFLRRISKDILTGKK{ct:Amid} | C7A | Amidation | Free | Linear | L | None | 27 | Antimicrobial | <40 % Hemolysis at 10 µM | Human | Nk-2-Derived Synthetic | α-Helix | NA | ||
| 23893605 | 2013 | KILRGVAKKIMRTFLRRISKDILTGKK{ct:Amid} | C7A | Amidation | Free | Linear | L | None | 27 | Antimicrobial | <80 % Hemolysis at 100 µM | Human | Nk-2-Derived Synthetic | α-Helix | NA | ||
| 23893605 | 2013 | KILRGVAKKIMRTFLRRISKKILTGKK{ct:Amid} | C7A-D21K | Amidation | Free | Linear | L | None | 27 | Antimicrobial | <30 % Hemolysis at 10 µM | Human | Nk-2-Derived Synthetic | α-Helix | NA | ||
| 23893605 | 2013 | KILRGVAKKIMRTFLRRISKKILTGKK{ct:Amid} | C7A-D21K | Amidation | Free | Linear | L | None | 27 | Antimicrobial | 30 % Hemolysis at 100 µM | Human | Nk-2-Derived Synthetic | α-Helix | NA | ||
| 23893605 | 2013 | KILRGVAKKIMRTFLRRILTGKK{ct:Amid} | C7A-Δ | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 10 % Hemolysis at 10 µM | Human | Nk-2-Derived Synthetic | α-Helix | NA | ||
| 23893605 | 2013 | KILRGVAKKIMRTFLRRILTGKK{ct:Amid} | C7A-Δ | Amidation | Free | Linear | L | None | 23 | Antimicrobial | <50 % Hemolysis at 100 µM | Human | Nk-2-Derived Synthetic | α-Helix | NA | ||
| 23893605 | 2013 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 90 % Hemolysis at 10 µM | Human | Bee Venom | α-Helix | NA | ||
| 23893605 | 2013 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | <100 % Hemolysis at 100 µM | Human | Bee Venom | α-Helix | NA | ||
| 23737519 | 2013 | GRFKRFRKKFKKLFKKLSPVIPLLHLGX | cathelicidin BMAP-27(b27) | Free | Free | Linear | L | None | 28 | Antimicrobial | 50 % Hemolysis at >>250 µM | Human | Bovine Myeloid Antimicrobial Peptide-27 | α-Helix | NA | ||
| 23737519 | 2013 | GEFAQFEQEAQSLEQELSQLEQQLESL | anti-cathelicidin BMAP-27 (anti-b27) | Free | Free | Linear | L | None | 27 | Antimicrobial | 50 % Hemolysis at >>250 µM | Human | Bovine Myeloid Antimicrobial Peptide-28 | α-Helix | NA | ||
| 24041697 | 2013 | GIVEQCCTSICSLYQLENYCN | Porcine Insulin | Free | Free | Linear | L | None | 21 | Amyloidogenicity | 57.4 ± 4.6 % Hemolysis at 60 µM | Human | Insulin Derived From Pigs | α-Helix | NA | ||
| 24041697 | 2013 | FVNQHLCGSHLVEALYLVCGERGFFYTPKA | DOI | Free | Free | Linear | L | None | 30 | Amyloidogenicity | 45.9 ± 3.4 % Hemolysis at 60 µM | Human | An Insulin Analog | α-Helix | NA | ||
| 23896552 | 2013 | RMKKLGNHKVSCERNTKRCRKAI | LBLP | Free | Free | Linear | L | None | 23 | Antifungal | 0 % Hemolysis at 80 µM | Human | Centipede S. S. Mutilans | α-Helix | Non-hemolytic | ||
| 23896552 | 2013 | RMKKLGNHKVSCERNTKRCRKAI | LBLP | Free | Free | Linear | L | None | 23 | Antifungal | 0 % Hemolysis at 40 µM | Human | Centipede S. S. Mutilans | α-Helix | Non-hemolytic | ||
| 23896552 | 2013 | RMKKLGNHKVSCERNTKRCRKAI | LBLP | Free | Free | Linear | L | None | 23 | Antifungal | 0 % Hemolysis at 20 µM | Human | Centipede S. S. Mutilans | α-Helix | Non-hemolytic | ||
| 23896552 | 2013 | RMKKLGNHKVSCERNTKRCRKAI | LBLP | Free | Free | Linear | L | None | 23 | Antifungal | 0 % Hemolysis at 10 µM | Human | Centipede S. S. Mutilans | α-Helix | Non-hemolytic | ||
| 23896552 | 2013 | RMKKLGNHKVSCERNTKRCRKAI | LBLP | Free | Free | Linear | L | None | 23 | Antifungal | 0 % Hemolysis at 5 µM | Human | Centipede S. S. Mutilans | α-Helix | Non-hemolytic | ||
| 23896552 | 2013 | RMKKLGNHKVSCERNTKRCRKAI | LBLP | Free | Free | Linear | L | None | 23 | Antifungal | 0 % Hemolysis at 2.5 µM | Human | Centipede S. S. Mutilans | α-Helix | Non-hemolytic | ||
| 23896552 | 2013 | RMKKLGNHKVSCERNTKRCRKAI | LBLP | Free | Free | Linear | L | None | 23 | Antifungal | 0 % Hemolysis at 1.3 µM | Human | Centipede S. S. Mutilans | α-Helix | Non-hemolytic | ||
| 23896552 | 2013 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 99 % Hemolysis at 80 µM | Human | Venom Of The Honey Bee Apis Mellifera | α-Helix | NA | ||
| 23896552 | 2013 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 99.1 % Hemolysis at 40 µM | Human | Venom Of The Honey Bee Apis Mellifera | α-Helix | NA | ||
| 23896552 | 2013 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 70.2 % Hemolysis at 20 µM | Human | Venom Of The Honey Bee Apis Mellifera | α-Helix | NA | ||
| 23896552 | 2013 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 54.3 % Hemolysis at 10 µM | Human | Venom Of The Honey Bee Apis Mellifera | α-Helix | NA | ||
| 23896552 | 2013 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 23.8 % Hemolysis at 5 µM | Human | Venom Of The Honey Bee Apis Mellifera | α-Helix | NA | ||
| 23896552 | 2013 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 13.3 % Hemolysis at 2.5 µM | Human | Venom Of The Honey Bee Apis Mellifera | α-Helix | NA | ||
| 23896552 | 2013 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 1.9 % Hemolysis at 1.3 µM | Human | Venom Of The Honey Bee Apis Mellifera | α-Helix | NA | ||
| 23933745 | 2013 | {nnr:*}(KK({nnr:x}(CYGRKKRRQRRRCYGRKKRRQRRR))LAQLAQ){ct:Amid} | Tat-G1L | Amidation | Free | Linear | Mix | * = 5(6)-carboxyfluorescein amidated to the N-terminus,x = the S–CH2–CO– bridge between the cysteine side-chain and the N-terminus of the dendrimer or lysine side-chain | 29 | Antimicrobial | 5 % Hemolysis at 10 µM | Human | Natural Translocating Proteins | α-Helix | NA | ||
| 23933745 | 2013 | {nnr:*}AGYLLGKINKLKALAALAKKIL{ct:Amid} | TP10K | Amidation | Free | Linear | L | * = 5(6)-carboxyfluorescein amidated to the N-terminus | 22 | Antimicrobial | 45324 % Hemolysis at 10 µM | Human | Natural Translocating Proteins | α-Helix | NA | ||
| 23982315 | 2013 | KFFRKLKKSVKKRAKKFFKKPRVIGVSIPF | Cbf-K16 | Free | Free | Linear | L | None | 30 | Antimicrobial | 0 % Hemolysis at 5 µM | Sheep | Snake Venom Of Bungarus Fasciatus | NA | Non-hemolytic | ||
| 23982315 | 2013 | KFFRKLKKSVKKRAKKFFKKPRVIGVSIPF | Cbf-K16 | Free | Free | Linear | L | None | 30 | Antimicrobial | <2 % Hemolysis at 10 µM | Sheep | Snake Venom Of Bungarus Fasciatus | NA | NA | ||
| 23982315 | 2013 | KFFRKLKKSVKKRAKKFFKKPRVIGVSIPF | Cbf-K16 | Free | Free | Linear | L | None | 30 | Antimicrobial | <2 % Hemolysis at 20 µM | Sheep | Snake Venom Of Bungarus Fasciatus | NA | NA | ||
| 23982315 | 2013 | KFFRKLKKSVKKRAKKFFKKPRVIGVSIPF | Cbf-K16 | Free | Free | Linear | L | None | 30 | Antimicrobial | 5.6 % Hemolysis at 40 µM | Sheep | Snake Venom Of Bungarus Fasciatus | NA | NA | ||
| 24185042 | 2013 | IKLSPETKDNLKKVLKGAIKGAIAVAKMV{ct:Amid} | Hymenochirin-1B | Amidation | Free | Linear | L | None | 29 | Antitumor | 50 % Hemolysis at 213 ± 18 µM | Human | Congo Clawed Frog Hymenochirus Boettgeri | α-Helix | NA | ||
| 24185042 | 2013 | LKIPGFVKDTLKKVAKGIFSAVAGAMTPS | Hymenochirin-2B | Free | Free | Linear | L | None | 29 | Antitumor | 50 % Hemolysis at 210 ± 21 µM | Human | Congo Clawed Frog Hymenochirus Boettgeri | α-Helix | NA | ||
| 24185042 | 2013 | IKIPAVVKDTLKKVAKGVLSAVAGALTQ | Hymenochirin-3B | Free | Free | Linear | L | None | 29 | Antitumor | 50 % Hemolysis at >400 µM | Human | Congo Clawed Frog Hymenochirus Boettgeri | α-Helix | NA | ||
| 24185042 | 2013 | IKIPAFVKDTLKKVAKGVISAVAGALTQ | Hymenochirin-4B | Free | Free | Linear | L | None | 28 | Antitumor | 50 % Hemolysis at 158 ± 6 µM | Human | Congo Clawed Frog Hymenochirus Boettgeri | α-Helix | NA | ||
| 24185042 | 2013 | IKLSKETKDNLKKVLKGAIKGAIAVAKMV{ct:Amid} | [P5K]-1B | Amidation | Free | Linear | L | None | 29 | Antitumor | 50 % Hemolysis at 205 ± 15 µM | Human | Congo Clawed Frog Hymenochirus Boettgeri | α-Helix | NA | ||
| 24185042 | 2013 | IKLSPKTKDNLKKVLKGAIKGAIAVAKMV{ct:Amid} | [E6K]-1B | Amidation | Free | Linear | L | None | 29 | Antitumor | 50 % Hemolysis at 186 ± 4 µM | Human | Congo Clawed Frog Hymenochirus Boettgeri | α-Helix | NA | ||
| 24185042 | 2013 | IKLSPETKKNLKKVLKGAIKGAIAVAKMV{ct:Amid} | [D9K]-1B | Amidation | Free | Linear | L | None | 29 | Antitumor | 50 % Hemolysis at 174 ± 12 µM | Human | Congo Clawed Frog Hymenochirus Boettgeri | α-Helix | NA | ||
| 24185042 | 2013 | IKLSKKTKDNLKKVLKGAIKGAIAVAKMV{ct:Amid} | [P5K,E6K]-1B | Amidation | Free | Linear | L | None | 29 | Antitumor | 50 % Hemolysis at 137 ± 11 µM | Human | Congo Clawed Frog Hymenochirus Boettgeri | α-Helix | NA | ||
| 24185042 | 2013 | IKLSKETKKNLKKVLKGAIKGAIAVAKMV{ct:Amid} | [P5K,D9K]-1B | Amidation | Free | Linear | L | None | 29 | Antitumor | 50 % Hemolysis at 127 ± 9 µM | Human | Congo Clawed Frog Hymenochirus Boettgeri | α-Helix | NA | ||
| 24185042 | 2013 | IKLSPKTKKNLKKVLKGAIKGAIAVAKMV{ct:Amid} | [E6K,D9K]-1B | Amidation | Free | Linear | L | None | 29 | Antitumor | 50 % Hemolysis at 85 ± 5 µM | Human | Congo Clawed Frog Hymenochirus Boettgeri | α-Helix | NA | ||
| 24185042 | 2013 | IKLSPK{d}TKDNLKKVLKGAIKGAIAVAKMV{ct:Amid} | [E6k]-1B | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 29 | Antitumor | 50 % Hemolysis at 188 ± 8 µM | Human | Congo Clawed Frog Hymenochirus Boettgeri | α-Helix | NA | ||
| 24185042 | 2013 | IKLSPETKK{d}NLKKVLKGAIKGAIAVAKMV{ct:Amid} | [D9k]-1B | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 29 | Antitumor | 50 % Hemolysis at >400 µM | Human | Congo Clawed Frog Hymenochirus Boettgeri | α-Helix | NA | ||
| 24185042 | 2013 | IKLSPK{d}TKK{d}NLKKVLKGAIKGAIAVAKMV{ct:Amid} | [E6k,D9k]-1B | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 29 | Antitumor | 50 % Hemolysis at 302 ± 21 µM | Human | Congo Clawed Frog Hymenochirus Boettgeri | α-Helix | NA | ||
| 23868208 | 2013 | ALAGTIIAGASLTFQVLDKVLEELGKVSRK{ct:Amid} | StII1–30 | Amidation | Free | Linear | L | None | 30 | Cytolytic | 1.0±0.02 % Hemolysis at 40 µM | Human | Stichodactyla Helianthus | α-Helical | Non-hemolytic | ||
| 23868208 | 2013 | AWAGTIIAGASLTFQVLDKVLEELGKVSRK{ct:Amid} | StII1–30L2W | Amidation | Free | Linear | L | None | 30 | Cytolytic | 1.0±0.02 % Hemolysis at 40 µM | Human | Analogs Of Stii1–30 | α-Helical | Non-hemolytic | ||
| 23868208 | 2013 | ALAGTIIAGASWTFQVLDKVLEELGKVSRK{ct:Amid} | StII1–30L12W | Amidation | Free | Linear | L | None | 30 | Cytolytic | 1.0±0.01 % Hemolysis at 40 µM | Human | Analogs Of Stii1–30 | α-Helical | Non-hemolytic | ||
| 23868208 | 2013 | ALAGTIIAGASLTFQVWDKVLEELGKVSRK{ct:Amid} | StII1–30L17W | Amidation | Free | Linear | L | None | 30 | Cytolytic | 0.9 ±0.8 % Hemolysis at 40 µM | Human | Analogs Of Stii1–30 | α-Helical | Non-hemolytic | ||
| 23868208 | 2013 | ALAGTIIAGASLTFQVLDKVLEEWGKVSRK{ct:Amid} | StII1–30L24W | Amidation | Free | Linear | L | None | 30 | Cytolytic | 1.0±0.02 % Hemolysis at 40 µM | Human | Analogs Of Stii1–30 | α-Helical | Non-hemolytic | ||
| 23925670 | 2013 | FWGALAKGALKLIPSLFSSFSKKD | L-Pin2 | Free | Free | Linear | L | None | 24 | Antimicrobial | 80 % Hemolysis at 10 µM | Human | African Scorpion Pandinus Imperator | α-Helical | NA | ||
| 23925670 | 2013 | F{d}W{d}G{d}A{d}L{d}A{d}K{d}G{d}A{d}L{d}K{d}L{d}I{d}P{d}S{d}L{d}F{d}S{d}S{d}F{d}S{d}K{d}K{d}D{d} | D-Pin2 | Free | Free | Linear | D | lowercase letters correspond to D-amino acids | 24 | Antimicrobial | 50 % Hemolysis at 10 µM | Human | African Scorpion Pandinus Imperator | α-Helical | NA | ||
| 24041699 | 2013 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antifungal | 13.5 % Hemolysis at 1.3 µM | Human | Bee Venom | α-Helical | NA | ||
| 24041699 | 2013 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antifungal | 38.7 % Hemolysis at 2.5 µM | Human | Bee Venom | α-Helical | NA | ||
| 24041699 | 2013 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antifungal | 74.9 % Hemolysis at 5 µM | Human | Bee Venom | α-Helical | NA | ||
| 24041699 | 2013 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antifungal | 100 % Hemolysis at 10 µM | Human | Bee Venom | α-Helical | NA | ||
| 24041699 | 2013 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antifungal | 100 % Hemolysis at 20 µM | Human | Bee Venom | α-Helical | NA | ||
| 24041699 | 2013 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antifungal | 100 % Hemolysis at 40 µM | Human | Bee Venom | α-Helical | NA | ||
| 24041699 | 2013 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antifungal | 100 % Hemolysis at 80 µM | Human | Bee Venom | α-Helical | NA | ||
| 24055160 | 2013 | AMPWRPATGLLPIKKPTHIKPLCGDD | Spinulosain-A1 | Free | Free | Linear | L | None | 26 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Skin Of H. Spinulosa | NA | Non-hemolytic | ||
| 24055160 | 2013 | GFLNTAMNTVTNLAGTLMDKAKCKIRGC | Ranatuerin-2SN1 | Free | Free | Linear | L | None | 28 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Skin Of H. Spinulosa | NA | Non-hemolytic | ||
| 24055160 | 2013 | FLPAVLKVAAHILPTAICAISRRC | Brevinin-1SN1 | Free | Free | Linear | L | None | 24 | Antimicrobial | 10.5 % Hemolysis at 50 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | FMGTALKIAANVLPAAFCKIFKKC | Brevinin-1SN2 | Free | Free | Linear | L | None | 24 | Antimicrobial | 51.5 % Hemolysis at 50 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | GAFGNLLKGVAKKAGLKILSIAQCKLSGTC | Brevinin-2SN3 | Free | Free | Linear | L | None | 30 | Antimicrobial | 12.7 % Hemolysis at 50 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | GAFGDLLKGVAKEAGLKLLNMAQCKLSGNO | Brevinin-2SN4 | Free | Free | Linear | L | None | 30 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Skin Of H. Spinulosa | NA | Non-hemolytic | ||
| 24055160 | 2013 | AMPWRPATGLLPIKKPTHIKPLCGDD | Spinulosain-A1 | Free | Free | Linear | L | None | 26 | Antimicrobial | 0 % Hemolysis at 100 µM | Human | Skin Of H. Spinulosa | NA | Non-hemolytic | ||
| 24055160 | 2013 | GFLNTAMNTVTNLAGTLMDKAKCKIRGC | Ranatuerin-2SN1 | Free | Free | Linear | L | None | 28 | Antimicrobial | 0 % Hemolysis at 100 µM | Human | Skin Of H. Spinulosa | NA | Non-hemolytic | ||
| 24055160 | 2013 | FLPAVLKVAAHILPTAICAISRRC | Brevinin-1SN1 | Free | Free | Linear | L | None | 24 | Antimicrobial | 30.2 % Hemolysis at 100 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | FMGTALKIAANVLPAAFCKIFKKC | Brevinin-1SN2 | Free | Free | Linear | L | None | 24 | Antimicrobial | 91.4 % Hemolysis at 100 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | GAFGNLLKGVAKKAGLKILSIAQCKLSGTC | Brevinin-2SN3 | Free | Free | Linear | L | None | 30 | Antimicrobial | 29.8 % Hemolysis at 100 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | GAFGDLLKGVAKEAGLKLLNMAQCKLSGNO | Brevinin-2SN4 | Free | Free | Linear | L | None | 30 | Antimicrobial | 0 % Hemolysis at 100 µM | Human | Skin Of H. Spinulosa | NA | Non-hemolytic | ||
| 24055160 | 2013 | AMPWRPATGLLPIKKPTHIKPLCGDD | Spinulosain-A1 | Free | Free | Linear | L | None | 26 | Antimicrobial | 0 % Hemolysis at 200 µM | Human | Skin Of H. Spinulosa | NA | Non-hemolytic | ||
| 24055160 | 2013 | GFLNTAMNTVTNLAGTLMDKAKCKIRGC | Ranatuerin-2SN1 | Free | Free | Linear | L | None | 28 | Antimicrobial | 10.3 % Hemolysis at 200 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | FLPAVLKVAAHILPTAICAISRRC | Brevinin-1SN1 | Free | Free | Linear | L | None | 24 | Antimicrobial | 50.2 % Hemolysis at 200 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | FMGTALKIAANVLPAAFCKIFKKC | Brevinin-1SN2 | Free | Free | Linear | L | None | 24 | Antimicrobial | 100 % Hemolysis at 200 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | GAFGNLLKGVAKKAGLKILSIAQCKLSGTC | Brevinin-2SN3 | Free | Free | Linear | L | None | 30 | Antimicrobial | 53.4 % Hemolysis at 200 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24055160 | 2013 | GAFGDLLKGVAKEAGLKLLNMAQCKLSGNO | Brevinin-2SN4 | Free | Free | Linear | L | None | 30 | Antimicrobial | 11.9 % Hemolysis at 200 µM | Human | Skin Of H. Spinulosa | NA | NA | ||
| 24349477 | 2013 | IWGLIAHGVGHVGRLIHGLIRG | Pc-pis | Free | Free | Linear | L | None | 22 | Antimicrobial | 15.303 % Hemolysis at 24 µM | Human | Pseudosciaena Crocea | α-Helix | NA | ||
| 24349477 | 2013 | IWGLIAHGVGHVGRLIHGLIRGH | Pc-pis-His | Free | Free | Linear | L | None | 23 | Antimicrobial | 0 % Hemolysis at 6 µM | Human | Pc-Pis Analogue | α-Helix | Non-hemolytic | ||
| 24349477 | 2013 | IWGLIAHGVGHVGRLIHGLIRGH | Pc-pis-His | Free | Free | Linear | L | None | 23 | Antimicrobial | 3.573 % Hemolysis at 12 µM | Human | Pc-Pis Analogue | α-Helix | NA | ||
| 24376887 | 2013 | KKLFKKILKYLKKLFKKILKYL | BP203 | Free | Free | Linear | L | None | 22 | Antimicrobial | 91 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKKLFKKILKYL | BP202 | Free | Free | Linear | L | None | 26 | Antimicrobial | 83 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | GKKLFKKILKYLAGPAKKLFKKILKYL | BP193 | Free | Free | Linear | L | None | 27 | Antimicrobial | 62 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | SKKLFKKILKYLAGPAKKLFKKILKYL | BP195 | Free | Free | Linear | L | None | 27 | Antimicrobial | 71 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKKLFKKILKYLAGPA | BP200 | Free | Free | Linear | L | None | 30 | Antimicrobial | 79 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLKKLFKKILKYLKDEL | BP198 | Free | Free | Linear | L | None | 26 | Antimicrobial | 59 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKKLFKKILKYLKDEL | BP192 | Free | Free | Linear | L | None | 30 | Antimicrobial | 51 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPALYKLIKKFLKKKDEL | BP213 | Free | Free | Linear | L | None | 30 | Antimicrobial | 90 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KDWEHLKDWEHLKDWEHLKDEL | tag54-2 | Free | Free | Linear | L | None | 22 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | Non-hemolytic | ||
| 24376887 | 2013 | KKLFKKILKYLTTGLPALISW | BP170 | Free | Free | Linear | L | None | 21 | Antimicrobial | 82 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPATTGLPALISW | BP171 | Free | Free | Linear | L | None | 25 | Antimicrobial | 5 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | GKKLFKKILKYLAGPATTGLPALISW | BP207 | Free | Free | Linear | L | None | 26 | Antimicrobial | 5 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | SKKLFKKILKYLAGPATTGLPALISW | BP208 | Free | Free | Linear | L | None | 26 | Antimicrobial | 15 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLTTGLPALISWKDEL | BP172 | Free | Free | Linear | L | None | 25 | Antimicrobial | 14 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPATTGLPALISWKDEL | BP173 | Free | Free | Linear | L | None | 29 | Antimicrobial | 8 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLGIGAVLKVLTTGLKDEL | BP189 | Free | Free | Linear | L | None | 28 | Antimicrobial | 41 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKFLHSAK | BP181 | Free | Free | Linear | L | None | 22 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | Non-hemolytic | ||
| 24376887 | 2013 | GKKLFKKILKYLAGPAKFLHSAK | BP211 | Free | Free | Linear | L | None | 23 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | Non-hemolytic | ||
| 24376887 | 2013 | SKKLFKKILKYLAGPAKFLHSAK | BP212 | Free | Free | Linear | L | None | 23 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | Non-hemolytic | ||
| 24376887 | 2013 | KKLFKKILKYLKFLHSAKKDEL | BP182 | Free | Free | Linear | L | None | 22 | Antimicrobial | 1 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKFLHSAKKDEL | BP183 | Free | Free | Linear | L | None | 26 | Antimicrobial | 1 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLGIGKFLHSAK | BP176 | Free | Free | Linear | L | None | 21 | Antimicrobial | 3 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAGIGKFLHSAK | BP175 | Free | Free | Linear | L | None | 25 | Antimicrobial | 6 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | GKKLFKKILKYLAGPAGIGKFLHSAK | BP209 | Free | Free | Linear | L | None | 26 | Antimicrobial | 1 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | SKKLFKKILKYLAGPAGIGKFLHSAK | BP210 | Free | Free | Linear | L | None | 26 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | Non-hemolytic | ||
| 24376887 | 2013 | KKLFKKILKYLGIGKFLHSAKKDEL | BP179 | Free | Free | Linear | L | None | 25 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | Non-hemolytic | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAGIGKFLHSAKKDEL | BP178 | Free | Free | Linear | L | None | 29 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | Non-hemolytic | ||
| 24376887 | 2013 | KKLFKKILKYLAVAVVGQATQIAKKDEL | BP188 | Free | Free | Linear | L | None | 28 | Antimicrobial | 10 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | AVAVVGQATQIAKKKLFKKILKYLKDEL | BP190 | Free | Free | Linear | L | None | 28 | Antimicrobial | 11 % Hemolysis at 50 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLKKLFKKILKYL | BP203 | Free | Free | Linear | L | None | 22 | Antimicrobial | 93 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKKLFKKILKYL | BP202 | Free | Free | Linear | L | None | 26 | Antimicrobial | 93 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | GKKLFKKILKYLAGPAKKLFKKILKYL | BP193 | Free | Free | Linear | L | None | 27 | Antimicrobial | 63 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | SKKLFKKILKYLAGPAKKLFKKILKYL | BP195 | Free | Free | Linear | L | None | 27 | Antimicrobial | 73 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKKLFKKILKYLAGPA | BP200 | Free | Free | Linear | L | None | 30 | Antimicrobial | 80 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLKKLFKKILKYLKDEL | BP198 | Free | Free | Linear | L | None | 26 | Antimicrobial | 72 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKKLFKKILKYLKDEL | BP192 | Free | Free | Linear | L | None | 30 | Antimicrobial | 69 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPALYKLIKKFLKKKDEL | BP213 | Free | Free | Linear | L | None | 30 | Antimicrobial | 92 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KDWEHLKDWEHLKDWEHLKDEL | tag54-2 | Free | Free | Linear | L | None | 22 | Antimicrobial | 0 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | Non-hemolytic | ||
| 24376887 | 2013 | KKLFKKILKYLTTGLPALISW | BP170 | Free | Free | Linear | L | None | 21 | Antimicrobial | 93 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPATTGLPALISW | BP171 | Free | Free | Linear | L | None | 25 | Antimicrobial | 16 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | GKKLFKKILKYLAGPATTGLPALISW | BP207 | Free | Free | Linear | L | None | 26 | Antimicrobial | 36 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | SKKLFKKILKYLAGPATTGLPALISW | BP208 | Free | Free | Linear | L | None | 26 | Antimicrobial | 47 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLTTGLPALISWKDEL | BP172 | Free | Free | Linear | L | None | 25 | Antimicrobial | 49 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPATTGLPALISWKDEL | BP173 | Free | Free | Linear | L | None | 29 | Antimicrobial | 16 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLGIGAVLKVLTTGLKDEL | BP189 | Free | Free | Linear | L | None | 28 | Antimicrobial | 60 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKFLHSAK | BP181 | Free | Free | Linear | L | None | 22 | Antimicrobial | 0 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | Non-hemolytic | ||
| 24376887 | 2013 | GKKLFKKILKYLAGPAKFLHSAK | BP211 | Free | Free | Linear | L | None | 23 | Antimicrobial | 1 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | SKKLFKKILKYLAGPAKFLHSAK | BP212 | Free | Free | Linear | L | None | 23 | Antimicrobial | 5 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLKFLHSAKKDEL | BP182 | Free | Free | Linear | L | None | 22 | Antimicrobial | 38 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKFLHSAKKDEL | BP183 | Free | Free | Linear | L | None | 26 | Antimicrobial | 4 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLGIGKFLHSAK | BP176 | Free | Free | Linear | L | None | 21 | Antimicrobial | 44 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAGIGKFLHSAK | BP175 | Free | Free | Linear | L | None | 25 | Antimicrobial | 14 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | GKKLFKKILKYLAGPAGIGKFLHSAK | BP209 | Free | Free | Linear | L | None | 26 | Antimicrobial | 13 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | SKKLFKKILKYLAGPAGIGKFLHSAK | BP210 | Free | Free | Linear | L | None | 26 | Antimicrobial | 17 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLGIGKFLHSAKKDEL | BP179 | Free | Free | Linear | L | None | 25 | Antimicrobial | 12 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAGIGKFLHSAKKDEL | BP178 | Free | Free | Linear | L | None | 29 | Antimicrobial | 3 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAVAVVGQATQIAKKDEL | BP188 | Free | Free | Linear | L | None | 28 | Antimicrobial | 24 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | AVAVVGQATQIAKKKLFKKILKYLKDEL | BP190 | Free | Free | Linear | L | None | 28 | Antimicrobial | 17 % Hemolysis at 150 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLKKLFKKILKYL | BP203 | Free | Free | Linear | L | None | 22 | Antimicrobial | 95 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKKLFKKILKYL | BP202 | Free | Free | Linear | L | None | 26 | Antimicrobial | 98 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | GKKLFKKILKYLAGPAKKLFKKILKYL | BP193 | Free | Free | Linear | L | None | 27 | Antimicrobial | 74 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | SKKLFKKILKYLAGPAKKLFKKILKYL | BP195 | Free | Free | Linear | L | None | 27 | Antimicrobial | 71 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKKLFKKILKYLAGPA | BP200 | Free | Free | Linear | L | None | 30 | Antimicrobial | 81 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLKKLFKKILKYLKDEL | BP198 | Free | Free | Linear | L | None | 26 | Antimicrobial | 72 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKKLFKKILKYLKDEL | BP192 | Free | Free | Linear | L | None | 30 | Antimicrobial | 69 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPALYKLIKKFLKKKDEL | BP213 | Free | Free | Linear | L | None | 30 | Antimicrobial | 98 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KDWEHLKDWEHLKDWEHLKDEL | tag54-2 | Free | Free | Linear | L | None | 22 | Antimicrobial | 0 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | Non-hemolytic | ||
| 24376887 | 2013 | KKLFKKILKYLTTGLPALISW | BP170 | Free | Free | Linear | L | None | 21 | Antimicrobial | 98 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPATTGLPALISW | BP171 | Free | Free | Linear | L | None | 25 | Antimicrobial | 34 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | GKKLFKKILKYLAGPATTGLPALISW | BP207 | Free | Free | Linear | L | None | 26 | Antimicrobial | 58 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | SKKLFKKILKYLAGPATTGLPALISW | BP208 | Free | Free | Linear | L | None | 26 | Antimicrobial | 68 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLTTGLPALISWKDEL | BP172 | Free | Free | Linear | L | None | 25 | Antimicrobial | 63 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPATTGLPALISWKDEL | BP173 | Free | Free | Linear | L | None | 29 | Antimicrobial | 40 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLGIGAVLKVLTTGLKDEL | BP189 | Free | Free | Linear | L | None | 28 | Antimicrobial | 86 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKFLHSAK | BP181 | Free | Free | Linear | L | None | 22 | Antimicrobial | 0 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | Non-hemolytic | ||
| 24376887 | 2013 | GKKLFKKILKYLAGPAKFLHSAK | BP211 | Free | Free | Linear | L | None | 23 | Antimicrobial | 6 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | SKKLFKKILKYLAGPAKFLHSAK | BP212 | Free | Free | Linear | L | None | 23 | Antimicrobial | 12 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLKFLHSAKKDEL | BP182 | Free | Free | Linear | L | None | 22 | Antimicrobial | 59 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAKFLHSAKKDEL | BP183 | Free | Free | Linear | L | None | 26 | Antimicrobial | 5 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLGIGKFLHSAK | BP176 | Free | Free | Linear | L | None | 21 | Antimicrobial | 59 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAGIGKFLHSAK | BP175 | Free | Free | Linear | L | None | 25 | Antimicrobial | 32 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | GKKLFKKILKYLAGPAGIGKFLHSAK | BP209 | Free | Free | Linear | L | None | 26 | Antimicrobial | 24 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | SKKLFKKILKYLAGPAGIGKFLHSAK | BP210 | Free | Free | Linear | L | None | 26 | Antimicrobial | 30 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLGIGKFLHSAKKDEL | BP179 | Free | Free | Linear | L | None | 25 | Antimicrobial | 35 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAGPAGIGKFLHSAKKDEL | BP178 | Free | Free | Linear | L | None | 29 | Antimicrobial | 25 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | KKLFKKILKYLAVAVVGQATQIAKKDEL | BP188 | Free | Free | Linear | L | None | 28 | Antimicrobial | 42 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24376887 | 2013 | AVAVVGQATQIAKKKLFKKILKYLKDEL | BP190 | Free | Free | Linear | L | None | 28 | Antimicrobial | 32 % Hemolysis at 250 µM | Human | Bp100 Analogues | NA | NA | ||
| 24530880 | 2013 | FFGRLKSVWSAVKHGWKAAKSR | trichoplaxin | Free | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at >800 µM | Rat | Trichoplax Adhaerens | α-Helix | NA | ||
| 23790040 | 2013 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | ~100 % Hemolysis at 10 µM | Mouse | Bee Venom | α-Helix | NA | ||
| 23790040 | 2013 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 50 µM | Mouse | Bee Venom | α-Helix | NA | ||
| 24102775 | 2014 | KKLFKKILKYLAGPATTGLPALISWKDEL | BP100.m | Free | Free | Linear | L | None | 29 | Antimicrobial | 0.7 % Hemolysis at 150 µM | Human | Endoplasmic Reticulum (Er) | α-Helix | Non-hemolytic | ||
| 24102775 | 2014 | KKLFKKILKYLAGPAKFLHSAKKDEL | BP100.g | Free | Free | Linear | L | None | 26 | Antimicrobial | 0.2 % Hemolysis at 150 µM | Human | Endoplasmic Reticulum (Er) | α-Helix | Non-hemolytic | ||
| 24102775 | 2014 | KKLFKKILKYLAGPAGIGKFLHSAKKDEL | BP100.g2 | Free | Free | Linear | L | None | 29 | Antimicrobial | 0.2 % Hemolysis at 150 µM | Human | Endoplasmic Reticulum (Er) | α-Helix | Non-hemolytic | ||
| 24102775 | 2014 | KDWEHLKDWEHLKDWEHLKDEL | Tag54 | Free | Free | Linear | L | None | 22 | Antimicrobial | 0 % Hemolysis at 150 µM | Human | Endoplasmic Reticulum (Er) | α-Helix | Non-hemolytic | ||
| 24221355 | 2014 | RGLRRLGRKIAHGVKKYGPTVLRIIRIA{ct:Amid} | SMAP-29 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 50 % Hemolysis at 86 µM | Human | Sheep Myeloid | α-Helix | NA | ||
| 24419338 | 2014 | LLPIVGNLLKSLLGWKRKRFG | LG21 | Free | Free | Linear | L | None | 21 | Antimicrobial | 8.5 % Hemolysis at 100 µM | mouse | Lipopolysaccharide Trap | α-Helix | NA | ||
| 24419338 | 2014 | FLPLIGRVLSGILGWKRKRFG | FG21 | Free | Free | Linear | L | None | 21 | Antimicrobial | 9.9 % Hemolysis at 100 µM | mouse | Lipopolysaccharide Trap | α-Helix | NA | ||
| 24419338 | 2014 | LLPIVGNLLKSLLGWKRKAFG | LG21R19A | Free | Free | Linear | L | None | 21 | Antimicrobial | 25 % Hemolysis at 100 µM | mouse | Analog Of Lg21, Lipopolysaccharide Trap | α-Helix | NA | ||
| 24419338 | 2014 | LLPIVGNLLKSLLGAKRKRAG | LG21W15AF20A | Free | Free | Linear | L | None | 21 | Antimicrobial | 60 % Hemolysis at 100 µM | mouse | Analog Of Lg21, Lipopolysaccharide Trap | α-Helix | NA | ||
| 24805306 | 2014 | KWKSFLKTFKSLKKTVLHTLLKAISS{nt:Acet}{ct:Amid} | P | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | 5.2 % Hemolysis at 650.4 μmol/L | Human | Peptide A12L/A20L | α-Helix | NA | ||
| 24805306 | 2014 | KWKSFLK{d}TFKSLKKTVLHTLLKAISS{nt:Acet}{ct:Amid} | K7D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | 10.41 % Hemolysis at 650.4 μmol/L | Human | Peptide A12L/A20L | α-Helix | NA | ||
| 24805306 | 2014 | KWKSFLKTFKSLKK{d}TVLHTLLKAISS{nt:Acet}{ct:Amid} | K14D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | 5.2 % Hemolysis at 650.4 μmol/L | Human | Peptide A12L/A20L | α-Helix | NA | ||
| 24805306 | 2014 | KWKSFLKTFKSLKKTVLHTLLK{d}AISS{nt:Acet}{ct:Amid} | K22D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | 20.81 % Hemolysis at 650.4 μmol/L | Human | Peptide A12L/A20L | α-Helix | NA | ||
| 24805306 | 2014 | KWKSFLK{d}TFKSLKK{d}TVLHTLLKAISS{nt:Acet}{ct:Amid} | K7D/K14D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | 20.81 % Hemolysis at 650.4 μmol/L | Human | Peptide A12L/A20L | α-Helix | NA | ||
| 24805306 | 2014 | KWKSFLK{d}TFKSLKKTVLHTLLK{d}AISS{nt:Acet}{ct:Amid} | K14D/K22D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | 20.81 % Hemolysis at 650.4 μmol/L | Human | Peptide A12L/A20L | α-Helix | NA | ||
| 24805306 | 2014 | KWKSFLK{d}TFKSLKK{d}TVLHTLLK{d}AISS{nt:Acet}{ct:Amid} | K7D/K14D/K22D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | 81.31 % Hemolysis at 650.4 μmol/L | Human | Peptide A12L/A20L | α-Helix | NA | ||
| 24805306 | 2014 | KWKSFLK{d}TFK{d}SLKK{d}TVLHTLLK{d}AISS{nt:Acet}{ct:Amid} | K7D/K10D/K14D/K22D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | 325.2 % Hemolysis at 650.4 μmol/L | Human | Peptide A12L/A20L | α-Helix | NA | ||
| 24805306 | 2014 | KWK{d}SFLK{d}TFK{d}SLKK{d}TVLHTLLK{d}AISS{nt:Acet}{ct:Amid} | K3D/K7D/K10D/K14D/K22D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | >325.2 % Hemolysis at 650.4 μmol/L | Human | Peptide A12L/A20L | α-Helix | NA | ||
| 24805306 | 2014 | K{d}WK{d}SFLK{d}TFK{d}SLKK{d}TVLHTLLK{d}AISS{nt:Acet}{ct:Amid} | K1D/K3D/K7D/K10D/K14D/K22D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | >325.2 % Hemolysis at 650.4 μmol/L | Human | Peptide A12L/A20L | α-Helix | NA | ||
| 24805306 | 2014 | KWKSFL{d}KTFKSLKKTVLHTLLKAISS{nt:Acet}{ct:Amid} | L6D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | 10.41 % Hemolysis at 650.4 μmol/L | Human | Peptide A12L/A20L | α-Helix | NA | ||
| 24805306 | 2014 | KWKSFLKTFKSL{d}KKTVLHTLLKAISS{nt:Acet}{ct:Amid} | L12D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | 20.81 % Hemolysis at 650.4 μmol/L | Human | Peptide A12L/A20L | α-Helix | NA | ||
| 24805306 | 2014 | KWKSFLKTFKSLKKTVLHTL{d}LKAISS{nt:Acet}{ct:Amid} | L20D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | 20.81 % Hemolysis at 650.4 μmol/L | Human | Peptide A12L/A20L | α-Helix | NA | ||
| 24805306 | 2014 | KWKSFL{d}KTFKSL{d}KKTVLHTLLKAISS{nt:Acet}{ct:Amid} | L6D/L12D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | 20.81 % Hemolysis at 650.4 μmol/L | Human | Peptide A12L/A20L | α-Helix | NA | ||
| 24805306 | 2014 | KWKSFLKTFKSL{d}KKTVLHTL{d}LKAISS{nt:Acet}{ct:Amid} | L12D/L20D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | 81.31 % Hemolysis at 650.4 μmol/L | Human | Peptide A12L/A20L | α-Helix | NA | ||
| 24805306 | 2014 | KWKSFL{d}KTFKSL{d}KKTVLHTL{d}LKAISS{nt:Acet}{ct:Amid} | L6D/L12D/L20D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | 162.61 % Hemolysis at 650.4 μmol/L | Human | Peptide A12L/A20L | α-Helix | NA | ||
| 24805306 | 2014 | KWKSFL{d}KTFKSL{d}KKTVL{d}HTL{d}LKAISS{nt:Acet}{ct:Amid} | L6D/L12D /L17D/L20D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | 81.3 % Hemolysis at 650.4 μmol/L | Human | Peptide A12L/A20L | α-Helix | NA | ||
| 24805306 | 2014 | KWKSFL{d}KTFKSL{d}KKTVL{d}HTL{d}L{d}KAISS{nt:Acet}{ct:Amid} | L6D/L12D /L17D/L20 D /L21D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | >325.2 % Hemolysis at 650.4 μmol/L | Human | Peptide A12L/A20L | α-Helix | NA | ||
| 25003126 | 2014 | GIGGALLNVGKVALKGLAKGLAEHFAN{ct:Amid} | Bombinin | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 100 % Hemolysis at 64 mg/L | Horse | European Yellow-Bellied Toad (Bombina Variegata) | α-Helix | NA | ||
| 24161537 | 2014 | FLPLLAGLAANFLPKIFCKITRK{ct:Amid} | B1CTcu2 | Amidation | Free | Linear | L | None | 23 | Antibacterial | 17.8 % Hemolysis at 10 µg/ml | Rabbit | Indian Ranid Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 24161537 | 2014 | LPLLAGLAANFLPKIFCKITRK{ct:Amid} | B1CTcu3 | Amidation | Free | Linear | L | None | 22 | Antibacterial | 45 % Hemolysis at 10 µg/ml | Rabbit | Indian Ranid Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 24161537 | 2014 | FLPFIAGMAAKFLPKIFCAISKK{ct:Amid} | B1CTcu4 | Amidation | Free | Linear | L | None | 23 | Antibacterial | 54.8 % Hemolysis at 10 µg/ml | Rabbit | Indian Ranid Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 24161537 | 2014 | LIAGLAANFLPQILCKIARKC{ct:Amid} | B1CTcu5 | Amidation | Free | Linear | L | None | 21 | Antibacterial | 37.5 % Hemolysis at 10 µg/ml | Rabbit | Indian Ranid Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 24269604 | 2014 | TCQYSVNPKIKRFELYFKGRMWCP | MrALF | Free | Free | Linear | L | None | 24 | Antimicrobial | 38.5 % Hemolysis at 250 µM | Mouse | Prawn Macrobrachium Rosenbergii | β-Sheet | NA | ||
| 24269604 | 2014 | TCQYSVNPKIKRFELYFKGRMWCP | MrALF | Free | Free | Linear | L | None | 24 | Antimicrobial | 29.6 % Hemolysis at 200 µM | Mouse | Prawn Macrobrachium Rosenbergii | β-Sheet | NA | ||
| 24269604 | 2014 | TCQYSVNPKIKRFELYFKGRMWCP | MrALF | Free | Free | Linear | L | None | 24 | Antimicrobial | 20.5 % Hemolysis at 150 µM | Mouse | Prawn Macrobrachium Rosenbergii | β-Sheet | NA | ||
| 24269604 | 2014 | TCQYSVNPKIKRFELYFKGRMWCP | MrALF | Free | Free | Linear | L | None | 24 | Antimicrobial | 17.7 % Hemolysis at 100 µM | Mouse | Prawn Macrobrachium Rosenbergii | β-Sheet | NA | ||
| 24269604 | 2014 | TCQYSVNPKIKRFELYFKGRMWCP | MrALF | Free | Free | Linear | L | None | 24 | Antimicrobial | 14.5 % Hemolysis at 50 µM | Mouse | Prawn Macrobrachium Rosenbergii | β-Sheet | NA | ||
| 24269604 | 2014 | TCQYSVNPKIKRFELYFKGRMWCP | MrALF | Free | Free | Linear | L | None | 24 | Antimicrobial | 10.3 % Hemolysis at 25 µM | Mouse | Prawn Macrobrachium Rosenbergii | β-Sheet | NA | ||
| 24269604 | 2014 | TCQYSVNPKIKRFELYFKGRMWCP | MrALF | Free | Free | Linear | L | None | 24 | Antimicrobial | 8.6 % Hemolysis at 10 µM | Mouse | Prawn Macrobrachium Rosenbergii | β-Sheet | NA | ||
| 24269604 | 2014 | TCQYSVNPKIKRFELYFKGRMWCP | MrALF | Free | Free | Linear | L | None | 24 | Antimicrobial | 5.5 % Hemolysis at 5 µM | Mouse | Prawn Macrobrachium Rosenbergii | β-Sheet | NA | ||
| 24389272 | 2014 | FWGALAKGALKLIPSLVSSFTKKD{ct:Amid} | Heterin-2 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 2 % Hemolysis at 0.8 µM | Human | Scorpion Heterometrus Spinifer | α-Helix | NA | ||
| 24389272 | 2014 | FWGALAKGALKLIPSLVSSFTKKD{ct:Amid} | Heterin-2 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 10.6 % Hemolysis at 1.6 µM | Human | Scorpion Heterometrus Spinifer | α-Helix | NA | ||
| 24389272 | 2014 | FWGALAKGALKLIPSLVSSFTKKD{ct:Amid} | Heterin-2 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 49.3 % Hemolysis at 3.2 µM | Human | Scorpion Heterometrus Spinifer | α-Helix | NA | ||
| 24389272 | 2014 | FWGALAKGALKLIPSLVSSFTKKD{ct:Amid} | Heterin-2 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 94 % Hemolysis at 6.4 µM | Human | Scorpion Heterometrus Spinifer | α-Helix | NA | ||
| 24389272 | 2014 | FWGALAKGALKLIPSLVSSFT{ct:Amid} | Heterin-2M | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 0 % Hemolysis at 0.8 µM | Human | Analog Of Heterinscorpion Heterometrus Spinifer | α-Helix | NA | ||
| 24389272 | 2014 | FWGALAKGALKLIPSLVSSFT{ct:Amid} | Heterin-2M | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 1.5 % Hemolysis at 1.6 µM | Human | Analog Of Heterinscorpion Heterometrus Spinifer | α-Helix | NA | ||
| 24389272 | 2014 | FWGALAKGALKLIPSLVSSFT{ct:Amid} | Heterin-2M | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 22.1 % Hemolysis at 3.2 µM | Human | Analog Of Heterinscorpion Heterometrus Spinifer | α-Helix | NA | ||
| 24389272 | 2014 | FWGALAKGALKLIPSLVSSFT{ct:Amid} | Heterin-2M | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 50.1 % Hemolysis at 6.4 µM | Human | Analog Of Heterinscorpion Heterometrus Spinifer | α-Helix | NA | ||
| 24652097 | 2014 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 25 µg/ml | Mouse | Bee Venom | α-Helix | NA | ||
| 24652097 | 2014 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 50 µg/ml | Mouse | Bee Venom | α-Helix | NA | ||
| 24652097 | 2014 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 99 % Hemolysis at 100 µg/ml | Mouse | Bee Venom | α-Helix | NA | ||
| 24666608 | 2014 | NEGKAKCGNTAGSKLTFKSADECTKTGQK | oshem 1 | Free | Free | Linear | L | None | 29 | cytotoxic | 51.7 ± 6.5 % Hemolysis at 0.2 mg/L | Human | Jellyfish Olindias Sambaquiensis | Random coils and small α-Helix | NA | ||
| 24675879 | 2014 | KKCKFFCKVKKKIKSIGFQIPIVSIPFK | Cathelicidin-RC1 | Free | Free | Linear | L | None | 28 | Antimicrobial | 0.2 % Hemolysis at 100 µg/ml | Human | Bullfrog Rana Catesbeiana | 44.8% Alphα-Helix, 12.2% Betα-Sheet, 14.9% Betα-Turn and 26.3% Random-coil | Low hemolytic | ||
| 24675879 | 2014 | KKCKFFCKVKKKIKSIGFQIPIVSIPFK | Cathelicidin-RC1 | Free | Free | Linear | L | None | 28 | Antimicrobial | 2.6 % Hemolysis at 200 µg/ml | Human | Bullfrog Rana Catesbeiana | 44.8% Alphα-Helix, 12.2% Betα-Sheet, 14.9% Betα-Turn and 26.3% Random-coil | Low hemolytic | ||
| 24127254 | 2014 | KWKSFLKTFKSAKKTVLHTALKA{nnr:I}SS{nt:Acet}{ct:Amid} | V13K | Amidation | Acetylation | Linear | L | I = L-Isoleucine, 2S,3S = 2-amino-3-methyl-valeric acid | 26 | Antimicrobial | 10 % Hemolysis at 250 µg/ml | Human | Model Peptide | α-Helix | NA | ||
| 24127254 | 2014 | KWKSFLKTFKSAKKTVLHTALKA{nnr:alloI}SS{nt:Acet}{ct:Amid} | a-V13K | Amidation | Acetylation | Linear | L | alloI = L-allo-Ile, 2S,3R = 2-amino-3-methyl-valeric acid | 26 | Antimicrobial | 10 % Hemolysis at 500 µg/ml | Human | Model Peptide | α-Helix | Non-hemolytic | ||
| 24168384 | 2014 | VIPFVASVAAEMMQHIFCAASRKC | Brevini-Eu | Free | Free | Linear | L | None | 24 | Antibacterial | 1.9 % Hemolysis at 500 µg/ml | Human | Skin Secretions Of Euphlyctis Cyanophlyctis | α-Helix | Non-hemolytic | ||
| 24723458 | 2014 | SSMKLSFRARAYGFRGPGPQL | Catestatin(SL21) | Free | Free | Linear | L | None | 21 | Antimicrobial | 0 % Hemolysis at 80 μg/ml | Human | Endogenous Neuropeptide | α-Helix | Non-hemolytic | ||
| 24871991 | 2014 | GIGAVLKVLTTGLPALISWIKRKRQQ | M(melittin) | Free | Free | Linear | L | None | 26 | Antibacterial | 50 % Hemolysis at 8 μg/ml | Sheep | Bee Venom | α-Helix | NA | ||
| 24871991 | 2014 | GIGAVLKVLTTGLFKRIVQRIKDFLRN | M-L | Free | Free | Linear | L | None | 27 | Antimicrobial | 50 % Hemolysis at >128 μg/ml | Sheep | Hybrid Peptide M (1-13)-L (17-30),Parental Peptides | α-Helix | NA | ||
| 25019413 | 2014 | FWGALAKGALKLIPSLFSSFSKKD | Pandinin 2(Pin2) | Free | Free | Linear | L | None | 24 | Antimicrobial | 91 % Hemolysis at 25 µM | Human | Scorpion Venom Pandinus Imperator | α-Helix | NA | ||
| 25019413 | 2014 | FWGALAKGALKLIGSLFSSFSKKD | Pin2 [G] | Free | Free | Linear | L | None | 24 | Antimicrobial | 100 % Hemolysis at 25 µM | Human | Variant Of Pandinin 2,Scorpion Venom Pandinus Imperator | α-Helix | NA | ||
| 25019413 | 2014 | FWGALAKGALKLIGPGSLFSSFSKKD | Pin2 [GPG] | Free | Free | Linear | L | None | 26 | Antimicrobial | 30 % Hemolysis at 25 µM | Human | Variant Of Pandinin 2,Scorpion Venom Pandinus Imperator | α-Helix | NA | ||
| 25061725 | 2014 | KWKSFLKTFKSAKKTVLHTALKAISS{nt:Acet}{ct:Amid} | P | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | 28.3 % Hemolysis at 1000 μg/ml | Human | Na | α-Helix | NA | ||
| 25061725 | 2014 | KWKSFLKTFKSAKKTKLHTALKAISS{nt:Acet}{ct:Amid} | V16LK | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | 6.2 % Hemolysis at 1000 μg/ml | Human | Analog Of V13K | α-Helix | NA | ||
| 25061725 | 2014 | KWKSFLKTFKSAKKTGLHTALKAISS{nt:Acet}{ct:Amid} | V16LG | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | 8.1 % Hemolysis at 1000 μg/ml | Human | Analog Of V13K | α-Helix | NA | ||
| 25061725 | 2014 | KWKSFLKTFKSAKKTSLHTALKAISS{nt:Acet}{ct:Amid} | V16LS | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | 11.3 % Hemolysis at 1000 μg/ml | Human | Analog Of V13K | α-Helix | NA | ||
| 25061725 | 2014 | KWKSFLKTFKSAKKTELHTALKAISS{nt:Acet}{ct:Amid} | V16LE | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | 3.9 % Hemolysis at 1000 μg/ml | Human | Analog Of V13K | α-Helix | NA | ||
| 25061725 | 2014 | KWKSFLKTFKSAKKTALHTALKAISS{nt:Acet}{ct:Amid} | V16LA | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | 14.3 % Hemolysis at 1000 μg/ml | Human | Analog Of V13K | α-Helix | NA | ||
| 25061725 | 2014 | KWKSFLKTFKSAKKTLLHTALKAISS{nt:Acet}{ct:Amid} | V16LL | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial | 53.9 % Hemolysis at 1000 μg/ml | Human | Analog Of V13K | α-Helix | NA | ||
| 25123187 | 2014 | KWKSFLKTFKSLKKTVLHTLLKAISS{nt:Acet}{ct:Amid} | P(PNW) | Amidation | Acetylation | Linear | L | None | 26 | Anticancer | MHC % Hemolysis at 10.41 ± 0.02 µM | Human | Peptide A12L/A20L | α-Helix | NA | ||
| 25123187 | 2014 | KIKSFLKTFKSWKKTVLHTLLKAISS{nt:Acet}{ct:Amid} | PMW | Amidation | Acetylation | Linear | L | None | 26 | Anticancer | MHC % Hemolysis at 10.41 ± 0.01 µM | Human | Peptide A12L/A20L | α-Helix | NA | ||
| 25123187 | 2014 | KIKSFLKTFKSLKKTVLHTLLKAWSS{nt:Acet}{ct:Amid} | PCW | Amidation | Acetylation | Linear | L | None | 26 | Anticancer | MHC % Hemolysis at 10.41 ± 0.01 µM | Human | Peptide A12L/A20L | α-Helix | NA | ||
| 24955933 | 2014 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 100 µM | Human | Venom Of The Honey Bee Apis Mellifera | NA | NA | ||
| 24955933 | 2014 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 50 µM | Human | Venom Of The Honey Bee Apis Mellifera | NA | NA | ||
| 24955933 | 2014 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 25 µM | Human | Venom Of The Honey Bee Apis Mellifera | NA | NA | ||
| 24955933 | 2014 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 12.5 µM | Human | Venom Of The Honey Bee Apis Mellifera | NA | NA | ||
| 24955933 | 2014 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 74.8 % Hemolysis at 6.3 µM | Human | Venom Of The Honey Bee Apis Mellifera | NA | NA | ||
| 24955933 | 2014 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 42 % Hemolysis at 3.1 µM | Human | Venom Of The Honey Bee Apis Mellifera | NA | NA | ||
| 24955933 | 2014 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 12.7 % Hemolysis at 1.6 µM | Human | Venom Of The Honey Bee Apis Mellifera | NA | NA | ||
| 25086320 | 2014 | GIKEFAHSLGKFGKAFVGGILNQ | Magainin-W1 | Free | Free | Linear | L | None | 23 | Antimicrobial | 50 % Hemolysis | Human | Skin Secretions Of Xenopus Wittei | α-Helix | NA | ||
| 25086320 | 2014 | GVGKFLHSASKFGKALVGELMKS | Magainin-W2 | Free | Free | Linear | L | None | 23 | Antimicrobial | 50 % Hemolysis at >500 µM | Human | Skin Secretions Of Xenopus Wittei | α-Helix | NA | ||
| 25086320 | 2014 | GISKFLHSASKFGKALVGEIMKS | Magainin-W3 | Free | Free | Linear | L | None | 23 | Antimicrobial | 50 % Hemolysis at >500 µM | Human | Skin Secretions Of Xenopus Wittei | α-Helix | NA | ||
| 25086320 | 2014 | GMASKAGTIVGKLAKVALNAL{ct:Amid} | PGLa-W1 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 50 % Hemolysis | Human | Skin Secretions Of Xenopus Wittei | α-Helix | NA | ||
| 25086320 | 2014 | GWASKIGQTLGKMAKVGLQELIQPK | XPF-W1 | Free | Free | Linear | L | None | 25 | Antimicrobial | 50 % Hemolysis | Human | Skin Secretions Of Xenopus Wittei | α-Helix | NA | ||
| 25086320 | 2014 | GFGSFLGKALKAGLKLGANLLGGAPQQ | CPF-W1 | Free | Free | Linear | L | None | 27 | Antimicrobial | 50 % Hemolysis | Human | Skin Secretions Of Xenopus Wittei | α-Helix | NA | ||
| 25086320 | 2014 | GFGSFLGKALKAGLKLGANLLGGAPQE | CPF-W3 | Free | Free | Linear | L | None | 27 | Antimicrobial | 50 % Hemolysis | Human | Skin Secretions Of Xenopus Wittei | α-Helix | NA | ||
| 25086320 | 2014 | GLGTFLGNALKTGLKIGTNLL{ct:Amid} | CPF-W7 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 50 % Hemolysis | Human | Skin Secretions Of Xenopus Wittei | α-Helix | NA | ||
| 25445609 | 2014 | MFKCRRWQWRMKKLGAPSITCVRRAF{nt:NH3} | bovine lactoferricin | Free | NH3 | Linear | L | None | 26 | Antibacterial and Antifungal | 0 % Hemolysis at 1 mM | Rabbit | Bovine Lactoferrins | NA | Non-hemolytic | ||
| 25473836 | 2014 | FFHHIFRGIVHVGKTIHRLVTG | Pis-1 | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | ~100 % Hemolysis at 100 µM | Human | Mast Cells Of Aquacultured Hybrid Striped Bass | α-Helical | NA | ||
| 25473836 | 2014 | AFHHIFRGIVHVGKTIHRLVTG | PisF1A | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 100 % Hemolysis at 100 µM | Human | Pis-1 Analog | α-Helical | NA | ||
| 25473836 | 2014 | FAHHIFRGIVHVGKTIHRLVTG | PisF2A | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | >12 % Hemolysis at 100 µM | Human | Pis-1 Analog | α-Helical | NA | ||
| 25473836 | 2014 | FFHHIARGIVHVGKTIHRLVTG | PisF6A | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 29 % Hemolysis at 100 µM | Human | Pis-1 Analog | α-Helical | NA | ||
| 25473836 | 2014 | KFHHIFRGIVHVGKTIHRLVTG | PisF1K | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 50 % Hemolysis at 100 µM | Human | Pis-1 Analog | α-Helical | NA | ||
| 25473836 | 2014 | FKHHIFRGIVHVGKTIHRLVTG | PisF2K | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 0 % Hemolysis at 100 µM | Human | Pis-1 Analog | α-Helical | Non-hemolytic | ||
| 25473836 | 2014 | FFHHIKRGIVHVGKTIHRLVTG | PisF6K | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 0 % Hemolysis at 100 µM | Human | Pis-1 Analog | α-Helical | Non-hemolytic | ||
| 25473836 | 2014 | FFHHIFRGIKHVGKTIHRLVTG | PisV10K | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 0 % Hemolysis at 50 µM | Human | Pis-1 Analog | α-Helical | Non-hemolytic | ||
| 25473836 | 2014 | FFHHIFRGIKHVGKTIHRLVTG | PisV10K | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 20 % Hemolysis at 100 µM | Human | Pis-1 Analog | α-Helical | NA | ||
| 25473836 | 2014 | KFHHIFRGIKHVGKTIHRLVTG | Pis-F1K/V10K | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 0 % Hemolysis at 100 µM | Human | Pis-1 Analog | α-Helical | Non-hemolytic | ||
| 25473836 | 2014 | FKHHIFRGIKHVGKTIHRLVTG | Pis-F2K/V10K | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 0 % Hemolysis at 100 µM | Human | Pis-1 Analog | α-Helical | Non-hemolytic | ||
| 25473836 | 2014 | FFHHIKRGIKHVGKTIHRLVTG | Pis-F6K/V10K | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 0 % Hemolysis at 100 µM | Human | Pis-1 Analog | α-Helical | Non-hemolytic | ||
| 25473836 | 2014 | KFHHIFRGIKHVGKTIHRLVTG | Pis-F1K/V10K | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | <20 % Hemolysis at 200 µM | Human | Pis-1 Analog | α-Helical | NA | ||
| 25473836 | 2014 | FFHHIKRGIKHVGKTIHRLVTG | Pis-F6K/V10K | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 19 % Hemolysis at 400 µM | Human | Pis-1 Analog | α-Helical | NA | ||
| 25473836 | 2014 | FFHHIKRGIKHVGKTIHRLVTG | Pis-F2K/V10K | Free | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 0 % Hemolysis at 400 µM | Human | Pis-1 Analog | α-Helical | Non-hemolytic | ||
| 25241629 | 2014 | LKLSPKTKDTLKKVLKGAIKGAIAIASMA{ct:Amid} | Hymenochirin-1Pa | Amidation | Free | Linear | L | None | 29 | Antimicrobial, Antitumor | 50 % Hemolysis at 162 ± 13 µM | Human | Skin Secretions Ofthe Frog Pseudhymenochirus Merlini | α-Helix | NA | ||
| 25241629 | 2014 | LKLSPKTKKTLKKVLKGAIKGAIAIASMA{ct:Amid} | [D9K]Hymenochirin-1Pa | Amidation | Free | Linear | L | None | 29 | Antimicrobial, Antitumor | 50 % Hemolysis at 192 ± 21 µM | Human | Analog Of Hymenochirin-1Pa, Skin Secretions Ofthe Frog Pseudhymenochirus Merlini | α-Helix | NA | ||
| 25241629 | 2014 | LKLSPKTKK{d}TLKKVLKGAIKGAIAIASMA{ct:Amid} | [D9k]Hymenochirin-1Pa | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 29 | Antimicrobial, Antitumor | 50 % Hemolysis at >400 µM | Human | Analog Of Hymenochirin-1Pa, Skin Secretions Ofthe Frog Pseudhymenochirus Merlini | α-Helix | NA | ||
| 25447194 | 2014 | IKIPSFFRNILKKVGKEAVSLIAGALKQS | Pseudhymenochirin-1Pb(Ps-1Pb) | Free | Free | Linear | L | None | 29 | Antimicrobial, Antitumor | 50 % Hemolysis at 28 ± 2 µM | Human | Skin Secretions Of The Frog Pseudhymenochirus Merlini | α-Helix | NA | ||
| 25447194 | 2014 | GIFPIFAKLLGKVIKVASSLISKGRTE | (Pseudhymenochirin-2Pa)Ps-2Pa | Free | Free | Linear | L | None | 27 | Antimicrobial, Antitumor | 50 % Hemolysis at 6.2 ± 1.0 µM | Human | Skin Secretions Of The Frog Pseudhymenochirus Merlini | α-Helix | NA | ||
| 25200682 | 2014 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin(MLT) | Free | Free | Linear | L | None | 26 | Antimicrobial, Antiviral | 50 % Hemolysis at 5 µM | Human | Bee Venom | α-Helix | NA | ||
| 25200682 | 2014 | GIGAVLKVLTTGLCALISWIKRKRQQ | MLT-P14C | Free | Free | Linear | L | None | 26 | Antibacterial | 50 % Hemolysis at 2.5 µM | Human | Analog Of Melittin, Bee Venom | α-Helix | NA | ||
| 25209888 | 2014 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 100 ± 2.3 % Hemolysis at 80 µM | Human | Venom Of The Honey Bee Apis Mellifera | α-Helix | NA | ||
| 25209888 | 2014 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 100 ± 3.3 % Hemolysis at 40 µM | Human | Venom Of The Honey Bee Apis Mellifera | α-Helix | NA | ||
| 25209888 | 2014 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 98.4 ± 2.0 % Hemolysis at 20 µM | Human | Venom Of The Honey Bee Apis Mellifera | α-Helix | NA | ||
| 25209888 | 2014 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 74.0 ± 7.4 % Hemolysis at 10 µM | Human | Venom Of The Honey Bee Apis Mellifera | α-Helix | NA | ||
| 25209888 | 2014 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 36.7 ± 9.5 % Hemolysis at 5 µM | Human | Venom Of The Honey Bee Apis Mellifera | α-Helix | NA | ||
| 25209888 | 2014 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 13.4 ± 7.1 % Hemolysis at 2.5 µM | Human | Venom Of The Honey Bee Apis Mellifera | α-Helix | NA | ||
| 25209888 | 2014 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 0 % Hemolysis at 1.3 µM | Human | Venom Of The Honey Bee Apis Mellifera | α-Helix | NA | ||
| 25016054 | 2014 | GIGAVLVKLTTGLPALISWIKRKRQQ{ct:Amid} | melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 50 μg/ml | Human | Bee Venom | NA | NA | ||
| 24466055 | 2014 | GVFRRLRKVTRKVLKKIGKVLKWI{ct:Amid} | GI24-V3 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolysis at 128 µM | Human | Residue-Substituted Derivative Of Cathelicidin Pmap-36 | α-Helix | NA | ||
| 24466055 | 2014 | GVFRVLRKVTRVVLKVIGKVLKWI{ct:Amid} | GI24-V6 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolysis at 8 µM | Human | Residue-Substituted Derivative Of Cathelicidin Pmap-36 | α-Helix | NA | ||
| 24466055 | 2014 | GRFRRLRKKTRKRLKKIGKVLKWI{ct:Amid} | GI24 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | <30 % Hemolysis at 128 µM | Human | Truncated Derivative Of Cathelicidin Pmap-36 | α-Helix | NA | ||
| 24466055 | 2014 | GRFRRLRKKTRKRLKKIGKVLKAI{ct:Amid} | GI24-W23A | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 0 % Hemolysis at 128 µM | Human | Residue-Substituted Derivative Of Cathelicidin Pmap-36 | α-Helix | Non-hemolytic | ||
| 24466055 | 2014 | GRFRRLRKKTRKRLKKIGKVLKKI{ct:Amid} | GI24-W23K | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 0 % Hemolysis at 128 µM | Human | Residue-Substituted Derivative Of Cathelicidin Pmap-36 | α-Helix | Non-hemolytic | ||
| 24466055 | 2014 | GRFRRLRKKTRKRLKKIGKVLKLI{ct:Amid} | GI24-W23L | Amidation | Free | Linear | L | None | 24 | Antimicrobial | <40 % Hemolysis at 128 µM | Human | Residue-Substituted Derivative Of Cathelicidin Pmap-36 | α-Helix | NA | ||
| 24466055 | 2014 | GIGAVLVKLTTGLPALISWIKRKRQQ{ct:Amid} | melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 128 µM | Human | Bee Venom | α-Helix | NA | ||
| 24670666 | 2014 | F{d}F{d}H{d}H{d}I{d}F{d}R{d}G{d}I{d}V{d}H{d}V{d}G{d}K{d}T{d}I{d}H{d}R{d}L{d}V{d}T{d}G{d}{nt:Amid}{ct:Amid} | D-Piscidin 1 | Amidation | Amidation | Linear | D | lowercase letters correspond to D-amino acids | 22 | Antimicrobial | 50 % Hemolysis at 1.8 µM | Human | Hybrid Striped Bass (Morone Saxatilis Male × Morone Chrysops Female) | α-Helix | NA | ||
| 24670666 | 2014 | F{d}F{d}H{d}H{d}I{d}F{d}R{d}G{d}I{d}V{d}H{d}V{d}K{d}K{d}T{d}I{d}H{d}R{d}L{d}V{d}T{d}G{d}{nt:Amid}{ct:Amid} | D-Piscidin 1 G13K | Amidation | Amidation | Linear | D | lowercase letters correspond to D-amino acids | 22 | Antimicrobial | 50 % Hemolysis at 7 µM | Human | Derivative Of Hybrid Striped Bass (Morone Saxatilis Male × Morone Chrysops Female) | α-Helix | NA | ||
| 24670666 | 2014 | F{d}F{d}H{d}H{d}I{d}F{d}R{d}G{d}I{d}V{d}H{d}K{d}G{d}K{d}T{d}I{d}H{d}R{d}L{d}V{d}T{d}G{d}{nt:Amid}{ct:Amid} | D-Piscidin 1 V12K | Amidation | Amidation | Linear | D | lowercase letters correspond to D-amino acids | 22 | Antimicrobial | 50 % Hemolysis at 35 µM | Human | Derivative Of Hybrid Striped Bass (Morone Saxatilis Male × Morone Chrysops Female) | α-Helix | NA | ||
| 24670666 | 2014 | F{d}F{d}H{d}H{d}I{d}F{d}R{d}G{d}K{d}V{d}H{d}V{d}G{d}K{d}T{d}I{d}H{d}R{d}L{d}V{d}T{d}G{d}{nt:Amid}{ct:Amid} | D-Piscidin 1 I9K | Amidation | Amidation | Linear | D | lowercase letters correspond to D-amino acids | 22 | Antimicrobial | 50 % Hemolysis at 98 µM | Human | Derivative Of Hybrid Striped Bass (Morone Saxatilis Male × Morone Chrysops Female) | α-Helix | NA | ||
| 24670666 | 2014 | A{d}L{d}W{d}M{d}T{d}L{d}L{d}K{d}K{d}V{d}L{d}K{d}A{d}A{d}A{d}A{d}K{d}A{d}L{d}N{d}A{d}V{d}L{d}V{d}G{d}A{d}N{d}A{d}{nt:Amid}{ct:Amid} | D-Dermaseptin S4 | Amidation | Amidation | Linear | D | lowercase letters correspond to D-amino acids | 27 | Antimicrobial | 50 % Hemolysis at 0.6 µM | Human | South American Frogs Of The Phyllomedusa | α-Helix | NA | ||
| 24670666 | 2014 | A{d}L{d}W{d}M{d}T{d}L{d}K{d}K{d}K{d}V{d}L{d}K{d}A{d}A{d}A{d}A{d}K{d}A{d}L{d}N{d}A{d}V{d}L{d}V{d}G{d}A{d}N{d}A{d}{nt:Amid}{ct:Amid} | D-Dermaseptin S4 L7K | Amidation | Amidation | Linear | D | lowercase letters correspond to D-amino acids | 27 | Antimicrobial | 50 % Hemolysis at 8.6 µM | Human | Derivative Of D-Dermaseptin S4 | α-Helix | NA | ||
| 24670666 | 2014 | A{d}L{d}W{d}M{d}T{d}L{d}K{d}K{d}K{d}V{d}L{d}K{d}A{d}K{d}A{d}K{d}A{d}L{d}N{d}A{d}V{d}L{d}V{d}G{d}A{d}N{d}A{d}{nt:Amid}{ct:Amid} | D-Dermaseptin S4 L7K,A14K | Amidation | Amidation | Linear | D | lowercase letters correspond to D-amino acids | 27 | Antimicrobial | 50 % Hemolysis at 241 µM | Human | Derivative Of D-Dermaseptin S4 | α-Helix | NA | ||
| 25106507 | 2014 | GGHGGHGGHGGHGGHGGHGHGGGGHG{ct:Amid} | Shep I (3-28)a | Amidation | Free | Linear | L | None | 26 | Antifungal, Anticandida | 0 % Hemolysis at 100 µM (IGP buffer) | Human | Shepherin I Is Roots, Shepherd'S Purse, Capsella Bursa-Pastoris Plant Analogues Peptide | β-Pleated Sheet | Non-hemolytic | ||
| 25106507 | 2014 | GGHGGHGGHGGHGGHGHGGGGHG{ct:Amid} | Shep I (6-28)a | Amidation | Free | Linear | L | None | 23 | Antifungal, Anticandida | 0 % Hemolysis at 100 µM (IGP buffer) | Human | Shepherin I Is Roots, Shepherd'S Purse, Capsella Bursa-Pastoris Plant Analogues Peptide | β-Pleated Sheet | Non-hemolytic | ||
| 25106507 | 2014 | GYGGHGGHGGHGGHGGHGGHGHGGGGHG{ct:Amid} | Shep Ia | Amidation | Free | Linear | L | None | 28 | Antifungal, Anticandida | 18 % Hemolysis at 100 µM (IGP buffer) | Human | Shepherin I Is Roots, Shepherd'S Purse, Capsella Bursa-Pastoris Plant Analogues Peptide | β-Pleated Sheet | NA | ||
| 25271126 | 2015 | KVLRDNIQGITKPAIRRLARRG | MrH4 N-terminal peptide(KVL22) | Free | Free | Linear | L | None | 22 | Antimicrobial | 8.4 ± 1.2 % Hemolysis at 5 µM | Human | Freshwater Giant Prawn Macrobrachium Rosenbergii | α-Helix | NA | ||
| 25271126 | 2015 | KVLRDNIQGITKPAIRRLARRG | MrH4 N-terminal peptide(KVL22) | Free | Free | Linear | L | None | 22 | Antimicrobial | 12.5 ± 1.5 % Hemolysis at 10 µM | Human | Freshwater Giant Prawn Macrobrachium Rosenbergii | α-Helix | NA | ||
| 25271126 | 2015 | KVLRDNIQGITKPAIRRLARRG | MrH4 N-terminal peptide(KVL22) | Free | Free | Linear | L | None | 22 | Antimicrobial | 18.4 ± 2.2 % Hemolysis at 25 µM | Human | Freshwater Giant Prawn Macrobrachium Rosenbergii | α-Helix | NA | ||
| 25271126 | 2015 | KVLRDNIQGITKPAIRRLARRG | MrH4 N-terminal peptide(KVL22) | Free | Free | Linear | L | None | 22 | Antimicrobial | 24.7 ± 1.7 % Hemolysis at 50 µM | Human | Freshwater Giant Prawn Macrobrachium Rosenbergii | α-Helix | NA | ||
| 25271126 | 2015 | KVLRDNIQGITKPAIRRLARRG | MrH4 N-terminal peptide(KVL22) | Free | Free | Linear | L | None | 22 | Antimicrobial | 33.6 ± 2.9 % Hemolysis at 100 µM | Human | Freshwater Giant Prawn Macrobrachium Rosenbergii | α-Helix | NA | ||
| 25271126 | 2015 | KVLRDNIQGITKPAIRRLARRG | MrH4 N-terminal peptide(KVL22) | Free | Free | Linear | L | None | 22 | Antimicrobial | 39.4 ± 2.5 % Hemolysis at 150 µM | Human | Freshwater Giant Prawn Macrobrachium Rosenbergii | α-Helix | NA | ||
| 25271126 | 2015 | KVLRDNIQGITKPAIRRLARRG | MrH4 N-terminal peptide(KVL22) | Free | Free | Linear | L | None | 22 | Antimicrobial | 45.1 ± 2.1 % Hemolysis at 200 µM | Human | Freshwater Giant Prawn Macrobrachium Rosenbergii | α-Helix | NA | ||
| 25271126 | 2015 | KVLRDNIQGITKPAIRRLARRG | MrH4 N-terminal peptide(KVL22) | Free | Free | Linear | L | None | 22 | Antimicrobial | 48.2 ± 1.6 % Hemolysis at 250 µM | Human | Freshwater Giant Prawn Macrobrachium Rosenbergii | α-Helix | NA | ||
| 25348533 | 2015 | ACPIFTKIQGTYRGKAKRIGRRIC | hBTD-1 | Free | Free | Linear | L | None | 24 | Antimicrobial | 0 % Hemolysis at 0 µM | Human | Hybrid Peptide Of Human Β-Defensin -1 And Θ-Defensin | α-Helix | Non-hemolytic | ||
| 25348533 | 2015 | ACPIFTKIQGTYRGKAKRIGRRIC | hBTD-1 | Free | Free | Linear | L | None | 24 | Antimicrobial | 0.0012 ± 0.001 % Hemolysis at 5 µM | Human | Hybrid Peptide Of Human Β-Defensin -1 And Θ-Defensin | α-Helix | Non-hemolytic | ||
| 25348533 | 2015 | ACPIFTKIQGTYRGKAKRIGRRIC | hBTD-1 | Free | Free | Linear | L | None | 24 | Antimicrobial | 0.0020 ± 0.001 % Hemolysis at 10 µM | Human | Hybrid Peptide Of Human Β-Defensin -1 And Θ-Defensin | α-Helix | Non-hemolytic | ||
| 25348533 | 2015 | ACPIFTKIQGTYRGKAKRIGRRIC | hBTD-1 | Free | Free | Linear | L | None | 24 | Antimicrobial | 0.0040 ± 0.0040 % Hemolysis at 50 µM | Human | Hybrid Peptide Of Human Β-Defensin -1 And Θ-Defensin | α-Helix | Non-hemolytic | ||
| 25348533 | 2015 | ACPIFTKIQGTYRGKAKRIGRRIC | hBTD-1 | Free | Free | Linear | L | None | 24 | Antimicrobial | 0.0053 ± 0.001 % Hemolysis at 100 µM | Human | Hybrid Peptide Of Human Β-Defensin -1 And Θ-Defensin | α-Helix | Non-hemolytic | ||
| 25433327 | 2015 | GIGKFLHSAGKFGKAFVGEIMKS | Magainin-G1 | Free | Free | Linear | L | None | 23 | Antibacterial | 50 % Hemolysis at >160 µM | Human | Skin Secretions Of X. Gilli From The Cape Peninsula | α-Helix | NA | ||
| 25433327 | 2015 | GMASKAGAIAGKIAKVALKAV{ct:Amid} | PGLa-G2 | Amidation | Free | Linear | L | None | 21 | Antibacterial | 50 % Hemolysis at >160 µM | Human | Skin Secretions Of X. Gilli From The Cape Peninsula | α-Helix | NA | ||
| 25433327 | 2015 | GWASKIGQTLGKMAKVGLQELIQPK | XPF-G1 | Free | Free | Linear | L | None | 25 | Antibacterial | 50 % Hemolysis at >160 µM | Human | Skin Secretions Of X. Gilli From The Cape Peninsula | α-Helix | NA | ||
| 25433327 | 2015 | GFGSFLGKALKAALKIGANALGGAPQQ | CPF-G2 | Free | Free | Linear | L | None | 27 | Antibacterial | 50 % Hemolysis | Human | Skin Secretions Of X. Gilli From The Cape Peninsula | α-Helix | NA | ||
| 25433327 | 2015 | GFGSFLGKALKAALKIGANALGGAPEQ | CPF-G3 | Free | Free | Linear | L | None | 27 | Antibacterial | 50 % Hemolysis at 85 µM | Human | Skin Secretions Of X. Gilli From The Cape Peninsula | α-Helix | NA | ||
| 25433327 | 2015 | GFGSVLGKLFKTAVKIIPSLLPSKQE | CPF-G4 | Free | Free | Linear | L | None | 26 | Antibacterial | 50 % Hemolysis at 35 µM | Human | Skin Secretions Of X. Gilli From The Cape Peninsula | α-Helix | NA | ||
| 25433327 | 2015 | GLASFLGKALKAGLKIGANLLGGAPQQ | CPF-G5 | Free | Free | Linear | L | None | 27 | Antibacterial | 50 % Hemolysis | Human | Skin Secretions Of X. Gilli From The Cape Peninsula | α-Helix | NA | ||
| 25433327 | 2015 | GFGSFLGKALKAALKVGANMLGGAPQQ | CPF-G6 | Free | Free | Linear | L | None | 27 | Antibacterial | 50 % Hemolysis at 60 µM | Human | Skin Secretions Of X. Gilli From The Cape Peninsula | α-Helix | NA | ||
| 25557880 | 2015 | RWCVYAYVRVRGVLVRYRRCW | Arenicin-1 | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 4.1 µM | Human | Coelomocytes Of Marine Polychaeta Lugworm Arenicola Marina | β-Hairpin | NA | ||
| 25557880 | 2015 | RGCVYAYVRVRGVLVRYRRCW | W2G | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 5.5 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RSCVYAYVRVRGVLVRYRRCW | W2S | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 5.5 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RRCVYAYVRVRGVLVRYRRCW | W2R | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 9.4 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCGYAYVRVRGVLVRYRRCW | V4G | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 36.2 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCSYAYVRVRGVLVRYRRCW | V4S | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 23.1 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCRYAYVRVRGVLVRYRRCW | V4R | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 48.5 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYGYVRVRGVLVRYRRCW | A6G | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 17 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYSYVRVRGVLVRYRRCW | A6S | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 13.9 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYRYVRVRGVLVRYRRCW | A6R | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 71 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYAYGRVRGVLVRYRRCW | V8G | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 6.7 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYAYSRVRGVLVRYRRCW | V8S | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 26.8 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYAYRRVRGVLVRYRRCW | V8R | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 125 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYAYVRGRGVLVRYRRCW | V10G | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 4.9 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYAYVRSRGVLVRYRRCW | V10S | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 4.3 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYAYVRRRGVLVRYRRCW | V10R | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 9.5 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYAYVRVRGGLVRYRRCW | V13G | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 5.9 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYAYVRVRGSLVRYRRCW | V13S | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 9.7 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYAYVRVRGRLVRYRRCW | V13R | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 13.7 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYAYVRVRGVGVRYRRCW | L14G | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 4.4 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYAYVRVRGVSVRYRRCW | L14S | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 3.1 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYAYVRVRGVRVRYRRCW | L14R | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 3.1 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYAYVRVRGVLGRYRRCW | V15G | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 12.8 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYAYVRVRGVLSRYRRCW | V15S | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 24.8 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYAYVRVRGVLRRYRRCW | V15R | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 28.3 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYAYVRVRGVLVRYRRCG | W21G | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 8.4 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYAYVRVRGVLVRYRRCS | W21S | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 9.2 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25557880 | 2015 | RWCVYAYVRVRGVLVRYRRCR | W21R | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 10.8 µM | Human | Arenicin Analog | β-Hairpin | NA | ||
| 25056849 | 2015 | GIGGALLSAKAALGLAKGLAEHFAN{ct:Amid} | FPA-Bombinin-BO | Amidation | Free | Linear | L | None | 25 | Antibaterial, Antifungal | 100 % Hemolysis at 125 µM | Horse | Synthetic, Skin Secretion Of Bombina Orientalis | α-Helix | NA | ||
| 25680229 | 2015 | GIGKFLKKAKKFGKAFVKILKK{ct:Amid} | MSI-78 | Amidation | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 53 % Hemolysis at 512 μg/ml | Human | Skin Of The African Clawed Frog | α-Helix | NA | ||
| 25680229 | 2015 | GIGKFLKKAKKFGKAFVKILKK{ct:Amid} | MSI-78 | Amidation | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 25 % Hemolysis at 256 μg/ml | Human | Skin Of The African Clawed Frog | α-Helix | NA | ||
| 25680229 | 2015 | GIGKFLKKAKKFGKAFVKILKK{ct:Amid} | MSI-78 | Amidation | Free | Linear | L | None | 22 | Antimicrobial, Antibacterial | 13 % Hemolysis at 128 μg/ml | Human | Skin Of The African Clawed Frog | α-Helix | NA | ||
| 25965506 | 2015 | GIWKKWIKKWLKKLLKKLWKKG{ct:Amid} | KABT-AMP | Amidation | Free | Linear | L | None | 22 | Antifungal | 10 % Hemolysis at 4.67 ± 2.09 mg/L | Human | Mixed Backbone Of Kabt-Amp And Uperin 3.6 | α-Helix | NA | ||
| 25965506 | 2015 | GIWKKWIKKWLKKLLKKLWKKG{ct:Amid} | KABT-AMP | Amidation | Free | Linear | L | None | 22 | Antifungal | 50 % Hemolysis at 81.23 ± 8.92 mg/L | Human | Mixed Backbone Of Kabt-Amp And Uperin 3.6 | α-Helix | NA | ||
| 25997127 | 2015 | LIAGLAANFLPQILCKIARKC{ct:Amid} | linear B1CTcu5 | Amidation | Free | Linear | L | None | 21 | Antibacterial | 37 % Hemolysis at 25 μg/ml | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 25997127 | 2015 | LIAGLAANFLPQILCKIARKC{cyc:N-C}{ct:Amid} | Cyclic B1CTcu5 | Amidation | Free | Cyclic | L | None | 21 | Antibacterial | 40 % Hemolysis at 25 μg/ml | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 25997127 | 2015 | KIAGLAANFLPQILCKIARKC{ct:Amid} | B1CTcu5K | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm | 15 % Hemolysis at 25 μg/ml | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 25997127 | 2015 | WIAGLAANFLPQILCKIARKC{ct:Amid} | B1CTcu5W | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm | 39.11 % Hemolysis at 100 μg/ml | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 25997127 | 2015 | RIAGLAANFLPQILCKIARKC{ct:Amid} | B1CTcu5R | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm | 19.4 % Hemolysis at 25 μg/ml | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 25997127 | 2015 | HIAGLAANFLPQILCKIARKC{ct:Amid} | B1CTcu5H | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm | 30.4 % Hemolysis at 50 μg/ml | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 25997127 | 2015 | LGGGLAANFLPQILCKIARKC{ct:Amid} | B1CTcu5LGG | Amidation | Free | Linear | L | None | 21 | Antibacterial | 23.4 % Hemolysis | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 25997127 | 2015 | LIAGLAANFLPQILC(AC{d}M{d})KIARKC{ct:Amid} | B1CTcu5C (Acm) | Amidation | Free | Linear | L | None | 21 | Antibacterial | 25 % Hemolysis at 12.5 μg/ml | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 25997127 | 2015 | LIAGLAANFLPQILCKIARKC{ct:Amid} | DB1CTcu5 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm | 40.22 % Hemolysis at 25 μg/ml | Human | Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes | α-Helix | NA | ||
| 25749154 | 2015 | FFGHLYRGITSVVKHVHGLLSG | Cnd | Free | Free | Linear | L | None | 22 | Antimicrobial | ~0.8 % Hemolysis at 50 μg/ml | Human | Gills Of The Chionodraco Hamatus | α-Helix | NA | ||
| 25807936 | 2015 | GIGKFLKKAKKFGKAFVKILKK{ct:Amid} | MSI-78 | Amidation | Free | Linear | L | None | 22 | Antibacterial | 50 % Hemolysis at 120 μg/ml | Human | Magainin Analogue | α-Helix | Non-hemolytic | ||
| 25966444 | 2015 | {nnr:βA}{nnr:βA}KIAKLKAKIQKLKQKIAKLK{nt:C12-aliphatic chain}{ct:Amid} | LH | Amidation | C12-aliphatic domain,βA- 2 spacer | Linear | L | C12 = aliphatic domain, βA = 2 spacer | 22 | Antibacterial | 50 % Hemolysis at >100 µM | Human | Host Defence Peptides | α-Helix | NA | ||
| 25966444 | 2015 | {nnr:βA}{nnr:βA}KIAKLKAKIQKLKQKIAKLK{nt:C12-aliphatic chain}{ct:Amid} | LH | Amidation | C12-aliphatic domain,βA- 2 spacer | Linear | L | C12 = aliphatic domain, βA = 2 spacer | 22 | Antibacterial | 50 % Hemolysis at >100 µM | Bovine | Host Defence Peptides | α-Helix | NA | ||
| 25869678 | 2015 | MQFITDLIKKAVDFFKGLFGNK | WRK | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at 2.78 µM | Human | Staphylococcus Warneri | α-Helix | NA | ||
| 25869678 | 2015 | MQFITDLIGKAVDFFKGLFGNK | WRK_K9G | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at >20 µM | Human | Staphylococcus Warneri | α-Helix | NA | ||
| 25869678 | 2015 | MQFITDLIKKAVDFFKGLFDNK | WRK_G20D | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at 9.09 µM | Human | Staphylococcus Warneri | α-Helix | NA | ||
| 25869678 | 2015 | MQFITDLIGKAVDFFKGLFDNK | WRK_K9G-G20D | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at >20 µM | Human | Staphylococcus Warneri | α-Helix | NA | ||
| 25869678 | 2015 | MQFITDLIKKAVDVFKGLFGNK | WRK_F14V | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at 12.5 µM | Human | Staphylococcus Warneri | α-Helix | NA | ||
| 25869678 | 2015 | MQFITDLIKKAVDFIKGLFGNK | WRK_F15I | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at 2.63 µM | Human | Staphylococcus Warneri | α-Helix | NA | ||
| 25869678 | 2015 | MQFITDLIKKAVDVIKGLFGNK | WRK_F14V-F15I | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at 8.33 µM | Human | Staphylococcus Warneri | α-Helix | NA | ||
| 25869678 | 2015 | MQFITDLIKKAVDFFKGLVGNK | WRK_F19V | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at 11.1 µM | Human | Staphylococcus Warneri | α-Helix | NA | ||
| 25869678 | 2015 | MQTFQDILGKVIEVIKAIVDAK | rPSM | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at 20 µM | Human | Staphylococcus Warneri | α-Helix | NA | ||
| 25869678 | 2015 | MADVIAKIVEIVKGLIDQFTQK | PSM | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at 7.14 µM | Human | Staphylococcus Epidermidis | α-Helix | NA | ||
| 25869678 | 2015 | MAGVIAKIVEIVKGLIDQFTQK | PSM_D3G | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at 3.7 µM | Human | Staphylococcus Epidermidis | α-Helix | NA | ||
| 25869678 | 2015 | MADVIAKIVEIVKKLIDQFTQK | PSM_G14K | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at 9.88 µM | Human | Staphylococcus Epidermidis | α-Helix | NA | ||
| 25869678 | 2015 | MAGVIAKIVEIVKKLIDQFTQK | PSM_D3G-G14K | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at 3.125 µM | Human | Staphylococcus Epidermidis | α-Helix | NA | ||
| 25869678 | 2015 | MADVIAKFVEIVKGLIDQFTQK | PSM_I8F | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at >20 µM | Human | Staphylococcus Epidermidis | α-Helix | NA | ||
| 25869678 | 2015 | MADVIAKIFEIVKGLIDQFTQK | PSM_V9F | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at 4.76 µM | Human | Staphylococcus Epidermidis | α-Helix | NA | ||
| 25869678 | 2015 | MADVIAKFFEIVKGLIDQFTQK | PSM_I8F-V9F | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at >20 µM | Human | Staphylococcus Epidermidis | α-Helix | NA | ||
| 25869678 | 2015 | MADFIAKIVEIVKGLIDQFTQK | PSM_V4F | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at 10 µM | Human | Staphylococcus Epidermidis | α-Helix | NA | ||
| 25869678 | 2015 | MNGFILGKFFDVAKKILDTIFQK | rWRK | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at 4 µM | Human | Staphylococcus Epidermidis | α-Helix | NA | ||
| 26156126 | 2015 | RWKIFKKIEKVGRNVRDGIIKA{ct:Amid} | PapN | Amidation | Free | Linear | L | None | 22 | Antimicrobial and Antiinflammatory Activities | 0 % Hemolysis at 100 µM | Human | Swallowtail Butterfly Papilio Xuthus | α-Helix | Non-hemolytic | ||
| 26156126 | 2015 | RAKIFKKIEKVGRNVRDGIIKA{ct:Amid} | PapN-2A | Amidation | Free | Linear | L | None | 22 | Antimicrobial and Antiinflammatory Activities | 0 % Hemolysis at 100 µM | Human | Swallowtail Butterfly Papilio Xuthus | α-Helix | Non-hemolytic | ||
| 26156126 | 2015 | RWKIAKKIEKVGRNVRDGIIKA{ct:Amid} | PapN-5A | Amidation | Free | Linear | L | None | 22 | Antimicrobial and Antiinflammatory Activities | 0 % Hemolysis at 100 µM | Human | Swallowtail Butterfly Papilio Xuthus | α-Helix | Non-hemolytic | ||
| 26156126 | 2015 | RAKIAKKIEKVGRNVRDGIIKA{ct:Amid} | PapN-2A5A | Amidation | Free | Linear | L | None | 22 | Antimicrobial and Antiinflammatory Activities | 0 % Hemolysis at 100 µM | Human | Swallowtail Butterfly Papilio Xuthus | α-Helix | Non-hemolytic | ||
| 26156126 | 2015 | RFKIWKKIEKVGRNVRDGIIKA{ct:Amid} | PapN-2F5W | Amidation | Free | Linear | L | None | 22 | Antimicrobial and Antiinflammatory Activities | 0 % Hemolysis at 100 µM | Human | Swallowtail Butterfly Papilio Xuthus | α-Helix | Non-hemolytic | ||
| 26107622 | 2015 | GVFDIIKDAGKQLVAHAMGKIAEKV{ct:Amid} | ocellatin-PT1 | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 1.98 ± 0.08 % Hemolysis at 800 μg/ml | Human | Leptodactylus Pustulatus | α-Helix | NA | ||
| 26107622 | 2015 | GVFDIIKDAGKQLVAHATGKIAEKV{ct:Amid} | ocellatin-PT2 | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 0 % Hemolysis at 800 μg/ml | Human | Leptodactylus Pustulatus | α-Helix | Non-hemolytic | ||
| 26107622 | 2015 | GVIDIIKGAGKDLIAHAIGKLAEKV{ct:Amid} | ocellatin-PT3 | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 0.69 ± 0.04 % Hemolysis at 800 μg/ml | Human | Leptodactylus Pustulatus | α-Helix | NA | ||
| 26107622 | 2015 | GVFDIIKGAGKQLIAHAMGKIAEKV{ct:Amid} | ocellatin-PT4 | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 4.29 ± 0.23 % Hemolysis at 800 μg/ml | Human | Leptodactylus Pustulatus | α-Helix | NA | ||
| 26107622 | 2015 | GVFDIIKDAGRQLVAHAMGKIAEKV{ct:Amid} | ocellatin-PT5 | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 4.05 ± 0.19 % Hemolysis at 800 μg/ml | Human | Leptodactylus Pustulatus | α-Helix | NA | ||
| 26028561 | 2015 | GIGAVLVKLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 250 µM | Rat | Bee Venom | α-Helix | NA | ||
| 26238108 | 2015 | KWKSFLKTFKSAKKTVLHTLLKAISS | A20L | Free | Free | Linear | L | None | 26 | Antibacterial | MHC % Hemolysis at 213.33 μg/ml | Human | Derivative Of V13K | α-Helix | NA | ||
| 26041027 | 2015 | RPHGAGEGIDRVPAGPSPSEVGLAIPSGK{ct:Amid} | Pep-7 | Amidation | Free | Linear | L | None | 29 | Antibacterial | 0.1 ± 0.1 % Hemolysis at 1.7 µM | Human | Porphyromonas Gingivalis | NA | NA | ||
| 26041027 | 2015 | RPHGAGEGIDRVPAGPSPSEVGLAIPSGK{ct:Amid} | Pep-7 | Amidation | Free | Linear | L | None | 29 | Antibacterial | 0.1 ± 0.1 % Hemolysis at 3.4 µM | Human | Porphyromonas Gingivalis | NA | NA | ||
| 26041027 | 2015 | RPHGAGEGIDRVPAGPSPSEVGLAIPSGK{ct:Amid} | Pep-7 | Amidation | Free | Linear | L | None | 29 | Antibacterial | 0.3 ± 0.1 % Hemolysis at 6.8 µM | Human | Porphyromonas Gingivalis | NA | NA | ||
| 26134716 | 2015 | ALAGTIIAGASLTFQVLDKVLEELGKVSRK{ct:Amid} | StII1-30 | Amidation | Free | Linear | L | None | 30 | Hemolytic | 50 % Hemolysis at 0.22 ± 0.002 nM | Human | Stichodactyla Helianthus | α-Helix | NA | ||
| 26160494 | 2015 | KKYRYHLKPFCKKKKYRYHLKPFCKK{nt:NH3+}{ct:Carboxyl (COO-)} | (p-BthTX-I)2 | Carboxyl (COO-) | NH3+ | Linear | L | None | 26 | Antibacterial | 50 % Hemolysis at >128 µmol/L | Human | Analogues Bothropstoxin-I (Bthtx-I) | α-Helix | NA | ||
| 26152423 | 2015 | MRLVKVSAAVILVLLAVSAS | Rhamp1- His | Free | Free | Linear | L | None | 22 | Antibacterial | Hemolysis at 10 µM | Rabbit | Rhipicephalus Haemaphysaloides | NA | NA | ||
| 26159095 | 2015 | GIVFLDHVESFQVKPKLRKFQLYF{cyc:N-C} | cMnALF24 | Free | Free | Cyclic | L | None | 24 | Antibacterial | ~10 % Hemolysis at 0.67 µM | Rabbit | Macrobrachium Nipponense | β-Sheets | Low hemolytic | ||
| 26159095 | 2015 | GIVFLDHVESFQVKPKLRKFQLYF{cyc:N-C} | cMnALF24 | Free | Free | Cyclic | L | None | 24 | Antibacterial | ~10 % Hemolysis at 3.35 µM | Rabbit | Macrobrachium Nipponense | β-Sheets | Low hemolytic | ||
| 26159095 | 2015 | GIVFLDHVESFQVKPKLRKFQLYF{cyc:N-C} | cMnALF24 | Free | Free | Cyclic | L | None | 24 | Antibacterial | ~10 % Hemolysis at 6.7 µM | Rabbit | Macrobrachium Nipponense | β-Sheets | Low hemolytic | ||
| 26159095 | 2015 | GIVFLDHVESFQVKPKLRKFQLYF{cyc:N-C} | cMnALF24 | Free | Free | Cyclic | L | None | 24 | Antibacterial | ~10 % Hemolysis at 33.5 µM | Rabbit | Macrobrachium Nipponense | β-Sheets | Low hemolytic | ||
| 26159095 | 2015 | GIVFLDHVESFQVKPKLRKFQLYF{cyc:N-C} | cMnALF24 | Free | Free | Cyclic | L | None | 24 | Antibacterial | 22 % Hemolysis at 67 µM | Rabbit | Macrobrachium Nipponense | β-Sheets | Low hemolytic | ||
| 26316200 | 2015 | GIGAVLKVLTTGLPALISWIKRKRQQ{nt:Amid}{ct:Amid} | Melittin | Amidation | Amidation | Linear | L | None | 26 | Antimicrobial | 0 % Hemolysis at 0.0625 μg/ml | Human | Apis Mellifera Meda | α-Helix | NA | ||
| 26316200 | 2015 | GIGAVLKVLTTGLPALISWIKRKRQQ{nt:Amid}{ct:Amid} | Melittin | Amidation | Amidation | Linear | L | None | 26 | Antimicrobial | 0 % Hemolysis at 0.125 μg/ml | Human | Apis Mellifera Meda | α-Helix | NA | ||
| 26316200 | 2015 | GIGAVLKVLTTGLPALISWIKRKRQQ{nt:Amid}{ct:Amid} | Melittin | Amidation | Amidation | Linear | L | None | 26 | Antimicrobial | 0 % Hemolysis at 0.25 μg/ml | Human | Apis Mellifera Meda | α-Helix | NA | ||
| 26316200 | 2015 | GIGAVLKVLTTGLPALISWIKRKRQQ{nt:Amid}{ct:Amid} | Melittin | Amidation | Amidation | Linear | L | None | 26 | Antimicrobial | 50 % Hemolysis at 0.5 μg/ml | Human | Apis Mellifera Meda | α-Helix | NA | ||
| 26316200 | 2015 | GIGAVLKVLTTGLPALISWIKRKRQQ{nt:Amid}{ct:Amid} | Melittin | Amidation | Amidation | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 1 μg/ml | Human | Apis Mellifera Meda | α-Helix | NA | ||
| 26316200 | 2015 | GIGAVLKVLTTGLPALISWIKRKRQQ{nt:Amid}{ct:Amid} | Melittin | Amidation | Amidation | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 2 μg/ml | Human | Apis Mellifera Meda | α-Helix | NA | ||
| 26316200 | 2015 | GIGAVLKVLTTGLPALISWIKRKRQQ{nt:Amid}{ct:Amid} | Melittin | Amidation | Amidation | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 4 μg/ml | Human | Apis Mellifera Meda | α-Helix | NA | ||
| 26316200 | 2015 | GIGAVLKVLTTGLPALISWIKRKRQQ{nt:Amid}{ct:Amid} | Melittin | Amidation | Amidation | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 8 μg/ml | Human | Apis Mellifera Meda | α-Helix | NA | ||
| 26088720 | 2015 | (WKWKWKWKWK)PG(KWKWKWKWKW){ct:Amid} | WK5 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 5 % Hemolysis at 4 µM | Human | Tryptophan Zipper | β-Hairpin | NA | ||
| 26342880 | 2015 | SPSEKAGLQPVGRIGIGRMLKK | Scolopendin | Free | Free | Linear | L | None | 21 | Antimicrobial | 0 % Hemolysis at 100 µM | Human | Centipede Scolopendra 21 Subspinipes Mutilans | NA | Non-hemolytic | ||
| 26342880 | 2015 | SPSEKAGLQPVGRIGIGRMLKK | Scolopendin | Free | Free | Linear | L | None | 21 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Centipede Scolopendra 21 Subspinipes Mutilans | NA | Non-hemolytic | ||
| 26342880 | 2015 | SPSEKAGLQPVGRIGIGRMLKK | Scolopendin | Free | Free | Linear | L | None | 21 | Antimicrobial | 0 % Hemolysis at 25 µM | Human | Centipede Scolopendra 21 Subspinipes Mutilans | NA | Non-hemolytic | ||
| 26342880 | 2015 | SPSEKAGLQPVGRIGIGRMLKK | Scolopendin | Free | Free | Linear | L | None | 21 | Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Centipede Scolopendra 21 Subspinipes Mutilans | NA | Non-hemolytic | ||
| 26342880 | 2015 | SPSEKAGLQPVGRIGIGRMLKK | Scolopendin | Free | Free | Linear | L | None | 21 | Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Centipede Scolopendra 21 Subspinipes Mutilans | NA | Non-hemolytic | ||
| 26342880 | 2015 | SPSEKAGLQPVGRIGIGRMLKK | Scolopendin | Free | Free | Linear | L | None | 21 | Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Centipede Scolopendra 21 Subspinipes Mutilans | NA | Non-hemolytic | ||
| 26342880 | 2015 | SPSEKAGLQPVGRIGIGRMLKK | Scolopendin | Free | Free | Linear | L | None | 21 | Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Centipede Scolopendra 21 Subspinipes Mutilans | NA | Non-hemolytic | ||
| 26342880 | 2015 | TRSSRAGLQFPVGRVHRLLRK | Buforin 2 | Free | Free | Linear | L | None | 21 | Antimicrobial | 0 % Hemolysis at 100 µM | Human | Bufo Bufo Gargarizans | Random coil | Non-hemolytic | ||
| 26342880 | 2015 | TRSSRAGLQFPVGRVHRLLRK | Buforin 2 | Free | Free | Linear | L | None | 21 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Bufo Bufo Gargarizans | Random coil | Non-hemolytic | ||
| 26342880 | 2015 | TRSSRAGLQFPVGRVHRLLRK | Buforin 2 | Free | Free | Linear | L | None | 21 | Antimicrobial | 0 % Hemolysis at 25 µM | Human | Bufo Bufo Gargarizans | Random coil | Non-hemolytic | ||
| 26342880 | 2015 | TRSSRAGLQFPVGRVHRLLRK | Buforin 2 | Free | Free | Linear | L | None | 21 | Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Bufo Bufo Gargarizans | Random coil | Non-hemolytic | ||
| 26342880 | 2015 | TRSSRAGLQFPVGRVHRLLRK | Buforin 2 | Free | Free | Linear | L | None | 21 | Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Bufo Bufo Gargarizans | Random coil | Non-hemolytic | ||
| 26342880 | 2015 | TRSSRAGLQFPVGRVHRLLRK | Buforin 2 | Free | Free | Linear | L | None | 21 | Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Bufo Bufo Gargarizans | Random coil | Non-hemolytic | ||
| 26342880 | 2015 | TRSSRAGLQFPVGRVHRLLRK | Buforin 2 | Free | Free | Linear | L | None | 21 | Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Bufo Bufo Gargarizans | Random coil | Non-hemolytic | ||
| 26342880 | 2015 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 ± 0.8 % Hemolysis at 100 µM | Human | Bee Vemon | α-Helix | NA | ||
| 26342880 | 2015 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 ± 1.8 % Hemolysis at 50 µM | Human | Bee Vemon | α-Helix | NA | ||
| 26342880 | 2015 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 98.1 ± 2.1 % Hemolysis at 25 µM | Human | Bee Vemon | α-Helix | NA | ||
| 26342880 | 2015 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 87.4 ± 3.3 % Hemolysis at 12.5 µM | Human | Bee Vemon | α-Helix | NA | ||
| 26342880 | 2015 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 52.6 ± 3.2 % Hemolysis at 6.3 µM | Human | Bee Vemon | α-Helix | NA | ||
| 26342880 | 2015 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 22.5 ± 2.7 % Hemolysis at 3.1 µM | Human | Bee Vemon | α-Helix | NA | ||
| 26342880 | 2015 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 8.6 ± 1.4 % Hemolysis at 1.6 µM | Human | Bee Vemon | α-Helix | NA | ||
| 26352292 | 2015 | FWGFLGKLAMKAVPSLIGGNKSSSK | VpAmp2.0 | Free | Free | Linear | L | None | 25 | Antimicrobial | 50 % Hemolysis at 167 ± 22.5 µM | Human | Scorpion Vaejovispunctatus | α-Helix | NA | ||
| 26352292 | 2015 | FWGFLGKLAMKAVPSLIGGNKK | VpAmp2.1 | Free | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 103.5 ± 1.7 µM | Human | Scorpion Vaejovispunctatus | α-Helix | NA | ||
| 26530005 | 2015 | GKLWLKGGKLWLKGGKLWLKG{ct:Amid} | GG3 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 5 % Hemolysis at >128 µM | Human | Centrosymmetric | α-Helix | NA | ||
| 26530005 | 2015 | GKLWLKGGKLWLKGGKLWLKGGKLWLKG{ct:Amid} | GG4 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 5 % Hemolysis at 16 µM | Human | Centrosymmetric | α-Helix | NA | ||
| 26530005 | 2015 | GKLWGLKGKLWGLKGKLWGLK{ct:Amid} | GG3s1 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 5 % Hemolysis at >128 µM | Human | Centrosymmetric | α-Helix | NA | ||
| 26530005 | 2015 | GLWKGKLGLWKGKLGLWKGKL{ct:Amid} | GG3s2 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 5 % Hemolysis at >128 µM | Human | Centrosymmetric | α-Helix | NA | ||
| 26530005 | 2015 | AKLWLKAAKLWLKAAKLWLKA{ct:Amid} | AA3 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 5 % Hemolysis at 8 µM | Human | Centrosymmetric | α-Helix | NA | ||
| 26530005 | 2015 | AKLWLKAAKLWLKAAKLWLKAAKLWLKA{ct:Amid} | AA4 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 5 % Hemolysis at 1 µM | Human | Centrosymmetric | α-Helix | NA | ||
| 26530005 | 2015 | AKLWALKAKLWALKAKLWALK{ct:Amid} | AA3s1 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 5 % Hemolysis at 16 µM | Human | Centrosymmetric | α-Helix | NA | ||
| 26530005 | 2015 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 5 % Hemolysis at 0.25 µM | Human | Centrosymmetric | α-Helix | NA | ||
| 26633506 | 2015 | FFSMIPKIAGGIASLVKNLG{ct:Amid} | Phylloseptin-PBa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 0 % Hemolysis at 0 mg/L | Horse | Leaf Frog (Phyllomedusa Baltea) | α-Helix | NA | ||
| 26633506 | 2015 | FFSMIPKIAGGIASLVKNLG{ct:Amid} | Phylloseptin-PBa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 0.2 % Hemolysis at 1 mg/L | Horse | Leaf Frog (Phyllomedusa Baltea) | α-Helix | NA | ||
| 26633506 | 2015 | FFSMIPKIAGGIASLVKNLG{ct:Amid} | Phylloseptin-PBa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 1.4 % Hemolysis at 2 mg/L | Horse | Leaf Frog (Phyllomedusa Baltea) | α-Helix | NA | ||
| 26633506 | 2015 | FFSMIPKIAGGIASLVKNLG{ct:Amid} | Phylloseptin-PBa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 1.3 % Hemolysis at 4 mg/L | Horse | Leaf Frog (Phyllomedusa Baltea) | α-Helix | NA | ||
| 26633506 | 2015 | FFSMIPKIAGGIASLVKNLG{ct:Amid} | Phylloseptin-PBa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 5 % Hemolysis at 8 mg/L | Horse | Leaf Frog (Phyllomedusa Baltea) | α-Helix | NA | ||
| 26633506 | 2015 | FFSMIPKIAGGIASLVKNLG{ct:Amid} | Phylloseptin-PBa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 9.5 % Hemolysis at 16 mg/L | Horse | Leaf Frog (Phyllomedusa Baltea) | α-Helix | NA | ||
| 26633506 | 2015 | FFSMIPKIAGGIASLVKNLG{ct:Amid} | Phylloseptin-PBa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 38.6 % Hemolysis at 32 mg/L | Horse | Leaf Frog (Phyllomedusa Baltea) | α-Helix | NA | ||
| 26633506 | 2015 | FFSMIPKIAGGIASLVKNLG{ct:Amid} | Phylloseptin-PBa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 79.6 % Hemolysis at 64 mg/L | Horse | Leaf Frog (Phyllomedusa Baltea) | α-Helix | NA | ||
| 26633506 | 2015 | FFSMIPKIAGGIASLVKNLG{ct:Amid} | Phylloseptin-PBa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 107.4 % Hemolysis at 128 mg/L | Horse | Leaf Frog (Phyllomedusa Baltea) | α-Helix | NA | ||
| 26633506 | 2015 | FFSMIPKIAGGIASLVKNLG{ct:Amid} | Phylloseptin-PBa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 104.1 % Hemolysis at 512 mg/L | Horse | Leaf Frog (Phyllomedusa Baltea) | α-Helix | NA | ||
| 26656394 | 2015 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antibacterial | 110 ± 1 % Hemolysis at 128 μg/ml | Horse | Insects, Honey Bee | α-Helical | NA | ||
| 26680226 | 2015 | NLCASLRARHTIPQCRKFGRR{ct:Amid} | mBjAMP1 | Amidation | Free | Linear | L | None | 21 | Antibacterial | little Hemolysis at 100 μg/ml | Human | Vaguely Eel Amphioxus Branchiostoma Japonicum | α-Helical | Low hemolytic | ||
| 26680226 | 2015 | NLCASLRARHTIPQCRKFGRR{ct:Amid} | mBjAMP1 | Amidation | Free | Linear | L | None | 21 | Antibacterial | little Hemolysis at 50 μg/ml | Human | Vaguely Eel Amphioxus Branchiostoma Japonicum | α-Helical | Low hemolytic | ||
| 26680226 | 2015 | NLCASLRARHTIPQCRKFGRR{ct:Amid} | mBjAMP1 | Amidation | Free | Linear | L | None | 21 | Antibacterial | little Hemolysis at 25 μg/ml | Human | Vaguely Eel Amphioxus Branchiostoma Japonicum | α-Helical | Low hemolytic | ||
| 26680226 | 2015 | NLCASLRARHTIPQCRKFGRR{ct:Amid} | mBjAMP1 | Amidation | Free | Linear | L | None | 21 | Antibacterial | little Hemolysis at 12.5 μg/ml | Human | Vaguely Eel Amphioxus Branchiostoma Japonicum | α-Helical | Low hemolytic | ||
| 26606380 | 2015 | IKIPSFFRNILKKVGKEAVSLIAGALKQS | pseudhymenochirin-1Pb | Free | Free | Linear | L | None | 29 | Antibacterial, Cytotoxicity | 30 ± 5 % Hemolysis at >100 µM | Mouse | Merlin’S Clawed Frog, Pseudhymenochirus Merlini | α-Helical | NA | ||
| 26606380 | 2015 | GIFPIFAKLLGKVIKVASSLISKGRTE | pseudhymenochirin-2Pa | Free | Free | Linear | L | None | 27 | Antibacterial, Cytotoxicity | 7 ± 2 % Hemolysis at >100 µM | Mouse | Merlin’S Clawed Frog, Pseudhymenochirus Merlini | α-Helical | NA | ||
| 26100634 | 2015 | GLFGVLAKVAAHVVPAIAEHF{ct:Amid} | Maculatin 1.1 | Amidation | Free | Linear | L | None | 21 | Anticancer, Antibacterial Gram- | 50 % Hemolysis at 29.5 ± 1.0 µM | Human | Australian Tree Frog Litoria Genimaculata | α-Helical | NA | ||
| 26100634 | 2015 | GIGAVLKVTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Anticancer, Antibacterial Gram- | 50 % Hemolysis at 1.2± 0.1 µM | Human | Bee Venom | α-Helical | NA | ||
| 25891396 | 2015 | AGYLLGKINLKALAALAKKIL{ct:Amid} | TP10 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm | 80 % Hemolysis at 512 μg/mL | Human | Deletion Analogue Of The Cpp Transportan | α-Helical-50% TFE solution | NA | ||
| 25891396 | 2015 | AGYLLGKINLKPLAALAKKIL{ct:Amid} | TP10-2 | Amidation | Free | Linear | L | None | 21 | Antibacterial | 0 % Hemolysis at 512 μg/mL | Human | Transportan 10 Analogues | α-Helical | Non-hemolytic | ||
| 25891396 | 2015 | AAYLLAKINLKALAALAKKIL{ct:Amid} | TP10-3 | Amidation | Free | Linear | L | None | 21 | Antibacterial | 39.57 % Hemolysis at 512 μg/mL | Human | Transportan 10 Analogues | α-Helical | NA | ||
| 25891396 | 2015 | AGYLLGKINLKKLAKL({nnr:Aib})KKIL{ct:Amid} | TP10-5 | Amidation | Free | Linear | L | Aib = α-aminoisobutyric acid | 21 | Antibacterial, Antibiofilm | 80 % Hemolysis at 512 μg/mL | Human | Transportan 10 Analogues | α-Helical | NA | ||
| 25891396 | 2015 | AGYLLGKINLKPLAKL({nnr:Aib})KKIL{ct:Amid} | TP10-7 | Amidation | Free | Linear | L | Aib = α-aminoisobutyric acid | 21 | Antibacterial, Antibiofilm | 59.45 % Hemolysis at 512 μg/mL | Human | Transportan 10 Analogues | α-Helical | NA | ||
| 25891396 | 2015 | AGYLLPKINLKPLAKLPKKIL{ct:Amid} | TP10-8 | Amidation | Free | Linear | L | None | 21 | Antibacterial | 0 % Hemolysis at 512 μg/mL | Human | Transportan 10 Analogues | α-Helical | Non-hemolytic | ||
| 25839356 | 2015 | FIHHIIGWISHGVRAIHRAIH{ct:Amid} | Gad-1 | Amidation | Free | Linear | L | None | 21 | Antibacterial Gram- | 50 % Hemolysis at 43 µM | Human | Atlantic Cod (Gadus Morhua) | α-Helical | NA | ||
| 25839356 | 2015 | FIHHIIGWISHGVRAIHRAIH{ct:Amid} | Gad-1 | Amidation | Free | Linear | L | None | 21 | Antibacterial Gram-, Anticancer | 100 % Hemolysis at 100 µM | Human | Atlantic Cod (Gadus Morhua) | α-Helical | NA | ||
| 25839356 | 2015 | FIHHIIGWISHGVRAIHRAIH{ct:Amid} | Gad-1 | Amidation | Free | Linear | L | None | 21 | Antibacterial Gram-, Anticancer | 100 % Hemolysis at 200 µM | Human | Atlantic Cod (Gadus Morhua) | α-Helical | NA | ||
| 25839356 | 2015 | FIHHIIGWISHGVRAIHRAIH{ct:Amid} | Gad-1 | Amidation | Free | Linear | L | None | 21 | Antibacterial Gram-, Anticancer | 100 % Hemolysis at 400 µM | Human | Atlantic Cod (Gadus Morhua) | α-Helical | NA | ||
| 25839356 | 2015 | FLHHIVGLIHHGLSLFGDR{ct:Amid} | Gad-2 | Amidation | Free | Linear | L | None | 21 | Antibacterial Gram-, Anticancer | 50 % Hemolysis at 56 µM | Human | Atlantic Cod (Gadus Morhua) | α-Helical | NA | ||
| 25839356 | 2015 | FLHHIVGLIHHGLSLFGDR{ct:Amid} | Gad-2 | Amidation | Free | Linear | L | None | 21 | Antibacterial Gram-, Anticancer | <90 % Hemolysis at 100 µM | Human | Atlantic Cod (Gadus Morhua) | α-Helical | NA | ||
| 25839356 | 2015 | FLHHIVGLIHHGLSLFGDR{ct:Amid} | Gad-2 | Amidation | Free | Linear | L | None | 21 | Antibacterial Gram-, Anticancer | 100 % Hemolysis at 200 µM | Human | Atlantic Cod (Gadus Morhua) | α-Helical | NA | ||
| 25839356 | 2015 | FLHHIVGLIHHGLSLFGDR{ct:Amid} | Gad-2 | Amidation | Free | Linear | L | None | 21 | Antibacterial Gram-, Anticancer | 100 % Hemolysis at 400 µM | Human | Atlantic Cod (Gadus Morhua) | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKKFGKAFVGEIMNS{ct:Amid} | MAG2-WT | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 7±4 % Hemolysis at 8 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKKFGKAFVGEIMNS{ct:Amid} | MAG2-WT | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 35±6 % Hemolysis at 128 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGK{nnr:X}LHSAKKFGKAFVGEIMNS{ct:Amid} | MAG2-F5A | Amidation | Free | Linear | L | X = Ala (“alanine scan”) | 23 | Antimicrobial | 19±2 % Hemolysis at 8 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGK{nnr:X}LHSAKKFGKAFVGEIMNS{ct:Amid} | MAG2-F5A | Amidation | Free | Linear | L | X = Ala (“alanine scan”) | 23 | Antimicrobial | 98±4 % Hemolysis at 128 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKF{nnr:X}HSAKKFGKAFVGEIMNS{ct:Amid} | MAG2-L6A | Amidation | Free | Linear | L | X = Ala (“alanine scan”) | 23 | Antimicrobial | 7±6 % Hemolysis at 8 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKF{nnr:X}HSAKKFGKAFVGEIMNS{ct:Amid} | MAG2-L6A | Amidation | Free | Linear | L | X = Ala (“alanine scan”) | 23 | Antimicrobial | 25±4 % Hemolysis at 128 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKK{nnr:X}GKAFVGEIMNS{ct:Amid} | MAG2-F12A | Amidation | Free | Linear | L | X = Ala (“alanine scan”) | 23 | Antimicrobial | 10±9 % Hemolysis at 8 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKK{nnr:X}GKAFVGEIMNS{ct:Amid} | MAG2-F12A | Amidation | Free | Linear | L | X = Ala (“alanine scan”) | 23 | Antimicrobial | 49±12 % Hemolysis at 128 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKKF{nnr:X}KAFVGEIMNS{ct:Amid} | MAG2-G13A | Amidation | Free | Linear | L | X = Ala (“alanine scan”) | 23 | Antimicrobial | 36±10 % Hemolysis at 8 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKKF{nnr:X}KAFVGEIMNS{ct:Amid} | MAG2-G13A | Amidation | Free | Linear | L | X = Ala (“alanine scan”) | 23 | Antimicrobial | 100±0 % Hemolysis at 128 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKKFGKA{nnr:X}VGEIMNS{ct:Amid} | MAG2-F16A | Amidation | Free | Linear | L | X = Ala (“alanine scan”) | 23 | Antimicrobial | 12±3 % Hemolysis at 8 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKKFGKA{nnr:X}VGEIMNS{ct:Amid} | MAG2-F16A | Amidation | Free | Linear | L | X = Ala (“alanine scan”) | 23 | Antimicrobial | 55±14 % Hemolysis at 128 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKKFGKAF{nnr:X}GEIMNS{ct:Amid} | MAG2-V17A | Amidation | Free | Linear | L | X = Ala (“alanine scan”) | 23 | Antimicrobial | 2±4 % Hemolysis at 8 μg/mL | Human | Mag2 Analogs | α-Helical | Non-hemolytic | ||
| 25898805 | 2015 | GIGKFLHSAKKFGKAF{nnr:X}GEIMNS{ct:Amid} | MAG2-V17A | Amidation | Free | Linear | L | X = Ala (“alanine scan”) | 23 | Antimicrobial | 30±7 % Hemolysis at 128 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKKFGKAFV{nnr:X}EIMNS{ct:Amid} | MAG2-G18A | Amidation | Free | Linear | L | X = Ala (“alanine scan”) | 23 | Antimicrobial | 29±5 % Hemolysis at 8 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKKFGKAFV{nnr:X}EIMNS{ct:Amid} | MAG2-G18A | Amidation | Free | Linear | L | X = Ala (“alanine scan”) | 23 | Antimicrobial | 88±2 % Hemolysis at 128 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKF{nnr:CF-3Bpg}HSAKKFGKAFVGEIMNS{ct:Amid} | MAG2-L6B | Amidation | Free | Linear | L | CF-3-Bpg = 3-(trifluoromethyl)-Lbicyclopent-1.1.1-1-ylglycine | 23 | Antimicrobial | 17±11 % Hemolysis at 8 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKF{nnr:CF-3Bpg}HSAKKFGKAFVGEIMNS{ct:Amid} | MAG2-L6B | Amidation | Free | Linear | L | CF-3-Bpg = 3-(trifluoromethyl)-Lbicyclopent-1.1.1-1-ylglycine | 23 | Antimicrobial | 35±8 % Hemolysis at 128 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKKF{nnr:CF-3Bpg}KAFVGEIMNS{ct:Amid} | MAG2-G13B | Amidation | Free | Linear | L | CF-3-Bpg = 3-(trifluoromethyl)-Lbicyclopent-1.1.1-1-ylglycine | 23 | Antimicrobial | 77±15 % Hemolysis at 8 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKKF{nnr:CF-3Bpg}KAFVGEIMNS{ct:Amid} | MAG2-G13B | Amidation | Free | Linear | L | CF-3-Bpg = 3-(trifluoromethyl)-Lbicyclopent-1.1.1-1-ylglycine | 23 | Antimicrobial | 100±0 % Hemolysis at 128 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKKFGK{nnr:CF-3Bpg}FVGEIMNS{ct:Amid} | MAG2-A15B | Amidation | Free | Linear | L | CF-3-Bpg = 3-(trifluoromethyl)-Lbicyclopent-1.1.1-1-ylglycine | 23 | Antimicrobial | 14±3 % Hemolysis at 8 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKKFGK{nnr:CF-3Bpg}FVGEIMNS{ct:Amid} | MAG2-A15B | Amidation | Free | Linear | L | CF-3-Bpg = 3-(trifluoromethyl)-Lbicyclopent-1.1.1-1-ylglycine | 23 | Antimicrobial | 72±13 % Hemolysis at 128 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKKFGKA{nnr:CF-3Bpg}VGEIMNS{ct:Amid} | MAG2-F16B | Amidation | Free | Linear | L | CF-3-Bpg = 3-(trifluoromethyl)-Lbicyclopent-1.1.1-1-ylglycine | 23 | Antimicrobial | 27±4 % Hemolysis at 8 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKKFGKA{nnr:CF-3Bpg}VGEIMNS{ct:Amid} | MAG2-F16B | Amidation | Free | Linear | L | CF-3-Bpg = 3-(trifluoromethyl)-Lbicyclopent-1.1.1-1-ylglycine | 23 | Antimicrobial | 84±20 % Hemolysis at 128 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKKFGKAF{nnr:CF-3Bpg}GEIMNS{ct:Amid} | MAG2-V17B | Amidation | Free | Linear | L | CF-3-Bpg = 3-(trifluoromethyl)-Lbicyclopent-1.1.1-1-ylglycine | 23 | Antimicrobial | 20±5 % Hemolysis at 8 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKKFGKAF{nnr:CF-3Bpg}GEIMNS{ct:Amid} | MAG2-V17B | Amidation | Free | Linear | L | CF-3-Bpg = 3-(trifluoromethyl)-Lbicyclopent-1.1.1-1-ylglycine | 23 | Antimicrobial | 95±9 % Hemolysis at 128 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKKFGKAFV{nnr:CF-3Bpg}EIMNS{ct:Amid} | MAG2-G18B | Amidation | Free | Linear | L | CF-3-Bpg = 3-(trifluoromethyl)-Lbicyclopent-1.1.1-1-ylglycine | 23 | Antimicrobial | 12±6 % Hemolysis at 8 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25898805 | 2015 | GIGKFLHSAKKFGKAFV{nnr:CF-3Bpg}EIMNS{ct:Amid} | MAG2-G18B | Amidation | Free | Linear | L | CF-3-Bpg = 3-(trifluoromethyl)-Lbicyclopent-1.1.1-1-ylglycine | 23 | Antimicrobial | 24±10 % Hemolysis at 128 μg/mL | Human | Mag2 Analogs | α-Helical | NA | ||
| 25728268 | 2015 | MLIFVHIIAPVISGCAIAFFSYWLSRRNTK{ct:Amid} | PepA1 | Amidation | Free | Linear | L | None | 30 | Antibacterial | 50 % Hemolysis at 70 µM | Human | Bacteria S. Aureus | α-Helical | NA | ||
| 25425644 | 2015 | {nnr:T1}-VAGVVGLALIVAGVVVLNVAS-{nnr:T2} | TM4 | Free | Free | Linear | L | T1 = CH3CO-Ala-Sar3-(N-methyl-Gly), T2 = -Lys3-NH2 | 28 | Antimicrobial | 10 % Hemolysis at 12.5 µM | Human | Synthetic | α-Helical | NA | ||
| 26456194 | 2016 | SPAIWGCDSFLGYCRLACFAHEA | defensin-TK | Free | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 1.5 % Hemolysis at 50 μg/ml | Human | Frog Theloderma Kwangsiensis | α-Helix/β-Sheet | NA | ||
| 26456194 | 2016 | SPAIWGCDSFLGYCRLACFAHEA | defensin-TK | Free | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 2.7 % Hemolysis at 100 μg/ml | Human | Frog Theloderma Kwangsiensis | α-Helix/β-Sheet | NA | ||
| 26456194 | 2016 | SPAIWGCDSFLGYCRLACFAHEA | defensin-TK | Free | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 6.2 % Hemolysis at 200 μg/ml | Human | Frog Theloderma Kwangsiensis | α-Helix/β-Sheet | NA | ||
| 26656137 | 2016 | KFFRKLKKSVKKRAKEFFKKPRVIGVSIPF | cathelicidin-BF | Free | Free | Linear | L | None | 30 | Antifungal | 50 % Hemolysis at >200 μg/ml | Human | Bungarus Fasciatus | α-Helix | NA | ||
| 26656137 | 2016 | RIKRFWPVVIRTVVAGYNLYRAIKKK | Pc-CATH1 | Free | Free | Linear | L | None | 26 | Antifungal | 50 % Hemolysis at >100 μg/ml | Human | Phasianus Colchicus | α-Helix | NA | ||
| 26656137 | 2016 | RVRRFWPLVPVAINTVAAGINLYKAIRRK | Cc-CATH3 | Free | Free | Linear | L | None | 29 | Antifungal | 50 % Hemolysis at >200 μg/ml | Human | Coturnix Coturnix | α-Helix | NA | ||
| 26814379 | 2016 | RWCVYAAYVRVRGVLVRYRRCW | Arenicin-1 | Free | Free | Linear | L | None | 21 | Antimicrobial | 10 % Hemolysis at 5 µM | Human | Arenicola Marina | β-Hairpin | NA | ||
| 26918792 | 2016 | DSHAKRHHGYKRKFHEKHHSHRGY{ct:Amid} | Hst5 | Amidation | Free | Linear | L | None | 24 | Antifungal | 0 % Hemolysis at 128 μg/ml | Rabbit | Salivary Histatins | α-Helix | Non-hemolytic | ||
| 26881456 | 2016 | KFFRKLKKSVKKRAKEFFKKPRVIGVSIPF{ct:Amid} | cathelicidin-BF | Amidation | Free | Linear | L | None | 30 | Antimicrobial | 10 % Hemolysis at >320 μg/ml | Human | Bungarus Fasciatus | α-Helix | NA | ||
| 26881456 | 2016 | KFFRKLKKSVKKRAKEFFKKPRVIGVSIPF{ct:Amid} | cathelicidin-BF | Amidation | Free | Linear | L | None | 30 | Antimicrobial | 50 % Hemolysis at >320 μg/ml | Human | Bungarus Fasciatus | α-Helix | NA | ||
| 27114317 | 2016 | FFVLKFLLKWAGKVGLEHLACKFKNWC | Megin 2 | Free | Free | Linear | L | None | 27 | Antibacterial, Antifungal | 3.9 % Hemolysis at 25 µM | Human | Skin Venoms Of Spadefoot Toad Megophrys Minor | NA | NA | ||
| 27114317 | 2016 | FFVLKFLLKWAGKVGLEHLACKFKNWC | Megin 2 | Free | Free | Linear | L | None | 27 | Antibacterial, Antifungal | 13.7 % Hemolysis at 50 µM | Human | Skin Venoms Of Spadefoot Toad Megophrys Minor | NA | NA | ||
| 27114317 | 2016 | FFVLKFLLKWAGKVGLEHLACKFKNWC | Megin 2 | Free | Free | Linear | L | None | 27 | Antibacterial, Antifungal | 27.7 % Hemolysis at 100 µM | Human | Skin Venoms Of Spadefoot Toad Megophrys Minor | NA | NA | ||
| 27114317 | 2016 | FFVLKFLLKWAGKVGLEHLACKFKNWC | Megin 2 | Free | Free | Linear | L | None | 27 | Antibacterial, Antifungal | 45.3 % Hemolysis at 200 µM | Human | Skin Venoms Of Spadefoot Toad Megophrys Minor | NA | NA | ||
| 27114317 | 2016 | FFVLKFLLKWAGKVGLEHLACKFKNWC | Megin 2 | Free | Free | Linear | L | None | 27 | Antibacterial, Antifungal | 5.6 % Hemolysis at 25 µM | Rabbit | Skin Venoms Of Spadefoot Toad Megophrys Minor | NA | NA | ||
| 27114317 | 2016 | FFVLKFLLKWAGKVGLEHLACKFKNWC | Megin 2 | Free | Free | Linear | L | None | 27 | Antibacterial, Antifungal | 15.2 % Hemolysis at 50 µM | Rabbit | Skin Venoms Of Spadefoot Toad Megophrys Minor | NA | NA | ||
| 27114317 | 2016 | FFVLKFLLKWAGKVGLEHLACKFKNWC | Megin 2 | Free | Free | Linear | L | None | 27 | Antibacterial, Antifungal | 36.2 % Hemolysis at 100 µM | Rabbit | Skin Venoms Of Spadefoot Toad Megophrys Minor | NA | NA | ||
| 27114317 | 2016 | FFVLKFLLKWAGKVGLEHLACKFKNWC | Megin 2 | Free | Free | Linear | L | None | 27 | Antibacterial, Antifungal | 50.3 % Hemolysis at 200 µM | Rabbit | Skin Venoms Of Spadefoot Toad Megophrys Minor | NA | NA | ||
| 27128941 | 2016 | VWLSALKFIGKHLAKHQLSKL{ct:Amid} | Lycosin-II | Amidation | Free | Linear | L | None | 21 | Antibacterial | <10 % Hemolysis at 6.25 µM | Human | Chinese Wolf Spider Lycosa Singoriensis | α-Helix | NA | ||
| 27128941 | 2016 | VWLSALKFIGKHLAKHQLSKL{ct:Amid} | Lycosin-II | Amidation | Free | Linear | L | None | 21 | Antibacterial | <10 % Hemolysis at 12.5 µM | Human | Chinese Wolf Spider Lycosa Singoriensis | α-Helix | NA | ||
| 27128941 | 2016 | VWLSALKFIGKHLAKHQLSKL{ct:Amid} | Lycosin-II | Amidation | Free | Linear | L | None | 21 | Antibacterial | <10 % Hemolysis at 25 µM | Human | Chinese Wolf Spider Lycosa Singoriensis | α-Helix | NA | ||
| 27128941 | 2016 | VWLSALKFIGKHLAKHQLSKL{ct:Amid} | Lycosin-II | Amidation | Free | Linear | L | None | 21 | Antibacterial | 20 % Hemolysis at 50 µM | Human | Chinese Wolf Spider Lycosa Singoriensis | α-Helix | NA | ||
| 27128941 | 2016 | VWLSALKFIGKHLAKHQLSKL{ct:Amid} | Lycosin-II | Amidation | Free | Linear | L | None | 21 | Antibacterial | <20 % Hemolysis at 100 µM | Human | Chinese Wolf Spider Lycosa Singoriensis | α-Helix | NA | ||
| 26795535 | 2016 | RGLRRLGRKIAHGVKKYGPTVLRIIRIA{ct:Amid} | SMAP-29 | Amidation | Free | Linear | L | None | 28 | Antimicrobial, Anti-MRSA | 10 % Hemolysis at 6 µM | Human | Sheep Myeloid Cells | α-Helix | NA | ||
| 26795535 | 2016 | R{d}G{d}L{d}R{d}R{d}L{d}G{d}R{d}K{d}I{d}A{d}H{d}G{d}V{d}K{d}K{d}Y{d}G{d}P{d}T{d}V{d}L{d}R{d}I{d}I{d}R{d}I{d}A{d}{ct:Amid} | SMAP-29-E1 | Amidation | Free | Linear | D | i = D-Isoleucine | 28 | Antimicrobial, Anti-MRSA | 10 % Hemolysis at 5.5 µM | Human | Smap-29 D-Enantiomeric Peptides | α-Helix | NA | ||
| 26795535 | 2016 | R{d}G{d}L{d}R{d}R{d}L{d}G{d}R{d}K{d}I{d}A{d}H{d}G{d}V{d}K{d}K{d}Y{d}G{d}P{d}T{d}V{d}L{d}R{d}{nnr:i}{nnr:i}R{d}{nnr:i}A{d}{ct:Amid} | SMAP-29-E2 | Amidation | Free | Linear | D | i = d-allo-isoleucine | 28 | Antimicrobial, Anti-MRSA | 10 % Hemolysis at 16 µM | Human | Smap-29 D-Enantiomeric Peptides | α-Helix | NA | ||
| 26795535 | 2016 | RGLRRLGRKIAHGVKKYGP{d}T{d}V{d}L{d}R{d}I{d}I{d}R{d}I{d}A{d}{ct:Amid} | SMAP-29-D1 | Amidation | Free | Linear | Mix | i = D-Isoleucine | 28 | Antimicrobial, Anti-MRSA, Anti-inflammatory | 10 % Hemolysis at 110 µM | Human | Smap-29 Diastereomeric Peptides | α-Helix | NA | ||
| 26795535 | 2016 | RGLRRLGRKIAHGVKKYGP{d}T{d}V{d}L{d}R{d}{nnr:i}{nnr:i}R{d}{nnr:i}A{d}{ct:Amid} | SMAP-29-D2 | Amidation | Free | Linear | Mix | i = d-allo-isoleucine | 28 | Antimicrobial, Anti-MRSA, Anti-inflammatory | 10 % Hemolysis at 217.5 µM | Human | Smap-29 Diastereomeric Peptides | α-Helix | NA | ||
| 26902768 | 2016 | KRFWPLVPVAINTVAAGINLYKAIRRK{ct:Amid} | Fow-3 | Amidation | Free | Linear | L | None | 27 | Antibacterial | 88.1 % Hemolysis at 256 µM | Human | Chicken Cathelicidin | Random coil- sodium phosphate buffer/α-Helical structure-SDS and TFE buffer | Non-hemolytic | ||
| 26902768 | 2016 | KRFWPLVPVAINTVAL{ct:Amid} | Fow-3(1-15-20-27) | Amidation | Free | Linear | L | None | 23 | Antibacterial | <5 % Hemolysis at 256 µM | Human | Truncated Peptides Of Fowlicidin-3 | Random coil- sodium phosphate buffer/α-Helical structure-SDS and TFE buffer | Non-hemolytic | ||
| 27243004 | 2016 | {nnr:O}W{nnr:O}W{nnr:O}W{nnr:O}RPVY{nnr:O}PRPRPPHPRL{nt:gu} | Api794 | Free | gu | Linear | L | gu = N,N,N′N′-tetramethylguanidino, O = L-Ornithine | 22 | Antibacterial Gram- | 1.7 ± 0.2 % Hemolysis at 0.1 g/L | Human | Apidaecin Analog Api137 | NA | Non-hemolytic | ||
| 27243004 | 2016 | {nnr:O}I{nnr:O}I{nnr:O}I{nnr:O}RPVY{nnr:O}PRPRPPHPRL{nt:gu} | Api796 | Free | gu | Linear | L | gu = N,N,N′N′-tetramethylguanidino, O = L-Ornithine | 22 | Antibacterial Gram- | −0.8 ± 0.2 % Hemolysis at 0.1 g/L | Human | Apidaecin Analog Api137 | NA | Non-hemolytic | ||
| 27243004 | 2016 | {nnr:O}W{nnr:O}W{nnr:O}W{nnr:O}RPVY{nnr:O}PRPRPPHPRL{nt:gu} | Api794 | Free | gu | Linear | L | gu = N,N,N′N′-tetramethylguanidino, O = L-Ornithine | 22 | Antibacterial Gram- | 1.9 ± 0.3 % Hemolysis at 0.6 g/L | Human | Apidaecin Analog Api137 | NA | Non-hemolytic | ||
| 27243004 | 2016 | {nnr:O}I{nnr:O}I{nnr:O}I{nnr:O}RPVY{nnr:O}PRPRPPHPRL{nt:gu} | Api796 | Free | gu | Linear | L | gu = N,N,N′N′-tetramethylguanidino, O = L-Ornithine | 22 | Antibacterial Gram- | −0.1 ± 0.8 % Hemolysis at 0.6 g/L | Human | Apidaecin Analog Api137 | NA | Non-hemolytic | ||
| 27187467 | 2016 | GMWSKIKETAMAAAKEAAKAAGKTISDMIKQ{ct:Amid} | Dermaseptin-PD-1 | Amidation | Free | Linear | L | None | 30 | Antibacterial, Antifungal, Anticancer | 100 % Hemolysis at >156.8 µM | Horse | Pachymedusa Dacnicolor | α-Helix | Low hemolytic | ||
| 26802742 | 2016 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antibacterial | 100 % Hemolysis at 10 µM | Rat | Bee Venom | α-Helix | NA | ||
| 27251456 | 2016 | RRLRKKTRKRLKKIGKVLKWI{ct:Amid} | RI21 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 5 % Hemolysis at 32 µM | Human | Pmap-36 Analogues | α-Helix(50% TFE and 30 mM SDS) | NA | ||
| 27271216 | 2016 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antibacterial | 10 % Hemolysis at 0.78 µM | Human | Bee Venom | α-Helix | NA | ||
| 27271216 | 2016 | RIGVLLARLPKLFSLFKLMGKKV{ct:Amid} | RV-23 | Amidation | Free | Linear | L | None | 23 | Antibacterial | 10 % Hemolysis at 6.25 µM | Human | Rana Draytonii | α-Helix | NA | ||
| 27271216 | 2016 | AIGSILGALAKGLPTLISWIKNR{ct:Amid} | AR-23 | Amidation | Free | Linear | L | None | 23 | Antibacterial | 10 % Hemolysis at 3.12 µM | Human | Rana Tagoi | α-Helix | NA | ||
| 27271216 | 2016 | RIGSILGALAKGLPTLISWIKNR{ct:Amid} | A(A1R) | Amidation | Free | Linear | L | None | 23 | Antibacterial | 10 % Hemolysis at 3.12 µM | Human | Ar-23 Analogues | α-Helix | NA | ||
| 27271216 | 2016 | AIGSILGRLAKGLPTLISWIKNR{ct:Amid} | A(A8R) | Amidation | Free | Linear | L | None | 23 | Antibacterial | 10 % Hemolysis at 3.12 µM | Human | Ar-23 Analogues | α-Helix | NA | ||
| 27271216 | 2016 | AIGSILGALAKGLPTLKSWIKNR{ct:Amid} | A(I17K) | Amidation | Free | Linear | L | None | 23 | Antibacterial | 10 % Hemolysis at 50 µM | Human | Ar-23 Analogues | α-Helix | NA | ||
| 27271216 | 2016 | AIGSILGALAKGLPTLRSWIKNR{ct:Amid} | A(I17R) | Amidation | Free | Linear | L | None | 23 | Antibacterial | 10 % Hemolysis at 25 µM | Human | Ar-23 Analogues | α-Helix | NA | ||
| 27271216 | 2016 | RIGSILGRLAKGLPTLISWIKNR{ct:Amid} | A(A1R, A8R) | Amidation | Free | Linear | L | None | 23 | Antibacterial | 10 % Hemolysis at 6.25 µM | Human | Ar-23 Analogues | α-Helix | NA | ||
| 27271216 | 2016 | RIGSILGALAKGLPTLKSWIKNR{ct:Amid} | A(A1R, I17K) | Amidation | Free | Linear | L | None | 23 | Antibacterial | 10 % Hemolysis at 100 µM | Human | Ar-23 Analogues | α-Helix | NA | ||
| 27271216 | 2016 | AIGSILGRLAKGLPTLKSWIKNR{ct:Amid} | A(A8R, I17K) | Amidation | Free | Linear | L | None | 23 | Antibacterial | 10 % Hemolysis at 100 µM | Human | Ar-23 Analogues | α-Helix | NA | ||
| 27271216 | 2016 | RIGSILGRLAKGLPTLKSWIKNR{ct:Amid} | A(A1R, A8R, I17K) | Amidation | Free | Linear | L | None | 23 | Antibacterial | 10 % Hemolysis at 200 µM | Human | Ar-23 Analogues | α-Helix | NA | ||
| 27271216 | 2016 | RIGSILGRLAKGLPTLRSWIKNR{ct:Amid} | A(A1R, A8R, I17R) | Amidation | Free | Linear | L | None | 23 | Antibacterial | 10 % Hemolysis at 100 µM | Human | Ar-23 Analogues | α-Helix | NA | ||
| 27331141 | 2016 | GFCWYVCVYRNGVRVCYRRCN | arenicin-3 | Free | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 4.4 ± 1.1 % Hemolysis at 300 μg/ml | Human | Coelomocytes Of Marine Polychaeta Lugworm Arenicola Marina | β-Hairpin | NA | ||
| 27331141 | 2016 | GSKKPVPIIYCNRRTGKCQRM{ct:Amid} | thanatin | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 1.3 ± 0.4 % Hemolysis at 300 μg/ml | Human | Spined Soldier Bug, Podisus Maculiventris | β-Hairpin | NA | ||
| 27367675 | 2016 | KWKLFKKIFKRIVQRIKDFLRN | C-L | Free | Free | Linear | L | None | 22 | Antibacterial | 50 % Hemolysis at 221 ± 3.27 µg/mL | Sheep | Hybrid Peptide | α-Helix | NA | ||
| 26883426 | 2016 | PPHKKKLAVYPVFLFYLFLSWFSLIV{ct:Amid} | cPcAMP1/26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | Little hemolysis % at 12.5 µg/mL | Human | Ciliata Paramecium Caudatum | α-Helix | NA | ||
| 26883426 | 2016 | PPHKKKLAVYPVFLFYLFLSWFSLIV{ct:Amid} | cPcAMP1/26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | Little hemolysis % at 25 µg/mL | Human | Ciliata Paramecium Caudatum | α-Helix | NA | ||
| 26883426 | 2016 | PPHKKKLAVYPVFLFYLFLSWFSLIV{ct:Amid} | cPcAMP1/26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | Little hemolysis % at 50 µg/mL | Human | Ciliata Paramecium Caudatum | α-Helix | NA | ||
| 26883426 | 2016 | PPHKKKLAVYPVFLFYLFLSWFSLIV{ct:Amid} | cPcAMP1/26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | Little hemolysis % at 100 µg/mL | Human | Ciliata Paramecium Caudatum | α-Helix | NA | ||
| 27019370 | 2016 | IWSFLIKAATKLLPSLFGGGKKDS | Smp24 | Free | Free | Linear | L | None | 24 | Antimicrobial | <5 % Hemolysis at 16 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | NA | ||
| 27019370 | 2016 | IWSFLIKAATKLLPSLFGGGKKDS | Smp24 | Free | Free | Linear | L | None | 24 | Antimicrobial | 11.8 % (±4.0) % Hemolysis at 32 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | NA | ||
| 27019370 | 2016 | IWSFLIKAATKLLPSLFGGGKKDS | Smp24 | Free | Free | Linear | L | None | 24 | Antimicrobial | <20 % Hemolysis at 64 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | NA | ||
| 27019370 | 2016 | IWSFLIKAATKLLPSLFGGGKKDS | Smp24 | Free | Free | Linear | L | None | 24 | Antimicrobial | <60 % Hemolysis at 128 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | NA | ||
| 27019370 | 2016 | IWSFLIKAATKLLPSLFGGGKKDS | Smp24 | Free | Free | Linear | L | None | 24 | Antimicrobial | 80 % Hemolysis at 256 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | NA | ||
| 27019370 | 2016 | IWSFLIKAATKLLPSLFGGGKKDS | Smp24 | Free | Free | Linear | L | None | 24 | Antimicrobial | 89.6 ±5.6 % Hemolysis at 512 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | NA | ||
| 27019370 | 2016 | IWSFLIKAATKLLGVGSLFGGGKKDS | Smp24GVG | Free | Free | Linear | L | None | 26 | Antimicrobial | <5 % Hemolysis at 16 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | NA | ||
| 27019370 | 2016 | IWSFLIKAATKLLGVGSLFGGGKKDS | Smp24GVG | Free | Free | Linear | L | None | 26 | Antimicrobial | 15.9 % (±1.9)) % Hemolysis at 32 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | NA | ||
| 27019370 | 2016 | IWSFLIKAATKLLGVGSLFGGGKKDS | Smp24GVG | Free | Free | Linear | L | None | 26 | Antimicrobial | <30 % Hemolysis at 64 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | NA | ||
| 27019370 | 2016 | IWSFLIKAATKLLGVGSLFGGGKKDS | Smp24GVG | Free | Free | Linear | L | None | 26 | Antimicrobial | <70 % Hemolysis at 128 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | NA | ||
| 27019370 | 2016 | IWSFLIKAATKLLGVGSLFGGGKKDS | Smp24GVG | Free | Free | Linear | L | None | 26 | Antimicrobial | <90 % Hemolysis at 256 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | NA | ||
| 27019370 | 2016 | IWSFLIKAATKLLGVGSLFGGGKKDS | Smp24GVG | Free | Free | Linear | L | None | 26 | Antimicrobial | 90 % Hemolysis at 512 µg/mL | Sheep | Venom Of Scorpio Maurus Palmatus | α-Helix | NA | ||
| 27542832 | 2016 | FSTKTRNWFSEHFKKVKEKLKDTFA | Apo5 APOC1 | Free | Free | Linear | L | None | 25 | Antimicrobial | <1 % Hemolysis at 300 µg/mL | Sheep | American Alligator, Alligator Mississippiensis | α-Helix | Non-hemolytic | ||
| 27542832 | 2016 | KTRNWFSEHFKKVKEKLKDTFA | Apo6 APOC1 | Free | Free | Linear | L | None | 22 | Antimicrobial | <1 % Hemolysis at 300 µg/mL | Sheep | American Alligator, Alligator Mississippiensis | α-Helix | Non-hemolytic | ||
| 27321580 | 2016 | GFLDIVKGVGKVALGAVSKLF{ct:Amid} | CZS-1 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 0 % Hemolysis at 2 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDIVKGVGKVALGAVSKLF{ct:Amid} | CZS-1 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 0 % Hemolysis at 4 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDIVKGVGKVALGAVSKLF{ct:Amid} | CZS-1 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 1 % Hemolysis at 8 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDIVKGVGKVALGAVSKLF{ct:Amid} | CZS-1 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 9 % Hemolysis at 16 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDIVKGVGKVALGAVSKLF{ct:Amid} | CZS-1 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 20 % Hemolysis at 32 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDIVKGVGKVALGAVSKLF{ct:Amid} | CZS-1 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 33 % Hemolysis at 64 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDIVKGVGKVALGAVSKLF{ct:Amid} | CZS-1 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 62 % Hemolysis at 128 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDIVKGVGKVALGAVSKLF{ct:Amid} | CZS-1 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 105 % Hemolysis at 256 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDIVKGVGKVALGAVSKLF{ct:Amid} | CZS-1 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 107 % Hemolysis at 512 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVIKHVGKAALGVVTHLINQ{ct:Amid} | CZS-1 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 0 % Hemolysis at 2 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVIKHVGKAALGVVTHLINQ{ct:Amid} | CZS-2 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 1 % Hemolysis at 4 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVIKHVGKAALGVVTHLINQ{ct:Amid} | CZS-2 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 1 % Hemolysis at 8 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVIKHVGKAALGVVTHLINQ{ct:Amid} | CZS-2 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 6 % Hemolysis at 16 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVIKHVGKAALGVVTHLINQ{ct:Amid} | CZS-2 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 26 % Hemolysis at 32 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVIKHVGKAALGVVTHLINQ{ct:Amid} | CZS-2 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 54 % Hemolysis at 64 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVIKHVGKAALGVVTHLINQ{ct:Amid} | CZS-2 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 75 % Hemolysis at 128 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVIKHVGKAALGVVTHLINQ{ct:Amid} | CZS-2 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 93 % Hemolysis at 256 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVIKHVGKAALGVVTHLINQ{ct:Amid} | CZS-2 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 100 % Hemolysis at 512 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVVKHIGKAALGAVTHLINQ{ct:Amid} | CZS-2 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 0 % Hemolysis at 2 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVVKHIGKAALGAVTHLINQ{ct:Amid} | CZS-3 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 1 % Hemolysis at 4 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVVKHIGKAALGAVTHLINQ{ct:Amid} | CZS-3 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 1 % Hemolysis at 8 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVVKHIGKAALGAVTHLINQ{ct:Amid} | CZS-3 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 2 % Hemolysis at 16 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVVKHIGKAALGAVTHLINQ{ct:Amid} | CZS-3 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 6 % Hemolysis at 32 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVVKHIGKAALGAVTHLINQ{ct:Amid} | CZS-3 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 24 % Hemolysis at 64 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVVKHIGKAALGAVTHLINQ{ct:Amid} | CZS-3 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 59 % Hemolysis at 128 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVVKHIGKAALGAVTHLINQ{ct:Amid} | CZS-3 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 83 % Hemolysis at 256 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVVKHIGKAALGAVTHLINQ{ct:Amid} | CZS-3 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 96 % Hemolysis at 512 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27598770 | 2016 | MQFITDLIKKAVDFFKGLFGNK | WRK | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at 2.78 µM | Human | Staphylococci | α-Helix | NA | ||
| 27598770 | 2016 | MQFITDLIKKAVDFFKGLFDNK | WarnG20D | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at 12.36 µM | Human | Warnericin Rk Derivative | α-Helix | NA | ||
| 27598770 | 2016 | MQFITDLIKKAVDVFKGLFGNK | WarnF14V | Free | Free | Linear | L | None | 22 | Anti-Legionella | 10 % Hemolysis at 12.5 µM | Human | Warnericin Rk Derivative | α-Helix | NA | ||
| 27723187 | 2016 | AAVLLPVLLAAPACHKKKKKKHC{nt:Acet}{ct:Amid} | MTS–ACHK6HC | Amidation | Acetylation | Linear | L | None | 23 | Cytotoxic | 9.12 % Hemolysis at 100 µg/mL | Rat | Cpp | α-Helix | NA | ||
| 27723187 | 2016 | AAVLLPVLLAAPARRRRRRRR{nt:Acet}{ct:Amid} | MTS–AR8 | Amidation | Acetylation | Linear | L | R8 = Octa-arginine | 21 | Cytotoxic | 13.28 % Hemolysis at 100 µg/mL | Rat | Cpp | α-Helix | NA | ||
| 27439393 | 2016 | FYTHVFRLKKWMQKVIDRFGG | T-6 | Free | Free | Linear | L | None | 21 | Antimicrobial | 5 % Hemolysis at >128 µM | Human | C-Terminal Sequences Of Porcine Thrombin | α-Helix | NA | ||
| 27439393 | 2016 | YGFYTHVFRLKKWMQKVIDRFGG | T-7 | Free | Free | Linear | L | None | 23 | Antimicrobial | 5 % Hemolysis at 34.5 µM | Human | C-Terminal Sequences Of Porcine Thrombin | α-Helix | NA | ||
| 27439393 | 2016 | GKYGFYTHVFRLKKWMQKVIDRFGG | T-8 | Free | Free | Linear | L | None | 25 | Antimicrobial | 5 % Hemolysis at 39.4 µM | Human | C-Terminal Sequences Of Porcine Thrombin | α-Helix | NA | ||
| 27809507 | 2016 | PSPCGESCVFIPCISALIGCSCKNKVCYR | parigidin-br3 | Free | Free | Linear | L | None | 29 | cytotoxic, Anticancer | ~13-20 % Hemolysis at 21-42 µM | Human | Plant Palicourea Rigida | α-Helix/β-Sheet | NA | ||
| 27917162 | 2016 | FFGTLFKLGSKLIPGVMKLFSKKKER | ToAP2 | Free | Free | Linear | L | None | 26 | Antifungal | >50 % Hemolysis at 25 µM | Human | Scorpion Tityus Obscurus | α-Helix | NA | ||
| 27554395 | 2016 | FIFHIIKGLFHAGKMIHGLVTRRRH | Em-Pis1M | Free | Free | Linear | L | None | 25 | Antimicrobial | 19.7 % Hemolysis at 20 µmoL/L | Fish | Synthetic Peptides | α-Helical | NA | ||
| 27554395 | 2016 | FIFHIIKGLFHAGKMIHGLVTRRRH | Em-Pis1M | Free | Free | Linear | L | None | 25 | Antimicrobial | 65.7 % Hemolysis at 5 µmoL/L | Rabbit | Synthetic Peptides | α-Helical | NA | ||
| 27554395 | 2016 | FIFHIIKGLFHAGKMIHGLVTRRRH | Em-Pis1M | Free | Free | Linear | L | None | 25 | Antimicrobial | 74.1 % Hemolysis at 20 µmoL/L | Rabbit | Synthetic Peptides | α-Helical | NA | ||
| 27554395 | 2016 | FFFHIIKGLFHAGRMIHGLVNRRRHRH | Em-Pis2M | Free | Free | Linear | L | None | 27 | Antimicrobial | 19 % Hemolysis at 20 µmoL/L | Fish | Synthetic Peptides | α-Helical | NA | ||
| 27554395 | 2016 | FFFHIIKGLFHAGRMIHGLVNRRRHRH | Em-Pis2M | Free | Free | Linear | L | None | 27 | Antimicrobial | 66 % Hemolysis at 5 µmoL/L | Rabbit | Synthetic Peptides | α-Helical | NA | ||
| 27554395 | 2016 | FFFHIIKGLFHAGRMIHGLVNRRRHRH | Em-Pis2M | Free | Free | Linear | L | None | 27 | Antimicrobial | 73.4 % Hemolysis at 20 µmoL/L | Rabbit | Synthetic Peptides | α-Helical | NA | ||
| 27554395 | 2016 | FIFHIIKGLFHAGKMIHGLVTRRRH | Em-Pis1M | Free | Free | Linear | L | None | 25 | Antimicrobial | 5 % Hemolysis at 5 µmoL/L | Fish | Synthetic Peptides | α-Helical | NA | ||
| 27554395 | 2016 | FIFHIIKGLFHAGKMIHGLVT | Em-Pis1S | Free | Free | Linear | L | None | 21 | Antimicrobial | 5 % Hemolysis at 5 µmoL/L | Fish | Synthetic Peptides | α-Helical | NA | ||
| 27554395 | 2016 | FIFHIIKGLFHAGKMIHGLVTRRRHGVEELQDLDQRAFEREKAFA | Em-Pis2M | Free | Free | Linear | L | None | 27 | Antimicrobial | 5 % Hemolysis at 5 µmoL/L | Fish | Synthetic Peptides | α-Helical | NA | ||
| 27067326 | 2016 | FFHHIFRGIVHVGKTIHRLVTG{ct:Amid} | Piscidin-1 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 15 µM | Human | Fish | α-Helical | NA | ||
| 27067326 | 2016 | FFHHAFRGIVHVGKTIHRLVTG{ct:Amid} | I5Apiscidin-1 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 500 µM | Human | Piscidin-1 Designed Analog | α-Helical | NA | ||
| 27067326 | 2016 | FFHHIFRGAVHVGKTIHRLVTG{ct:Amid} | I9Apiscidin-1 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 150 µM | Human | Piscidin-1 Designed Analog | α-Helical | NA | ||
| 27067326 | 2016 | FFHHIFRGIVHVGKTAHRLVTG{ct:Amid} | I16Apiscidin-1 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 500 µM | Human | Piscidin-1 Designed Analog | α-Helical | NA | ||
| 27067326 | 2016 | FFHHVFRGIVHVGKTIHRLVTG{ct:Amid} | I5Vpiscidin-1 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 40 µM | Human | Piscidin-1 Designed Analog | α-Helical | NA | ||
| 27067326 | 2016 | FFHHIFRGVVHVGKTIHRLVTG{ct:Amid} | I9Vpiscidin-1 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 35 µM | Human | Piscidin-1 Designed Analog | α-Helical | NA | ||
| 27067326 | 2016 | FFHHIFRGIVHVGKTVHRLVTG{ct:Amid} | I16Vpiscidin-1 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 40 µM | Human | Piscidin-1 Designed Analog | α-Helical | NA | ||
| 27067326 | 2016 | FFHHFARGIVHVGKTIHRLVTG{ct:Amid} | I5F,F6Apiscidin-1 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 150 µM | Human | Piscidin-1 Designed Analog | α-Helical | NA | ||
| 27067326 | 2016 | FFHHIFRGIVHIGKTIHRLVTG{ct:Amid} | V12Ipiscidin-1 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 7 µM | Human | Piscidin-1 Designed Analog | α-Helical | NA | ||
| 27487034 | 2017 | RRGRRGP{nnr:O}GP{nnr:O}GP{nnr:O}GP{nnr:O}GP{nnr:O}GPCCY{ct:Amid} | RR4 | Amidation | Free | Linear | L | O = 4-hydroxy-L-proline | 25 | Antimicrobial | 0 % Hemolysis at 0.3-30 µM | Human | R3 Derivatives | Triple-Helical | Non-hemolytic | ||
| 27487329 | 2017 | GLPVCGETCVGGTCNTPGCTCSWPVCTRN{cyc:N-C} | kB1 | Free | Free | Cyclic | L | None | 29 | cytotoxic | <60 % Hemolysis at 50 µM | Human | Möbius Family | Loop | NA | ||
| 27487329 | 2017 | GLPVCGETCVGGTCPGACTCSWPVCTRN{cyc:N-C} | kL3 | Free | Free | Cyclic | L | None | 28 | cytotoxic | 0 % Hemolysis at 10-50 µM | Human | Chimeric Cyclotides | Loop | Non-hemolytic | ||
| 27487329 | 2017 | GLPVCGETCVGGTCNTPGCICSWPVCTRN{cyc:N-C} | kL4 | Free | Free | Cyclic | L | None | 29 | cytotoxic | <60 % Hemolysis at 50 µM | Human | Chimeric Cyclotides | Loop | NA | ||
| 27487329 | 2017 | GLPVCGETCVGGTCNTPGCTCRGNGYCTRN{cyc:N-C} | kL5 | Free | Free | Cyclic | L | None | 30 | cytotoxic | 0 % Hemolysis at 10-50 µM | Human | Chimeric Cyclotides | Loop | Non-hemolytic | ||
| 28067810 | 2017 | FPFLKLSLKIPKSAIKSAIKRL{ct:Amid} | D10 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 10 % Hemolysis at 149.75 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | FPFLKLSLKIPKSAIKSAIKRL{ct:Amid} | D10 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 1726 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28067810 | 2017 | FPFLKLSLKIPKSAIKSAIKRL{ct:Amid} | D10 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 90 % Hemolysis at 19894.17 µM | Pig | Scorpion Urodacus Yaschenkoi | α-Helix | NA | ||
| 28115922 | 2017 | GVVDILKGAAKDIAGHLASKVM{ct:Amid} | Ocellatin-LB1 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 6 % Hemolysis at 0.46 µM | Rabbit | American Frog Leptodactylus Labyrinthicus | α-Helix | NA | ||
| 28115922 | 2017 | GVVDILKGAAKDIAGHLASKVMN{ct:Amid} | Ocellatin-LB2 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 1 % Hemolysis at 0.5 µM | Rabbit | American Frog Leptodactylus Labyrinthicus | α-Helix | NA | ||
| 28115922 | 2017 | GVVDILKGAAKDIAGHLASKVMNKL{ct:Amid} | Ocellatin-F1 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 13 % Hemolysis at 0.4 µM | Rabbit | American Frog Leptodactylus Labyrinthicus | α-Helix | NA | ||
| 27935673 | 2017 | RIIDLLWRVRRPQKPKFVTVWVR{nt:Dansyl}{ct:Amid} | DNS-PMAP23 | Amidation | Dansyl | Linear | L | Dansyl(DNS) = 5-(dimetylamino)napthalene-1-sulphonyl | 23 | Antimicrobial | 50 % Hemolysis at 29 µM | Human | Analogue Of The Cathelicidin Hdp Pmap-23 | NA | NA | ||
| 28122029 | 2017 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | moro-NH2 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 25 % Hemolysis at 25 µM | Sheep | Hybrid Striped Bass | α-Helix | NA | ||
| 28122029 | 2017 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | moro-NH2 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | <20 % Hemolysis at 12.5 µM | Sheep | Hybrid Striped Bass | α-Helix | NA | ||
| 28122029 | 2017 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | moro-NH2 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 10 % Hemolysis at 6.25 µM | Sheep | Hybrid Striped Bass | α-Helix | NA | ||
| 28122029 | 2017 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | moro-NH2 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | <10 % Hemolysis at 5 µM | Sheep | Hybrid Striped Bass | α-Helix | NA | ||
| 28122029 | 2017 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | moro-NH2 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 60 % Hemolysis at 25 µM | Horse | Hybrid Striped Bass | α-Helix | NA | ||
| 28122029 | 2017 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | moro-NH2 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 70 % Hemolysis at 50 µM | Horse | Hybrid Striped Bass | α-Helix | NA | ||
| 28122029 | 2017 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | moro-NH2 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 40 % Hemolysis at 6.25 µM | Horse | Hybrid Striped Bass | α-Helix | NA | ||
| 28122029 | 2017 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | moro-NH2 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 20 % Hemolysis at 5 µM | Horse | Hybrid Striped Bass | α-Helix | NA | ||
| 28122029 | 2017 | FFWHHIGHALDAAKRVHGMLSG{ct:Amid} | moroNC-NH2 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | ~10 % Hemolysis at 50 µM | Horse | Notothenia Coriiceps | α-Helix | NA | ||
| 28122029 | 2017 | FFWHHIGHALDAAKRVHGMLSG{ct:Amid} | moroNC-NH2 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | <1 % Hemolysis at 25 µM | Sheep | Notothenia Coriiceps | α-Helix | NA | ||
| 28122029 | 2017 | FFWHHIGHALDAAKRVHGMLSG{ct:Amid} | moroNC-NH2 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | <1 % Hemolysis at 25 µM | Horse | Notothenia Coriiceps | α-Helix | NA | ||
| 28122029 | 2017 | FFGHLFRGIINVGKHIHGLLSG{ct:Amid} | moroPC-NH2 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 10 % Hemolysis at 50 µM | Sheep | Parachaenichthys Charcoti | α-Helix | NA | ||
| 28122029 | 2017 | FFGHLFRGIINVGKHIHGLLSG{ct:Amid} | moroPC-NH2 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | <10 % Hemolysis at 25 µM | Sheep | Parachaenichthys Charcoti | α-Helix | NA | ||
| 28122029 | 2017 | FFGHLFRGIINVGKHIHGLLSG{ct:Amid} | moroPC-NH2 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 50 µM | Horse | Parachaenichthys Charcoti | α-Helix | NA | ||
| 28122029 | 2017 | FFGHLFRGIINVGKHIHGLLSG{ct:Amid} | moroPC-NH2 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | <10 % Hemolysis at 25 µM | Horse | Parachaenichthys Charcoti | α-Helix | NA | ||
| 28012857 | 2017 | FALALKALKKALKKLKKALKKAL | Hecate | Free | Free | Linear | L | None | 23 | Antimicrobial | 0 % Hemolysis at 0-25 µM | Horse | Synthetic, Derivate Of Melittin | α-Helix | NA | ||
| 28012857 | 2017 | FALALKALKKALKKLKKALKKAL | Hecate | Free | Free | Linear | L | None | 23 | Antimicrobial | <60 % Hemolysis at 25 µM | Human | Synthetic, Derivate Of Melittin | α-Helix | NA | ||
| 28012857 | 2017 | FALALKALKKALKKLKKALKKAL | Hecate | Free | Free | Linear | L | None | 23 | Antimicrobial | <40 % Hemolysis at 15 µM | Human | Synthetic, Derivate Of Melittin | α-Helix | NA | ||
| 28012857 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 50 % Hemolysis at 5 µM | Horse | Apis Mellifera | α-Helix | NA | ||
| 28012857 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 75 % Hemolysis at 10 µM | Horse | Apis Mellifera | α-Helix | NA | ||
| 28012857 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 15-25 µM | Horse | Apis Mellifera | α-Helix | NA | ||
| 28012857 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 80 % Hemolysis at 5 µM | Human | Apis Mellifera | α-Helix | NA | ||
| 28012857 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 25 µM | Human | Apis Mellifera | α-Helix | NA | ||
| 28012857 | 2017 | RGLRRLGRKIAHGVKKYGPTVLRIIRIAG | SMAP29 | Free | Free | Linear | L | None | 29 | Antimicrobial | 0 % Hemolysis at 0-25 µM | Horse | Derivative Of Ovispirin, Ovis Aries | α-Helix | Non-hemolytic | ||
| 28012857 | 2017 | RGLRRLGRKIAHGVKKYGPTVLRIIRIAG | SMAP29 | Free | Free | Linear | L | None | 29 | Antimicrobial | 40 % Hemolysis at 20 µM | Human | Derivative Of Ovispirin, Ovis Aries | α-Helix | NA | ||
| 28012857 | 2017 | RGLRRLGRKIAHGVKKYGPTVLRIIRIAG | SMAP29 | Free | Free | Linear | L | None | 29 | Antimicrobial | 50 % Hemolysis at 25 µM | Human | Derivative Of Ovispirin, Ovis Aries | α-Helix | NA | ||
| 28012857 | 2017 | KWKLWKKIEKWGQGIGAVLKWLTTWL | CAM-W | Free | Free | Linear | L | None | 26 | Antimicrobial | 10 % Hemolysis at 1 µM | Human | Synthetic, Cecropin A / Melittin Hybrid | α-Helix | NA | ||
| 28012857 | 2017 | KWKLWKKIEKWGQGIGAVLKWLTTWL | CAM-W | Free | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 10 µM | Human | Synthetic, Cecropin A / Melittin Hybrid | α-Helix | NA | ||
| 28012857 | 2017 | KWKLWKKIEKWGQGIGAVLKWLTTWL | CAM-W | Free | Free | Linear | L | None | 26 | Antimicrobial | <80 % Hemolysis at 5 µM | Human | Synthetic, Cecropin A / Melittin Hybrid | α-Helix | NA | ||
| 28012857 | 2017 | KWKLWKKIEKWGQGIGAVLKWLTTWL | CAM-W | Free | Free | Linear | L | None | 26 | Antimicrobial | 80 % Hemolysis at 5 µM | Horse | Synthetic, Cecropin A / Melittin Hybrid | α-Helix | NA | ||
| 28012857 | 2017 | KWKLWKKIEKWGQGIGAVLKWLTTWL | CAM-W | Free | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 10 µM | Horse | Synthetic, Cecropin A / Melittin Hybrid | α-Helix | NA | ||
| 28012857 | 2017 | WEAALAEALAEALAEHLAEALAEALEALAA | GALA | Free | Free | Linear | L | None | 30 | Antimicrobial | 10 % Hemolysis at 25 µM | Horse | Synthetic, Cecropin A / Melittin Hybrid | α-Helix | NA | ||
| 28012857 | 2017 | WEAALAEALAEALAEHLAEALAEALEALAA | GALA | Free | Free | Linear | L | None | 30 | Antimicrobial | 0 % Hemolysis at 0-25 µM | Human | Synthetic | α-Helix | Non-hemolytic | ||
| 28012857 | 2017 | WEAKLAKALAKALAKHLAKALAKALKACEA | KALA | Free | Free | Linear | L | None | 30 | Antimicrobial | 60 % Hemolysis at 25 µM | Human | Synthetic | α-Helix | NA | ||
| 28012857 | 2017 | WEAKLAKALAKALAKHLAKALAKALKACEA | KALA | Free | Free | Linear | L | None | 30 | Antimicrobial | <60 % Hemolysis at 25 µM | Horse | Synthetic | α-Helix | NA | ||
| 28012857 | 2017 | WEAKLAKALAKALAKHLAKALAKALKACEA | KALA | Free | Free | Linear | L | None | 30 | Antimicrobial | 50 % Hemolysis at 15 µM | Horse | Synthetic | α-Helix | NA | ||
| 28012857 | 2017 | WEAKLAKALAKALAKHLAKALAKALKACEA | KALA | Free | Free | Linear | L | None | 30 | Antimicrobial | 40 % Hemolysis at 10 µM | Horse | Synthetic | α-Helix | NA | ||
| 28165293 | 2017 | FKCRRWQWRMKKLGAPSITCVRRAF{cyc:N-C} | LFcinB | Free | Free | Cyclic | L | None | 25 | Anticancer | <2 % Hemolysis at 10 µM | Human | Bovine Lf (Blf) | β-Hairpin | NA | ||
| 28165293 | 2017 | FK{nnr:*}RRWQWRMKKLGAPSIT{nnr:*}VRRAF | LFcinB-CLICK | Free | Free | Linear | L | * = triazole linkage | 23 | Anticancer | <2 % Hemolysis at 10 µM | Human | Lf-Derived | β-Hairpin | NA | ||
| 28165293 | 2017 | GRRRRSVQWCAGRRRRSVQWCA | Dimer hLF11 | Free | Free | Linear | L | None | 22 | Anticancer | <2 % Hemolysis at 10 µM | Human | Human-Derived | β-Hairpin | NA | ||
| 28165293 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Anticancer | 90 % Hemolysis at 10 µM | Human | Bee Venom | Helical | NA | ||
| 28282123 | 2017 | KIAGKIAKIAGKIAKIAGKIA{ct:Amid} | KIA21 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 9 % Hemolysis at 8 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAAIAGKIAKIAGKIAK{ct:Amid} | KIA(7)22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 16 % Hemolysis at 8 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAAIAGKIAKIAGKIAKIA{ct:Amid} | KIA(7)24 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 18 % Hemolysis at 8 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAAIAGKIAKIAGAIAKIAGK{ct:Amid} | KIA(7)26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 39 % Hemolysis at 8 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAAIAGKIAKIAGAIAKIAGKIA{ct:Amid} | KIA(7)28 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 90 % Hemolysis at 8 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIASIAGKIAKIAGKIAK{ct:Amid} | KISA22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 7 % Hemolysis at 8 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKIAGKIAKIAGKIAKIA{ct:Amid} | KISA24 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 24 % Hemolysis at 8 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIASIAGKIAKIAGSIAKIAGK{ct:Amid} | KISA26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 18 % Hemolysis at 8 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIASIAGKIAKIAGSIAKIAGKIA{ct:Amid} | KISA28 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 53 % Hemolysis at 8 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKIAGKIAKIAGKIA{ct:Amid} | KIA21 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 17 % Hemolysis at 32 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAAIAGKIAKIAGKIAK{ct:Amid} | KIA(7)22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 24 % Hemolysis at 32 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAAIAGKIAKIAGKIAKIA{ct:Amid} | KIA(7)24 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 62 % Hemolysis at 32 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAAIAGKIAKIAGAIAKIAGK{ct:Amid} | KIA(7)26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 72 % Hemolysis at 32 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAAIAGKIAKIAGAIAKIAGKIA{ct:Amid} | KIA(7)28 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 100 % Hemolysis at 32 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIASIAGKIAKIAGKIAK{ct:Amid} | KISA22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 12 % Hemolysis at 32 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKIAGKIAKIAGKIAKIA{ct:Amid} | KISA24 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 44 % Hemolysis at 32 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIASIAGKIAKIAGSIAKIAGK{ct:Amid} | KISA26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 29 % Hemolysis at 32 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIASIAGKIAKIAGSIAKIAGKIA{ct:Amid} | KISA28 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 82 % Hemolysis at 32 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKIAGKIAKIAGKIA{ct:Amid} | KIA21 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 43 % Hemolysis at 128 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAAIAGKIAKIAGKIAK{ct:Amid} | KIA(7)22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 44 % Hemolysis at 128 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAAIAGKIAKIAGKIAKIA{ct:Amid} | KIA(7)24 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 98 % Hemolysis at 128 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAAIAGKIAKIAGAIAKIAGK{ct:Amid} | KIA(7)26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 98 % Hemolysis at 128 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAAIAGKIAKIAGAIAKIAGKIA{ct:Amid} | KIA(7)28 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 100 % Hemolysis at 128 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIASIAGKIAKIAGKIAK{ct:Amid} | KISA22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 19 % Hemolysis at 128 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKIAGKIAKIAGKIAKIA{ct:Amid} | KISA24 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 89 % Hemolysis at 128 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIASIAGKIAKIAGSIAKIAGK{ct:Amid} | KISA26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 63 % Hemolysis at 128 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIASIAGKIAKIAGSIAKIAGKIA{ct:Amid} | KISA28 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 98 % Hemolysis at 128 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKIAGKIAKIAGKIA{ct:Amid} | KIA21 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 83 % Hemolysis at 512 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAAIAGKIAKIAGKIAK{ct:Amid} | KIA(7)22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 76 % Hemolysis at 512 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAAIAGKIAKIAGKIAKIA{ct:Amid} | KIA(7)24 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 100 % Hemolysis at 512 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAAIAGKIAKIAGAIAKIAGK{ct:Amid} | KIA(7)26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 512 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAAIAGKIAKIAGAIAKIAGKIA{ct:Amid} | KIA(7)28 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 100 % Hemolysis at 512 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIASIAGKIAKIAGKIAK{ct:Amid} | KISA22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 39 % Hemolysis at 512 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIAKIAGKIAKIAGKIAKIA{ct:Amid} | KISA24 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 100 % Hemolysis at 512 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIASIAGKIAKIAGSIAKIAGK{ct:Amid} | KISA26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 512 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28282123 | 2017 | KIAGKIASIAGKIAKIAGSIAKIAGKIA{ct:Amid} | KISA28 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 99 % Hemolysis at 512 μg/ml | Human | Msi-103 Analogues | α-Helix | NA | ||
| 28322271 | 2017 | GGLRSLGRKILRAWKKYGPIIVPIIRI{ct:Amid} | BMAP-28 | Amidation | Free | Linear | L | None | 27 | Antimicrobial, Antiprotozoal | 38 % Hemolysis at 10 µM | Human | Synthetic | α-Helix | NA | ||
| 28322271 | 2017 | GGLRSLGRKILRAWKKYGPIIVPIIRI{ct:Amid} | BMAP-28 | Amidation | Free | Linear | L | None | 27 | Antimicrobial, Antiprotozoal | 81.7 % Hemolysis at 30 µM | Human | Synthetic | α-Helix | NA | ||
| 28230992 | 2017 | LRRLRRRLRRLRRRWRRRLRRLRRRLRRL{ct:Amid} | 6 | Amidation | Free | Branched | L | None | 29 | Antibacterial | 10 % Hemolysis at 64 mg/L | Human | Synthetic | α-Helix | NA | ||
| 28089718 | 2017 | KIKKGFKKIFKRLPPIGVGVSIPLAGKR | AM-CATH28 | Free | Free | Linear | L | None | 28 | Antimicrobial | 0 % Hemolysis at 300 μg/ml | Sheep | A. Mississippiensis | α-Helix | Non-hemolytic | ||
| 28089718 | 2017 | GLFKKLRRKIKKGFKKIFKRL | AM-CATH21 | Free | Free | Linear | L | None | 21 | Antimicrobial | 0 % Hemolysis at 300 μg/ml | Sheep | A. Mississippiensis | α-Helix | Non-hemolytic | ||
| 28370835 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 93 at pH-7.4 % Hemolysis at 2.5 µM | Human | Apis Mellifera Honeybees | α-Helix | NA | ||
| 28370835 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 4 at pH-5 % Hemolysis at 2.5 µM | Human | Apis Mellifera Honeybees | α-Helix | NA | ||
| 28370835 | 2017 | GIGAVLEVLTTGLPALISWIEEEEQQ{ct:Amid} | aMel | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 74 at pH-5 % Hemolysis at 10 µM | Human | Mel Analogs | α-Helix | NA | ||
| 28370835 | 2017 | GIGAVLEVLTTGLPALISWIEEEEQQ{ct:Amid} | aMel | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 15 at pH-7.4 % Hemolysis at 10 µM | Human | Mel Analogs | α-Helix | NA | ||
| 28370835 | 2017 | RIGVLLARLPKLFSLFKLMGKKV{ct:Amid} | RV-23 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 4 at pH-7.4 % Hemolysis at 2.5 µM | Human | Mel Analogs | α-Helix | NA | ||
| 28370835 | 2017 | RIGVLLAELPELFSLFELMGEEV{ct:Amid} | aRV | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 0 at pH-7.4 % Hemolysis at 160 µM | Human | Mel Analogs | α-Helix | Non-hemolytic | ||
| 28546807 | 2017 | GIGAVLEVLTTGLPALISWIEEEEQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 91.8 ± 1.8 % Hemolysis at 10 µM | Rat | Apis Mellifera | α-Helix | NA | ||
| 28258530 | 2017 | MMRVMRRKTKVIWEKKDFIGLYSID | Catesbeianin-1 | Free | Free | Linear | L | None | 25 | Antimicrobial | 8 % Hemolysis at 100 μg/ml | Human | Lithobates Catesbeianus | α-Helix | NA | ||
| 28258530 | 2017 | MMRVMRRKTKVIWEKKDFIGLYSID | Catesbeianin-1 | Free | Free | Linear | L | None | 25 | Antimicrobial | 30 % Hemolysis at 200 μg/ml | Human | Lithobates Catesbeianus | α-Helix | NA | ||
| 28258530 | 2017 | MMRVMRRKTKVIWEKKDFIGLYSID | Catesbeianin-1 | Free | Free | Linear | L | None | 25 | Antimicrobial | 50 % Hemolysis at 300 μg/ml | Human | Lithobates Catesbeianus | α-Helix | NA | ||
| 28258530 | 2017 | MMRVMRRKTKVIWEKKDFIGLYSID | Catesbeianin-1 | Free | Free | Linear | L | None | 25 | Antimicrobial | <100 % Hemolysis at 400 μg/ml | Human | Lithobates Catesbeianus | α-Helix | NA | ||
| 28258530 | 2017 | MMRVMRRKTKVIWEKKDFIGLYSID | Catesbeianin-1 | Free | Free | Linear | L | None | 25 | Antimicrobial | <100 % Hemolysis at 500 μg/ml | Human | Lithobates Catesbeianus | α-Helix | NA | ||
| 28314993 | 2017 | AGYLLGKINLKALAALAKKIL{ct:Amid} | Transportan | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 50 % Hemolysis at 38.0 ± 3.79 µM | Human | Hybrid Peptide | α-Helix | NA | ||
| 28314993 | 2017 | GIGKFLHSAKKFGKAFVGEIMNS{ct:Amid} | Magainin | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 50 % Hemolysis at >300 µM | Human | Amphibians | α-Helix | NA | ||
| 28314993 | 2017 | VCRTGRSRWRDVCRNFMRRYQSR{ct:Amid} | GranF2 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 50 % Hemolysis at >300 µM | Human | Synthetic Derivative | Helix-Loop-Helix | NA | ||
| 28314993 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 50 % Hemolysis at 0.339 ± 0.0854 µM | Human | Bee Venom | α-Helix | NA | ||
| 28611397 | 2017 | FFGWLIKGAIHAGKAIHGLIHRRRH | Chrysophsin-1 | Free | Free | Linear | L | None | 25 | Antimicrobial | 100 % Hemolysis at 10-50 µM | Human | Chrysophrys Major | α-Helix | NA | ||
| 28611397 | 2017 | FFGWLIKPAIHAGKAIHGLIHRRRH | G8P-Chr-1 | Free | Free | Linear | L | None | 25 | Antimicrobial | 20 % Hemolysis at 50 µM | Human | Chrysophsin-1 Analogs | α-Helix | Low hemolytic | ||
| 28611397 | 2017 | FFGWLIKGAIHAPKAIHGLIHRRRH | G13P-Chr-1 | Free | Free | Linear | L | None | 25 | Antimicrobial | <20 % Hemolysis at 50 µM | Human | Chrysophsin-1 Analogs | α-Helix | Low hemolytic | ||
| 28611397 | 2017 | FFGWLIKGAIHAGKAIHPLIHRRRH | G18P-Chr-1 | Free | Free | Linear | L | None | 25 | Antimicrobial | <10 % Hemolysis at 50 µM | Human | Chrysophsin-1 Analogs | α-Helix | Low hemolytic | ||
| 28611397 | 2017 | FFGWLIKGAIHAPKAIHPLIHRRRH | G13,18P-Chr-1 | Free | Free | Linear | L | None | 25 | Antimicrobial | 0 % Hemolysis at 50 µM | Human | Chrysophsin-1 Analogs | α-Helix | Non-hemolytic | ||
| 28733329 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 91.1 % Hemolysis at 40 µM | Human | Bee Venom | NA | NA | ||
| 28733329 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 70.2 % Hemolysis at 20 µM | Human | Bee Venom | NA | NA | ||
| 28733329 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 54.3 % Hemolysis at 10 µM | Human | Bee Venom | NA | NA | ||
| 28733329 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 23.8 % Hemolysis at 5 µM | Human | Bee Venom | NA | NA | ||
| 28733329 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 13.3 % Hemolysis at 2.5 µM | Human | Bee Venom | NA | NA | ||
| 28733329 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 1.9 % Hemolysis at 1.3 µM | Human | Bee Venom | NA | NA | ||
| 28850103 | 2017 | FLSLIPKIAGGIAALAKHL{ct:Amid} | Phylloseptin-PTa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 10 % Hemolysis at 7.79 µM | Horse | Phyllomedusa Tarsius | α-Helix | NA | ||
| 28850103 | 2017 | FLSLIPKIAGGIAALAKHL{ct:Amid} | Phylloseptin-PTa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 22.8 µM | Horse | Phyllomedusa Tarsius | α-Helix | NA | ||
| 28850103 | 2017 | FLSLIPAAISAVSALANHF{ct:Amid} | phylloseptin-PHa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 10 % Hemolysis at 76.5 µM | Horse | Phyllomedusa Hypochondrialis | α-Helix | NA | ||
| 28850103 | 2017 | FLSLIPAAISAVSALANHF{ct:Amid} | phylloseptin-PHa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 109.5 µM | Horse | Phyllomedusa Hypochondrialis | α-Helix | NA | ||
| 28630199 | 2017 | HRVKRNGFRKFMRRLKKFFAGG | Pb-CATH3 | Free | Free | Linear | L | None | 22 | Antimicrobial | 0 % Hemolysis at 4 μg/ml | Chicken | Python Bivittatus | α-Helix | Non-hemolytic | ||
| 28630199 | 2017 | HRVKRNGFRKFMRRLKKFFAGG | Pb-CATH3 | Free | Free | Linear | L | None | 22 | Antimicrobial | 0 % Hemolysis at 8 μg/ml | Chicken | Python Bivittatus | α-Helix | Non-hemolytic | ||
| 28630199 | 2017 | HRVKRNGFRKFMRRLKKFFAGG | Pb-CATH3 | Free | Free | Linear | L | None | 22 | Antimicrobial | 1.7±0.5 % Hemolysis at 16 μg/ml | Chicken | Python Bivittatus | α-Helix | NA | ||
| 28630199 | 2017 | HRVKRNGFRKFMRRLKKFFAGG | Pb-CATH3 | Free | Free | Linear | L | None | 22 | Antimicrobial | 3.1±0.5 % Hemolysis at 32 μg/ml | Chicken | Python Bivittatus | α-Helix | NA | ||
| 28630199 | 2017 | HRVKRNGFRKFMRRLKKFFAGG | Pb-CATH3 | Free | Free | Linear | L | None | 22 | Antimicrobial | 4.0±0.2 % Hemolysis at 64 μg/ml | Chicken | Python Bivittatus | α-Helix | NA | ||
| 28630199 | 2017 | TRSRWRRFIRGAGRFARRYGWRIAL | Pb-CATH4 | Free | Free | Linear | L | None | 25 | Antimicrobial | 0 % Hemolysis at 4 μg/ml | Chicken | Python Bivittatus | α-Helix | Non-hemolytic | ||
| 28630199 | 2017 | TRSRWRRFIRGAGRFARRYGWRIAL | Pb-CATH4 | Free | Free | Linear | L | None | 25 | Antimicrobial | 1.2±0.3 % Hemolysis at 8 μg/ml | Chicken | Python Bivittatus | α-Helix | NA | ||
| 28630199 | 2017 | TRSRWRRFIRGAGRFARRYGWRIAL | Pb-CATH4 | Free | Free | Linear | L | None | 25 | Antimicrobial | 3.2±0.4 % Hemolysis at 16 μg/ml | Chicken | Python Bivittatus | α-Helix | NA | ||
| 28630199 | 2017 | TRSRWRRFIRGAGRFARRYGWRIAL | Pb-CATH4 | Free | Free | Linear | L | None | 25 | Antimicrobial | 6.5±0.4 % Hemolysis at 32 μg/ml | Chicken | Python Bivittatus | α-Helix | NA | ||
| 28630199 | 2017 | TRSRWRRFIRGAGRFARRYGWRIAL | Pb-CATH4 | Free | Free | Linear | L | None | 25 | Antimicrobial | 10.7±0.2 % Hemolysis at 64 μg/ml | Chicken | Python Bivittatus | α-Helix | NA | ||
| 28630199 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ | melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 13±1.1 % Hemolysis at 4 μg/ml | Chicken | Bee Venom | α-Helix | NA | ||
| 28630199 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ | melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 71.3±5.2 % Hemolysis at 8 μg/ml | Chicken | Bee Venom | α-Helix | NA | ||
| 28630199 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ | melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 110.3±1.5 % Hemolysis at 16 μg/ml | Chicken | Bee Venom | α-Helix | NA | ||
| 28630199 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ | melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 114.7±1.7 % Hemolysis at 32 μg/ml | Chicken | Bee Venom | α-Helix | NA | ||
| 28630199 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ | melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 113.4±0.2 % Hemolysis at 64 μg/ml | Chicken | Bee Venom | α-Helix | NA | ||
| 28653651 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{nt:Amid}{ct:Amid} | melittin | Amidation | Amidation | Linear | L | None | 26 | Antimicrobial | 10 % Hemolysis at 25 µM | Human | Bee Venom | α-Helix | NA | ||
| 28894024 | 2017 | GIGGALLSFGKSALKGLAKGLAEHF{ct:Amid} | BHL-bombinin | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 50 % Hemolysis at 64 mg/l | Horse | Bombina Orientalis | α-Helix | NA | ||
| 28894024 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 50 % Hemolysis at 1 mg/l | Horse | Bee Venom | α-Helix | NA | ||
| 29185466 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 93 % Hemolysis at 25 µM | Human | Bee Venom | α-Helical | NA | ||
| 29135962 | 2017 | HSDAVFTDNYTRLRKQMAVKKYLNSILN | VIP 1(vasoactive intestinal peptide) | Free | Free | Linear | L | None | 28 | Antimicrobial | 0 % Hemolysis at <19.2 µM | Porcine | Host-Defence Peptide | α-Helical | Non-hemolytic | ||
| 29135962 | 2017 | HSKAVFTKNYTRLRKQMAVKKYLNSILN | VIP 2 | Free | Free | Linear | L | None | 28 | Antimicrobial | 0 % Hemolysis at <19.2 µM | Porcine | Vip Analogues | α-Helical | Non-hemolytic | ||
| 29135962 | 2017 | HSDAVFTDNSTRLRKQMAVKKSLNSILN | VIP 3 | Free | Free | Linear | L | None | 28 | Antimicrobial | 0 % Hemolysis at <19.2 µM | Porcine | Vip Analogues | α-Helical | Non-hemolytic | ||
| 29135962 | 2017 | HSDAVFTDNYTRLRKQMAVKKYLNSILT | VIP 4 | Free | Free | Linear | L | None | 28 | Antimicrobial | 0 % Hemolysis at <19.2 µM | Porcine | Vip Analogues | α-Helical | Non-hemolytic | ||
| 29135962 | 2017 | HSKAVFTKNYTRLRKQMAVKKYLNSILT | VIP 5 | Free | Free | Linear | L | None | 28 | Antimicrobial | 0 % Hemolysis at <19.2 µM | Porcine | Vip Analogues | α-Helical | Non-hemolytic | ||
| 29135962 | 2017 | HSDAVFTDNSTRLRKQMAVKKSLNSILT | VIP 6 | Free | Free | Linear | L | None | 28 | Antimicrobial | 0 % Hemolysis at <19.2 µM | Porcine | Vip Analogues | α-Helical | Non-hemolytic | ||
| 29135962 | 2017 | HSDAVFTANYTRLRRQLAVRRYLAAILGRR | VIP 7 | Free | Free | Linear | L | None | 30 | Antimicrobial | 0 % Hemolysis at <19.2 µM | Porcine | Vip Analogues | α-Helical | Non-hemolytic | ||
| 29135962 | 2017 | FTANYTRLRRQLAVRRYLAAILGRR | VIP 8 | Free | Free | Linear | L | None | 26 | Antimicrobial | 0 % Hemolysis at <19.2 µM | Porcine | Vip Analogues | α-Helical | Non-hemolytic | ||
| 29135962 | 2017 | FTANYTRLRRQLAVRRYLAAILGRR | VIP 8 | Free | Free | Linear | L | None | 26 | Antimicrobial | 1.12 % Hemolysis at 76.8 µM | Porcine | Vip Analogues | α-Helical | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFRKKPRLIGLSTLL | Hc-CATH | Free | Free | Linear | L | None | 30 | Antimicrobial | 0 % Hemolysis at 12.5 µg/mL | Human | Sea Snake, Hydrophis Cyanocinctus | α-Helix | Non-hemolytic | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFRKKPRLIGLSTLL | Hc-CATH | Free | Free | Linear | L | None | 30 | Antimicrobial | 0 % Hemolysis at 25 µg/mL | Human | Sea Snake, Hydrophis Cyanocinctus | α-Helix | Non-hemolytic | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFRKKPRLIGLSTLL | Hc-CATH | Free | Free | Linear | L | None | 30 | Antimicrobial | 0 % Hemolysis at 50 µg/mL | Human | Sea Snake, Hydrophis Cyanocinctus | α-Helix | Non-hemolytic | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFRKKPRLIGLSTLL | Hc-CATH | Free | Free | Linear | L | None | 30 | Antimicrobial | 0 % Hemolysis at 100 µg/mL | Human | Sea Snake, Hydrophis Cyanocinctus | α-Helix | Non-hemolytic | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFRKKPRLIGLSTLL | Hc-CATH | Free | Free | Linear | L | None | 30 | Antimicrobial | 5.25 % Hemolysis at 200 µg/mL | Human | Sea Snake, Hydrophis Cyanocinctus | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFCWTKSIPPKPC | H3TI | Free | Free | Linear | L | None | 28 | Antimicrobial | 1.8 % Hemolysis at 12.5 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFCWTKSIPPKPC | H3TI | Free | Free | Linear | L | None | 28 | Antimicrobial | 1.55 % Hemolysis at 25 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFCWTKSIPPKPC | H3TI | Free | Free | Linear | L | None | 28 | Antimicrobial | 2.28 % Hemolysis at 50 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFCWTKSIPPKPC | H3TI | Free | Free | Linear | L | None | 28 | Antimicrobial | 3.5 % Hemolysis at 100 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRLLKSVRRAVKKFCWTKSIPPKPC | H3TI | Free | Free | Linear | L | None | 28 | Antimicrobial | 7.39 % Hemolysis at 200 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRFFKSFRRAFKKFCWTKSIPPKPC | H3TIF | Free | Free | Linear | L | None | 28 | Antimicrobial | 1.6 % Hemolysis at 12.5 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRFFKSFRRAFKKFCWTKSIPPKPC | H3TIF | Free | Free | Linear | L | None | 28 | Antimicrobial | 1.23 % Hemolysis at 25 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRFFKSFRRAFKKFCWTKSIPPKPC | H3TIF | Free | Free | Linear | L | None | 28 | Antimicrobial | 1.96 % Hemolysis at 50 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRFFKSFRRAFKKFCWTKSIPPKPC | H3TIF | Free | Free | Linear | L | None | 28 | Antimicrobial | 2.35 % Hemolysis at 100 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28572668 | 2017 | KFFKRFFKSFRRAFKKFCWTKSIPPKPC | H3TIF | Free | Free | Linear | L | None | 28 | Antimicrobial | 5.53 % Hemolysis at 200 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28572668 | 2017 | CWTKSIPPKPCKFFKRLLKSVRRAVKKF{ct:Amid} | TIH3 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 1.94 % Hemolysis at 12.5 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28572668 | 2017 | CWTKSIPPKPCKFFKRLLKSVRRAVKKF{ct:Amid} | TIH3 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 0.94 % Hemolysis at 25 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28572668 | 2017 | CWTKSIPPKPCKFFKRLLKSVRRAVKKF{ct:Amid} | TIH3 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 1.76 % Hemolysis at 50 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28572668 | 2017 | CWTKSIPPKPCKFFKRLLKSVRRAVKKF{ct:Amid} | TIH3 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 3.17 % Hemolysis at 100 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28572668 | 2017 | CWTKSIPPKPCKFFKRLLKSVRRAVKKF{ct:Amid} | TIH3 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 3.08 % Hemolysis at 200 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28572668 | 2017 | CWTKSIPPKPCKFFKRFFKSFRRAFKKF{ct:Amid} | TIH3F | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 4.91 % Hemolysis at 12.5 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28572668 | 2017 | CWTKSIPPKPCKFFKRFFKSFRRAFKKF{ct:Amid} | TIH3F | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 2.62 % Hemolysis at 25 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28572668 | 2017 | CWTKSIPPKPCKFFKRFFKSFRRAFKKF{ct:Amid} | TIH3F | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 5.44 % Hemolysis at 50 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28572668 | 2017 | CWTKSIPPKPCKFFKRFFKSFRRAFKKF{ct:Amid} | TIH3F | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 6.41 % Hemolysis at 100 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28572668 | 2017 | CWTKSIPPKPCKFFKRFFKSFRRAFKKF{ct:Amid} | TIH3F | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 10 % Hemolysis at 200 µg/mL | Human | Hybrid Peptide | α-Helix | NA | ||
| 28402481 | 2017 | FLPLLAGLAANFLPTIICKIARKC{ct:Amid} | Brevinin-1DY1 | Amidation | Free | Linear | L | None | 24 | Antioxidant, Antimicrobial | 100 % Hemolysis at 200 µM | Human | Amolops Daiyunensis | NA | NA | ||
| 28402481 | 2017 | FLPLLAGLAANFLPTIICKIARKC{ct:Amid} | Brevinin-1DY1 | Amidation | Free | Linear | L | None | 24 | Antioxidant, Antimicrobial | 91.5 % Hemolysis at 100 µM | Human | Amolops Daiyunensis | NA | NA | ||
| 28402481 | 2017 | FLPLLAGLAANFLPTIICKIARKC{ct:Amid} | Brevinin-1DY1 | Amidation | Free | Linear | L | None | 24 | Antioxidant, Antimicrobial | 89.3 % Hemolysis at 50 µM | Human | Amolops Daiyunensis | NA | NA | ||
| 28402481 | 2017 | FLPLLAGLAANFLPTIICKIARKC{ct:Amid} | Brevinin-1DY1 | Amidation | Free | Linear | L | None | 24 | Antioxidant, Antimicrobial | 86.9 % Hemolysis at 25 µM | Human | Amolops Daiyunensis | NA | NA | ||
| 28402481 | 2017 | FLPLLAGLAANFLPTIICKIARKC{ct:Amid} | Brevinin-1DY1 | Amidation | Free | Linear | L | None | 24 | Antioxidant, Antimicrobial | 85.2 % Hemolysis at 12.5 µM | Human | Amolops Daiyunensis | NA | NA | ||
| 28402481 | 2017 | FLPLLAGLAANFLPTIICKIARKC{ct:Amid} | Brevinin-1DY1 | Amidation | Free | Linear | L | None | 24 | Antioxidant, Antimicrobial | 84.9 % Hemolysis at 6.3 µM | Human | Amolops Daiyunensis | NA | NA | ||
| 28402481 | 2017 | FLPLLAGLAANFLPTIICKIARKC{ct:Amid} | Brevinin-1DY1 | Amidation | Free | Linear | L | None | 24 | Antioxidant, Antimicrobial | 10.8 % Hemolysis at 3.1 µM | Human | Amolops Daiyunensis | NA | NA | ||
| 28402481 | 2017 | FLPLLAGLAANFLPTIICKIARKC{ct:Amid} | Brevinin-1DY1 | Amidation | Free | Linear | L | None | 24 | Antioxidant, Antimicrobial | 10.3 % Hemolysis at 1.6 µM | Human | Amolops Daiyunensis | NA | NA | ||
| 28402481 | 2017 | GIMDTIKNAAKDVVQSLLNKASCKLAKTC{ct:Amid} | Palustrin-2DY1 | Amidation | Free | Linear | L | None | 29 | Antioxidant, Antimicrobial | 19.5 % Hemolysis at 200 µM | Human | Amolops Daiyunensis | NA | NA | ||
| 28402481 | 2017 | GIMDTIKNAAKDVVQSLLNKASCKLAKTC{ct:Amid} | Palustrin-2DY1 | Amidation | Free | Linear | L | None | 29 | Antioxidant, Antimicrobial | 0 % Hemolysis at 100 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | GIMDTIKNAAKDVVQSLLNKASCKLAKTC{ct:Amid} | Palustrin-2DY1 | Amidation | Free | Linear | L | None | 29 | Antioxidant, Antimicrobial | 0 % Hemolysis at 50 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | GIMDTIKNAAKDVVQSLLNKASCKLAKTC{ct:Amid} | Palustrin-2DY1 | Amidation | Free | Linear | L | None | 29 | Antioxidant, Antimicrobial | 0 % Hemolysis at 25 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | GIMDTIKNAAKDVVQSLLNKASCKLAKTC{ct:Amid} | Palustrin-2DY1 | Amidation | Free | Linear | L | None | 29 | Antioxidant, Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | GIMDTIKNAAKDVVQSLLNKASCKLAKTC{ct:Amid} | Palustrin-2DY1 | Amidation | Free | Linear | L | None | 29 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | GIMDTIKNAAKDVVQSLLNKASCKLAKTC{ct:Amid} | Palustrin-2DY1 | Amidation | Free | Linear | L | None | 29 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | GIMDTIKNAAKDVVQSLLNKASCKLAKTC{ct:Amid} | Palustrin-2DY1 | Amidation | Free | Linear | L | None | 29 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFGTKGIFSKVEPIFCKISHSC{ct:Amid} | Daiyunin-2 | Amidation | Free | Linear | L | None | 22 | Antioxidant, Antimicrobial | 0 % Hemolysis at 200 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFGTKGIFSKVEPIFCKISHSC{ct:Amid} | Daiyunin-2 | Amidation | Free | Linear | L | None | 22 | Antioxidant, Antimicrobial | 0 % Hemolysis at 100 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFGTKGIFSKVEPIFCKISHSC{ct:Amid} | Daiyunin-2 | Amidation | Free | Linear | L | None | 22 | Antioxidant, Antimicrobial | 0 % Hemolysis at 50 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFGTKGIFSKVEPIFCKISHSC{ct:Amid} | Daiyunin-2 | Amidation | Free | Linear | L | None | 22 | Antioxidant, Antimicrobial | 0 % Hemolysis at 25 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFGTKGIFSKVEPIFCKISHSC{ct:Amid} | Daiyunin-2 | Amidation | Free | Linear | L | None | 22 | Antioxidant, Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFGTKGIFSKVEPIFCKISHSC{ct:Amid} | Daiyunin-2 | Amidation | Free | Linear | L | None | 22 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFGTKGIFSKVEPIFCKISHSC{ct:Amid} | Daiyunin-2 | Amidation | Free | Linear | L | None | 22 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FFGTKGIFSKVEPIFCKISHSC{ct:Amid} | Daiyunin-2 | Amidation | Free | Linear | L | None | 22 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Amolops Daiyunensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FLPAIIGMAAKVLPAFLCKITKKC{ct:Amid} | Brevinin-1HB1 | Amidation | Free | Linear | L | None | 24 | Antioxidant, Antimicrobial | 61.8 % Hemolysis at 200 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | FLPAIIGMAAKVLPAFLCKITKKC{ct:Amid} | Brevinin-1HB1 | Amidation | Free | Linear | L | None | 24 | Antioxidant, Antimicrobial | 61.3 % Hemolysis at 100 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | FLPAIIGMAAKVLPAFLCKITKKC{ct:Amid} | Brevinin-1HB1 | Amidation | Free | Linear | L | None | 24 | Antioxidant, Antimicrobial | 60.6 % Hemolysis at 50 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | FLPAIIGMAAKVLPAFLCKITKKC{ct:Amid} | Brevinin-1HB1 | Amidation | Free | Linear | L | None | 24 | Antioxidant, Antimicrobial | 46 % Hemolysis at 25 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | FLPAIIGMAAKVLPAFLCKITKKC{ct:Amid} | Brevinin-1HB1 | Amidation | Free | Linear | L | None | 24 | Antioxidant, Antimicrobial | 38.1 % Hemolysis at 12.5 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | FLPAIIGMAAKVLPAFLCKITKKC{ct:Amid} | Brevinin-1HB1 | Amidation | Free | Linear | L | None | 24 | Antioxidant, Antimicrobial | 10.2 % Hemolysis at 6.3 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | FLPAIIGMAAKVLPAFLCKITKKC{ct:Amid} | Brevinin-1HB1 | Amidation | Free | Linear | L | None | 24 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | FLPAIIGMAAKVLPAFLCKITKKC{ct:Amid} | Brevinin-1HB1 | Amidation | Free | Linear | L | None | 24 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | GILMDTFKGAAKNVAGFLLDKLKCKITGGC{ct:Amid} | Pelophylaxin-HB1 | Amidation | Free | Linear | L | None | 30 | Antioxidant, Antimicrobial | 40.9 % Hemolysis at 200 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | GILMDTFKGAAKNVAGFLLDKLKCKITGGC{ct:Amid} | Pelophylaxin-HB1 | Amidation | Free | Linear | L | None | 30 | Antioxidant, Antimicrobial | 23.1 % Hemolysis at 100 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | GILMDTFKGAAKNVAGFLLDKLKCKITGGC{ct:Amid} | Pelophylaxin-HB1 | Amidation | Free | Linear | L | None | 30 | Antioxidant, Antimicrobial | 11.7 % Hemolysis at 50 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | GILMDTFKGAAKNVAGFLLDKLKCKITGGC{ct:Amid} | Pelophylaxin-HB1 | Amidation | Free | Linear | L | None | 30 | Antioxidant, Antimicrobial | 0 % Hemolysis at 25 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | GILMDTFKGAAKNVAGFLLDKLKCKITGGC{ct:Amid} | Pelophylaxin-HB1 | Amidation | Free | Linear | L | None | 30 | Antioxidant, Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | GILMDTFKGAAKNVAGFLLDKLKCKITGGC{ct:Amid} | Pelophylaxin-HB1 | Amidation | Free | Linear | L | None | 30 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | GILMDTFKGAAKNVAGFLLDKLKCKITGGC{ct:Amid} | Pelophylaxin-HB1 | Amidation | Free | Linear | L | None | 30 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | GILMDTFKGAAKNVAGFLLDKLKCKITGGC{ct:Amid} | Pelophylaxin-HB1 | Amidation | Free | Linear | L | None | 30 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | GLWTTIKEGLKKFSLGVLDKIRCKIAGGC{ct:Amid} | Palustrin-2HB1 | Amidation | Free | Linear | L | None | 29 | Antioxidant, Antimicrobial | 100 % Hemolysis at 200 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | GLWTTIKEGLKKFSLGVLDKIRCKIAGGC{ct:Amid} | Palustrin-2HB1 | Amidation | Free | Linear | L | None | 29 | Antioxidant, Antimicrobial | 68.4 % Hemolysis at 100 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | GLWTTIKEGLKKFSLGVLDKIRCKIAGGC{ct:Amid} | Palustrin-2HB1 | Amidation | Free | Linear | L | None | 29 | Antioxidant, Antimicrobial | 45.4 % Hemolysis at 50 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | GLWTTIKEGLKKFSLGVLDKIRCKIAGGC{ct:Amid} | Palustrin-2HB1 | Amidation | Free | Linear | L | None | 29 | Antioxidant, Antimicrobial | 35.2 % Hemolysis at 25 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | GLWTTIKEGLKKFSLGVLDKIRCKIAGGC{ct:Amid} | Palustrin-2HB1 | Amidation | Free | Linear | L | None | 29 | Antioxidant, Antimicrobial | 22.8 % Hemolysis at 12.5 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | GLWTTIKEGLKKFSLGVLDKIRCKIAGGC{ct:Amid} | Palustrin-2HB1 | Amidation | Free | Linear | L | None | 29 | Antioxidant, Antimicrobial | 13 % Hemolysis at 6.3 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | GLWTTIKEGLKKFSLGVLDKIRCKIAGGC{ct:Amid} | Palustrin-2HB1 | Amidation | Free | Linear | L | None | 29 | Antioxidant, Antimicrobial | 8.4 % Hemolysis at 3.1 µM | Human | Pelophylax Hubeiensis | NA | NA | ||
| 28402481 | 2017 | GLWTTIKEGLKKFSLGVLDKIRCKIAGGC{ct:Amid} | Palustrin-2HB1 | Amidation | Free | Linear | L | None | 29 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Pelophylax Hubeiensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CVVSSGWKWNYKIRCKLTGMC{ct:Amid} | Nigroain-B-MS1 | Amidation | Free | Linear | L | None | 21 | Antioxidant, Antimicrobial | 8.6 % Hemolysis at 200 µM | Human | Hylarana Maosuoensis | NA | NA | ||
| 28402481 | 2017 | CVVSSGWKWNYKIRCKLTGMC{ct:Amid} | Nigroain-B-MS1 | Amidation | Free | Linear | L | None | 21 | Antioxidant, Antimicrobial | 5.7 % Hemolysis at 100 µM | Human | Hylarana Maosuoensis | NA | NA | ||
| 28402481 | 2017 | CVVSSGWKWNYKIRCKLTGMC{ct:Amid} | Nigroain-B-MS1 | Amidation | Free | Linear | L | None | 21 | Antioxidant, Antimicrobial | 0 % Hemolysis at 50 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CVVSSGWKWNYKIRCKLTGMC{ct:Amid} | Nigroain-B-MS1 | Amidation | Free | Linear | L | None | 21 | Antioxidant, Antimicrobial | 0 % Hemolysis at 25 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CVVSSGWKWNYKIRCKLTGMC{ct:Amid} | Nigroain-B-MS1 | Amidation | Free | Linear | L | None | 21 | Antioxidant, Antimicrobial | 0 % Hemolysis at 12.5 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CVVSSGWKWNYKIRCKLTGMC{ct:Amid} | Nigroain-B-MS1 | Amidation | Free | Linear | L | None | 21 | Antioxidant, Antimicrobial | 0 % Hemolysis at 6.3 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CVVSSGWKWNYKIRCKLTGMC{ct:Amid} | Nigroain-B-MS1 | Amidation | Free | Linear | L | None | 21 | Antioxidant, Antimicrobial | 0 % Hemolysis at 3.1 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28402481 | 2017 | CVVSSGWKWNYKIRCKLTGMC{ct:Amid} | Nigroain-B-MS1 | Amidation | Free | Linear | L | None | 21 | Antioxidant, Antimicrobial | 0 % Hemolysis at 1.6 µM | Human | Hylarana Maosuoensis | NA | Non-hemolytic | ||
| 28756544 | 2017 | GIGKFLKKAKKFGKAFVKILKK{ct:Amid} | pexiganan | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 0 % Hemolysis at 1 μg/ml | Human | African Clawed Frog, Xenopus Laevis | distorted α-Helix | Non-hemolytic | ||
| 28756544 | 2017 | GIGKFLKKAKKFGKAFVKILKK{ct:Amid} | pexiganan | Amidation | Free | Linear | L | None | 22 | Antimicrobial | <20 % Hemolysis at 512 μg/ml | Human | African Clawed Frog, Xenopus Laevis | distorted α-Helix | NA | ||
| 28756544 | 2017 | KKLIKVFAKGFKKAKKLFKGIG{ct:Amid} | r-pexiganan | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 0 % Hemolysis at 1-512 μg/ml | Human | Analog Of Pexiganan | α-Helical | Non-hemolytic | ||
| 28921993 | 2017 | QQRKRKIWSILAPLGTTLVKLVAGIG{ct:Amid} | DRIM(1) | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 60 % Hemolysis at 5 μg/mL | Human | Cell-Penetrating Peptides (Cpps) | α-Helical | NA | ||
| 28921993 | 2017 | QQRKRKIWSILAPLGTTLVKLVAGIG{ct:Amid} | DRIM(1) | Amidation | Free | Linear | L | None | 26 | Antimicrobial | <100 % Hemolysis at 10 μg/mL | Human | Cell-Penetrating Peptides (Cpps) | α-Helical | NA | ||
| 28921993 | 2017 | QQRKRKIWSILAPLGTTLVKLVAGIG{ct:Amid} | DRIM(1) | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 15 μg/mL | Human | Cell-Penetrating Peptides (Cpps) | α-Helical | NA | ||
| 28921993 | 2017 | QQRKRKIWSILAPLGTTLVKLVAGIG{ct:Amid} | DRIM(1) | Amidation | Free | Linear | L | None | 26 | Antimicrobial | <100 % Hemolysis at 20 μg/mL | Human | Cell-Penetrating Peptides (Cpps) | α-Helical | NA | ||
| 28921993 | 2017 | QQRKRKIWSILAPLGTTLVKLVAGIG{ct:Amid} | DRIM(1) | Amidation | Free | Linear | L | None | 26 | Antimicrobial | <100 % Hemolysis at 25 μg/mL | Human | Cell-Penetrating Peptides (Cpps) | α-Helical | NA | ||
| 28921993 | 2017 | QQRKRKIWSILAPLGTTLVKLVAGIG{ct:Amid} | DRIM(1) | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 30 μg/mL | Human | Cell-Penetrating Peptides (Cpps) | α-Helical | NA | ||
| 28921993 | 2017 | QQRKRKIWSILAPLGTTLVKLVAGIG{ct:Amid} | DRIM(1) | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 40 μg/mL | Human | Cell-Penetrating Peptides (Cpps) | α-Helical | NA | ||
| 28921993 | 2017 | QQRKRKIWSKLAPDGTTLVKLVAGIG{ct:Amid} | sDRIM(5) | Amidation | Free | Linear | L | None | 26 | Antimicrobial | <20 % Hemolysis at 5 μg/mL | Human | Cpps Stapled Analogues | α-Helical | NA | ||
| 28921993 | 2017 | QQRKRKIWSKLAPDGTTLVKLVAGIG{ct:Amid} | sDRIM(5) | Amidation | Free | Linear | L | None | 26 | Antimicrobial | <30 % Hemolysis at 10 μg/mL | Human | Cpps Stapled Analogues | α-Helical | NA | ||
| 28921993 | 2017 | QQRKRKIWSKLAPDGTTLVKLVAGIG{ct:Amid} | sDRIM(5) | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 30 % Hemolysis at 15 μg/mL | Human | Cpps Stapled Analogues | α-Helical | NA | ||
| 28921993 | 2017 | QQRKRKIWSKLAPDGTTLVKLVAGIG{ct:Amid} | sDRIM(5) | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 40 % Hemolysis at 20 μg/mL | Human | Cpps Stapled Analogues | α-Helical | NA | ||
| 28921993 | 2017 | QQRKRKIWSKLAPDGTTLVKLVAGIG{ct:Amid} | sDRIM(5) | Amidation | Free | Linear | L | None | 26 | Antimicrobial | <50 % Hemolysis at 25 μg/mL | Human | Cpps Stapled Analogues | α-Helical | NA | ||
| 28921993 | 2017 | QQRKRKIWSKLAPDGTTLVKLVAGIG{ct:Amid} | sDRIM(5) | Amidation | Free | Linear | L | None | 26 | Antimicrobial | <40 % Hemolysis at 30 μg/mL | Human | Cpps Stapled Analogues | α-Helical | NA | ||
| 28921993 | 2017 | QQRKRKIWSKLAPDGTTLVKLVAGIG{ct:Amid} | sDRIM(5) | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 50 % Hemolysis at 40 μg/mL | Human | Cpps Stapled Analogues | α-Helical | NA | ||
| 37760701 | 2023 | FLGSLFSIGSKLLPGVFKLFSRKKQ{ct:α-Amidation} | TtAP-1 | α-Amidation | Free | Linear | L | None | 25 | Antimicrobial | 50 % Hemolysis at 18 ± 2 μg/mL | Mouse | Trinidad Thick-Tailed Scorpion Tityus Trinitatis | α-Helical | NA | ||
| 37764334 | 2023 | ALWKSILKNAGKAALNEINQIVQ{ct:Amid} | SS1 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 50 % Hemolysis at 256 µM | Human | American Tarsier Leaf Frog, Phyllomedusa Tarsius | α-Helical | NA | ||
| 37764334 | 2023 | ALWKSILKNAGKALNEINQIVQ{ct:Amid} | L14 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 256 µM | Human | Ss1 Analogues | α-Helical | NA | ||
| 37764334 | 2023 | ALWKSILKNAGKAVLNEINQIVQ{ct:Amid} | 14V | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 50 % Hemolysis at 256 µM | Human | Ss1 Analogues | α-Helical | NA | ||
| 37764334 | 2023 | ALWKSILKNAGKAGLNEINQIVQ{ct:Amid} | 14G | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 50 % Hemolysis at 256 µM | Human | Ss1 Analogues | α-Helical | NA | ||
| 37764334 | 2023 | ALWKSILKNVGKVLNEINQIVQ{ct:Amid} | L2V | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 256 µM | Human | Ss1 Analogues | α-Helical | NA | ||
| 37764334 | 2023 | ALWKKILKNAGKAVLNEINQIVQ{ct:Amid} | 14V5K | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 50 % Hemolysis at 256 µM | Human | Ss1 Analogues | α-Helical | NA | ||
| 37764334 | 2023 | ALWKSILKNAGKAVLNEINQIV{ct:Amid} | 14VL23 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 256 µM | Human | Ss1 Analogues | α-Helical | NA | ||
| 37762357 | 2023 | GWLIRGAIHAGKAIHGLI | Octominin II | Free | Free | Linear | L | None | 23 | Antimicrobial | 0 % Hemolysis at 6.25 μg/mL | Murine | Original Octominin | Random coil | Non-hemolytic | ||
| 37762357 | 2023 | GWLIRGAIHAGKAIHGLI | Octominin II | Free | Free | Linear | L | None | 23 | Antimicrobial | 0 % Hemolysis at 12.5 μg/mL | Murine | Original Octominin | Random coil | Non-hemolytic | ||
| 37762357 | 2023 | GWLIRGAIHAGKAIHGLI | Octominin II | Free | Free | Linear | L | None | 23 | Antimicrobial | 0 % Hemolysis at 25 μg/mL | Murine | Original Octominin | Random coil | Non-hemolytic | ||
| 37762357 | 2023 | GWLIRGAIHAGKAIHGLI | Octominin II | Free | Free | Linear | L | None | 23 | Antimicrobial | 0 % Hemolysis at 50 μg/mL | Murine | Original Octominin | Random coil | Non-hemolytic | ||
| 37762357 | 2023 | GWLIRGAIHAGKAIHGLI | Octominin II | Free | Free | Linear | L | None | 23 | Antimicrobial | 10 % Hemolysis at 100 μg/mL | Murine | Original Octominin | Random coil | NA | ||
| 37892141 | 2023 | RITKQPWAPPQAARICQFVLIRVCR | CATH 1 | Free | Free | Linear | L | None | 25 | Antimicrobial | <2 % Hemolysis at 25 μg/mL | Mouse | Goat Submandibular Glands | α-Helical/irregularly coiled | NA | ||
| 37892141 | 2023 | RITKQPWAPPQAARICQFVLIRVCR | CATH 1 | Free | Free | Linear | L | None | 25 | Antimicrobial | <2 % Hemolysis at 50 μg/mL | Mouse | Goat Submandibular Glands | α-Helical/irregularly coiled | NA | ||
| 37892141 | 2023 | RITKQPWAPPQAARICQFVLIRVCR | CATH 1 | Free | Free | Linear | L | None | 25 | Antimicrobial | <2 % Hemolysis at 100 μg/mL | Mouse | Goat Submandibular Glands | α-Helical/irregularly coiled | NA | ||
| 37892141 | 2023 | RITKQPWAPPQAARICQFVLIRVCR | CATH 1 | Free | Free | Linear | L | None | 25 | Antimicrobial | 2.13 % Hemolysis at 200 μg/mL | Mouse | Goat Submandibular Glands | α-Helical/irregularly coiled | NA | ||
| 37892141 | 2023 | RFRLPFRRPPIRIHPPPFYPPFRRFLGRR | CATH 2 | Free | Free | Linear | L | None | 29 | Antimicrobial | <2 % Hemolysis at 25 μg/mL | Mouse | Goat Submandibular Glands | α-Helical/irregularly coiled | NA | ||
| 37892141 | 2023 | RFRLPFRRPPIRIHPPPFYPPFRRFLGRR | CATH 2 | Free | Free | Linear | L | None | 29 | Antimicrobial | <2 % Hemolysis at 50 μg/mL | Mouse | Goat Submandibular Glands | α-Helical/irregularly coiled | NA | ||
| 37892141 | 2023 | RFRLPFRRPPIRIHPPPFYPPFRRFLGRR | CATH 2 | Free | Free | Linear | L | None | 29 | Antimicrobial | <2.5 % Hemolysis at 100 μg/mL | Mouse | Goat Submandibular Glands | α-Helical/irregularly coiled | NA | ||
| 37892141 | 2023 | RFRLPFRRPPIRIHPPPFYPPFRRFLGRR | CATH 2 | Free | Free | Linear | L | None | 29 | Antimicrobial | 2.13 % Hemolysis at 200 μg/mL | Mouse | Goat Submandibular Glands | α-Helical/irregularly coiled | NA | ||
| 37768945 | 2023 | QRSVSNAATRVCRTGRSRWRDVCRNFMRR{nt:Acet}{ct:Amid} | Human granulysin (hGRNL) | Amidation | acetylation | Linear | L | None | 29 | Antimicrobial | 0 % Hemolysis at 0.39-50 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVIEVASKMCSKMRLLKGLCKSITKRFLRR{nt:Acet}{ct:Amid} | bovine NKlysin NK2A (bNK2A) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | <0.8 % Hemolysis at 50 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVIEVASKMCSKMRLLKGLCKSITKRFLRR{nt:Acet}{ct:Amid} | bovine NKlysin NK2A (bNK2A) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | <0.8 % Hemolysis at 25 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVIEVASKMCSKMRLLKGLCKSITKRFLRR{nt:Acet}{ct:Amid} | bovine NKlysin NK2A (bNK2A) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | <0.4 % Hemolysis at 12.5 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVIEVASKMCSKMRLLKGLCKSITKRFLRR{nt:Acet}{ct:Amid} | bovine NKlysin NK2A (bNK2A) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | <0.4 % Hemolysis at 6.25 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVIEVASKMCSKMRLLKGLCKSITKRFLRR{nt:Acet}{ct:Amid} | bovine NKlysin NK2A (bNK2A) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | <0.4 % Hemolysis at 3.12 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVIEVASKMCSKMRLLKGLCKSITKRFLRR{nt:Acet}{ct:Amid} | bovine NKlysin NK2A (bNK2A) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | <0.8 % Hemolysis at 1.56 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVIEVASKMCSKMRLLKGLCKSITKRFLRR{nt:Acet}{ct:Amid} | bovine NKlysin NK2A (bNK2A) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | <0.4 % Hemolysis at 0.78 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVIEVASKMCSKMRLLKGLCKSITKRFLRR{nt:Acet}{ct:Amid} | bovine NKlysin NK2A (bNK2A) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | <0.4 % Hemolysis at 0.39 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVTQAASRVCDKMKILRGVCKKIMRTFLRR{nt:Acet}{ct:Amid} | porcine NKlysin (pNKL) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | <1.6 % Hemolysis at 50 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVTQAASRVCDKMKILRGVCKKIMRTFLRR{nt:Acet}{ct:Amid} | porcine NKlysin (pNKL) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | ~0.4 % Hemolysis at 25 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVTQAASRVCDKMKILRGVCKKIMRTFLRR{nt:Acet}{ct:Amid} | porcine NKlysin (pNKL) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | 0.4 % Hemolysis at 12.5 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVTQAASRVCDKMKILRGVCKKIMRTFLRR{nt:Acet}{ct:Amid} | porcine NKlysin (pNKL) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | <0.4 % Hemolysis at 6.25 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVTQAASRVCDKMKILRGVCKKIMRTFLRR{nt:Acet}{ct:Amid} | porcine NKlysin (pNKL) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | <0.4 % Hemolysis at 3.12 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVTQAASRVCDKMKILRGVCKKIMRTFLRR{nt:Acet}{ct:Amid} | porcine NKlysin (pNKL) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | 0 % Hemolysis at 1.56 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVTQAASRVCDKMKILRGVCKKIMRTFLRR{nt:Acet}{ct:Amid} | porcine NKlysin (pNKL) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | 0 % Hemolysis at 0.78 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVTQAASRVCDKMKILRGVCKKIMRTFLRR{nt:Acet}{ct:Amid} | porcine NKlysin (pNKL) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | 0 % Hemolysis at 0.39 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37797458 | 2023 | VDKPPYLPRPRPPRR{d}IYNR{d}{ct:Amid} | Oncocin112(8) | Amidation | Free | Linear | Mix | None | 21 | Antimicrobial | 3.3 % Hemolysis at 800 μg/mL | Human | Analogues Of Oncocin | NA | NA | ||
| 38139394 | 2023 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | <60 % Hemolysis at 5 μg/mL | mouse | Bee Venom | α-Helical | NA | ||
| 38139394 | 2023 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | <100 % Hemolysis at 10 μg/mL | mouse | Bee Venom | α-Helical | NA | ||
| 38139394 | 2023 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 25 μg/mL | mouse | Bee Venom | α-Helical | NA | ||
| 38139394 | 2023 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 50 μg/mL | mouse | Bee Venom | α-Helical | NA | ||
| 38139394 | 2023 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 100 μg/mL | mouse | Bee Venom | α-Helical | NA | ||
| 38247598 | 2023 | KFRNWFSQHFKKFKQKLKNTFA | GATR-3 | Free | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 5000 μg/mL | Human | Short Apo6 Peptide | α-Helical | NA | ||
| 38287360 | 2024 | RWCVYAYVRVRGVLVRYRRCW | Ar-1 | Free | Free | Linear | L | None | 21 | Antibacterial | 50 % Hemolysis at >100 µM | Human | Arenicin Derivatives | anti-parallel β-Sheets | NA | ||
| 38287360 | 2024 | RWCVYAYVRVRGVLVRYRRCW | Ar-1 | Free | Free | Linear | L | None | 21 | Antibacterial | 10 % Hemolysis at 20.2±1.8 µM | Human | Arenicin Derivatives | anti-parallel β-Sheets | NA | ||
| 38287360 | 2024 | RW-{nnr:Abu}-VYAYVRVRGVLVRYRR-{nnr:Abu}-W | Ar-1-Abu | Free | Free | Linear | L | Abu = alpha-amino-n-butyric acid | 21 | Antibacterial | 50 % Hemolysis at >100 µM | Human | Arenicin Derivatives | anti-parallel β-Sheets | NA | ||
| 38287360 | 2024 | RW-{nnr:Abu}-VYAYVRVRGVLVRYRR-{nnr:Abu}-W | Ar-1-Abu | Free | Free | Linear | L | Abu = alpha-amino-n-butyric acid | 21 | Antibacterial | 10 % Hemolysis at >100 µM | Human | Arenicin Derivatives | anti-parallel β-Sheets | NA | ||
| 38287360 | 2024 | RWCVYAYVRIRGVLVRYRRCW | Ar-2 | Free | Free | Linear | L | None | 21 | Antibacterial | 50 % Hemolysis at 29.2±2.4 µM | Human | Arenicin Derivatives | anti-parallel β-Sheets | NA | ||
| 38287360 | 2024 | RWCVYAYVRIRGVLVRYRRCW | Ar-2 | Free | Free | Linear | L | None | 21 | Antibacterial | 10 % Hemolysis at 4.9±0.7 µM | Human | Arenicin Derivatives | anti-parallel β-Sheets | NA | ||
| 38287360 | 2024 | RW-{nnr:Abu}-VYAYVRIRGVLVRYRR-{nnr:Abu}-W | Ar-2-Abu | Free | Free | Linear | L | Abu = alpha-amino-n-butyric acid | 21 | Antibacterial | 50 % Hemolysis at >100 µM | Human | Arenicin Derivatives | anti-parallel β-Sheets | NA | ||
| 38287360 | 2024 | RW-{nnr:Abu}-VYAYVRIRGVLVRYRR-{nnr:Abu}-W | Ar-2-Abu | Free | Free | Linear | L | Abu = alpha-amino-n-butyric acid | 21 | Antibacterial | 10 % Hemolysis at 15.4±1.0 µM | Human | Arenicin Derivatives | anti-parallel β-Sheets | NA | ||
| 38287360 | 2024 | GFCWYVCVYRNGVRVCYRRCN | Ar-3 | Free | Free | Linear | L | None | 21 | Antibacterial | 50 % Hemolysis at >100 µM | Human | Arenicin Derivatives | anti-parallel β-Sheets | NA | ||
| 38287360 | 2024 | GFCWYVCVYRNGVRVCYRRCN | Ar-3 | Free | Free | Linear | L | None | 21 | Antibacterial | 10 % Hemolysis at 30.3±2.5 µM | Human | Arenicin Derivatives | anti-parallel β-Sheets | NA | ||
| 38287360 | 2024 | GF-{nnr:Abu}-WYV-{nnr:Abu}-VYRNGVRV-{nnr:Abu}-YRR-{nnr:Abu}-N | Ar-3-Abu | Free | Free | Linear | L | Abu = alpha-amino-n-butyric acid | 21 | Antibacterial | 50 % Hemolysis at >100 µM | Human | Arenicin Derivatives | anti-parallel β-Sheets | NA | ||
| 38287360 | 2024 | GF-{nnr:Abu}-WYV-{nnr:Abu}-VYRNGVRV-{nnr:Abu}-YRR-{nnr:Abu}-N | Ar-3-Abu | Free | Free | Linear | L | Abu = alpha-amino-n-butyric acid | 21 | Antibacterial | 10 % Hemolysis at 39.3±3.2 µM | Human | Arenicin Derivatives | anti-parallel β-Sheets | NA | ||
| 38287360 | 2024 | GFCWYV-{nnr:Abu}-VYRNGVRV-{nnr:Abu}-YRRCN | Ar-3(3–20) | Free | Free | Linear | L | Abu = alpha-amino-n-butyric acid | 21 | Antibacterial | 50 % Hemolysis at >100 µM | Human | Arenicin Derivatives | anti-parallel β-Sheets | NA | ||
| 38287360 | 2024 | GFCWYV-{nnr:Abu}-VYRNGVRV-{nnr:Abu}-YRRCN | Ar-3(3–20) | Free | Free | Linear | L | Abu = alpha-amino-n-butyric acid | 21 | Antibacterial | 10 % Hemolysis at >100 µM | Human | Arenicin Derivatives | anti-parallel β-Sheets | NA | ||
| 38287360 | 2024 | GF-{nnr:Abu}-WYVCVYRNGVRVCYRR-{nnr:Abu}-N | Ar-3(7–16) | Free | Free | Linear | L | Abu = alpha-amino-n-butyric acid | 21 | Antibacterial | 50 % Hemolysis at >100 µM | Human | Arenicin Derivatives | anti-parallel β-Sheets | NA | ||
| 38287360 | 2024 | GF-{nnr:Abu}-WYVCVYRNGVRVCYRR-{nnr:Abu}-N | Ar-3(7–16) | Free | Free | Linear | L | Abu = alpha-amino-n-butyric acid | 21 | Antibacterial | 10 % Hemolysis at 41.1±4.3 µM | Human | Arenicin Derivatives | anti-parallel β-Sheets | NA | ||
| 38467553 | 2024 | (WKKIRVRLSWKKIRVRLS)KAC{ct:Amid} | AB-14 | Amidation | Free | Linear | L | None | 21 | Antioxidant (Antiradical) | <20 % Hemolysis at 1000 μg/mL | Human | Synthetic | NA | NA | ||
| 38467553 | 2024 | (WKKIRVRLSWKKIRVRLS)KAC{ct:Amid} | AB-14 | Amidation | Free | Linear | L | None | 21 | Antioxidant (Antiradical) | 10 % Hemolysis at 500 μg/mL | Human | Synthetic | NA | NA | ||
| 38467553 | 2024 | (WKKIRVRLSWKKIRVRLS)KAC{ct:Amid} | AB-14 | Amidation | Free | Linear | L | None | 21 | Antioxidant (Antiradical) | 0 % Hemolysis at 100 μg/mL | Human | Synthetic | NA | Non-hemolytic | ||
| 38467553 | 2024 | ({nnr:GA}KKIRARLK{nnr:GA}KKIRARLK)KYAC{ct:Amid} | AB-15 | Amidation | Free | Linear | L | GA = gallic acid | 24 | Antioxidant (Antiradical) | <20 % Hemolysis at 1000 μg/mL | Human | Synthetic | NA | NA | ||
| 38467553 | 2024 | ({nnr:GA}KKIRARLK{nnr:GA}KKIRARLK)KYAC{ct:Amid} | AB-15 | Amidation | Free | Linear | L | GA = gallic acid | 24 | Antioxidant (Antiradical) | <10 % Hemolysis at 500 μg/mL | Human | Synthetic | NA | NA | ||
| 38467553 | 2024 | ({nnr:GA}KKIRARLK{nnr:GA}KKIRARLK)KYAC{ct:Amid} | AB-15 | Amidation | Free | Linear | L | GA = gallic acid | 24 | Antioxidant (Antiradical) | <10 % Hemolysis at 100 μg/mL | Human | Synthetic | NA | NA | ||
| 38467553 | 2024 | (KKLRLKTAFKKKLRLKTAFK)KAC{ct:Amid} | ST-10 | Amidation | Free | Linear | L | None | 23 | Antioxidant (Antiradical) | 0 % Hemolysis at 1000 μg/mL | Human | Synthetic | NA | Non-hemolytic | ||
| 38467553 | 2024 | (KKLRLKTAFKKKLRLKTAFK)KAC{ct:Amid} | ST-10 | Amidation | Free | Linear | L | None | 23 | Antioxidant (Antiradical) | 0 % Hemolysis at 500 μg/mL | Human | Synthetic | NA | Non-hemolytic | ||
| 38467553 | 2024 | (KKLRLKTAFKKKLRLKTAFK)KAC{ct:Amid} | ST-10 | Amidation | Free | Linear | L | None | 23 | Antioxidant (Antiradical) | 0 % Hemolysis at 100 μg/mL | Human | Synthetic | NA | Non-hemolytic | ||
| 38276499 | 2024 | AGLGKIGALIQKVIAKYKA | LC-AMP-F1 | Free | Free | Linear | L | None | 21 | Antimicrobial and Antibiofilm | 0 % Hemolysis at 5-160 µM | Rabbit | Wolf Spider Lycosa Coelestis | α-Helical | Non-hemolytic | ||
| 38276499 | 2024 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 98 % Hemolysis at 5 µM | Rabbit | Bee Venom | α-Helical | NA | ||
| 38276499 | 2024 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 10-160 µM | Rabbit | Bee Venom | α-Helical | NA | ||
| 38328670 | 2024 | MAKRRKKAKKKAKKAKKRRRRR | MR-22 | Free | Free | Linear | L | None | 21 | Antibacterial | 0 % Hemolysis at 2-256 μg/mL | Human | Synthetic | Helix/coil | Non-hemolytic | ||
| 38755634 | 2024 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 10 % Hemolysis at <0.98 μg/mL | Human | Bee Venom | α-Helical | NA | ||
| 38585074 | 2024 | KGIRGYKGGYKGAFKQTKYWWWWW | Os−C(W5) | Free | Free | Linear | L | None | 24 | Antifungal | <10 % Hemolysis at 0.78 µM | Human | Modified Form Of Os−C | Disordered | NA | ||
| 38585074 | 2024 | KGIRGYKGGYKGAFKQTKYWWWWW | Os−C(W5) | Free | Free | Linear | L | None | 24 | Antifungal | <10 % Hemolysis at 1.56 µM | Human | Modified Form Of Os−C | Disordered | NA | ||
| 38585074 | 2024 | KGIRGYKGGYKGAFKQTKYWWWWW | Os−C(W5) | Free | Free | Linear | L | None | 24 | Antifungal | <10 % Hemolysis at 3.12 µM | Human | Modified Form Of Os−C | Disordered | NA | ||
| 38585074 | 2024 | KGIRGYKGGYKGAFKQTKYWWWWW | Os−C(W5) | Free | Free | Linear | L | None | 24 | Antifungal | <10 % Hemolysis at 6.25 µM | Human | Modified Form Of Os−C | Disordered | NA | ||
| 38585074 | 2024 | KGIRGYKGGYKGAFKQTKYWWWWW | Os−C(W5) | Free | Free | Linear | L | None | 24 | Antifungal | <10 % Hemolysis at 12.5 µM | Human | Modified Form Of Os−C | Disordered | NA | ||
| 38585074 | 2024 | KGIRGYKGGYKGAFKQTKYWWWWW | Os−C(W5) | Free | Free | Linear | L | None | 24 | Antifungal | <10 % Hemolysis at 25 µM | Human | Modified Form Of Os−C | Disordered | NA | ||
| 38585074 | 2024 | KGIRGYKGGYKGAFKQTKYWWWWW | Os−C(W5) | Free | Free | Linear | L | None | 24 | Antifungal | <10 % Hemolysis at 50 µM | Human | Modified Form Of Os−C | Disordered | NA | ||
| 38585074 | 2024 | KGIRGYKGGYKGAFKQTKYWWWWW | Os−C(W5) | Free | Free | Linear | L | None | 24 | Antifungal | <10 % Hemolysis at 100 µM | Human | Modified Form Of Os−C | Disordered | NA | ||
| 38655253 | 2024 | TLKQKLLSVCDKVGFLKSMCKGLMKKH | NK1 | Free | Free | Linear | L | None | 27 | Antimicrobial | <30 % Hemolysis at 10 µM | Fish | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSYCGKLPLVKSTCEDLVKKH | NK2 | Free | Free | Linear | L | None | 27 | Antimicrobial | 10 % Hemolysis at 10 µM | Fish | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSVCDKMGLLKSLCKGMVKKH | NK3 | Free | Free | Linear | L | None | 27 | Antimicrobial | 10 % Hemolysis at 10 µM | Fish | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | TLKQKLLSVCDKVGFLKSMCKGLMKKH | NK1 | Free | Free | Linear | L | None | 27 | Antimicrobial | <40 % Hemolysis at 20 µM | Fish | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSYCGKLPLVKSTCEDLVKKH | NK2 | Free | Free | Linear | L | None | 27 | Antimicrobial | 10 % Hemolysis at 20 µM | Fish | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSVCDKMGLLKSLCKGMVKKH | NK3 | Free | Free | Linear | L | None | 27 | Antimicrobial | 10 % Hemolysis at 20 µM | Fish | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | TLKQKLLSVCDKVGFLKSMCKGLMKKH | NK1 | Free | Free | Linear | L | None | 27 | Antimicrobial | <60 % Hemolysis at 30 µM | Fish | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSYCGKLPLVKSTCEDLVKKH | NK2 | Free | Free | Linear | L | None | 27 | Antimicrobial | 10 % Hemolysis at 30 µM | Fish | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSVCDKMGLLKSLCKGMVKKH | NK3 | Free | Free | Linear | L | None | 27 | Antimicrobial | 10 % Hemolysis at 30 µM | Fish | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | TLKQKLLSVCDKVGFLKSMCKGLMKKH | NK1 | Free | Free | Linear | L | None | 27 | Antimicrobial | <70 % Hemolysis at 40 µM | Fish | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSYCGKLPLVKSTCEDLVKKH | NK2 | Free | Free | Linear | L | None | 27 | Antimicrobial | 10 % Hemolysis at 40 µM | Fish | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSVCDKMGLLKSLCKGMVKKH | NK3 | Free | Free | Linear | L | None | 27 | Antimicrobial | 10 % Hemolysis at 40 µM | Fish | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | TLKQKLLSVCDKVGFLKSMCKGLMKKH | NK1 | Free | Free | Linear | L | None | 27 | Antimicrobial | <90 % Hemolysis at 50 µM | Fish | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSYCGKLPLVKSTCEDLVKKH | NK2 | Free | Free | Linear | L | None | 27 | Antimicrobial | 10 % Hemolysis at 50 µM | Fish | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSVCDKMGLLKSLCKGMVKKH | NK3 | Free | Free | Linear | L | None | 27 | Antimicrobial | 10 % Hemolysis at 50 µM | Fish | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | TLKQKLLSVCDKVGFLKSMCKGLMKKH | NK1 | Free | Free | Linear | L | None | 27 | Antimicrobial | <100 % Hemolysis at 100 µM | Fish | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSYCGKLPLVKSTCEDLVKKH | NK2 | Free | Free | Linear | L | None | 27 | Antimicrobial | 10 % Hemolysis at 100 µM | Fish | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSVCDKMGLLKSLCKGMVKKH | NK3 | Free | Free | Linear | L | None | 27 | Antimicrobial | 10 % Hemolysis at 100 µM | Fish | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | TLKQKLLSVCDKVGFLKSMCKGLMKKH | NK1 | Free | Free | Linear | L | None | 27 | Antimicrobial | <30 % Hemolysis at 10 µM | Human | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSYCGKLPLVKSTCEDLVKKH | NK2 | Free | Free | Linear | L | None | 27 | Antimicrobial | <20 % Hemolysis at 10 µM | Human | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSVCDKMGLLKSLCKGMVKKH | NK3 | Free | Free | Linear | L | None | 27 | Antimicrobial | 10 % Hemolysis at 10 µM | Human | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | TLKQKLLSVCDKVGFLKSMCKGLMKKH | NK1 | Free | Free | Linear | L | None | 27 | Antimicrobial | <50 % Hemolysis at 20 µM | Human | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSYCGKLPLVKSTCEDLVKKH | NK2 | Free | Free | Linear | L | None | 27 | Antimicrobial | <20 % Hemolysis at 20 µM | Human | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSVCDKMGLLKSLCKGMVKKH | NK3 | Free | Free | Linear | L | None | 27 | Antimicrobial | <20 % Hemolysis at 20 µM | Human | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | TLKQKLLSVCDKVGFLKSMCKGLMKKH | NK1 | Free | Free | Linear | L | None | 27 | Antimicrobial | <60 % Hemolysis at 30 µM | Human | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSYCGKLPLVKSTCEDLVKKH | NK2 | Free | Free | Linear | L | None | 27 | Antimicrobial | <20 % Hemolysis at 30 µM | Human | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSVCDKMGLLKSLCKGMVKKH | NK3 | Free | Free | Linear | L | None | 27 | Antimicrobial | 10 % Hemolysis at 30 µM | Human | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | TLKQKLLSVCDKVGFLKSMCKGLMKKH | NK1 | Free | Free | Linear | L | None | 27 | Antimicrobial | <80 % Hemolysis at 40 µM | Human | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSYCGKLPLVKSTCEDLVKKH | NK2 | Free | Free | Linear | L | None | 27 | Antimicrobial | 10 % Hemolysis at 40 µM | Human | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSVCDKMGLLKSLCKGMVKKH | NK3 | Free | Free | Linear | L | None | 27 | Antimicrobial | <30 % Hemolysis at 40 µM | Human | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | TLKQKLLSVCDKVGFLKSMCKGLMKKH | NK1 | Free | Free | Linear | L | None | 27 | Antimicrobial | <80 % Hemolysis at 50 µM | Human | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSYCGKLPLVKSTCEDLVKKH | NK2 | Free | Free | Linear | L | None | 27 | Antimicrobial | 10 % Hemolysis at 50 µM | Human | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSVCDKMGLLKSLCKGMVKKH | NK3 | Free | Free | Linear | L | None | 27 | Antimicrobial | <30 % Hemolysis at 50 µM | Human | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | TLKQKLLSVCDKVGFLKSMCKGLMKKH | NK1 | Free | Free | Linear | L | None | 27 | Antimicrobial | 100 % Hemolysis at 100 µM | Human | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSYCGKLPLVKSTCEDLVKKH | NK2 | Free | Free | Linear | L | None | 27 | Antimicrobial | <30 % Hemolysis at 100 µM | Human | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38655253 | 2024 | EIKQKLLSVCDKMGLLKSLCKGMVKKH | NK3 | Free | Free | Linear | L | None | 27 | Antimicrobial | 10 % Hemolysis at 100 µM | Human | Pig Small Intestine, Nk-Lysin-Derived | Helical-bundle | NA | ||
| 38673786 | 2024 | FFHHIFRGIVHVGKTIHRLVTG{ct:Amid} | Piscidin 1 | Amidation | Free | Linear | L | None | 22 | Antibacterial | <20 % Hemolysis at 2 µM | Horse | Mast Cells Of Fish | α-Helical | NA | ||
| 38673786 | 2024 | FFHHIFRGIVHVGKTIHRLVTG{ct:Amid} | Piscidin 1 | Amidation | Free | Linear | L | None | 22 | Antibacterial | <40 % Hemolysis at 4 µM | Horse | Mast Cells Of Fish | α-Helical | NA | ||
| 38673786 | 2024 | FFHHIFRGIVHVGKTIHRLVTG{ct:Amid} | Piscidin 1 | Amidation | Free | Linear | L | None | 22 | Antibacterial | <70 % Hemolysis at 8 µM | Horse | Mast Cells Of Fish | α-Helical | NA | ||
| 38673786 | 2024 | FFHHIFRGIVHVGKTIHRLVTG{ct:Amid} | Piscidin 1 | Amidation | Free | Linear | L | None | 22 | Antibacterial | <120 % Hemolysis at 16 µM | Horse | Mast Cells Of Fish | α-Helical | NA | ||
| 38673786 | 2024 | FFHHIFRGIVHVGKTIHRLVTG{ct:Amid} | Piscidin 1 | Amidation | Free | Linear | L | None | 22 | Antibacterial | <120 % Hemolysis at 32 µM | Horse | Mast Cells Of Fish | α-Helical | NA | ||
| 38673786 | 2024 | FFHHIFRGIVHVGKTIHRLVTG{ct:Amid} | Piscidin 1 | Amidation | Free | Linear | L | None | 22 | Antibacterial | <120 % Hemolysis at 64 µM | Horse | Mast Cells Of Fish | α-Helical | NA | ||
| 38673786 | 2024 | FFHHIFRGIVHVGKTIHRLVTG{ct:Amid} | Piscidin 1 | Amidation | Free | Linear | L | None | 22 | Antibacterial | <120 % Hemolysis at 128 µM | Horse | Mast Cells Of Fish | α-Helical | NA | ||
| 38561076 | 2024 | GVFDTVKKIGKAVGKFALGVAKNYLNS{ct:Amid} | Raniseptin PL | Amidation | Free | Linear | L | None | 27 | Antimicrobial | 50 % Hemolysis at 262 ± 14 µM | Mouse | Skin Secretions Of The Banana Tree Dwelling Frog Boana Platanera | α-Helical | NA | ||
| 38561076 | 2024 | FLGTVLKLGKAIAKTVVPMLTNAMQPKQ{ct:Amid} | Figainin 2PL | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 50 % Hemolysis at 157 ± 16 µM | Mouse | Skin Secretions Of The Banana Tree Dwelling Frog Boana Platanera | α-Helical | NA | ||
| 36988897 | 2024 | GIGAVLKVLTTGLPALISWIKRKRQQCONH2{ct:Amid} | MLT | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 16 μg/mL | Human | Bee Venom Apis Mellifera | α-Helical | NA | ||
| 38004789 | 2024 | FFKKVKKSVKKRLKKIFKKPMVI{ct:Amid} | Vcn-23 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | <1.2 % Hemolysis at | Rat | Derivative Peptide | α-Helical | NA | | ||
| 37734650 | 2024 | KLKSKLMVVCNKIGLLKSLCRKFVKSH | NKL-WT | Free | Free | Linear | L | None | 27 | Antibacterial and Anticancer | 16.3 % Hemolysis at 40 µM | Rabbit | Antarctic Teleost Trematomus Bernacchii | α-Helical | NA | ||
| 37734650 | 2024 | KLKSKLMVVCNKIGLLKSLCRKFVKSH | NKL-WT | Free | Free | Linear | L | None | 27 | Antibacterial and Anticancer | 40.5 % Hemolysis at 80 µM | Rabbit | Antarctic Teleost Trematomus Bernacchii | α-Helical | NA | ||
| 37734650 | 2024 | KLKSKLMVVANKIGLLKSLARKFVKSH | NKL-MUT | Free | Free | Linear | L | None | 27 | Antibacterial and Anticancer | 0.9 % Hemolysis at 5 µM | Rabbit | Antarctic Teleost Trematomus Bernacchii | α-Helical | NA | ||
| 37734650 | 2024 | KLKSKLMVVANKIGLLKSLARKFVKSH | NKL-MUT | Free | Free | Linear | L | None | 27 | Antibacterial and Anticancer | 2.6 % Hemolysis at 80 µM | Rabbit | Antarctic Teleost Trematomus Bernacchii | α-Helical | NA | ||
| 37880286 | 2024 | GIGAVLKVLTTGLPALISWIKRKRQQ | Mel | Free | Free | Linear | L | None | 26 | Anticancer | <40 % Hemolysis at 256 μg/mL | Human | Bee Venom | α-Helical | NA | ||
| 37880286 | 2024 | CGIGAVLKVLTTGLPALISWIKRKRQQ | C-Mel | Free | Free | Linear | L | None | 27 | Anticancer | 30 % Hemolysis at 256 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 37880286 | 2024 | GIGAVLKVLTTGLPALISWIKRKRQQC | Mel-C | Free | Free | Linear | L | None | 27 | Anticancer | <40 % Hemolysis at 256 μg/mL | Human | Synthetic | α-Helical | NA | ||
| 28941793 | 2017 | FLGSLFSIGSKLLPGVIKLFQRKKQ | Im-5 | Free | Free | Linear | L | None | 25 | Antimicrobial and Insecticidal | 50 % Hemolysis at 28 µM | Sheep | Isometrus Maculatus Scorpion Venom | α-Helix | NA | ||
| 29196622 | 2017 | GIGKFLKKAKKFGKAFVKILKK{ct:Amid} | pexiganan | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 10 % Hemolysis at 73 μM | Human | Synthetic Peptide Xenopus Laevis Frog | α-Helical | NA | ||
| 29196622 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 10 % Hemolysis at 1 μM | Human | Bee Venom-Derived | NA | NA | ||
| 29196622 | 2017 | RVKRVWPLVIRTVIAGYNLYRAIKKK | fowlicidin-1 | Free | Free | Linear | L | None | 26 | Antimicrobial | 10 % Hemolysis at 7 μM | Human | Cathelicidin-1 | α-Helical | NA | ||
| 29196622 | 2017 | GIGKFLKKAKKFGKAFVKILKK{ct:Amid} | pexiganan | Amidation | Free | Linear | L | None | 22 | Antimicrobial peptides | 50 % Hemolysis at >200 μM | Human | Synthetic Peptide Xenopus Laevis Frog | α-Helical | NA | ||
| 29196622 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial peptide | 50 % Hemolysis at 6 μM | Human | Bee Venom-Derived | NA | NA | ||
| 29196622 | 2017 | RVKRVWPLVIRTVIAGYNLYRAIKKK | fowlicidin-1 | Free | Free | Linear | L | None | 26 | Antimicrobial | 50 % Hemolysis at >20 μM | Human | Cathelicidin-1 | α-Helical | NA | ||
| 29219046 | 2017 | FFGSTIGALANFLPSLISKIRN{ct:Amid} | brevinin-1ULf | Amidation | Free | Linear | L | None | 22 | Antimicrobial Peptides | 13.1 % Hemolysis at 32 μg/ml | Horse | Brown Frog Rana Ulma | NA | NA | ||
| 29219046 | 2017 | FFGSTIGALANFLPSLISKIRN{ct:Amid} | brevinin-1ULf | Amidation | Free | Linear | L | None | 22 | Antimicrobial Peptides | 54.7 % Hemolysis at 64 μg/ml | Horse | Brown Frog Rana Ulma | NA | NA | ||
| 29219046 | 2017 | FFGSTIGALANFLPSLISKIRN{ct:Amid} | brevinin-1ULf | Amidation | Free | Linear | L | None | 22 | Antimicrobial Peptides | 90.1 % Hemolysis at 128 μg/ml | Horse | Brown Frog Rana Ulma | NA | NA | ||
| 29280948 | 2017 | KWKSFLKTFKSAKKTVLHTALKAISS{nt:Acet}{ct:Amid} | V13K | Amidation | Acetylation | Linear | L | None | 26 | Antimicrobial, Anticancer | <20 % Hemolysis at 250 μM | Human | Magainin (African Clawed Frog) | α-Helical | Low hemolytic | ||
| 29280948 | 2017 | KWKSFLKTFKSAKK{d}TVLHTALKAISS{nt:Acet}{ct:Amid} | K14D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | <20 % Hemolysis at 125 μM | Human | V13K Analogs | NA | Low hemolytic | ||
| 29280948 | 2017 | KWKSFLKTFKS{d}AKK{d}TVLHTALKAISS{nt:Acet}{ct:Amid} | S11D/K14D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | <20 % Hemolysis at 125 μM | Human | V13K Analogs | NA | Low hemolytic | ||
| 29280948 | 2017 | KWKSFLKTFKSAKK{d}T{d}VLHTALKAISS{nt:Acet}{ct:Amid} | K14D/T15D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | <20 % Hemolysis at 250 μM | Human | V13K Analogs | NA | Low hemolytic | ||
| 29280948 | 2017 | KWKSFLKTFKS{d}AKK{d}T{d}VLHTALKAISS{nt:Acet}{ct:Amid} | S11D/K14D/T15D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | <20 % Hemolysis at 250 μM | Human | V13K Analogs | NA | Low hemolytic | ||
| 29280948 | 2017 | KWKSFLKTFKSA{d}KKTVLHTALKAISS{nt:Acet}{ct:Amid} | A12D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | <20 % Hemolysis at 125 μM | Human | V13K Analogs | NA | Low hemolytic | ||
| 29280948 | 2017 | KWKSFLKTFKSA{d}KKTVLHTALKAISS{nt:Acet}{ct:Amid} | F9D/A12D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | <20 % Hemolysis at 250 μM | Human | V13K Analogs | NA | Low hemolytic | ||
| 29280948 | 2017 | KWKSFLKTFKSA{d}KKTVLHTALKAISS{nt:Acet}{ct:Amid} | A12D/V16D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | 0 % Hemolysis at >500 μM | Human | V13K Analogs | NA | Non-hemolytic | ||
| 29280948 | 2017 | KWKSFLKTF{d}KSA{d}KKTV{d}LHTALKAISS{nt:Acet}{ct:Amid} | F9D/A12D/V16D | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acids | 26 | Antimicrobial | 0 % Hemolysis at >500 μM | Human | V13K Analogs | NA | Non-hemolytic | ||
| 28636781 | 2018 | GIGGALLSAGKSALKGLAKGLAEHFAN{ct:Amid} | BLP-7 | Amidation | Free | Linear | L | None | 27 | Antimicrobial and Haemolytic | 0 % Hemolysis at 128 mg/ml | Human | African Clawed Frog (Xenopus Laevis) | α-Helical | NA | ||
| 28636781 | 2018 | GIGGALLSAGKSALKGLAKGLAEHFAN{ct:Amid} | BLP-7 | Amidation | Free | Linear | L | None | 27 | Antimicrobial and Haemolytic | >80 % Hemolysis at 256 mg/ml | Human | African Clawed Frog (Xenopus Laevis) | α-Helical | NA | ||
| 28636788 | 2018 | A{d}L{d}K{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}K{d}A{d}K{d}A{d}A{d}K{d}L{d}K{d}T{d}L{d}L{d}K{d}A{d}L{d}S{d}K{d}{nt:Acet}{ct:Amid} | D33 | Amidation | Acetylation | Linear | D | Positions 13 and 16 are Lys residues is Non-polar{nnr} | 26 | Antimicrobial peptides | 30 % Hemolysis at 89 μM | Human | Synthesized | α-Helical | NA | ||
| 28636788 | 2018 | A{d}L{d}K{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}A{d}A{d}K{d}K{d}K{d}K{d}L{d}A{d}T{d}L{d}L{d}K{d}A{d}L{d}S{d}K{d}{nt:Acet}{ct:Amid} | D34 | Amidation | Acetylation | Linear | D | Positions 13 and 16 are Lys residues is Non-polar{nnr} | 26 | Antimicrobial peptides | 30 % Hemolysis at 126 μM | Human | Synthesized | α-Helical | NA | ||
| 28636788 | 2018 | A{d}L{d}K{d}S{d}L{d}L{d}A{d}T{d}L{d}S{d}K{d}A{d}K{d}K{d}K{d}K{d}L{d}K{d}T{d}L{d}L{d}A{d}A{d}L{d}S{d}K{d}{nt:Acet}{ct:Amid} | D35 | Amidation | Acetylation | Linear | D | Positions 13 and 16 are Lys residues is Non-polar{nnr} | 26 | Antimicrobial peptides | 30 % Hemolysis at 30 μM | Human | Synthesized | α-Helical | NA | ||
| 28636788 | 2018 | A{d}L{d}A{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}K{d}A{d}K{d}K{d}K{d}K{d}L{d}K{d}T{d}L{d}L{d}K{d}A{d}L{d}S{d}A{d}{nt:Acet}{ct:Amid} | D36 | Amidation | Acetylation | Linear | D | Positions 13 and 16 are Lys residues is Non-polar{nnr} | 26 | Antimicrobial peptides | 30 % Hemolysis at 61 μM | Human | Synthesized | α-Helical | NA | ||
| 28636788 | 2018 | A{d}L{d}K{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}K{d}A{d}A{d}A{d}A{d}A{d}L{d}K{d}T{d}L{d}L{d}K{d}A{d}L{d}S{d}K{d}{nt:Acet}{ct:Amid} | D37 | Amidation | Acetylation | Linear | D | Positions 13 and 16 are Ala residues is Non-polar{nnr} | 26 | Antimicrobial peptides | 30 % Hemolysis at 2.6 μM | Human | Synthesized | α-Helical | NA | ||
| 28636788 | 2018 | A{d}L{d}K{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}A{d}A{d}A{d}K{d}K{d}A{d}L{d}A{d}T{d}L{d}L{d}K{d}A{d}L{d}S{d}K{d}{nt:Acet}{ct:Amid} | D38 | Amidation | Acetylation | Linear | D | Positions 13 and 16 are Ala residues is Non-polar{nnr} | 26 | Antimicrobial peptides | 30 % Hemolysis at 2.8 μM | Human | Synthesized | α-Helical | NA | ||
| 28636788 | 2018 | A{d}L{d}K{d}S{d}L{d}L{d}A{d}T{d}L{d}S{d}K{d}A{d}A{d}K{d}K{d}A{d}L{d}K{d}T{d}L{d}L{d}A{d}A{d}L{d}S{d}K{d}{nt:Acet}{ct:Amid} | D39 | Amidation | Acetylation | Linear | D | Positions 13 and 16 are Ala residues is Non-polar{nnr} | 26 | Antimicrobial peptides | 30 % Hemolysis at 2.8 μM | Human | Synthesized | α-Helical | NA | ||
| 28636788 | 2018 | A{d}L{d}A{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}K{d}A{d}A{d}K{d}K{d}A{d}L{d}K{d}T{d}L{d}L{d}K{d}A{d}L{d}S{d}A{d}{nt:Acet}{ct:Amid} | D40 | Amidation | Acetylation | Linear | D | Positions 13 and 16 are Ala residues is Non-polar{nnr} | 26 | Antimicrobial peptides | 30 % Hemolysis at 2.8 μM | Human | Synthesized | α-Helical | NA | ||
| 28815904 | 2018 | RWCVYAYVRVRGVLVRYRRCW | Arenicin-1 | Free | Free | Linear | L | None | 21 | Antimicrobial peptides | 50 % Hemolysis at 21 μM | Human | Polychaeta Arenicola Marina | β-Hairpin | NA | ||
| 29108968 | 2018 | FIHHIIGGLFHVGKSIHDLIR | pteroicidin-α-COOH or α-Pte | Free | Free | Linear | L | None | 21 | Antimicrobial | 60 % Hemolysis at 200 μM | Human | Lionfish (Pterois Volitans),Piscidin-1 | NA | NA | ||
| 29108968 | 2018 | FIHHIIGGLFHVGKSIHDLIR{ct:Amid} | Pteroicidin-α-CONH2 or α-Pte-CONH2 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 90 % Hemolysis at 50 μM | Human | Lionfish (Pterois Volitans),Piscidin-1 | α-Helix | NA | ||
| 29108968 | 2018 | FIHHIIGGLFHVGKSIHDLIR | α-Pte | Free | Free | Linear | L | None | 21 | Antimicrobial | 50 % Hemolysis at 50 μM | Fish | Lionfish (Pterois Volitans),Piscidin-1 | NA | NA | ||
| 29108968 | 2018 | FIHHIIGGLFHVGKSIHDLIR | α-Pte | Free | Free | Linear | L | None | 21 | Antimicrobial | 97 % Hemolysis at 100 μM | Fish | Lionfish (Pterois Volitans),Piscidin-1 | NA | NA | ||
| 29108968 | 2018 | FIHHIIGGLFHVGKSIHDLIR | α-Pte | Free | Free | Linear | L | None | 21 | Antimicrobial | 97 % Hemolysis at 200 μM | Fish | Lionfish (Pterois Volitans),Piscidin-1 | NA | NA | ||
| 29108968 | 2018 | FIHHIIGGLFHVGKSIHDLIR{ct:Amid} | α-PteCONH2 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 90 % Hemolysis at 50 μM | Fish | Lionfish (Pterois Volitans),Piscidin-1 | α-Helix | NA | ||
| 29108968 | 2018 | FIHHIIGGLFHVGKSIHDLIR | α-Pte | Free | Free | Linear | L | None | 21 | Antimicrobial | 60 % Hemolysis at 200 μM | Fish | Lionfish (Pterois Volitans),Piscidin-1 | NA | NA | ||
| 29108968 | 2018 | FIHHIIGGLFHVGKSIHDLIR{ct:Amid} | α-PteCONH2 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 90 % Hemolysis at 50 μM | Fish | Lionfish (Pterois Volitans),Piscidin-1 | α-Helix | NA | ||
| 29205108 | 2018 | WAGGFGVAGGAMALGGGIAAAVG | α2 peptide | Free | Free | Linear | L | None | 23 | ND | ~50 % Hemolysis at 100 μM | Sheep | Bordetella Pertussis (Bacteria)- Adenylate Cyclase Toxin (Cyaa) | NA | NA | ||
| 29205108 | 2018 | GAEIALQLTGGTVELASSIALALAAAR | α3 peptide | Free | Free | Linear | L | None | 27 | ND | ~5 % Hemolysis at 100 μM | Sheep | Bordetella Pertussis (Bacteria)- Adenylate Cyclase Toxin (Cyaa) | NA | NA | ||
| 29198866 | 2018 | GIGKFLKKAKKFGKAFVKILKK{ct:Amid} | Pexiganan | Amidation | Free | Linear | L | None | 22 | Antimicrobial peptides | 21.5 ± 2.9 % Hemolysis at 200 mM | Rat | Synthetic Peptide Xenopus Laevis Frog | α-Helical | NA | ||
| 29198866 | 2018 | GIGKFLKKAKKFGKAFVKILKK{ct:Amid} | Pexiganan | Amidation | Free | Linear | L | None | 22 | Antimicrobial peptides | 10 % Hemolysis at 113.4 μM | Rat | Synthetic Peptide Xenopus Laevis Frog | α-Helical | NA | ||
| 29198866 | 2018 | GIGKFLKKAKKFGKAFVKILKK{ct:Amid} | Pexiganan | Amidation | Free | Linear | L | None | 22 | Antimicrobial peptides | 50 % Hemolysis at >200 μM | Rat | Synthetic Peptide Xenopus Laevis Frog | α-Helical | NA | ||
| 29343843 | 2018 | IGRDPTWSHLAASCLKCIFDDLPKTHN | Cathelicidin-OA1 | Free | Free | Linear | L | None | 27 | Antioxidant activity | 5.4 ± 0.14 % Hemolysis at 1 nM | Human | Frog (Odorrana Andersonii) | NA | NA | ||
| 29343843 | 2018 | IGRDPTWSHLAASCLKCIFDDLPKTHN | Cathelicidin-OA1 | Free | Free | Linear | L | None | 27 | Antioxidant activity | 4.5 ± 0.61 % Hemolysis at 10 nM | Human | Frog (Odorrana Andersonii) | NA | NA | ||
| 29343843 | 2018 | IGRDPTWSHLAASCLKCIFDDLPKTHN | Cathelicidin-OA1 | Free | Free | Linear | L | None | 27 | Antioxidant activity | 5.4 ± 0.81 % Hemolysis at 100 nM | Human | Frog (Odorrana Andersonii) | NA | NA | ||
| 29343843 | 2018 | IGRDPTWSHLAASCLKCIFDDLPKTHN | Cathelicidin-OA1 | Free | Free | Linear | L | None | 27 | Antioxidant activity | 6.9 ± 0.57 % Hemolysis at 1 μM | Human | Frog (Odorrana Andersonii) | NA | NA | ||
| 29343843 | 2018 | IGRDPTWSHLAASCLKCIFDDLPKTHN | Cathelicidin-OA1 | Free | Free | Linear | L | None | 27 | Antioxidant activity | 5.0 ± 0.86 % Hemolysis at 10 μM | Human | Frog (Odorrana Andersonii) | NA | NA | ||
| 29343843 | 2018 | IGRDPTWSHLAASCLKCIFDDLPKTHN | Cathelicidin-OA1 | Free | Free | Linear | L | None | 27 | Antioxidant activity | 7.7 ± 0.11 % Hemolysis at 100 μM | Human | Frog (Odorrana Andersonii) | NA | NA | ||
| 29191658 | 2018 | FLPIVAKLLSGLLGRKKRRQRRR{ct:Amid} | Temporin-PEb | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 50 % Hemolysis at 44.64 μM | Horse | Frog(Pelophylax Kl. Esculentus) | α-Helical | NA | ||
| 29359791 | 2018 | ALAGTIIAGASLTFQVLDKVLEELGKVSRK{ct:Amid} | StII1-30 | Amidation | Free | Linear | L | None | 30 | Candidacidal | 50 % Hemolysis at 42.5 μM | Human | Derived From Sticholysin Ii (Sea Anemone Stichodactyla Helianthus) | amphiphilic α-Helix | NA | ||
| 29098406 | 2018 | GIGSAILSAGKSIIKGLAKGLAEHF{ct:Amid} | Bombinin-BO1 | Amidation | Free | Linear | L | None | 25 | broad-spectrum Antimicrobial | 2.89 % Hemolysis at 26.3 μM | Human | Oriental Fre-Bellied Toad, Bombina Orientalis, | Alphα-Helical amphipathic | NA | ||
| 29098406 | 2018 | GIGSAILSAGKSIIKGLAKGLAEHF{ct:Amid} | Bombinin-BO1 | Amidation | Free | Linear | L | None | 25 | broad-spectrum Antimicrobial | 38.05 % Hemolysis at 52.5 μM | Human | Oriental Fre-Bellied Toad, Bombina Orientalis, | Alphα-Helical amphipathic | NA | ||
| 29473887 | 2018 | (KFFRKLKKSVKKRAKEFFKKPRVIGVSIPF){nnr:4-arm-PEG-PLGA} | cathelicidin-BF-30loaded 4-arm-PEG-PLGA | Free | Free | NA | L | 4-arm-PEG-PLGA = ethylene glycol-b-dl-lactic acid-co-glycolic acid(microspheres) | 30 | Antimicrobial | ~15 % Hemolysis at 1000 μg/mL | Rabbit | Snake Venoms Of Bungarus Fasciatus | α-Helical | NA | ||
| 29407961 | 2018 | {nnr:dab}{nnr:Dab}{nnr:Dab}L{nnr:dab}{nnr:Dab}{nnr:Dab}L{nnr:dab}{nnr:Dab}{nnr:Dab}LF{d}{nnr:Dab}{nnr:Dab}L{nnr:dab}{nnr:Dab}{nnr:Dab}LF{d}{nnr:Dab}{nnr:Dab}L{nt:R6 = 4-methyl-hexanoyl}{ct:Amid} | Lipopeptide-13 | Amidation | R6 = 4-methyl-hexanoyl | Linear | Mix | Dab = 2,4-diaminobutanoic acid, dab = D-2,4-diaminobutanoic acid, f = D-phenylalanine | 24 | Antifungal, Antibiofilm | 21 % Hemolysis at 1 mM | Mouse | Linear Battacin Analogue | NA | NA | ||
| 29599756 | 2018 | FLFSLIPSAISGLISAFKGRRKRDLN{ct:Amid} | Marmelittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 25 μM | Mouse | Mesobuthus Martensii Scorpion Species | α-Helical | NA | ||
| 29599756 | 2018 | FFGHLFKLATKIIPSFFRRKNQ | Marcin-22 | Free | Free | Linear | L | None | 22 | Antimicrobial | 100 % Hemolysis at 25 μM | Mouse | Mesobuthus Martensii Scorpion Species | α-Helical | NA | ||
| 29599756 | 2018 | FFGHLFKLATKIIPSLFQRKKE | Meucin-22 | Free | Free | Linear | L | None | 22 | Antimicrobial | 100 % Hemolysis at 25 μM | Mouse | Mesobuthus Eupeus Scorpion Species | α-Helical | NA | ||
| 29599756 | 2018 | FFGHLFKLATKIIPSLFQRKKE | Meucin-22 | Free | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 25 μM | Lizard | Mesobuthus Eupeus Scorpion Species | α-Helical | NA | ||
| 29599756 | 2018 | FFGHLFKLATKIIPSFFRRKNQ | Marcin-22 | Free | Free | Linear | L | None | 22 | Antimicrobial | 99 % Hemolysis at 25 μM | Lizard | Mesobuthus Martensii Scorpion Species | α-Helical | NA | ||
| 29599756 | 2018 | FLFSLIPSAISGLISAFKGRRKRDLN{ct:Amid} | Marmelittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 99 % Hemolysis at 25 μM | Lizard | Mesobuthus Martensii Scorpion Species | α-Helical | NA | ||
| 29599756 | 2018 | FFGHLFKLATKIIPSLFQRKKE | Meucin-22 | Free | Free | Linear | L | None | 22 | Antimicrobial | 45 % Hemolysis at 25 μM | Pigeons | Mesobuthus Eupeus Scorpion Species | α-Helical | NA | ||
| 29599756 | 2018 | FFGHLFKLATKIIPSFFRRKNQ | Marcin-22 | Free | Free | Linear | L | None | 22 | Antimicrobial | 40 % Hemolysis at 25 μM | Pigeons | Mesobuthus Martensii Scorpion Species | α-Helical | NA | ||
| 29599756 | 2018 | FLFSLIPSAISGLISAFKGRRKRDLN{ct:Amid} | Marmelittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 25 μM | Pigeons | Mesobuthus Martensii Scorpion Species | α-Helical | NA | ||
| 29551999 | 2018 | RRWQWRRRWQWRRRWQWRRRWQWRKK{nnr:Ahx}{nnr:Ahx}CC | Tetrameric (LfcinB (20–25)4) | Free | Free | Branched | L | Ahx = hydrophobic spacer that prevents steric hindrance | 30 | Antibacterial | 49.1 % Hemolysis at 100 µM | Human | Bovine Lfcinb -Lactoferricin B (Lfcinb)-Based Synthetic Peptides | NA | NA | ||
| 29551999 | 2018 | RRWQWRRRWQWRRRWQWRRRWQWRKK{nnr:Ahx}{nnr:Ahx}CC | Tetrameric (LfcinB (20–25)4) | Free | Free | Branched | L | Ahx = hydrophobic spacer that prevents steric hindrance | 30 | Antibacterial | 50 % Hemolysis at >100 µM | Human | Bovine Lfcinb -Lactoferricin B (Lfcinb)-Based Synthetic Peptides | NA | NA | ||
| 29515090 | 2018 | KFFKKLKNSVKKRAKKFFKKPRVIGVSIPF | OH-CATH30 | Free | Free | Linear | L | None | 30 | Antimicrobial | ~10 % Hemolysis at 125 µg/mL | Human | Cathelicidin-Derived Peptide From The King Cobra | NA | NA | ||
| 29515090 | 2018 | K{d}F{d}F{d}K{d}K{d}L{d}K{d}N{d}S{d}V{d}K{d}K{d}R{d}A{d}K{d}K{d}F{d}F{d}K{d}K{d}P{d}R{d}V{d}I{d}G{d}V{d}S{d}I{d}P{d}F{d} | analog D-OH-CATH30 | Free | Free | Linear | D | None | 30 | Antimicrobial | ~10 % Hemolysis at 125 µg/mL | Human | Cathelicidin-Derived Peptide From The King Cobra | NA | NA | ||
| 29515090 | 2018 | KFFKKLKNSVKKRAKKFFKKPRVIGVSIPF | OH-CATH30 | Free | Free | Linear | L | None | 30 | Antimicrobial | 70 % Hemolysis at 250 µg/mL | Human | Analog D-Oh-Cath30 | NA | NA | ||
| 29515090 | 2018 | K{d}F{d}F{d}K{d}K{d}L{d}K{d}N{d}S{d}V{d}K{d}K{d}R{d}A{d}K{d}K{d}F{d}F{d}K{d}K{d}P{d}R{d}V{d}I{d}G{d}V{d}S{d}I{d}P{d}F{d} | analog D-OH-CATH30 | Free | Free | Linear | D | None | 30 | Antimicrobial | 80 % Hemolysis at 250 µg/mL | Human | Analog D-Oh-Cath30 | NA | NA | ||
| 29282543 | 2018 | SWLSKTAKKLENSAKKRISEGIAIAQGGPR{ct:Amid} | CP-1 | Amidation | Free | Linear | L | None | 30 | Antimicrobial | 0.35 % Hemolysis at 128 μM | Human | Pig (Ascaris Suum) | NA | Low hemolytic | ||
| 29282543 | 2018 | SWLSKTAKKLENSAKKRISEGIAIAQGGPR{ct:Amid} | CP-1 | Amidation | Free | Linear | L | None | 30 | Antimicrobial | ≥5 % Hemolysis at >128 μM | Human | Pig (Ascaris Suum) | NA | Low hemolytic | ||
| 29904274 | 2018 | RKKRRQRRRLNLKALLAVAKKIL{ct:Amid} | tMP-C | Amidation | Free | Linear | L | None | 23 | Anticancer | 50 % Hemolysis at 77.94 µM | Horse | Modifcation In Mp-N-Terminal Extension Via Tat-Linked | Random-coil at aq, α-Helical at membrane mimic solution | NA | ||
| 29266746 | 2018 | SWLSKTAKKLENSAKKRISEGIAIAQGGPR{ct:Amid} | CP-1 | Amidation | Free | Linear | L | None | 30 | Antimicrobial | >5 % Hemolysis at >128 µM | Human | Pig Nematode Porcine Small Intestine | Helical | Non-hemolytic | ||
| 29307075 | 2018 | GIGKFLKKAKKFGKAFVKILKK ({nnr:AcO−}){ct:Amid} | Pexiganan acetate | Amidation | Free | Linear | L | AcO− = Counter-ion acetate | 22 | Antimicrobial | 30.75 % Hemolysis at 256 µg/mL | Human | Synthetic Peptide | NA | NA | ||
| 29307075 | 2018 | GIGKFLKKAKKFGKAFVKILKK ({nnr:TFA−}){ct:Amid} | Pexiganan trifluoroacetate | Amidation | Free | Linear | L | TFA− = Counter-ion trifluoroacetate | 22 | Antimicrobial | 8.51 % Hemolysis at 256 µg/mL | Human | Synthetic Peptide | NA | NA | ||
| 29307075 | 2018 | GIGKFLKKAKKFGKAFVKILKK ({nnr:Cl−}){ct:Amid} | Pexiganan chloride | Amidation | Free | Linear | L | Cl− = Counter-ion chloride | 22 | Antimicrobial | 9 % Hemolysis at 256 µg/mL | Human | Synthetic Peptide | NA | NA | ||
| 29501691 | 2018 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial | 35 % Hemolysis at 200 µg/mL | Sheep | Honeybee Venom | NA | NA | ||
| 29688003 | 2018 | GIGKFLHSAKKFGKAFVGEIMNSC | Magainin 2 | Free | Free | Linear | L | None | 24 | Antibacterial | 7 % Hemolysis | Human | Synthetic Peptide | NA | NA | ||
| 29783753 | 2018 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 5 % Hemolysis at 1 µM | Human | Bee Venom | unordered conformation at 10 mM sodium phosphate, α-Helix at TFE and SDS | NA | ||
| 29783753 | 2018 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 46.8 % Hemolysis at 2 µM | Human | Bee Venom | unordered conformation at 10 mM sodium phosphate, α-Helix at TFE and SDS | NA | ||
| 29910626 | 2018 | KFKKLFKKLSPVIGKEFKRIVERIKRFLR | H4 | Free | Free | Linear | L | None | 29 | Antimicrobial | 0 % Hemolysis at 5 µM | Human | N-Terminal Fragment Obtained From Residues 9–26 Of Bmap-27 And A C-Terminal Fragment From Residues 1–16 Of Op-145 | α-Helix | Non-hemolytic | ||
| 29910626 | 2018 | KFKKLFKKLSPVIGKEFKRIVERIKRFLR | H4 | Free | Free | Linear | L | None | 29 | Antimicrobial | 0 % Hemolysis at 10 µM | Human | N-Terminal Fragment Obtained From Residues 9–26 Of Bmap-27 And A C-Terminal Fragment From Residues 1–16 Of Op-145 | α-Helix | Non-hemolytic | ||
| 29910626 | 2018 | KFKKLFKKLSPVIGKEFKRIVERIKRFLR | H4 | Free | Free | Linear | L | None | 29 | Antimicrobial | 0 % Hemolysis at 25 µM | Human | N-Terminal Fragment Obtained From Residues 9–26 Of Bmap-27 And A C-Terminal Fragment From Residues 1–16 Of Op-145 | α-Helix | Non-hemolytic | ||
| 29910626 | 2018 | KFKKLFKKLSPVIGKEFKRIVERIKRFLR | H4 | Free | Free | Linear | L | None | 29 | Antimicrobial | 0 % Hemolysis at 40 µM | Human | N-Terminal Fragment Obtained From Residues 9–26 Of Bmap-27 And A C-Terminal Fragment From Residues 1–16 Of Op-145 | α-Helix | Non-hemolytic | ||
| 29910626 | 2018 | KFKKLFKKLSPVIGKEFKRIVERIKRFLR | H4 | Free | Free | Linear | L | None | 29 | Antimicrobial | 0 % Hemolysis at 55 µM | Human | N-Terminal Fragment Obtained From Residues 9–26 Of Bmap-27 And A C-Terminal Fragment From Residues 1–16 Of Op-145 | α-Helix | Non-hemolytic | ||
| 29910626 | 2018 | KFKKLFKKLSPVIGKEFKRIVERIKRFLR | H4 | Free | Free | Linear | L | None | 29 | Antimicrobial | 0 % Hemolysis at 70 µM | Human | N-Terminal Fragment Obtained From Residues 9–26 Of Bmap-27 And A C-Terminal Fragment From Residues 1–16 Of Op-145 | α-Helix | Non-hemolytic | ||
| 29910626 | 2018 | KFKKLFKKLSPVIGKEFKRIVERIKRFLR | H4 | Free | Free | Linear | L | None | 29 | Antimicrobial | 0 % Hemolysis at 85 µM | Human | N-Terminal Fragment Obtained From Residues 9–26 Of Bmap-27 And A C-Terminal Fragment From Residues 1–16 Of Op-145 | α-Helix | Non-hemolytic | ||
| 29910626 | 2018 | KFKKLFKKLSPVIGKEFKRIVERIKRFLR | H4 | Free | Free | Linear | L | None | 29 | Antimicrobial | 2.1 % Hemolysis at 100 µM | Human | N-Terminal Fragment Obtained From Residues 9–26 Of Bmap-27 And A C-Terminal Fragment From Residues 1–16 Of Op-145 | α-Helix | NA | ||
| 29984236 | 2018 | RRWQWRRRWQWRK-{nnr:Ahx}-CRRWQWRRRWQWRK-{nnr:Ahx}-C | Tetrameric | Free | Free | Linear | L | Ahx = Aminohexanoic acid | 28 | Antibacterial | 49.1 % Hemolysis at 100 μM | Human | Synthesised And Modified From Motif | NA | NA | ||
| 29752337 | 2018 | GLLSGHYGRVVSTQSGHYGRG | OA-GL21 | Free | Free | Linear | L | None | 21 | Wound-healing | 0 % Hemolysis at 50 μM | Human | Frog Skin Secretions Of Odorrana Andersonii | aqueous = Helical conformation, membrane-mimetic environments = Helical conformation | Non-hemolytic | ||
| 29799150 | 2018 | EEEEAAAGK{d}W{d}K{d}L{d}F{d}K{d}K{d}L{d}P{d}K{d}F{d}L{d}H{d}L{d}A{d}K{d}K{d}F{d}{nt:Acet}{ct:Amid} | Pro‐P18 | Amidation | Acetylation | Linear | Mix | None | 26 | ND | 0 % Hemolysis at 10 μM | Human | Cecropin/Magainin Hybrid | NA | Non-hemolytic | ||
| 29799150 | 2018 | EEEEAAAGW{d}G{d}L{d}R{d}R{d}L{d}L{d}K{d}Y{d}G{d}K{d}R{d}S{d}{nt:Acet}{ct:Amid} | Pro‐WMR | Amidation | Acetylation | Linear | Mix | None | 21 | ND | 0 % Hemolysis at 10 μM | Human | Myxinidin Analogue From Hagfish | NA | Non-hemolytic | ||
| 28072492 | 2018 | FFPGIIKVASAILPTAICAITKRC | Brevinin1 HYba1 B1/1 COOH | Free | Free | Linear | L | None | 24 | Antimicrobial, Antibacterial | >40 % Hemolysis at 100 μM | Human | Frog Crude Skin Secretion Of Hydrophylax Bahuvistara | membrane-mimetic environment like trifluoroethanol (TFE) in water 30% (v/v = Alphα-Helical conformation | NA | ||
| 28072492 | 2018 | FFPGIIKVASAILPTAICAITKRC{ct:Amid} | Brevinin1 HYba1 B1/1 CONH2 | Amidation | Free | Linear | L | None | 24 | Antimicrobial, Antibacterial | >80 % Hemolysis at 100 μM | Human | Frog Crude Skin Secretion Of Hydrophylax Bahuvistara | membrane-mimetic environment like trifluoroethanol (TFE) in water 30% (v/v = Alphα-Helical conformation | NA | ||
| 28072492 | 2018 | FFPGIIKVAGAILPTAICAITKRC | Brevinin1 HYba2 B1/2 COOH | Free | Free | Linear | L | None | 24 | Antimicrobial, Antibacterial | >50 % Hemolysis at 100 μM | Human | Frog Crude Skin Secretion Of Hydrophylax Bahuvistara | membrane-mimetic environment like trifluoroethanol (TFE) in water 30% (v/v = Alphα-Helical conformation | NA | ||
| 28072492 | 2018 | FFPGIIKVAGAILPTAICAITKRC{ct:Amid} | Brevinin1 HYba2 B1/2 CONH2 | Amidation | Free | Linear | L | None | 24 | Antimicrobial, Antibacterial | >90 % Hemolysis at 100 μM | Human | Frog Crude Skin Secretion Of Hydrophylax Bahuvistara | membrane-mimetic environment like trifluoroethanol (TFE) in water 30% (v/v = Alphα-Helical conformation | NA | ||
| 29682907 | 2018 | SCLPKEEQIGKSTRGRKCRRKK{ct:myristoylated} | MPhd3 | myristoylated | Free | Linear | L | Myr = Myristic acid | 22 | Antimicrobial, Antibacterial | >40 % Hemolysis at 10 μM | Rat | Human-Β-Defensins | buffer = unordered conformation | NA | ||
| 29770868 | 2018 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | melittin monomer | Amidation | Free | Linear | L | None | 26 | Antibacterial, Anticancer | 100 % Hemolysis at 10 μM | mouse | Bee Venom | α-Helix | NA | ||
| 29931753 | 2018 | GIGAVLKVLTTGLPALISWIKRKRQQ{nt:-NH2/Ce6} | MEL/Ce6 | Free | -NH2/Ce6 | Linear | L | Ce6 = porphyrin derivatives chlorin e6 | 26 | Anticancer | >30 % Hemolysis at 40 μM | mouse | Modified Melittin | NA | NA | ||
| 29931753 | 2018 | GIGAVLKVLTTGLPALISWIKRKRQQ{nt:NH2/Ce6@HA} | MEL/Ce6@HA | Free | NH2/Ce6@HA | Linear | L | Ce6 = porphyrin derivatives chlorin e6, HA = hyaluronic acid | 26 | Anticancer | >10 % Hemolysis at 40 μM | mouse | Modified Melittin | NA | NA | ||
| 30087268 | 2018 | ALWKDILKNAGKAALNEINQIVQ{ct:Amid} | DPS3 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 50 % Hemolysis at 138.1 μM | Horse | Frog Phyllomedusa Sauvagii | aqueous = Random coils, membrane-mimicking solution = α-Helical | NA | ||
| 30087268 | 2018 | ALWKKILKNAGKAALNKINQIVQ{ct:Amid} | K5, 17-DPS3 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 50 % Hemolysis at 14.98 μM | Horse | Analogs Of Dermaseptin-Ps3 | aqueous = Random coils, membrane-mimicking solution = α-Helical | NA | ||
| 30087268 | 2018 | ALWKDILKNLLKAALNEINQIVQ{ct:Amid} | L10, 11-DPS3 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Anticancer | 50 % Hemolysis at 3.44 μM | Horse | Analogs Of Dermaseptin-Ps3 | aqueous = Random coils, membrane-mimicking solution = α-Helical | NA | ||
| 29760411 | 2018 | L/I-A-L/I-L/I-L/I-R-L/I -L/I-V-K-L/I-(K-K-S-L/I-T-L/I-K-V-L/I-L/I-R-I/L){cyc:N-C} | Paenialvin-A | Free | Free | Bicyclic | Mix | None | 23 | Antibacterial,Antitumor | 3.61 % Hemolysis at 50 μg/ml | Rabbit | Bacteria Paenibacillus Alvei Dsm 29 | NA | Non-hemolytic | ||
| 29760411 | 2018 | L/I-A-L/I-L/I-I/L-R-L/I -L/I-V-K-L/I-(K-K-A-L/I-T-L/I-K-V-L/I-L/I-R-I/L){cyc:N-C} | Paenialvin-B | Free | Free | Bicyclic | Mix | None | 23 | Antibacterial | 1.93 % Hemolysis at 50 μg/ml | Rabbit | Bacteria Paenibacillus Alvei Dsm 29 | NA | Non-hemolytic | ||
| 29760411 | 2018 | L-A-L-L-V-R-L-L-V-K-L-(K-K-S-L/I-T-L/I-K-V-L/I-L/I-R-V){cyc:N-C} | Paenialvin-C | Free | Free | Bicyclic | D | None | 23 | Antibacterial | 0 % Hemolysis at 50 μg/ml | Rabbit | Bacteria Paenibacillus Alvei Dsm 29 | NA | Non-hemolytic | ||
| 30192822 | 2018 | KLLKFVTKVGKAIFKALIKAI{d} | Ocellatin4-analogue | Free | Free | Linear | Mix | None | 21 | Antimicrobial | 88 % Hemolysis at 25 mM | Human | Leptodatylus Ocellatus Analogue Of Ocellatin 4 | amphipathic α-Helix | NA | ||
| 30192822 | 2018 | KLLKFVTKVGKAIFKALIKAI{d} | Ocellatin4-analogue | Free | Free | Linear | Mix | None | 21 | Antimicrobial | 100 % Hemolysis at 50 mM | Human | Leptodatylus Ocellatus Analogue Of Ocellatin 4 | amphipathic α-Helix | NA | ||
| 30192822 | 2018 | KLLKFVTKVGKAIFKALIKAI{d} | Ocellatin4-analogue | Free | Free | Linear | Mix | None | 21 | Antimicrobial | 100 % Hemolysis at 75 mM | Human | Leptodatylus Ocellatus Analogue Of Ocellatin 4 | amphipathic α-Helix | NA | ||
| 30192822 | 2018 | KLLKFVTKVGKAIFKALIKAI{d} | Ocellatin4-analogue | Free | Free | Linear | Mix | None | 21 | Antimicrobial | 100 % Hemolysis at 100 mM | Human | Leptodatylus Ocellatus Analogue Of Ocellatin 4 | amphipathic α-Helix | NA | ||
| 29859288 | 2018 | DSHAKRHHGYKRKFHEKHHSHRGY | histatin Hst-5 | Free | Free | Linear | L | None | 24 | Antifungal | 1.6±0.6 % Hemolysis at 500 μg/ml | Human | Human Saliva Histatin | α-Helical | Low hemolytic | ||
| 30045878 | 2018 | ARGKKECKDDRCRLLMKRGSFSYV | Cathelicidin-NV | Free | Free | Linear | L | None | 24 | Wound healing-promoting activity | 0 % Hemolysis at 200 μg/ml | Rabbit | Frog Nanorana Ventripunctata | NA | Non-hemolytic | ||
| 30095906 | 2018 | GFAWNVCVYRNGVRVCHRRAN | 2 | Free | Free | Linear | L | None | 21 | Antibacterial | 2.06 % Hemolysis at 100 μM | Human | Cathepsin-Cleavable Linker | NA | Non-hemolytic | ||
| 30216370 | 2018 | ILKPGGGTSGGLLGGLLGKVTSVIPGLNNI | α4 | Free | Free | Linear | L | None | 30 | Antibiofilm | 0 % Hemolysis at 100 μM | Human | Human Splunc1 (Short Palate Lung And Nasal Epithelial Clone 1) | Helical amphipathic structure | Non-hemolytic | ||
| 30216370 | 2018 | ILKKWWGTSGGLLGGLLGKVTSVIKGLNNI | α4M1 | Free | Free | Linear | L | None | 30 | Antibiofilm | 0 % Hemolysis at 100 μM | Human | Human Splunc1 (Short Palate Lung And Nasal Epithelial Clone 1) | Helical amphipathic structure | Non-hemolytic | ||
| 30216370 | 2018 | RRWVRRVRRVWRRVVRVVRRWVRR | WLBU2 | Free | Free | Linear | L | None | 24 | Antibacterial | 20 % Hemolysis at 100 μM | Human | Human Splunc1 (Short Palate Lung And Nasal Epithelial Clone 1) | Helical amphipathic structure | NA | ||
| 30258724 | 2018 | ALWKDLLKNVGKAAGKAVLNKVTDMVNQ{ct:Amid} | DRS-CA-1 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 50 % Hemolysis at 114.7 μM | Horse | Callimedusa Camba(Phyllomedusa) | α-Helical | NA | ||
| 30258724 | 2018 | ALWKSLLKNVGKAAGKAALNAVTDMVNQ{ct:Amid} | DRS-DU-1 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 50 % Hemolysis at 216.6 μM | Horse | Phyllomedusa Duellmani | α-Helical | NA | ||
| 30258724 | 2018 | GRKKRRQRRRGALWKSLLKNVGKA{ct:Amid} | DP-2 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolysis at >512 μM | Horse | Tat-Fused Dp-1 | α-Helical | NA | ||
| 30215282 | 2018 | SMWSGMWRRKLKKLRNALKKKLKGE | Ltc 1 | Free | Free | Linear | L | None | 25 | Antibacterial | 20 % Hemolysis at 80 μM | Rabbit | Spider Lachesana Tarabaevi | water = Random coil, 50% trifluoroethano = α-helice | NA | ||
| 30215282 | 2018 | GLFGKLIKKFGRKAISYAVKKARGKH | Ltc 2a | Free | Free | Linear | L | None | 26 | Antibacterial | 20 % Hemolysis at 6 μM | Rabbit | Spider Lachesana Tarabaevi | water = Random coil, 50% trifluoroethano = α-helice | NA | ||
| 30215282 | 2018 | GLKDKFKSMGEKLKQYIQTWKAKF{ct:Amid} | Ltc 4a | Amidation | Free | Linear | L | None | 24 | Antibacterial | 20 % Hemolysis at >120 μM | Rabbit | Spider Lachesana Tarabaevi | water = Random coil, 50% trifluoroethano = α-helice | NA | ||
| 30215282 | 2018 | SLKDKVKSMGEKLKQYIQTWKAKF{ct:Amid} | Ltc 4b | Amidation | Free | Linear | L | None | 24 | Antibacterial | 20 % Hemolysis at >120 μM | Rabbit | Spider Lachesana Tarabaevi | water = Random coil, 50% trifluoroethano = α-helice | NA | ||
| 30215282 | 2018 | GFFGKMKEYFKKFGASFKRRFANLKKRL{ct:Amid} | Ltc 5 | Amidation | Free | Linear | L | None | 28 | Antibacterial | 20 % Hemolysis at 40 μM | Rabbit | Spider Lachesana Tarabaevi | water = Random coil, 50% trifluoroethano = α-helice | NA | ||
| 30215282 | 2018 | GIRCPKSWKCKAFKQRVLKRLLAMLRQHAF | Oxt 4a | Free | Free | Linear | L | None | 30 | Antibacterial | 50 % Hemolysis at 7 μM | Human | Lynx Spider Peptide | aqueous = Disordered, SDS= α-Helical | NA | ||
| 30301180 | 2018 | GIGKFLHSAKKFGKAFVGEIMNS{ct:Amid} | Magainin 2 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antibiofilm | 0 % Hemolysis at 64 µM | Mouse | African Clawed Fogs Xenopus Laevis | 50% TFE and 30mM SDS = α-Helical, 10 mM sodium phosphate buffer = Random coil | Non-hemolytic | ||
| 30322120 | 2018 | FLGAVLKVAGKLVPAAICKISKKC | Brevinin-1GHa | Free | Free | Linear | L | None | 24 | Antibiofilm, Antibacterial, Antifungal | 20 % Hemolysis at 16 µM | Horse | Frog Hylarana Guentheri | α-Helix | NA | ||
| 30322120 | 2018 | FLGAVLKVCKISKKCAGKLVPAAI | Brevinin-1GHc | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal | 20 % Hemolysis at 128 µM | Horse | Analogue Of Brevinin-1Gha | α-Helix | NA | ||
| 30325956 | 2018 | GVWGIAKIAGKVLGNILPHVFSSNQS{nt:H3N = amine}{ct:Carboxyl (COO-)} | DMS-DA6-OH | Carboxyl (COO-) | H3N = amine | Linear | L | None | 26 | Antibacterial | 0.9 ± 1.5 % Hemolysis at 10 µM | Human | Frog Pachymedusa Dacnicolor | phosphate buffer = Random coil, POPG = α-Helix | Non-hemolytic | ||
| 30325956 | 2018 | GVWGIAKIAGKVLGNILPHVFSSNQS{nt:H3N = amine}{ct:Amid} | DMS-DA6-NH2 | Amidation | H3N = amine | Linear | L | None | 26 | Antibacterial | 1.2 ± 1.8 % Hemolysis at 10 µM | Human | Frog Pachymedusa Dacnicolor | phosphate buffer = Random coil, POPG = α-Helix | Non-hemolytic | ||
| 30325956 | 2018 | GVWGIAKIAGKVLGNILPHVFSSNQS{nt:H3N = amine}{ct:Carboxyl (COO-)} | DMS-DA6-OH | Carboxyl (COO-) | H3N = amine | Linear | L | None | 26 | Antibacterial | 7.4 ± 5.5 % Hemolysis at 50 µM | Human | Frog Pachymedusa Dacnicolor | phosphate buffer = Random coil, POPG = α-Helix | NA | ||
| 30325956 | 2018 | GVWGIAKIAGKVLGNILPHVFSSNQS{nt:H3N = amine}{ct:Amid} | DMS-DA6-NH2 | Amidation | H3N = amine | Linear | L | None | 26 | Antibacterial | 3.7 ± 3.3 % Hemolysis at 50 µM | Human | Frog Pachymedusa Dacnicolor | phosphate buffer = Random coil, POPG = α-Helix | Low hemolytic | ||
| 30325956 | 2018 | GVWGIAKIAGKVLGNILPHVFSSNQS{nt:H3N = amine}{ct:Carboxyl (COO-)} | DMS-DA6-OH | Carboxyl (COO-) | H3N = amine | Linear | L | None | 26 | Antibacterial | 0 ± 2.8 % Hemolysis at 10 µM | Mouse | Frog Pachymedusa Dacnicolor | phosphate buffer = Random coil, POPG = α-Helix | Non-hemolytic | ||
| 30325956 | 2018 | GVWGIAKIAGKVLGNILPHVFSSNQS{nt:H3N = amine}{ct:Amid} | DMS-DA6-NH2 | Amidation | H3N = amine | Linear | L | None | 26 | Antibacterial | 0 ± 1.1 % Hemolysis at 10 µM | Mouse | Frog Pachymedusa Dacnicolor | phosphate buffer = Random coil, POPG = α-Helix | Non-hemolytic | ||
| 30325956 | 2018 | GVWGIAKIAGKVLGNILPHVFSSNQS{nt:H3N = amine}{ct:Carboxyl (COO-)} | DMS-DA6-OH | Carboxyl (COO-) | H3N = amine | Linear | L | None | 26 | Antibacterial | 5.4 ± 3.5 % Hemolysis at 50 µM | Mouse | Frog Pachymedusa Dacnicolor | phosphate buffer = Random coil, POPG = α-Helix | NA | ||
| 30325956 | 2018 | GVWGIAKIAGKVLGNILPHVFSSNQS{nt:H3N = amine}{ct:Amid} | DMS-DA6-NH2 | Amidation | H3N = amine | Linear | L | None | 26 | Antibacterial | 4.7 ± 5.6 % Hemolysis at 50 µM | Mouse | Frog Pachymedusa Dacnicolor | phosphate buffer = Random coil, POPG = α-Helix | NA | ||
| 30365554 | 2018 | FLRSLLRGAKAIYRGARAGWRG | dicentracin-like | Free | Free | Linear | L | None | 22 | Antibacterial | 50 % Hemolysis at 2.34 μg/ml | Human | Fish Barramundi (Lates Calcarifer) | α-Helix | NA | ||
| 30365554 | 2018 | FLRSLLRGAKAIYRGARAGWRG | dicentracin-like | Free | Free | Linear | L | None | 22 | Antibacterial | <100 % Hemolysis at 75 μg/ml | Human | Fish Barramundi (Lates Calcarifer) | α-Helix | NA | ||
| 30365554 | 2018 | FFHHIFRGIVHVGKTIHRLVTG | moronecidin | Free | Free | Linear | L | None | 22 | Antibacterial | 50 % Hemolysis at 57 μg/ml | Human | Fish Striped Bass (Morone Saxatilis) | α-Helix | NA | ||
| 30121851 | 2018 | GSTSFHLIYNKWFAVKRRRKR | GR21 | Free | Free | Linear | L | None | 21 | Antibacterial | 0 % Hemolysis at 5 µM | Human | Fish (Sepia Ofcinalis) | 70%TFE = α-Helix | Non-hemolytic | ||
| 30121851 | 2018 | GSTSFHLIYNKWFAVKRRRKR | GR21 | Free | Free | Linear | L | None | 21 | Antibacterial | 3.76 % Hemolysis at 50 µM | Human | Fish (Sepia Ofcinalis) | 70%TFE = α-Helix | NA | ||
| 30121851 | 2018 | GSTSFHLIYNKWFAVKRRRKR | GR21 | Free | Free | Linear | L | None | 21 | Antibacterial | 7.15 % Hemolysis at 100 µM | Human | Fish (Sepia Ofcinalis) | 70%TFE = α-Helix | NA | ||
| 30121851 | 2018 | GSTSFHLIYNKWFAVKRRRKR | GR21 | Free | Free | Linear | L | None | 21 | Antibacterial | 8.5 % Hemolysis at 200 µM | Human | Fish (Sepia Ofcinalis) | 70%TFE = α-Helix | NA | ||
| 30149134 | 2018 | CVKGGKKYKRQGKGHRMRRYRNNH | TO24 | Free | Free | Linear | L | None | 24 | Antimicrobial | 0 % Hemolysis | Fish | Fish Red Drum (Sciaenops Ocellatus) | NA | Non-hemolytic | ||
| 30462698 | 2018 | SYSRYRKQMAVKKYLAAVLGKRYKQRVKNK | PACAP(9–38) | Free | Free | Linear | L | None | 30 | Antibacterial | 0 % Hemolysis at 45 μg/mL | Human | Human | α-Helix | Non-hemolytic | ||
| 30387611 | 2018 | GLPICGETCVFGKCNTPGCSCRRPICYKN{cyc:N-C} | Rivi1 | Free | Free | Cyclic | L | None | 29 | Anticancer | 50 % Hemolysis at ≫10 µM | Human | Plant Rinorea Virgata | Loop | NA | ||
| 30387611 | 2018 | GSYLCGETCVQGKCYTPGCTCSWPICKKN{cyc:N-C} | Rivi2 | Free | Free | Cyclic | L | None | 29 | Anticancer | 50 % Hemolysis at ≫10 µM | Human | Plant Rinorea Virgata | Loop | NA | ||
| 30387611 | 2018 | GLPICGETCLLGKCYTPGCSCRRPVCYKN{cyc:N-C} | Rivi3 | Free | Free | Cyclic | L | None | 29 | Anticancer | 50 % Hemolysis at ≫10 µM | Human | Plant Rinorea Virgata | Loop | NA | ||
| 30555431 | 2018 | GLLSGILGAGKKIVCGLSGLC | Nigrocin-HL | Free | Free | Linear | L | None | 21 | Antibacterial | 0 % Hemolysis at 2 µM | Horse | Frog Hylarana Latouchii | α-Helix | Non-hemolytic | ||
| 30555431 | 2018 | GLLSGILGAGKKIVCGLSGLC | Nigrocin-HL | Free | Free | Linear | L | None | 21 | Antibacterial | 1 % Hemolysis at 4 µM | Horse | Frog Hylarana Latouchii | α-Helix | Non-hemolytic | ||
| 30555431 | 2018 | GLLSGILGAGKKIVCGLSGLC | Nigrocin-HL | Free | Free | Linear | L | None | 21 | Antibacterial | 18.72 % Hemolysis at 16 µM | Horse | Frog Hylarana Latouchii | α-Helix | NA | ||
| 30555431 | 2018 | GLLSGILGAGKKIVCGLSGLC | Nigrocin-HL | Free | Free | Linear | L | None | 21 | Antibacterial | 32 % Hemolysis at 32 µM | Horse | Frog Hylarana Latouchii | α-Helix | NA | ||
| 30555431 | 2018 | GLLSGILGAGKKIVCGLSGLC | Nigrocin-HL | Free | Free | Linear | L | None | 21 | Antibacterial | 43 % Hemolysis at 64 µM | Horse | Frog Hylarana Latouchii | α-Helix | NA | ||
| 30555431 | 2018 | GLLSGILGAGKKIVCGLSGLC | Nigrocin-HL | Free | Free | Linear | L | None | 21 | Antibacterial | 67 % Hemolysis at 128 µM | Horse | Frog Hylarana Latouchii | α-Helix | NA | ||
| 30555431 | 2018 | GLLSGILGAGKKIVCGLSGLC | Nigrocin-HL | Free | Free | Linear | L | None | 21 | Antibacterial | 76 % Hemolysis at 256 µM | Horse | Frog Hylarana Latouchii | α-Helix | NA | ||
| 30555431 | 2018 | GLLSGILGAGKKIVCGLSGLC | Nigrocin-HL | Free | Free | Linear | L | None | 21 | Antibacterial | 85 % Hemolysis at 512 µM | Horse | Frog Hylarana Latouchii | α-Helix | NA | ||
| 30555984 | 2018 | YYHFWHRGVTKRSLSPHRPRHSR | YR23 | Free | Free | Linear | L | None | 23 | Antibacterial | ~5 % Hemolysis at 100 µM | Human | Human Prodomain Of Human Furin | NA | Low hemolytic | ||
| 30555984 | 2018 | YYHFWHRGVTKRSLSPHRPRHSRLQR | YR26 | Free | Free | Linear | L | None | 26 | Antibacterial | ~8 % Hemolysis at 100 µM | Human | Human Prodomain Of Human Furin | SDS micelle = Helix-Turn-Helix | NA | ||
| 30555984 | 2018 | RKHGFLNLQGIFGDYYHFWHRGV | RV23 | Free | Free | Linear | L | None | 23 | Antibacterial | 48 % Hemolysis at 100 µM | Human | Human Prodomain Of Human Furin | NA | NA | ||
| 30039186 | 2018 | FFRNLWKGAKAAFRAGHAAWRA | Moronecidin-like | Free | Free | Linear | L | None | 22 | Antimicrobial, Anti-bioflim | 50 % Hemolysis at 87.5 μg/mL | Human | Fish Seahorse Hippocampus Comes | α-Helix | NA | ||
| 30039186 | 2018 | FFHHIFRGIVHVGKTIHRLVTG | Moronecidin | Free | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 2.34 μg/mL | Human | Fish Hybrid Striped Bass | α-Helix | Low hemolytic | ||
| 35559296 | 2018 | WFGHLYRGITKVVKHVHGLLKG | KS-Cnd | Free | Free | Linear | L | None | 22 | Antibacterial | 10 % Hemolysis at 8 µM | Human | Fish Derived From Chionodracine(Chionodraco Hamatus) | aqueous = Random coil, POPC = α-Helix | NA | ||
| 35559296 | 2018 | WFGKLYRGITSVVKKVKGLLSG | KH-Cnd | Free | Free | Linear | L | None | 22 | Antibacterial | 10 % Hemolysis at 9 µM | Human | Fish Derived From Chionodracine(Chionodraco Hamatus) | aqueous = Random coil, POPC = α-Helix | NA | ||
| 35559296 | 2018 | WFGKLYRGITKVVKKVKGLLKG | KHS_Cnd | Free | Free | Linear | L | None | 22 | Antibacterial | 10 % Hemolysis at 13 µM | Human | Fish Derived From Chionodracine(Chionodraco Hamatus) | aqueous = Random coil, POPC = α-Helix | NA | ||
| 30622471 | 2018 | GRFKRFRKKLKRLWHKVGPFVGPILHY | ChMAP-28 | Free | Free | Linear | L | None | 27 | Anticancer | <10 % Hemolysis at 10 µM | Human | Capra Hircus Goat Leukocytes | α-Helix | NA | ||
| 30622471 | 2018 | GRFKRFRKKLKRLWHKVGPFVGPILHY | ChMAP-28 | Free | Free | Linear | L | None | 27 | Anticancer | 50 % Hemolysis at ~100 µM | Human | Capra Hircus Goat Leukocytes | α-Helix | NA | ||
| 30475621 | 2018 | NLCASLRARHTIPQCRKFGRR{nt:Amid}{ct:Amid} | mBjAMP1-ox | Amidation | Amidation | Linear | L | None | 21 | Antimicrobial | <1 % Hemolysis at 256 µM | Sheep | Lancelet Branchiostoma Japonicum Mbjamp1 Analogs | TFE or SDS = α-Helix | Non-hemolytic | ||
| 30475621 | 2018 | NLSASLRARHTIPQSRKFGRR{nt:Amid}{ct:Amid} | mBjAMP1-sre | Amidation | Amidation | Linear | L | None | 21 | Antimicrobial | <1 % Hemolysis at 256 µM | Sheep | Lancelet Branchiostoma Japonicum Mbjamp1 Analogs | 10 mM sodium phosphate buffer = Random coil, TFE or SDS = α-Helix | Non-hemolytic | ||
| 34377965 | 2019 | K{d}L{d}LS{d}L{d}L{d}LT{d}L{d}S{d}LA{d}K{d}A{d}A{d}K{d}L{d}LT{d}L{d}L{d}LA{d}L{d}S{d}L{nt:Acet}{ct:Amid} | D84 (Lys1-6 Lys-1) | Amidation | Acetylation | Linear | Mix | None | 26 | Antibacterial | 50 % Hemolysis at 54.3 µM | Human | Synthetic Cationic Antimicrobial Peptides | aqueous = α-Helix, 50%TFE = α-Helix | NA | ||
| 34377965 | 2019 | K{d}L{d}{nnr:Dab}S{d}L{d}L{d}{nnr:Dab}T{d}L{d}S{d}{nnr:Dab}A{d}K{d}A{d}A{d}K{d}L{d}{nnr:Dab}T{d}L{d}L{d}{nnr:Dab}A{d}L{d}S{d}{nnr:Dab}{nt:Acet}{ct:Amid} | D86 (Lys1-6 Dab-1) | Amidation | Acetylation | Linear | Mix | L-Dab = (2,4-diaminobutyric acid) | 26 | Antibacterial | 50 % Hemolysis at >742 µM | Human | Synthetic Cationic Antimicrobial Peptides | aqueous = α-Helix, 50%TFE = α-Helix | NA | ||
| 34377965 | 2019 | K{d}L{d}{nnr:Dap}S{d}L{d}L{d}{nnr:Dap}T{d}L{d}S{d}{nnr:Dap}A{d}K{d}A{d}A{d}K{d}L{d}{nnr:Dap}T{d}L{d}L{d}{nnr:Dap}A{d}L{d}S{d}{nnr:Dap}{nt:Acet}{ct:Amid} | D105 (Lys1-6 Dap-1) | Amidation | Acetylation | Linear | Mix | L-Dap = (2,3-diaminopropionic acid) | 26 | Antibacterial | 50 % Hemolysis at >1148 µM | Human | Synthetic Cationic Antimicrobial Peptides | aqueous = α-Helix, 50%TFE = α-Helix | NA | ||
| 34377965 | 2019 | K{d}L{d}LS{d}L{d}L{d}LT{d}L{d}S{d}LA{d}K{d}A{d}A{d}K{d}L{d}LT{d}L{d}L{d}LA{d}L{d}S{d}S{nt:Acet}{ct:Amid} | D101 (Lys1Ser26-5 Lys-1) | Amidation | Acetylation | Linear | Mix | None | 26 | Antibacterial | 50 % Hemolysis at 103.9 µM | Human | Synthetic Cationic Antimicrobial Peptides | aqueous = α-Helix, 50%TFE = α-Helix | NA | ||
| 34377965 | 2019 | K{d}L{d}{nnr:Dab}S{d}L{d}L{d}{nnr:Dab}T{d}L{d}S{d}{nnr:Dab}A{d}K{d}A{d}A{d}K{d}L{d}{nnr:Dab}T{d}L{d}L{d}{nnr:Dab}A{d}L{d}S{d}S{nt:Acet}{ct:Amid} | D102 (Lys1Ser26-5 Dab-1) | Amidation | Acetylation | Linear | Mix | L-Dab = (2,4-diaminobutyric acid) | 26 | Antibacterial | 50 % Hemolysis at >708 µM | Human | Synthetic Cationic Antimicrobial Peptides | aqueous = α-Helix, 50%TFE = α-Helix | NA | ||
| 34377965 | 2019 | K{d}L{d}LS{d}L{d}L{d}LT{d}L{d}S{d}A{d}A{d}K{d}LLK{d}L{d}A{d}T{d}L{d}L{d}LA{d}L{d}S{d}L{nt:Acet}{ct:Amid} | D88 (Lys1-6 Lys-2) | Amidation | Acetylation | Linear | Mix | None | 26 | Antibacterial | 50 % Hemolysis at 80.6 µM | Human | Synthetic Cationic Antimicrobial Peptides | aqueous = α-Helix, 50%TFE = α-Helix | NA | ||
| 34377965 | 2019 | AKR{nnr:bip}{nnr:bip}GYKRKF{nnr:bip}{nt:Acet}{ct:Amid} | D89 (Lys1-6 Dab-2) | Amidation | Acetylation | Linear | Mix | L-Dab = (2,4-diaminobutyric acid) | 26 | Antibacterial | 50 % Hemolysis at >1112 µM | Human | Synthetic Cationic Antimicrobial Peptides | aqueous = α-Helix, 50%TFE = α-Helix | NA | ||
| 34377965 | 2019 | K{d}L{d}{nnr:Dap}S{d}L{d}L{d}{nnr:Dap}T{d}L{d}S{d}A{d}A{d}K{d}{nnr:Dap}{nnr:Dap}K{d}L{d}A{d}T{d}L{d}L{d}{nnr:Dap}A{d}L{d}S{d}{nnr:Dap}{nt:Acet}{ct:Amid} | D106 (Lys1-6 Dap-2) | Amidation | Acetylation | Linear | Mix | L-Dap = (2,3-diaminopropionic acid) | 26 | Antibacterial | 50 % Hemolysis at 340.2 µM | Human | Synthetic Cationic Antimicrobial Peptides | aqueous = α-Helix, 50%TFE = α-Helix | NA | ||
| 34377965 | 2019 | K{d}L{d}LS{d}L{d}L{d}LT{d}L{d}S{d}A{d}A{d}K{d}LLK{d}L{d}A{d}T{d}L{d}L{d}LA{d}L{d}S{d}S{nt:Acet}{ct:Amid} | D103 (Lys1Ser26-5 Lys-2) | Amidation | Acetylation | Linear | Mix | None | 26 | Antibacterial | 50 % Hemolysis at 134.9 µM | Human | Synthetic Cationic Antimicrobial Peptides | aqueous = α-Helix, 50%TFE = α-Helix | NA | ||
| 34377965 | 2019 | K{d}L{d}{nnr:Dab}S{d}L{d}L{d}{nnr:Dab}T{d}L{d}S{d}A{d}A{d}K{d}{nnr:Dab}{nnr:Dab}K{d}L{d}A{d}T{d}L{d}L{d}{nnr:Dab}A{d}L{d}S{d}S{nt:Acet}{ct:Amid} | D104 (Lys1Ser26-5 Dab-2) | Amidation | Acetylation | Linear | Mix | L-Dab = (2,4-diaminobutyric acid) | 26 | Antibacterial | 50 % Hemolysis at >1490 µM | Human | Synthetic Cationic Antimicrobial Peptides | aqueous = α-Helix, 50%TFE = α-Helix | NA | ||
| 30658410 | 2019 | GVKELFGKAWGLVKKHLPKACGLLGYVKQ | PLP4 | Free | Free | Linear | L | None | 29 | Antimicrobial, histamine-releasing activity | 10.5 % Hemolysis at 50 µM | Human | Ant Odontomachus Monticola | α-Helix | NA | ||
| 30658410 | 2019 | GVKELFGKAWGLVKKHLPKACGLLGYVKQ | PLP4 | Free | Free | Linear | L | None | 29 | Antimicrobial, histamine-releasing activity | 0 % Hemolysis at 10 µM | Human | Ant Odontomachus Monticola | α-Helix | Non-hemolytic | ||
| 30508627 | 2019 | GWGSFFKKAAHVGKHVGKAALTHYL | Pleurocidin | Free | Free | Linear | L | None | 25 | Antibiofilm, Antibacterial | 10 % Hemolysis at 32 µM | Mouse | Fish Winter Flounder (Pseudopleuronectes Americanus) | 10 mM sodium phosphate buffer = Random coil, SDS and TFE = α-Helix | NA | ||
| 30702120 | 2019 | RRWVRRVRRWVRRVVRVVRRWVRR | WLBU2 | Free | Free | Linear | L | None | 24 | Antibacterial | 14 ± 1 % Hemolysis at 50 μM | Human | Synthetic Peptide | NA | NA | ||
| 30702120 | 2019 | RRWV{d}RRV{d}RRWV{d}RRV{d}V{d}RV{d}V{d}RRWV{d}RR | D8 | Free | Free | Linear | Mix | None | 24 | Antibacterial | 0 ± 1 % Hemolysis at 50 μM | Human | Synthetic Peptide | NA | Non-hemolytic | ||
| 30811391 | 2019 | KLKNFAKGVAQSLLNKASCKLSGQC | Brevinin 2R | Free | Free | Linear | L | None | 25 | Antibacterial, Anti-leishmanial | 0 % Hemolysis at 500 μg/mL | Human | Frog Skin (Rana Brevipoda) | NA | Non-hemolytic | ||
| 30811391 | 2019 | KLKNFAKGVAQSLLNKASCKLSGQC{nt:lauric acid} | L- Brevinin 2R | Free | lauric acid | Linear | L | l = Lau(lauric acid) | 25 | Antibacterial, Anti-leishmanial | 50 % Hemolysis at 250 μg/mL | Human | Modified Brevinin 2R | NA | NA | ||
| 30811391 | 2019 | LPKPPKPVSKMRMATPLLMQALPM | CLIP | Free | Free | Linear | L | None | 24 | Antibacterial, Anti-leishmanial | 0 % Hemolysis at 500 μg/mL | Human | Derived From The Mhc Class Ii Associated Invariant Chain | NA | Non-hemolytic | ||
| 30811391 | 2019 | LPKPPKPVSKMRMATPLLMQALPM{nt:lauric acid} | L-CLIP | Free | lauric acid | Linear | L | l = Lau(lauric acid) | 24 | Antibacterial, Anti-leishmanial | 30 % Hemolysis at 500 μg/mL | Human | Modified Clip | NA | NA | ||
| 30449002 | 2019 | IWLTALKFLGKNLGKLAKQQLAKL{ct:Amid} | LyeTxI-b | Amidation | Free | Linear | L | None | 24 | Anticancer, Antitumor | ~35 % Hemolysis at 100 µM | Human | Spider Venom Lycosa Erythrognatha | α-Helix | Low hemolytic | ||
| 30824786 | 2019 | AGYLLGKINLKALAALAKKIL{nt:Van-NH-PEG3-Tra(1,4)-C(O)}{ct:Amid} | Van-PEG3-TP10 | Amidation | Van-NH-PEG3-Tra(1,4)-C(O) | Linear | L | Van = vancomycin, PEG3 = 3,6,9-trioxaundecane linker, Tra = 1,2,3-triazole ring | 21 | Antibacterial | 15 % Hemolysis at 12.5 µM | Sheep | Synthetic Conjugate Transportan 10 (Tp10) Peptide | α-Helix | NA | ||
| 30824786 | 2019 | AGYLLGKINLKALAALAKKIL{nt:Van-C(O)-PEG4-Tra(1,4)-C(O)}{ct:Amid} | Van-PEG4-TP10 | Amidation | Van-C(O)-PEG4-Tra(1,4)-C(O) | Linear | L | Van = vancomycin, PEG4 = 4,7,10,13-tetraoxapentadecane linker, Tra = 1,2,3-triazole ring | 21 | Antibacterial | 5 % Hemolysis at 12.5 µM | Sheep | Synthetic Conjugate Transportan 10 (Tp10) Peptide | α-Helix | NA | ||
| 30824786 | 2019 | AGYLLGKINLKALAALAKKIL{nt:Van-NH-PEG3-Tra(1,4)-C(O)}{ct:Amid} | Van-PEG3-TP10 | Amidation | Van-NH-PEG3-Tra(1,4)-C(O) | Linear | L | Van = vancomycin, PEG3 = 3,6,9-trioxaundecane linker, Tra = 1,2,3-triazole ring | 21 | Antibacterial | 93 % Hemolysis at 100 µM | Sheep | Synthetic Conjugate Transportan 10 (Tp10) Peptide | α-Helix | NA | ||
| 30824786 | 2019 | AGYLLGKINLKALAALAKKIL{nt:Van-C(O)-PEG4-Tra(1,4)-C(O)}{ct:Amid} | Van-PEG4-TP10 | Amidation | Van-C(O)-PEG4-Tra(1,4)-C(O) | Linear | L | Van = vancomycin, PEG4 = 4,7,10,13-tetraoxapentadecane linker, Tra = 1,2,3-triazole ring | 21 | Antibacterial | 77 % Hemolysis at 100 µM | Sheep | Synthetic Conjugate Transportan 10 (Tp10) Peptide | α-Helix | NA | ||
| 30690103 | 2019 | LEAAPKKVQDLLKKANITVKGAFQLFS{nt:Amid} | BAR | Free | Amidation | Linear | L | None | 27 | NA | 0 % Hemolysis at 3.4 µM | Sheep | Bacteria Sspb (Antigen I/Ii) Protein Of Streptococcus Gordonii (Sg) | NA | Non-hemolytic | ||
| 30690103 | 2019 | LEAAPKKVQDLLKKANITVKGAFQLFS{nt:Amid} | BAR | Free | Amidation | Linear | L | None | 27 | NA | 0 % Hemolysis at 1.3 µM | Sheep | Bacteria Sspb (Antigen I/Ii) Protein Of Streptococcus Gordonii (Sg) | NA | Non-hemolytic | ||
| 30886247 | 2019 | RFGRFLRKIRRFRPKVTITIQGSARF{ct:Amid} | CATH-2 | Amidation | Free | Linear | L | None | 26 | Antibacterial, Antifungal | <10 % Hemolysis at 40 µM | Porcine | Chicken | α-Helix and α-Helix | NA | ||
| 30648626 | 2019 | QSHLSLCRWCCNCCHNKGCGFCCKF | Bthepc | Free | Free | Linear | L | None | 25 | Antimicrobial | 50 % Hemolysis at 34.71 µM | Human | Hepcidin Gene Brown Trout (Salmo Trutta) | NA | NA | ||
| 30648626 | 2019 | QSHLSLCRWCCNCCHNKGCGFCCKF | Bthepc | Free | Free | Linear | L | None | 25 | Antimicrobial | 28.2 % Hemolysis at 2.17 µM | Human | Hepcidin Gene Brown Trout (Salmo Trutta) | NA | NA | ||
| 30967458 | 2019 | ILKPGGGTSGGLLGGLLGKVTSVIPGLNNI | α4 | Free | Free | Linear | L | None | 30 | Antibacterial, Antiiofilm | 0 % Hemolysis at 64 µM | Human | Derived From The Human Respiratory Host Defense Protein Splunc1 | α-Helix | Non-hemolytic | ||
| 30967458 | 2019 | LKKWW K TS K GLLGGLLGKVTSVIK | α4-short | Free | Free | Linear | L | None | 24 | Antibacterial, Antiiofilm | 0 % Hemolysis at 64 µM | Human | Modified Α4 | NA | Non-hemolytic | ||
| 30848594 | 2019 | K{d}L{d}R{d}S{d}L{d}L{d}R{d}T{d}L{d}S{d}R{d}A{d}K{d}A{d}A{d}K{d}L{d}R{d}T{d}L{d}L{d}R{d}A{d}L{d}S{d}R{d}{nt:Acet}{ct:Amid} | D87(Lys'-6 Arg-1) | Amidation | Acetylation | Linear | D | substituted with positive charged Arg | 26 | Antimicrobial | 50 % Hemolysis at 12 μg/mL | Human | Synthetic Peptide | α-Helix | NA | ||
| 30848594 | 2019 | K{d}L{d}K{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}K{d}A{d}K{d}A{d}A{d}K{d}L{d}K{d}T{d}L{d}L{d}K{d}A{d}L{d}S{d}K{d}{nt:Acet}{ct:Amid} | D84(Lys¹-6 Lys-1) | Amidation | Acetylation | Linear | D | substituted with positive charged Lys | 26 | Antimicrobial | 50 % Hemolysis at 155.5 μg/mL | Human | Synthetic Peptide | α-Helix | NA | ||
| 30848594 | 2019 | K{d}L{d}{nnr:o}S{d}L{d}L{d}{nnr:o}T{d}L{d}S{d}{nnr:o}A{d}K{d}A{d}A{d}K{d}L{d}{nnr:o}T{d}L{d}L{d}{nnr:o}A{d}L{d}S{d}{nnr:o} | D85(Lys'-6 Orn-1) | Amidation | Acetylation | Linear | D | o = D-Ornithine | 26 | Antimicrobial | 50 % Hemolysis at 406.5 μg/mL | Human | Synthetic Peptide | α-Helix | NA | ||
| 30848594 | 2019 | K{d}L{d}{nnr:Dab}S{d}L{d}L{d}{nnr:Dab}T{d}L{d}S{d}{nnr:Dab}A{d}K{d}A{d}A{d}K{d}L{d}{nnr:Dab}T{d}L{d}L{d}{nnr:Dab}A{d}L{d}S{d}{nnr:Dab} | D86(Lys¹-6 Dab-1) | Amidation | Acetylation | Linear | Mix | Dab = diaminobutyric acid | 26 | Antimicrobial | 50 % Hemolysis at >2000 μg/mL | Human | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 30848594 | 2019 | K{d}L{d}{nnr:Dap}S{d}L{d}L{d}{nnr:Dap}T{d}L{d}S{d}{nnr:Dap}aK{d}A{d}A{d}K{d}L{d}{nnr:Dap}T{d}L{d}L{d}{nnr:Dap}A{d}L{d}S{d}{nnr:Dap} | D105(Lys¹-6 Dap-1) | Amidation | Acetylation | Linear | Mix | Dap = diaminopropionic acid | 26 | Antimicrobial | 50 % Hemolysis at >3000 μg/mL | Human | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 30848594 | 2019 | K{d}L{d}K{d}S{d}L{d}L{d}K{d}T{d}L{d}S{d}K{d}A{d}K{d}A{d}A{d}K{d}L{d}K{d}T{d}L{d}L{d}K{d}A{d}L{d}S{d}S{d}{nt:Acet}{ct:Amid} | D101(Lys' Ser26-5 Lys-1) | Amidation | Acetylation | Linear | D | substituted with positive charged Lys | 26 | Antimicrobial | 50 % Hemolysis at 279 μg/mL | Human | Synthetic Peptide | α-Helix | NA | ||
| 30848594 | 2019 | K{d}L{d}{nnr:Dab}S{d}L{d}L{d}{nnr:Dab}T{d}L{d}S{d}{nnr:Dab}A{d}K{d}A{d}A{d}K{d}L{d}{nnr:Dab}T{d}L{d}L{d}{nnr:Dab}A{d}L{d}S{d}S{d} | D102(Lys Ser26-5 Dab-1) | Amidation | Acetylation | Linear | Mix | Dab = diaminobutyric acid | 26 | Antimicrobial | 50 % Hemolysis at >2000 μg/mL | Human | Synthetic Peptide | α-Helix | Low hemolytic | ||
| 30848594 | 2019 | K{d}L{d}{nnr:o}S{d}L{d}L{d}{nnr:o}T{d}L{d}S{d}{nnr:o}A{d}A{d}A{d}A{d}A{d}L{d}{nnr:o}T{d}L{d}L{d}{nnr:o}A{d}L{d}S{d}{nnr:o} | D85(K13A/K16A) -(Lys'-6 Orn-1) | Amidation | Acetylation | Linear | D | o = D-Ornithine | 26 | Antimicrobial | 50 % Hemolysis at 2.3 μg/mL | Human | Synthetic Peptide | α-Helix | NA | ||
| 30848594 | 2019 | K{d}L{d}{nnr:Dab}S{d}L{d}L{d}{nnr:Dab}T{d}L{d}S{d}{nnr:Dab}A{d}A{d}A{d}A{d}A{d}L{d}{nnr:Dab}T{d}L{d}L{d}{nnr:Dab}A{d}L{d}S{d}{nnr:Dab} | D86(K13A/K16A) -(Lys¹-6 Dab-1) | Amidation | Acetylation | Linear | Mix | Dab = diaminobutyric acid | 26 | Antimicrobial | 50 % Hemolysis at 20 μg/mL | Human | Synthetic Peptide | α-Helix | NA | ||
| 30848594 | 2019 | K{d}L{d}{nnr:Dap}S{d}L{d}L{d}{nnr:Dap}T{d}L{d}S{d}{nnr:Dap}A{d}A{d}A{d}A{d}A{d}L{d}{nnr:Dap}T{d}L{d}L{d}{nnr:Dap}A{d}L{d}S{d}{nnr:Dap} | D105(K13A/K16A) -(Lys'-6 Dap-1) | Amidation | Acetylation | Linear | Mix | Dap = diaminopropionic acid | 26 | Antimicrobial | 50 % Hemolysis at 7.2 μg/mL | Human | Synthetic Peptide | α-Helix | NA | ||
| 31118709 | 2019 | KFKKLFKKLSPVFKRIVQRIKDFLR{nt:Amid} | B1 | Free | Amidation | Linear | L | None | 25 | Antibiofilm, Antibacterial | 37 % Hemolysis at 150 µM | Human | Hybrid Peptide From Ll-37 And Bmap-27 | α-Helix = 88% and Random coils = 12% | NA | ||
| 30773822 | 2019 | LSVKAFTGLQLRGVCGLEVKARG | MCh-AMP1 | Free | Free | Linear | L | None | 23 | Antifungal | 10.6 % Hemolysis at 105.58 µM | Human | Matricaria Chamomilla | NA | NA | ||
| 30773822 | 2019 | LSVKAFTGLQLRGVCGLEVKARG | MCh-AMP1 | Free | Free | Linear | L | None | 23 | Antifungal | 3.65 % Hemolysis at 13.32 µM | Human | Matricaria Chamomilla | NA | Low hemolytic | ||
| 31159194 | 2019 | CGIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 27 | Antimicrobial | 50 % Hemolysis at 0.8 ± 0.2 (n at25) µM (pH 5.5) | Human | Cell-Penetrating Peptide | NA | NA | ||
| 31159194 | 2019 | CGLFEAIAGFIENGWEGMIDGWYG | HA2 | Free | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolysis at >20 µM (pH 5.5) | Human | Parent Influenza Hemagglutinin Peptide | NA | NA | ||
| 31159194 | 2019 | CGLFEAIEGFIENGWEGMIDGWYG | INF7 | Free | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolysis at 16 µM (pH 5.5) | Human | Ha2 Analog | NA | NA | ||
| 31159194 | 2019 | CGLFEAIEGFIENGWEGMIDGWYGYGRKKR | 37g | Free | Free | Linear | L | None | 30 | NA | 50 % Hemolysis at 7.8 µM (pH 5.5) | Human | Chimeric Peptide | NA | NA | ||
| 31159194 | 2019 | CGIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 27 | Antimicrobial | 50 % Hemolysis at 2.6 ± 0.6 (n at 25) µM (pH 7.4) | Human | Cell-Penetrating Peptide | NA | NA | ||
| 31159194 | 2019 | CGLFEAIAGFIENGWEGMIDGWYG | HA2 | Free | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolysis at >20 µM (pH 7.4) | Human | Parent Influenza Hemagglutinin Peptide | NA | NA | ||
| 31159194 | 2019 | CGLFEAIEGFIENGWEGMIDGWYG | INF7 | Free | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolysis at >20 µM (pH 7.4) | Human | Ha2 Analog | NA | NA | ||
| 31159194 | 2019 | CGLFEAIEGFIENGWEGMIDGWYGYGRKKR | 37g | Free | Free | Linear | L | None | 30 | NA | 50 % Hemolysis at >100 µM (pH 7.4) | Human | Chimeric Peptide | NA | NA | ||
| 31001677 | 2019 | HRHQGPIFDTRPSPFNPNQPRPGPIY | Mtk-1 | Free | Free | Linear | L | None | 26 | Antiparasitic | <20 % Hemolysis at 100 μM | Mouse | Drosophila Melanogaster | NA | Low hemolytic | ||
| 31001677 | 2019 | HRRQGPIFDTRPSPFNPNQPRPGPIY | Mtk-2 | Free | Free | Linear | L | None | 26 | Antiparasitic | <20 % Hemolysis at 100 μM | Mouse | Drosophila Melanogaster | NA | NA | ||
| 31001677 | 2019 | HRHQGPIFDTRPSPFNPNQPRPGPIY | Mtk-1 | Free | Free | Linear | L | None | 26 | Antiparasitic | <20 % Hemolysis at 100 μM | Pig | Drosophila Melanogaster | NA | NA | ||
| 31001677 | 2019 | HRRQGPIFDTRPSPFNPNQPRPGPIY | Mtk-2 | Free | Free | Linear | L | None | 26 | Antiparasitic | <20 % Hemolysis at 100 μM | Pig | Drosophila Melanogaster | NA | NA | ||
| 31303986 | 2019 | IWLTALKFLGKHAAKHLAKQQLSKL{ct:Amid} | M-lycotoxin | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 50 % Hemolysis at 0.78 μM | Human | Wolf Spider Lycosa Carolinensis | α-Helix | NA | ||
| 31303986 | 2019 | GIGKFLHSAKKFGKAFVGEIMNS{nt:Acet}{ct:Amid} | Magainin 2 derivative | Amidation | Acetylation | Linear | L | None | 23 | Antimicrobial | 50 % Hemolysis at >100 μM | Human | Xenopus Laevis (The African Clawed Frog | α-Helix | Non-hemolytic | ||
| 31303986 | 2019 | KKKKKKKKKGGGLLALLALLA{nt:H}{ct:Amid} | Block | Amidation | H | Linear | L | None | 21 | Antibacterial | 50 % Hemolysis at 25 μM | Human | Synthetic Peptide | 20 mM phosphate buffer solution with 1% SDS solution = α-Helix | NA | ||
| 31303986 | 2019 | KLLKKAGKLLKKAGKLLKKAG{nt:H}{ct:Amid} | Stripe | Amidation | H | Linear | L | None | 21 | Antibacterial | 50 % Hemolysis at >100 μM | Human | Synthetic Peptide | 20 mM phosphate buffer solution with 1% SDS solution = α-Helix | Non-hemolytic | ||
| 31303986 | 2019 | KKKLAKLKLGAKLKLKGKLGA{nt:H}{ct:Amid} | Random | Amidation | H | Linear | L | None | 21 | Antibacterial | 50 % Hemolysis at 100 μM | Human | Synthetic Peptide | 20 mM phosphate buffer solution with 1% SDS solution = α-Helix | Low hemolytic | ||
| 31216348 | 2019 | TVIEVASKMCSKMRLLKGLCKSITKRFLRR | bNK2A-C10C20 | Free | Free | Linear | L | None | 30 | Antibacterial | <2 % Hemolysis at 5 μM | Cattle | Nk-Lysin-Derived Peptides | TFE = α-Helix, NaPB = Random coil | Non-hemolytic | ||
| 31216348 | 2019 | TVIEVASKMSSKMRLLKGLSKSITKRFLRR | bNK2A-S10S20 | Free | Free | Linear | L | None | 30 | Antibacterial | <2 % Hemolysis at 5 μM | Cattle | Nk-Lysin-Derived Peptides | TFE = α-Helix, NaPB = Random coil | Non-hemolytic | ||
| 31216348 | 2019 | TVIEVASKMCSKMRLLKGLCKSITKRFLRR | bNK2A-C10C20 | Free | Free | Linear | L | None | 30 | Antibacterial | <2 % Hemolysis at 20 μM | Cattle | Nk-Lysin-Derived Peptides | TFE = α-Helix, NaPB = Random coil | Non-hemolytic | ||
| 31216348 | 2019 | TVIEVASKMSSKMRLLKGLSKSITKRFLRR | bNK2A-S10S20 | Free | Free | Linear | L | None | 30 | Antibacterial | <2 % Hemolysis at 20 μM | Cattle | Nk-Lysin-Derived Peptides | TFE = α-Helix, NaPB = Random coil | Non-hemolytic | ||
| 30790604 | 2019 | WFGKLYRGKTKVVKKVKGLLKG{nt:Amid} | Cnd-m3a | Free | Amidation | Linear | L | None | 22 | Antibacterial | 5 % Hemolysis at 3 μM | Human | Mutant Of Cnd(Icefish Chionodraco Hamatus) | α-Helix | NA | ||
| 30790604 | 2019 | WFGKLYRGKTKVVKKVKGLLKG{nt:Amid} | Cnd-m3a | Free | Amidation | Linear | L | None | 22 | Antibacterial | 30 % Hemolysis at 50 μM | Human | Mutant Of Cnd(Icefish Chionodraco Hamatus) | α-Helix | NA | ||
| 30927490 | 2019 | ACYCRIPACIAGERRYGTCIYQGRLWAFCC | HNP-1 | Free | Free | Linear | L | None | 30 | Antimicrobial | 9.3 % Hemolysis at 5 μM | Mouse | Α‐Defensin (Human Neutrophil Peptide‐1) | Triple-Stranded β-Sheet structure | NA | ||
| 30927490 | 2019 | ACYCRIPACIAGERRYGTCIYQGRLWAFCC | HNP-1 | Free | Free | Linear | L | None | 30 | Antimicrobial | 8.7 % Hemolysis at 500 μM | Mouse | Α‐Defensin (Human Neutrophil Peptide‐1) | Triple-Stranded β-Sheet structure | Low hemolytic | ||
| 30927490 | 2019 | ACYCRIPACIAGERRYGTCIYQGRLWAFCC | HNP-1 | Free | Free | Linear | L | None | 30 | Antimicrobial | 8.8 % Hemolysis at 5000 μM | Mouse | Α‐Defensin (Human Neutrophil Peptide‐1) | Triple-Stranded β-Sheet structure | Low hemolytic | ||
| 31145591 | 2019 | RWKRHISEQLRRRDRLQRQAF | K18 | Free | Free | Linear | L | None | 21 | Antibacterial | >1 % Hemolysis at 500 μM | Mouse | Synthetic Amp | NA | Non-hemolytic | ||
| 31145591 | 2019 | RWKRHISEQLRRRDRLQRQA{nnr:J} | K22 | Free | Free | Linear | L | J = 2-naphthyl alanine (2-Nal) | 21 | Antibacterial | >1 % Hemolysis at 500 μM | Mouse | Analogue Of K18 | NA | Non-hemolytic | ||
| 31145591 | 2019 | RWKRHISEQLRRRDRLQRQA{nnr:J}{ct:Amid} | K22.2 | Amidation | Free | Linear | L | J = 2-naphthyl alanine (2-Nal) | 21 | Antibacterial | >1 % Hemolysis at 500 μM | Mouse | Synthetic Amp | NA | Non-hemolytic | ||
| 31145591 | 2019 | {conj:R1}RWKRHISEQLRRRDRLQRQA{nnr:J}{ct:Amid} | K30 | Amidation | R1 | Linear | L | R1 = 4-methylhexanoyl, J = 2-naphthyl alanine (2-Nal) | 21 | Antibacterial | >1 % Hemolysis at 500 μM | Mouse | Fatty Acid Conjugated With K22.2 | D8PG at 206nm = Random coil, D8PG at 220nm = α-Helix | Non-hemolytic | ||
| 31145591 | 2019 | {conj:R2}RWKRHISEQLRRRDRLQRQA{nnr:J}{ct:Amid} | K31 | Amidation | R2 | Linear | L | R2 = myristoyl, J = 2-naphthyl alanine (2-Nal) | 21 | Antibacterial | >80 % Hemolysis at 500 μM | Mouse | Fatty Acid Conjugated With K22.2 | NA | NA | ||
| 31145591 | 2019 | {conj:R3}RWKRHISEQLRRRDRLQRQA{nnr:J}{ct:Amid} | K33 | Amidation | R3 | Linear | L | R3 = palmitoyl, J = 2-naphthyl alanine (2-Nal) | 21 | Antibacterial | 100 % Hemolysis at 500 μM | Mouse | Fatty Acid Conjugated With K22.2 | NA | NA | ||
| 31145591 | 2019 | {conj:R5}RWKRHISEQLRRRDRLQRQA{nnr:J}{ct:Amid} | K36 | Amidation | R5 | Linear | L | R5 = Fmoc, J = 2-naphthyl alanine (2-Nal) | 21 | Antibacterial | >20 % Hemolysis at 500 μM | Mouse | Fatty Acid Conjugated With K22.2 | NA | NA | ||
| 31145591 | 2019 | {conj:R4}RWKRHISEQLRRRDRLQRQA{nnr:J}{ct:Amid} | K46 | Amidation | R4 | Linear | L | R4 = capryl, J = 2-naphthyl alanine (2-Nal) | 21 | Antibacterial | >10 % Hemolysis at 500 μM | Mouse | Fatty Acid Conjugated With K22.2 | NA | NA | ||
| 31128493 | 2019 | GRTSKQELCTWERGSVRQADKTIAG | Skh-AMP1 | Free | Free | Linear | L | None | 25 | Antifungal | 0.19 % Hemolysis at 3.6 μM | Human | Plant Leaves Satureja Khuzistanica | α-Helix | Low hemolytic | ||
| 31128493 | 2019 | GRTSKQELCTWERGSVRQADKTIAG | Skh-AMP1 | Free | Free | Linear | L | None | 25 | Antifungal | 2.1 % Hemolysis at 72 μM | Human | Plant Leaves Satureja Khuzistanica | α-Helix | Low hemolytic | ||
| 31128493 | 2019 | GRTSKQELCTWERGSVRQADKTIAG | Skh-AMP1 | Free | Free | Linear | L | None | 25 | Antifungal | 0.67 % Hemolysis at 25.2 μM | Human | Plant Leaves Satureja Khuzistanica | α-Helix | Low hemolytic | ||
| 31128493 | 2019 | GRTSKQELCTWERGSVRQADKTIAG | Skh-AMP1 | Free | Free | Linear | L | None | 25 | Antifungal | 0.98 % Hemolysis at 32 μM | Human | Plant Leaves Satureja Khuzistanica | α-Helix | Low hemolytic | ||
| 31128493 | 2019 | GRTSKQELCTWERGSVRQADKTIAG | Skh-AMP1 | Free | Free | Linear | L | None | 25 | Antifungal | 1.45 % Hemolysis at 54 μM | Human | Plant Leaves Satureja Khuzistanica | α-Helix | Low hemolytic | ||
| 31321199 | 2019 | KDRPKKPGLCPLIWWLIIKVG{nt:Amid}{ct:Amid} | omw1 | Amidation | Amidation | Linear | L | None | 21 | Antibiofilm, Antibacterial | 4.30 ± 0.15 % Hemolysis at 31.25 µg/ml | Human | Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus) | NA | Low hemolytic | ||
| 31321199 | 2019 | KDRPKKPGLCPLIWWLIIKVG{nt:Amid}{ct:Amid} | omw1 | Amidation | Amidation | Linear | L | None | 21 | Antibiofilm, Antibacterial | 4.82 ± 0.33 % Hemolysis at 62.5 µg/ml | Human | Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus) | NA | Low hemolytic | ||
| 31321199 | 2019 | KDRPKKPGLCPLIWWLIIKVG{nt:Amid}{ct:Amid} | omw1 | Amidation | Amidation | Linear | L | None | 21 | Antibiofilm, Antibacterial | 6.58 ± 0.25 % Hemolysis at 125 µg/ml | Human | Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus) | NA | NA | ||
| 31321199 | 2019 | KDRPKKPGLCPLIWWLIIKVG{nt:Amid}{ct:Amid} | omw1 | Amidation | Amidation | Linear | L | None | 21 | Antibiofilm, Antibacterial | 10.01 ± 0.52 % Hemolysis at 250 µg/ml | Human | Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus) | NA | NA | ||
| 31321199 | 2019 | KDRPKKPGLCPLIWWLIIKVG{nt:Amid}{ct:Amid} | omw1 | Amidation | Amidation | Linear | L | None | 21 | Antibiofilm, Antibacterial | 14.46 ± 1.82 % Hemolysis at 500 µg/ml | Human | Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus) | NA | NA | ||
| 31321199 | 2019 | KDRPKKPGLCPAAKKAAAAKA{nt:Amid}{ct:Amid} | omw2 | Amidation | Amidation | Linear | L | None | 21 | Antibiofilm, Antibacterial | 1.26 ± 0.38 % Hemolysis at 31.25 µg/ml | Human | Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus) | NA | Low hemolytic | ||
| 31321199 | 2019 | KDRPKKPGLCPAAKKAAAAKA{nt:Amid}{ct:Amid} | omw2 | Amidation | Amidation | Linear | L | None | 21 | Antibiofilm, Antibacterial | 3.12 ± 0.38 % Hemolysis at 62.5 µg/ml | Human | Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus) | NA | Low hemolytic | ||
| 31321199 | 2019 | KDRPKKPGLCPAAKKAAAAKA{nt:Amid}{ct:Amid} | omw2 | Amidation | Amidation | Linear | L | None | 21 | Antibiofilm, Antibacterial | 2.32 ± 0.43 % Hemolysis at 125 µg/ml | Human | Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus) | NA | Low hemolytic | ||
| 31321199 | 2019 | KDRPKKPGLCPAAKKAAAAKA{nt:Amid}{ct:Amid} | omw2 | Amidation | Amidation | Linear | L | None | 21 | Antibiofilm, Antibacterial | 4.82 ± 0.74 % Hemolysis at 250 µg/ml | Human | Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus) | NA | Low hemolytic | ||
| 31321199 | 2019 | KDRPKKPGLCPAAKKAAAAKA{nt:Amid}{ct:Amid} | omw2 | Amidation | Amidation | Linear | L | None | 21 | Antibiofilm, Antibacterial | 9.27 ± 0.27 % Hemolysis at 500 µg/ml | Human | Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus) | NA | NA | ||
| 31426323 | 2019 | ALWKTLLKHVGKAAGKAALNAVTDMVNQ{ct:Amid} | Der-PS4 | Amidation | Free | Linear | L | None | 28 | Antimicrobial, Antibiofilm, Antiproliferative, Anticancer | 50 % Hemolysis at 128 μM | Horse | Waxy Monkey Tree Frog, Phyllomedusa Sauvagii | mimetic environment(DOPE, DOPC and DOPG, TFE) = α-Helix | NA | ||
| 31252047 | 2019 | SRSSRAGLQFPVGRIHRLLRK{nt:Acet}{ct:Amid} | Fi-His1-21 | Amidation | Acetylation | Linear | L | None | 21 | Antimicrobial, Anticancer | 18 % Hemolysis at 400 μM | Human | Indian White Shrimp Histone, H2A Derived Amp From Fenneropenaeus Indicus | α-Helix | Low hemolytic | ||
| 31252047 | 2019 | SRSSRAGLQFPVGRIHRLLRK{nt:Acet}{ct:Amid} | Fi-His1-21 | Amidation | Acetylation | Linear | L | None | 21 | Antimicrobial, Anticancer | 5 % Hemolysis at 200 μM | Human | Indian White Shrimp Histone, H2A Derived Amp From Fenneropenaeus Indicus | α-Helix | Low hemolytic | ||
| 31252047 | 2019 | SRSSRAGLQFPVGRIHRLLRK{nt:Acet}{ct:Amid} | Fi-His1-21 | Amidation | Acetylation | Linear | L | None | 21 | Antimicrobial, Anticancer | 0 % Hemolysis at 100 μM | Human | Indian White Shrimp Histone, H2A Derived Amp From Fenneropenaeus Indicus | α-Helix | Non-hemolytic | ||
| 31252047 | 2019 | SRSSRAGLQFPVGRIHRLLRK{nt:Acet}{ct:Amid} | Fi-His1-21 | Amidation | Acetylation | Linear | L | None | 21 | Antimicrobial, Anticancer | 0 % Hemolysis at 50 μM | Human | Indian White Shrimp Histone, H2A Derived Amp From Fenneropenaeus Indicus | α-Helix | Non-hemolytic | ||
| 31252047 | 2019 | SRSSRAGLQFPVGRIHRLLRK{nt:Acet}{ct:Amid} | Fi-His1-21 | Amidation | Acetylation | Linear | L | None | 21 | Antimicrobial, Anticancer | 0 % Hemolysis at 25 μM | Human | Indian White Shrimp Histone, H2A Derived Amp From Fenneropenaeus Indicus | α-Helix | Non-hemolytic | ||
| 31252047 | 2019 | SRSSRAGLQFPVGRIHRLLRK{nt:Acet}{ct:Amid} | Fi-His1-21 | Amidation | Acetylation | Linear | L | None | 21 | Antimicrobial, Anticancer | 0 % Hemolysis at 12.5 μM | Human | Indian White Shrimp Histone, H2A Derived Amp From Fenneropenaeus Indicus | α-Helix | Non-hemolytic | ||
| 31252047 | 2019 | SRSSRAGLQFPVGRIHRLLRK{nt:Acet}{ct:Amid} | Fi-His1-21 | Amidation | Acetylation | Linear | L | None | 21 | Antimicrobial, Anticancer | 0 % Hemolysis at 6.25 μM | Human | Indian White Shrimp Histone, H2A Derived Amp From Fenneropenaeus Indicus | α-Helix | Non-hemolytic | ||
| 31252047 | 2019 | SRSSRAGLQFPVGRIHRLLRK{nt:Acet}{ct:Amid} | Fi-His1-21 | Amidation | Acetylation | Linear | L | None | 21 | Antimicrobial, Anticancer | 0 % Hemolysis at 3.125 μM | Human | Indian White Shrimp Histone, H2A Derived Amp From Fenneropenaeus Indicus | α-Helix | Non-hemolytic | ||
| 31635388 | 2019 | GLWSKIKDAA-KTAGKAALGFVNEMV | DPT9 | Free | Free | Linear | L | None | 25 | Antimicrobial, Antibiofilm, Anticancer | 50 % Hemolysis at 210 μM | Horse | Derived From Frog Phyllomedusa Tarsius Dpt9 | NA | NA | ||
| 31635388 | 2019 | GLWSKIKKAA-KTAGKAALGFVNKMV | K8, 23-DPT9 | Free | Free | Linear | L | None | 25 | Antimicrobial, Antibiofilm, Anticancer | 50 % Hemolysis at 107 μM | Horse | Analogue And Modified Dtp9 | NA | Low hemolytic | ||
| 31653005 | 2019 | ALWKSILKNVGKAAGKAVLNAVTDMVNQ{ct:Amid} | DM-PC | Amidation | Free | Linear | L | None | 28 | Antimicrobial | >80 % Hemolysis at 256 μM | Horse | Frog Phyllomedusa Coelestis | aqueous = Random coil, 50% TFE buffer = Helical | NA | ||
| 31671555 | 2019 | FLSLIPHVISAIPHVVNALSNL{ct:Amid} | Phylloseptin-SP1 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | >40 % Hemolysis at 64 μM | Human | Agalychnis Spurrelli (Gliding Leaf Frog) | α-Helix | NA | ||
| 31671555 | 2019 | SLWSSIKDMAAAAGRAALNAVNGIVNP{ct:Amid} | Dermaseptin-SP3 | Amidation | Free | Linear | L | None | 30 | Antimicrobial | <4 % Hemolysis at 64 μM | Human | Agalychnis Spurrelli (Gliding Leaf Frog) | α-Helix | Non-hemolytic | ||
| 31671555 | 2019 | SLWSSIKDMAAAAGRAALNAVNGILNP{ct:Amid} | Dermaseptin-SP4 | Amidation | Free | Linear | L | None | 30 | Antimicrobial | <4 % Hemolysis at 64 μM | Human | Agalychnis Spurrelli (Gliding Leaf Frog) | α-Helix | Non-hemolytic | ||
| 31671555 | 2019 | SLRSSIKDMAAAAGRAALNAVNGIVNP{ct:Amid} | Dermaseptin-SP5 | Amidation | Free | Linear | L | None | 30 | Antimicrobial | <2 % Hemolysis at 64 μM | Human | Agalychnis Spurrelli (Gliding Leaf Frog) | α-Helix | Non-hemolytic | ||
| 31671555 | 2019 | FLSLIPHVISAIPHVVNALSNL{ct:Amid} | Phylloseptin-SP1 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | >85 % Hemolysis at 256 μM | Human | Agalychnis Spurrelli (Gliding Leaf Frog) | α-Helix | NA | ||
| 31671555 | 2019 | SLWSSIKDMAAAAGRAALNAVNGIVNP{ct:Amid} | Dermaseptin-SP3 | Amidation | Free | Linear | L | None | 30 | Antimicrobial | >10 % Hemolysis at 256 μM | Human | Agalychnis Spurrelli (Gliding Leaf Frog) | α-Helix | NA | ||
| 31671555 | 2019 | SLWSSIKDMAAAAGRAALNAVNGILNP{ct:Amid} | Dermaseptin-SP4 | Amidation | Free | Linear | L | None | 30 | Antimicrobial | >10 % Hemolysis at 256 μM | Human | Agalychnis Spurrelli (Gliding Leaf Frog) | α-Helix | NA | ||
| 31667994 | 2019 | GIGKFLHSAKKFGKAFVGEIMNS{nt:H}{ct:Amid} | Mag 2 | Amidation | H | Linear | L | None | 23 | Antibacterial | Hemolysis at >100 µM | Human | Frogs | 1%SDS = α-Helix | NA | ||
| 31713951 | 2019 | KGIRGYKGGYCKGAFKQTCKCY | Os | Free | Free | Linear | L | None | 22 | Antibacterial | 0 % Hemolysis at 25 µM | Human | Soft Tick Ornithodoros Savignyi | NA | Non-hemolytic | ||
| 31713951 | 2019 | KGIRGYKGGYCKGAFKQTCKCY | Os | Free | Free | Linear | L | None | 22 | Antibacterial | 0 % Hemolysis at 100 µM | Human | Soft Tick Ornithodoros Savignyi | NA | Non-hemolytic | ||
| 31549575 | 2019 | GVTF{d}NALK{d}GVAK{d}TVAAQLLK{d}TAR{cT{d}:Amid} | Brevinin-GR23 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antibiofilm | 0.13 % Hemolysis at 25 µM | Human | Frog Hylarana Guentheri | aqueous = Random coil, 30 mM SDS and 50% TFE solution(MME) = α-Helical | Non-hemolytic | ||
| 31549575 | 2019 | GVTF{d}NALK{d}GVAK{d}TVAAQLLK{d}TAR{cT{d}:Amid} | Brevinin-GR23 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antibiofilm | 0.23 % Hemolysis at 50 µM | Human | Frog Hylarana Guentheri | aqueous = Random coil, 30 mM SDS and 50% TFE solution(MME) = α-Helical | Non-hemolytic | ||
| 31549575 | 2019 | GVTF{d}NALK{d}GVAK{d}TVAAQLLK{d}TAR{cT{d}:Amid} | Brevinin-GR23 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antibiofilm | 0.38 % Hemolysis at 75 µM | Human | Frog Hylarana Guentheri | aqueous = Random coil, 30 mM SDS and 50% TFE solution(MME) = α-Helical | Non-hemolytic | ||
| 31549575 | 2019 | GVTF{d}NALK{d}GVAK{d}TVAAQLLK{d}TAR{cT{d}:Amid} | Brevinin-GR23 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antibiofilm | 0.75 % Hemolysis at 100 µM | Human | Frog Hylarana Guentheri | aqueous = Random coil, 30 mM SDS and 50% TFE solution(MME) = α-Helical | Non-hemolytic | ||
| 31549575 | 2019 | GVTF{d}NALK{d}GVAK{d}TVAAQLLK{d}TAR{cT{d}:Amid} | Brevinin-GR23 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antibiofilm | 0.83 % Hemolysis at 150 µM | Human | Frog Hylarana Guentheri | aqueous = Random coil, 30 mM SDS and 50% TFE solution(MME) = α-Helical | Non-hemolytic | ||
| 31549575 | 2019 | GVTF{d}NALK{d}GVAK{d}TVAAQLLK{d}TAR{cT{d}:Amid} | Brevinin-GR23 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antibiofilm | 1.6 % Hemolysis at 200 µM | Human | Frog Hylarana Guentheri | aqueous = Random coil, 30 mM SDS and 50% TFE solution(MME) = α-Helical | Low hemolytic | ||
| 31676352 | 2019 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 75 % Hemolysis at 2 µM | mouse | Honey Bee Apis Mellifera | α-Helical | NA | ||
| 31887002 | 2020 | LKKLCARLKKLCARLKKLCAR{ct:Amid} | CAR3 | Amidation | Free | Linear | L | None | 21 | Antifungal, Antibacterial | 10 % Hemolysis at >128 µM | Human | Heptad Repeat Sequence Antifungal Peptide | PBS = Random coil, PBS(208-222nm) = α-Helical, SDS/TFE = α-Helical | Low hemolytic | ||
| 31887002 | 2020 | LKKLCARLKKLCARLKKLCARLKKLCAR{ct:Amid} | CAR4 | Amidation | Free | Linear | L | None | 28 | Antifungal, Antibacterial | 10 % Hemolysis at 8 µM | Human | Heptad Repeat Sequence Antifungal Peptide | PBS = Random coil, SDS/TFE = α-Helical | NA | ||
| 31887002 | 2020 | LKKLACRLKKLACRLKKLACR{ct:Amid} | ACR3 | Amidation | Free | Linear | L | None | 21 | Antibiofilm, Antifungal, Antibacterial | 10 % Hemolysis at >128 µM | Human | Heptad Repeat Sequence Antifungal Peptide | PBS = Random coil, PBS(208-222nm) = α-Helical, SDS/TFE = α-Helical | Low hemolytic | ||
| 31887002 | 2020 | LKKLACRLKKLACRLKKLACRLKKLACR{ct:Amid} | ACR4 | Amidation | Free | Linear | L | None | 28 | Antifungal, Antibacterial | 10 % Hemolysis at 32 µM | Human | Heptad Repeat Sequence Antifungal Peptide | PBS = Random coil, PBS(208-222nm) = α-Helical, SDS/TFE = α-Helical | NA | ||
| 31887002 | 2020 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin (MLT) | Amidation | Free | Linear | L | None | 26 | Antifungal, Antibacterial | 10 % Hemolysis at 1 µM | Human | Heptad Repeat Sequence Antifungal Peptide | PBS = Random coil, PBS(208-222nm) = α-Helical, SDS/TFE = α-Helical | NA | ||
| 31802582 | 2020 | GWWRRTVDKVRNAGRKVAGFASKACGALGH{ct:-OH} | P1-HC1 (EeCentrocin 1) | -OH | Free | Linear | L | None | 30 | Antimicrobial | 74.6 % Hemolysis at 200 μM | Human | Sea Urchin Echinus Esculentus | α‐Helix | NA | ||
| 31802582 | 2020 | GWWRRTVDKVRNAGRKVAGFASKACGALGH{ct:-OH} | P1-HC1 (EeCentrocin 1) | -OH | Free | Linear | L | None | 30 | Antimicrobial | 13.5 % Hemolysis at 25 μM | Human | Sea Urchin Echinus Esculentus | α‐Helix | NA | ||
| 31862270 | 2020 | LPKPPKPVSKMRMATPLLMQALPM | CLIP | Free | Free | Linear | L | None | 24 | Anti-leishmanial | 0 % Hemolysis at 500 μg/ml | Human | Mhc Class Ii Associated Invariant Chain Peptide | NA | Non-hemolytic | ||
| 31862270 | 2020 | {conj:Lauric acid}LPKPPKPVSKMRMATPLLMQALPM | Lauric acid-LIP (L-CLIP) | Free | Lauric acid | Linear | L | None | 24 | Antibacterial | 58 % Hemolysis at 319 μg/ml | Human | Lauric Acid Conjugated Clip | NA | NA | ||
| 32024261 | 2020 | KARKKKLNKKGRKMAGRKRGRPKK | Dot1l | Free | Free | Linear | L | None | 24 | CPPs (Cell-penetrating peptides) | <0.5 % Hemolysis at 10 μM | Human | Human Gene Dot1L | α-Helical | Non-hemolytic | ||
| 32024261 | 2020 | KARKKKLNKKGRKMAGRKRGRPKK | Dot1l | Free | Free | Linear | L | None | 24 | CPPs (Cell-penetrating peptides) | <0.5 % Hemolysis at 7.5 μM | Human | Human Gene Dot1L | α-Helical | Non-hemolytic | ||
| 32041161 | 2020 | FFGHLLRGIVSVGKHIHGLITG | Trematocine | Free | Free | Linear | L | None | 22 | Antimicrobial | 1 % Hemolysis at 5 μM | Rabbit | Teleost Fish Trematomus Bernacchii | PE/PG 70:30(large unilamellar vesicles (LUVs) = α-Helix, buffer = Random coil | Low hemolytic | ||
| 32041161 | 2020 | FFGHLLRGIVSVGKHIHGLITG | Trematocine | Free | Free | Linear | L | None | 22 | Antimicrobial | 7 % Hemolysis at 10 μM | Rabbit | Teleost Fish Trematomus Bernacchii | PE/PG 70:30(large unilamellar vesicles (LUVs) = α-Helix, buffer = Random coil | NA | ||
| 32041161 | 2020 | FFGHLLRGIVSVGKHIHGLITG | Trematocine | Free | Free | Linear | L | None | 22 | Antimicrobial | 55 % Hemolysis at 50 μM | Rabbit | Teleost Fish Trematomus Bernacchii | PE/PG 70:30(large unilamellar vesicles (LUVs) = α-Helix, buffer = Random coil | NA | ||
| 32153547 | 2020 | RNGCIVDPRCPYQQCRRPLYCRRR | NCR247 | Free | Free | Linear | L | None | 24 | Antibacterial | 1.75 % Hemolysis at 100 μM | Human | Plant Medicago Truncatula Nodule-Specific Cysteine-Rich (Ncr) Peptides | NA | Low hemolytic | ||
| 32153547 | 2020 | RPLNFKMLRFWGQQQCRRPLYCRRR | X1-NCR247C | Free | Free | Linear | L | None | 25 | Antibacterial | 3.51 % Hemolysis at 100 μM | Human | Derivatives Of Ncr247 | NA | Low hemolytic | ||
| 32153547 | 2020 | QQCRRPLYCRRRKALAALAKKIL | NCR247C-X2 | Free | Free | Linear | L | None | 23 | Antibacterial | 7.02 % Hemolysis at 100 μM | Human | Derivatives Of Ncr247 | NA | NA | ||
| 32153547 | 2020 | KALAALAKKILQQCRRPLYCRRR | X2-NCR247C | Free | Free | Linear | L | None | 23 | Antibacterial | 6.14 % Hemolysis at 100 μM | Human | Derivatives Of Ncr247 | NA | NA | ||
| 32153547 | 2020 | GWTLNSAGYLLGKINLKALAALAKKIL | Transportan | Free | Free | Linear | L | None | 27 | Antibacterial | 95.61 % Hemolysis at 100 μM | Human | Derivatives Of Ncr247 | NA | NA | ||
| 32153547 | 2020 | RNGCIVDPRCPYQQCRRPLYCRRR | NCR247 | Free | Free | Linear | L | None | 24 | Antibacterial | 0.88 % Hemolysis at 25 μM | Human | Plant Medicago Truncatula Nodule-Specific Cysteine-Rich (Ncr) Peptides | NA | Low hemolytic | ||
| 32153547 | 2020 | RPLNFKMLRFWGQQQCRRPLYCRRR | X1-NCR247C | Free | Free | Linear | L | None | 25 | Antibacterial | 1.75 % Hemolysis at 25 μM | Human | Derivatives Of Ncr247 | NA | Low hemolytic | ||
| 32153547 | 2020 | QQCRRPLYCRRRKALAALAKKIL | NCR247C-X2 | Free | Free | Linear | L | None | 23 | Antibacterial | 1.75 % Hemolysis at 25 μM | Human | Derivatives Of Ncr247 | NA | Low hemolytic | ||
| 32153547 | 2020 | KALAALAKKILQQCRRPLYCRRR | X2-NCR247C | Free | Free | Linear | L | None | 23 | Antibacterial | 1.75 % Hemolysis at 25 μM | Human | Derivatives Of Ncr247 | NA | Low hemolytic | ||
| 32153547 | 2020 | GWTLNSAGYLLGKINLKALAALAKKIL | Transportan | Free | Free | Linear | L | None | 27 | Antibacterial | 38.6 % Hemolysis at 25 μM | Human | Derivatives Of Ncr247 | NA | NA | ||
| 32258871 | 2020 | SCLPKEEQIGKSTRGRKCRRKK | Phd3 | Free | Free | Linear | L | None | 22 | Antibacterial | >12.5 % Hemolysis at 12 μM | Rat | Human-Β-Defensins Hbd3 Analogues | NA | NA | ||
| 32258871 | 2020 | SCLPKEEQIGKSTRGRKCRRKK{nt:Myr = myristoylated} | MPhd3 | Free | Myr = myristoylated | Linear | L | None | 22 | Antibacterial | >50 % Hemolysis at 12 μM | Rat | Myristoylated Mphd3 | NA | NA | ||
| 32242658 | 2020 | RRRRRRRRRRRRRRRRRRRRRRRRKKK{ct:Amid} | 4R6 | Amidation | Free | Linear | L | None | 27 | Antibacterial | 5 % Hemolysis at >4000 μg/mL | Rat | Arginine-Based Four-Armed Copolypeptides | NA | Non-hemolytic | ||
| 32242658 | 2020 | RGRGRGRGRGRGRGRGRGRGRGRGKKK{ct:Amid} | 4R3G3 | Amidation | Free | Linear | L | None | 27 | Antibacterial | 5 % Hemolysis at >4000 μg/mL | Rat | Arginine-Based Four-Armed Copolypeptides | NA | Non-hemolytic | ||
| 32342079 | 2020 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicobial | 5 % Hemolysis at 0.25 μM | Human | Honey Bee | α-Helical | NA | ||
| 33937618 | 2020 | LLKELWTKMKGAGKAVLGKIKGLL | L1 | Free | Free | Linear | L | None | 24 | Antibacterial | 1 % Hemolysis at 15 μM | Human | Ponerine Ant Neoponera Goeldii | water = Random/dosordered structure, lipid vesicles = α-Helix | Low hemolytic | ||
| 33937618 | 2020 | LLKQLWTKMKGAGKAVLGKIKGLL | L1-Q | Free | Free | Linear | L | None | 24 | Antibacterial | 1 % Hemolysis at 15 μM | Human | L1 Variants | water = Random/dosordered structure, lipid vesicles = α-Helix | Low hemolytic | ||
| 33937618 | 2020 | LLKKLWTKMKGAGKAVLGKIKGLL | L1-K | Free | Free | Linear | L | None | 24 | Antibacterial | 1 % Hemolysis at 15 μM | Human | L1 Variants | water = Random/dosordered structure, lipid vesicles = α-Helix | Low hemolytic | ||
| 33937618 | 2020 | LLRELWTRMRGAGRAVLGRIRGLL | L1-R | Free | Free | Linear | L | None | 24 | Antibacterial | <5 % Hemolysis at 15 μM | Human | L1 Variants | water = Random/dosordered structure, lipid vesicles = α-Helix | Low hemolytic | ||
| 33937618 | 2020 | LL{nnr:O}ELWT{nnr:O}M{nnr:O}GAG{nnr:O}AVLG{nnr:O}I{nnr:O}GLL | L1-O | Free | Free | Linear | L | O = L-Ornithine | 24 | Antibacterial | 1 % Hemolysis at 15 μM | Human | L1 Variants | water = Helical, lipid vesicles = α-Helix | Low hemolytic | ||
| 33937618 | 2020 | LL{nnr:X}ELWT{nnr:X}M{nnr:X}GAG{nnr:X}AVLG{nnr:X}I{nnr:X}GLL | L1-X | Free | Free | Linear | L | X = L-di-amino-propionic acid | 24 | Antibacterial | 1 % Hemolysis at 15 μM | Human | L1 Variants | water = Random/dosordered structure, lipid vesicles = α-Helix | Low hemolytic | ||
| 32397600 | 2020 | SLWGKLKEMAAAAGKAALNAVNGLVNQ{ct:Amid} | DRP-AC4 | Amidation | Free | Linear | L | None | 27 | Antimicrobial, Antibiofilm | 10 % Hemolysis at 26.25 μM | Horse | Frog Skin Agalychnis Callidryas(Dermaseptin) | aqueous = Random coil,50%(TFE) = α-Helix | NA | ||
| 32397600 | 2020 | SLWGKLKEMLAKAGKAVANAVNGLANQ{ct:Amid} | DRP-AC4a | Amidation | Free | Linear | L | None | 27 | Antimicrobial, Antibiofilm | 10 % Hemolysis at 14.49 μM | Horse | Analogue Of Drp-Ac4 | aqueous = Random coil,50%(TFE) = α-Helix | NA | ||
| 32397600 | 2020 | SLWGKLKEMLAAAGKAVANAVNGLANQ{ct:Amid} | DRP-AC4b | Amidation | Free | Linear | L | None | 27 | Antimicrobial, Antibiofilm | 10 % Hemolysis at 21.53 μM | Horse | Analogue Of Drp-Ac4 | aqueous = Random coil,50%(TFE) = α-Helix | NA | ||
| 32443921 | 2020 | FLGAILKIGHALAKTVLPMVTNAFKPKQ | Figainin 2 | Free | Free | Linear | L | None | 28 | Antibacterial, Anticancer, Anti-Epimastigote, Antiviral, Antitrypanosomal, exhibits immunomodulatory effects in human neutrophils | 50 % Hemolysis at 48.9 μM | Human | Skin Chaco Tree Frog, Boana Raniceps | α-Helix, Milli-Q water and 10% (v/v) TFE = Random coil, 30% and 50% (v/v) TFE = α-Helix | NA | ||
| 32443921 | 2020 | FLGAILKIGHALAKTVLPMVTNAFKPKQ | Figainin 2 | Free | Free | Linear | L | None | 28 | Antibacterial, Anticancer, Anti-Epimastigote, Antiviral, Antitrypanosomal, exhibits immunomodulatory effects in human neutrophils | 23 % Hemolysis at 32 μM | Human | Skin Chaco Tree Frog, Boana Raniceps | α-Helix, Milli-Q water and 10% (v/v) TFE = Random coil, 30% and 50% (v/v) TFE = α-Helix | NA | ||
| 32443921 | 2020 | FLGAILKIGHALAKTVLPMVTNAFKPKQ | Figainin 2 | Free | Free | Linear | L | None | 28 | Antibacterial, Anticancer, Anti-Epimastigote, Antiviral, Antitrypanosomal, exhibits immunomodulatory effects in human neutrophils | 9 % Hemolysis at 16 μM | Human | Skin Chaco Tree Frog, Boana Raniceps | α-Helix, Milli-Q water and 10% (v/v) TFE = Random coil, 30% and 50% (v/v) TFE = α-Helix | NA | ||
| 32347293 | 2020 | FLGALFKVASKLVPAAICSISKKC | Brevinin-1GHd | Free | Free | Linear | L | None | 24 | Antimicrobial, Anticancer, Antibiotic, Antibiofilm | 13 % Hemolysis at 32 μM | Horse | Frog Skin, Hylarana Guenther | aqueous(10 mM NH4AC buffer) = Random coil, membrane-mimetic environment (50% TFE in 10 mM NH4AC)membrane-mimetic environment (50% TFE in 10 mM NH4AC) = α-Helix | NA | ||
| 32499514 | 2020 | KIAKRIWKILRRRLFRRVKKVAG{ct:Amid} | P7A3 | Amidation | Free | Linear | L | None | 23 | Antibacterial | 10 % Hemolysis at 3.91 µg/ml | Human | Hybrid Peptide Derivatives Of P7 & A3 | NA | NA | ||
| 32582642 | 2020 | ALWKDMLKGIGKLAGKAALGAVKTLV{ct:Amid} | Dermaseptin-PP | Amidation | Free | Linear | L | None | 26 | Antimicrobial, Antitumor | <20 % Hemolysis at 16 μM | Horse | Frog Phyllomedusa Palliata | 50% TFE-10 mmol/L NH4Ac solution (MME) = α-Helical | NA | ||
| 32582642 | 2020 | ALWKDMLKGIGKLAGKAALGAVKTLV{ct:Amid} | Dermaseptin-PP | Amidation | Free | Linear | L | None | 26 | Antimicrobial, Antitumor | 50 % Hemolysis at 38.77 μM | Horse | Frog Phyllomedusa Palliata | 50% TFE-10 mmol/L NH4Ac solution (MME) = α-Helical | NA | ||
| 32576824 | 2020 | GFCWYVCVYRNGVRVCYRRCN | Arenicin-3 | Free | Free | Linear | L | None | 21 | Antibacterial | 10 % Hemolysis at 204 µg/ml | Human | Marine Lugworm Arenicola Marina | (twisted β-Hairpin) anti-parallel β-Sheet and two stabilizing disulfide bonds | NA | ||
| 32576824 | 2020 | GFCWYVCARRNGARVCYRRCN | AA139 | Free | Free | Linear | L | None | 21 | Antibacterial | 10 % Hemolysis at >300 µg/ml | Human | Arenicin-3 Analogs | NA | Non-hemolytic | ||
| 32576824 | 2020 | GFCWRVCASRNGLRVCYRRCN | NZ17125 | Free | Free | Linear | L | None | 21 | Antibacterial | 10 % Hemolysis at 181 µg/ml | Human | Arenicin-3 Analogs | NA | NA | ||
| 32576824 | 2020 | GFCWYACAKRNGLRVCYRRCN | NZ17126 | Free | Free | Linear | L | None | 21 | Antibacterial | 10 % Hemolysis at 232 µg/ml | Human | Arenicin-3 Analogs | NA | NA | ||
| 32576824 | 2020 | GFCWNVCVRRNGVRVCHRRCN | NZ17143 | Free | Free | Linear | L | None | 21 | Antibacterial | 10 % Hemolysis at >300 µg/ml | Human | Arenicin-3 Analogs | NA | Non-hemolytic | ||
| 32576824 | 2020 | GFCWYVCVKRNGVRSCYRRCN | NZ17160 | Free | Free | Linear | L | None | 21 | Antibacterial | 10 % Hemolysis at >300 µg/ml | Human | Arenicin-3 Analogs | NA | Non-hemolytic | ||
| 32576824 | 2020 | GFCWNVCVYRNGVRICHRRCN | NZ17211 | Free | Free | Linear | L | None | 21 | Antibacterial | 10 % Hemolysis at >300 µg/ml | Human | Arenicin-3 Analogs | NA | Non-hemolytic | ||
| 32576824 | 2020 | GFCWHVCARRNGVRVCYRRCN | NZ17224 | Free | Free | Linear | L | None | 21 | Antibacterial | 10 % Hemolysis at >300 µg/ml | Human | Arenicin-3 Analogs | NA | Non-hemolytic | ||
| 32576824 | 2020 | GFCWRACVYRNGVRACYRRCN | NZ17228 | Free | Free | Linear | L | None | 21 | Antibacterial | 10 % Hemolysis at >300 µg/ml | Human | Arenicin-3 Analogs | NA | Non-hemolytic | ||
| 32576824 | 2020 | GFCWRACVYRNGVRVCYRRCN | NZ17230 | Free | Free | Linear | L | None | 21 | Antibacterial | 10 % Hemolysis at >300 µg/ml | Human | Arenicin-3 Analogs | NA | Non-hemolytic | ||
| 32437150 | 2020 | GIP-CGESCVYIPCITAALGCSCKSKVCYRN{cyc:N-C} | viar 1 | Free | Free | Cyclic | L | None | 30 | Anticancer | 50 % Hemolysis at 11.1 ± 0.02 μM | Human | Plant Viola Arcuata | α-Helical | Low hemolytic | ||
| 32437150 | 2020 | GIP-CGESCVWIPCISAAIGCSCKSKVCYRN{cyc:N-C} | cO13 | Free | Free | Cyclic | L | None | 30 | Anticancer | 50 % Hemolysis at 14.9 ± 0.01 μM | Human | Plant Viola Arcuata | α-Helical | Low hemolytic | ||
| 32437150 | 2020 | GLPVCGETCVGGTCNTPG--CSCSWPVCTRN{cyc:N-C} | kalata S | Free | Free | Cyclic | L | None | 29 | Anticancer | 50 % Hemolysis at ≥50 μM | Human | Plant Viola Arcuata | NA | NA | ||
| 32722535 | 2020 | GIFSKLAGKKIKNLLISGLKG{ct:Amid} | Esc(1-21) | Amidation | Free | Linear | L | None | 21 | Antibacterial | ~10 % Hemolysis at 64 μM | Sheep | Frog Derived Esculentin Peptide | NA | NA | ||
| 32229648 | 2020 | FWGTLAKWALKAIPAAMGMKQNK | Dq-2562 | Free | Free | Linear | L | None | 23 | Antibacterial, Antifungal, histamine-releasing | 5.1 % Hemolysis at 10 μM | Rat | Giant Ant Dinoponera Quadriceps | NA | NA | ||
| 32229648 | 2020 | GLKDWWNKHKDKIVKVVKEMGKAGINAA{ct:Amid} | Dq-3162 | Amidation | Free | Linear | L | None | 28 | Antibacterial, Antifungal, histamine-releasing | 0 % Hemolysis at 10 μM | Rat | Giant Ant Dinoponera Quadriceps | NA | Non-hemolytic | ||
| 32229648 | 2020 | FWGTLAKWALKAIPAAMGMKQNK | Dq-2562 | Free | Free | Linear | L | None | 23 | Antibacterial, Antifungal, histamine-releasing | 82.9 % Hemolysis at 50 μM | Rat | Giant Ant Dinoponera Quadriceps | NA | NA | ||
| 32229648 | 2020 | GLKDWWNKHKDKIVKVVKEMGKAGINAA{ct:Amid} | Dq-3162 | Amidation | Free | Linear | L | None | 28 | Antibacterial, Antifungal, histamine-releasing | 5.6 % Hemolysis at 50 μM | Rat | Giant Ant Dinoponera Quadriceps | NA | NA | ||
| 32126228 | 2020 | GIGKWLHSAKKFGKAFVGEIMNS | MagaininF5W-Lys | Free | Free | Linear | L | None | 23 | Anticancer | 50 % Hemolysis at ≥65 μM | Human | Antimicrobial Peptides | NA | NA | ||
| 32126228 | 2020 | GIGRWLHSARRFGRAFVGEIMNS | MagaininF5W-Arg | Free | Free | Linear | L | None | 23 | Anticancer | 50 % Hemolysis at ≥65 μM | Human | Antimicrobial Peptides | NA | NA | ||
| 32126228 | 2020 | GALFLGFLGAAGSTMGAWSQPKKKRKV{nt:Acet}{ct:CM = CysteAmidation} | MPG | CM = CysteAmidation | Acetylation | Linear | L | CM = CysteAmidation | 27 | Anticancer | 50 % Hemolysis at ≥65 μM | Human | Antimicrobial Peptides | NA | NA | ||
| 32126228 | 2020 | KETWWETWWTEWSQPKKKRKV{nt:Acet}{ct:CM = CysteAmidation} | Pep-1 | CM = CysteAmidation | Acetylation | Linear | L | CM = CysteAmidation | 21 | Anticancer | 50 % Hemolysis at ≥65 μM | Human | Antimicrobial Peptides | NA | NA | ||
| 32126228 | 2020 | TRSSRAGLQFPVGRVHRLLRK | Buforin-2 | Free | Free | Linear | L | None | 21 | Anticancer | 50 % Hemolysis at ≥65 μM | Human | Antimicrobial Peptides | NA | NA | ||
| 32126228 | 2020 | GIGAVLKVLTTGLPAALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 21 | Anticancer | 50 % Hemolysis at ≤6.5 μM | Human | Antimicrobial Peptides | NA | NA | ||
| 32406577 | 2020 | ALWKTLLKKVLKAAAKAALNAVLVGANA | K4S4 | Free | Free | Linear | L | None | 28 | Antibacterial | 50 % Hemolysis at 27.92 ± 8.1 μM | Human | Dermaseptin S4 Peptide Derivatives | α-Helix | NA | ||
| 32406577 | 2020 | TLLKKVLKAAAKAALNAVLVGANA | S4(5–28) | Free | Free | Linear | L | None | 24 | Antibacterial | 50 % Hemolysis at >100 ± 0.0 μM | Human | Dermaseptin S4 Peptide Derivatives | α-Helix | NA | ||
| 32406577 | 2020 | TLLKKVLKAAAKAALNAVLVGANA{ct:Amid} | S4(5–28)a | Amidation | Free | Linear | L | None | 24 | Antibacterial | 50 % Hemolysis at >100 ± 0.0 μM | Human | Dermaseptin S4 Peptide Derivatives | α-Helix | NA | ||
| 32406577 | 2020 | TLLKKVLKAAAKAALKAVLVGANA | K20S4(5–28) | Free | Free | Linear | L | None | 24 | Antibacterial | 50 % Hemolysis at >100 ± 0.0 μM | Human | Dermaseptin S4 Peptide Derivatives | α-Helix | NA | ||
| 32752241 | 2020 | RHHWRRYARIGFRAVRTVIGK{ct:Amid} | Trichoplaxin-2A [T2R1] | Amidation | Free | Linear | L | None | 21 | Antimicrobial, Anticancer | 10 % Hemolysis at 3 μM | Human | Analog Of Trichoplaxin-2 | Helical | NA | ||
| 32752241 | 2020 | GIKKAVGKALKGLKGLLKALGES{ct:Amid} | Adepantin-1A [A1A] | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Anticancer | 10 % Hemolysis at 25 μM | Human | Adepantin-1 Analog | Helical | NA | ||
| 32752241 | 2020 | GIGKFLKKAKKFGKAFVLILKK{ct:Amid} | Pexiganan-L18 [PEXA] | Amidation | Free | Linear | L | None | 22 | Antimicrobial, Anticancer | 10 % Hemolysis at 1.6 μM | Human | Pexiganan Analog | Helical | NA | ||
| 32752241 | 2020 | GIKKWVKGVAKGVAKDLAKKIL{ct:Amid} | Flexampin [FLEX] | Amidation | Free | Linear | L | None | 22 | Antimicrobial, Anticancer | 10 % Hemolysis at 6 μM | Human | Template From Ranatuerin-2Csa | Helical | NA | ||
| 32752241 | 2020 | GIGREIIKKIIKKIGKKIGRII{ct:Amid} | Zyk-1 [ZYK1] | Amidation | Free | Linear | L | None | 22 | Antimicrobial, Anticancer | 10 % Hemolysis at 3 μM | Human | Zyk Strain Of Bacillus Oryziterrae Peptide | Helical | NA | ||
| 32752241 | 2020 | RHHWRRYARIGFRAVRTVIGK{ct:Amid} | Trichoplaxin-2A [T2R1] | Amidation | Free | Linear | L | None | 21 | Antimicrobial, Anticancer | 20 % Hemolysis at 25 μM | Human | Analog Of Trichoplaxin-2 | Helical | NA | ||
| 32752241 | 2020 | GIKKAVGKALKGLKGLLKALGES{ct:Amid} | Adepantin-1A [A1A] | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Anticancer | 20 % Hemolysis at 80 μM | Human | Adepantin-1 Analog | Helical | NA | ||
| 32752241 | 2020 | GIGKFLKKAKKFGKAFVLILKK{ct:Amid} | Pexiganan-L18 [PEXA] | Amidation | Free | Linear | L | None | 22 | Antimicrobial, Anticancer | 20 % Hemolysis at 7 μM | Human | Pexiganan Analog | Helical | NA | ||
| 32752241 | 2020 | GIKKWVKGVAKGVAKDLAKKIL{ct:Amid} | Flexampin [FLEX] | Amidation | Free | Linear | L | None | 22 | Antimicrobial, Anticancer | 20 % Hemolysis at 25 μM | Human | Template From Ranatuerin-2Csa | Helical | NA | ||
| 32752241 | 2020 | GIGREIIKKIIKKIGKKIGRII{ct:Amid} | Zyk-1 [ZYK1] | Amidation | Free | Linear | L | None | 22 | Antimicrobial, Anticancer | 20 % Hemolysis at 8 μM | Human | Zyk Strain Of Bacillus Oryziterrae Peptide | Helical | NA | ||
| 32752241 | 2020 | RHHWRRYARIGFRAVRTVIGK{ct:Amid} | Trichoplaxin-2A [T2R1] | Amidation | Free | Linear | L | None | 21 | Antimicrobial, Anticancer | 50 % Hemolysis at 7000 μM | Human | Analog Of Trichoplaxin-2 | Helical | Low hemolytic | ||
| 32752241 | 2020 | GIKKAVGKALKGLKGLLKALGES{ct:Amid} | Adepantin-1A [A1A] | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Anticancer | 50 % Hemolysis at 125 μM | Human | Adepantin-1 Analog | Helical | NA | ||
| 32752241 | 2020 | GIGKFLKKAKKFGKAFVLILKK{ct:Amid} | Pexiganan-L18 [PEXA] | Amidation | Free | Linear | L | None | 22 | Antimicrobial, Anticancer | 50 % Hemolysis at 520 μM | Human | Pexiganan Analog | Helical | NA | ||
| 32752241 | 2020 | GIKKWVKGVAKGVAKDLAKKIL{ct:Amid} | Flexampin [FLEX] | Amidation | Free | Linear | L | None | 22 | Antimicrobial, Anticancer | 50 % Hemolysis at 1600 μM | Human | Template From Ranatuerin-2Csa | Helical | Low hemolytic | ||
| 32752241 | 2020 | GIGREIIKKIIKKIGKKIGRII{ct:Amid} | Zyk-1 [ZYK1] | Amidation | Free | Linear | L | None | 22 | Antimicrobial, Anticancer | 50 % Hemolysis at 29 μM | Human | Zyk Strain Of Bacillus Oryziterrae Peptide | Helical | NA | ||
| 32781587 | 2020 | FLPLIAGLAAKFLPKIFCAITKKC | B1A | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal | 10 % Hemolysis at 1.576 µM | Horse | Modified From Brevinin-1 (Lithobates Palustris (Rana Palustris)) Frog | aqueous, 1% SDS micelle solution = α-Helix | NA | ||
| 32770019 | 2020 | QNLCNIYYIQHADHCLAVINS | AtR100 | Free | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 0.49 % Hemolysis at 125 µg/ml | Porcine | Plant Aegilops Tauschii Cosson | α-Helix β-Strand | Non-hemolytic | ||
| 32770019 | 2020 | QNLCNIYYIQHADHCLAVINS | AtR100 | Free | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 0.98 % Hemolysis at 250 µg/ml | Porcine | Plant Aegilops Tauschii Cosson | α-Helix β-Strand | Non-hemolytic | ||
| 32770019 | 2020 | QNLCNIYYIQHADHCLAVINS | AtR100 | Free | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 1.35 % Hemolysis at 500 µg/ml | Porcine | Plant Aegilops Tauschii Cosson | α-Helix β-Strand | Non-hemolytic | ||
| 32770019 | 2020 | QNLCNIYYIQHADHCLAVINS | AtR100 | Free | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 2.09 % Hemolysis at 1000 µg/ml | Porcine | Plant Aegilops Tauschii Cosson | α-Helix β-Strand | Non-hemolytic | ||
| 32847054 | 2020 | GFCNFMHLKPISRELRRELYGRTRRRRK | GK28 | Free | Free | Linear | L | None | 28 | Antibacterial | 0 % Hemolysis at 5 μM | Human | Cuttlefish (Sepia Officinalis) | NA | Non-hemolytic | ||
| 32847054 | 2020 | LKALKLPKGSTSTEVRRILVLEIRV | LV25 | Free | Free | Linear | L | None | 25 | NA | 0 % Hemolysis at 5 μM | Human | Cuttlefish (Sepia Officinalis) | α-Helix | Non-hemolytic | ||
| 32847054 | 2020 | GFCNFMHLKPISRELRRELYGRTRRRRK | GK28 | Free | Free | Linear | L | None | 28 | Antibacterial | 0 % Hemolysis at 100 μM | Human | Cuttlefish (Sepia Officinalis) | NA | Non-hemolytic | ||
| 32847054 | 2020 | LKALKLPKGSTSTEVRRILVLEIRV | LV25 | Free | Free | Linear | L | None | 25 | NA | 0 % Hemolysis at 100 μM | Human | Cuttlefish (Sepia Officinalis) | α-Helix | Non-hemolytic | ||
| 32847054 | 2020 | GFCNFMHLKPISRELRRELYGRTRRRRK | GK28 | Free | Free | Linear | L | None | 28 | Antibacterial | 0 % Hemolysis at 20 μM | Human | Cuttlefish (Sepia Officinalis) | NA | Non-hemolytic | ||
| 32847054 | 2020 | LKALKLPKGSTSTEVRRILVLEIRV | LV25 | Free | Free | Linear | L | None | 25 | NA | 0 % Hemolysis at 20 μM | Human | Cuttlefish (Sepia Officinalis) | α-Helix | Non-hemolytic | ||
| 32847054 | 2020 | GFCNFMHLKPISRELRRELYGRTRRRRK | GK28 | Free | Free | Linear | L | None | 28 | Antibacterial | 0 % Hemolysis at 50 μM | Human | Cuttlefish (Sepia Officinalis) | NA | Non-hemolytic | ||
| 32847054 | 2020 | LKALKLPKGSTSTEVRRILVLEIRV | LV25 | Free | Free | Linear | L | None | 25 | NA | 0 % Hemolysis at 50 μM | Human | Cuttlefish (Sepia Officinalis) | α-Helix | Non-hemolytic | ||
| 32512236 | 2020 | GIGKFLKKAKKFGKAFVKILKK{nt:H}{ct:OH} | MSI-78 | OH | H | Linear | L | None | 22 | Antimicrobial | >50 % Hemolysis at 200 μg/mL | Sheep | Synthesized Peptide Prepared By Mimotopes | α-Helical | NA | ||
| 32673701 | 2020 | KKKKKKKKKYYKYKKKEKEKK | JR21 | Free | Free | Linear | L | None | 21 | Antimalarial | 0 % Hemolysis at 5 μM | Human | Designed Based On The Junctional Region Of Pfdhfr-Ts | Helical | Non-hemolytic | ||
| 32673701 | 2020 | KKKKKKKKKYYKYKKKEKEKK | JR21 | Free | Free | Linear | L | None | 21 | Antimalarial | 0 % Hemolysis at 10 μM | Human | Designed Based On The Junctional Region Of Pfdhfr-Ts | Helical | Non-hemolytic | ||
| 32673701 | 2020 | KKKKKKKKKYYKYKKKEKEKK | JR21 | Free | Free | Linear | L | None | 21 | Antimalarial | 0.8 % Hemolysis at 20 μM | Human | Designed Based On The Junctional Region Of Pfdhfr-Ts | Helical | Non-hemolytic | ||
| 32673701 | 2020 | KKKKKKKKKYYKYKKKEKEKK | JR21 | Free | Free | Linear | L | None | 21 | Antimalarial | 1 % Hemolysis at 40 μM | Human | Designed Based On The Junctional Region Of Pfdhfr-Ts | Helical | Non-hemolytic | ||
| 32673701 | 2020 | R{d}RR{d}RR{d}RRR-KKKKKKKKKYYKYKKKEKEKK | rR8-JR21 | Free | Free | Linear | Mix | None | 29 | Antimalarial | 0 % Hemolysis at 5 μM | Human | Combination Of Rr8 And Jr21 Sequences | Random coil and Helical | Non-hemolytic | ||
| 32673701 | 2020 | R{d}RR{d}RR{d}RRR-KKKKKKKKKYYKYKKKEKEKK | rR8-JR21 | Free | Free | Linear | Mix | None | 29 | Antimalarial | 0 % Hemolysis at 10 μM | Human | Combination Of Rr8 And Jr21 Sequences | Random coil and Helical | Non-hemolytic | ||
| 32673701 | 2020 | R{d}RR{d}RR{d}RRR-KKKKKKKKKYYKYKKKEKEKK | rR8-JR21 | Free | Free | Linear | Mix | None | 29 | Antimalarial | 0.8 % Hemolysis at 20 μM | Human | Combination Of Rr8 And Jr21 Sequences | Random coil and Helical | Non-hemolytic | ||
| 32673701 | 2020 | R{d}RR{d}RR{d}RRR-KKKKKKKKKYYKYKKKEKEKK | rR8-JR21 | Free | Free | Linear | Mix | None | 29 | Antimalarial | 1.3 % Hemolysis at 40 μM | Human | Combination Of Rr8 And Jr21 Sequences | Random coil and Helical | Non-hemolytic | ||
| 32673701 | 2020 | DDDDEEEDDFVYFNFNKEKEE | JR helix | Free | Free | Linear | L | None | 21 | NA | 0 % Hemolysis at 5 μM | Human | Designed Based On The Junctional Region Of Pfdhfr-Ts | Helical | Non-hemolytic | ||
| 32673701 | 2020 | DDDDEEEDDFVYFNFNKEKEE | JR helix | Free | Free | Linear | L | None | 21 | NA | 0 % Hemolysis at 10 μM | Human | Designed Based On The Junctional Region Of Pfdhfr-Ts | Helical | Non-hemolytic | ||
| 32673701 | 2020 | DDDDEEEDDFVYFNFNKEKEE | JR helix | Free | Free | Linear | L | None | 21 | NA | 0.6 % Hemolysis at 20 μM | Human | Designed Based On The Junctional Region Of Pfdhfr-Ts | Helical | Non-hemolytic | ||
| 32673701 | 2020 | DDDDEEEDDFVYFNFNKEKEE | JR helix | Free | Free | Linear | L | None | 21 | NA | 1 % Hemolysis at 40 μM | Human | Designed Based On The Junctional Region Of Pfdhfr-Ts | Helical | Non-hemolytic | ||
| 32673701 | 2020 | R{d}RR{d}RR{d}RRR- DDDDEEEDDFVYFNFNKEKEE | rR8-JR helix | Free | Free | Linear | Mix | None | 29 | NA | 0 % Hemolysis at 5 μM | Human | Combination Of Rr8 And Jr Helix Sequences | Random coil and Helical | Non-hemolytic | ||
| 32673701 | 2020 | R{d}RR{d}RR{d}RRR- DDDDEEEDDFVYFNFNKEKEE | rR8-JR helix | Free | Free | Linear | Mix | None | 29 | NA | 0 % Hemolysis at 10 μM | Human | Combination Of Rr8 And Jr Helix Sequences | Random coil and Helical | Non-hemolytic | ||
| 32673701 | 2020 | R{d}RR{d}RR{d}RRR- DDDDEEEDDFVYFNFNKEKEE | rR8-JR helix | Free | Free | Linear | Mix | None | 29 | NA | 0.8 % Hemolysis at 20 μM | Human | Combination Of Rr8 And Jr Helix Sequences | Random coil and Helical | Non-hemolytic | ||
| 32673701 | 2020 | R{d}RR{d}RR{d}RRR- DDDDEEEDDFVYFNFNKEKEE | rR8-JR helix | Free | Free | Linear | Mix | None | 29 | NA | 1.1 % Hemolysis at 40 μM | Human | Combination Of Rr8 And Jr Helix Sequences | Random coil and Helical | Non-hemolytic | ||
| 32786271 | 2020 | KFFKRLLKSVRRAVKKFRKKPRLIGLSTLL | Hc-CATH | Free | Free | Linear | Mix | None | 30 | Antimicrobial, Anti-inflammatory, Antibiofilm | 37 % Hemolysis at 50 μM | Mouse | Hc-Cath Derivatives | amphipathic α-Helical | NA | ||
| 32786271 | 2020 | KFFKRLLKSVRRAVKKFRKKPRLIGLSTLL | Hc-CATH | Free | Free | Linear | Mix | None | 30 | Antimicrobial, Anti-inflammatory, Antibiofilm | 16 % Hemolysis at 50 μM | Human | Hc-Cath Derivatives | amphipathic α-Helical | NA | ||
| 32841003 | 2020 | ATLTAKDLTFLQDYKKTKKRVK | Sm-A2 | Free | Free | Linear | L | None | 22 | Antibacterial | 10 % Hemolysis at 20 μM | Human | Derived From Turbot Viscera Hydrolysate | α-Helix | NA | ||
| 33194795 | 2020 | RFRLPFRRPPIRIHPPPFYPPFRRFL{ct:Amid} | ChBac3.4-NH2(caprine proline-rich bactenecin) | Amidation | Free | Linear | L | None | 26 | Antitumor, Antimicrobial, Antibiofilm | 25 ± 2 % Hemolysis at 64 μM | Human | Domestic Goat Capra Hircus | NA | NA | ||
| 33194795 | 2020 | RFRLPFRRPPIRIHPPPFYPPFRRFL | ChBac3.4-COOH | Free | Free | Linear | L | None | 26 | Antibacterial | <5 % Hemolysis at 64 μM | Human | Chbac3.4 Full-Lenght Variants | NA | Low hemolytic | ||
| 33194795 | 2020 | RFRLPFRRIHPPPFVRIHPPPFYRRFL{ct:Amid} | ChBac3.4-1-NH2 | Amidation | Free | Linear | L | None | 27 | Antibacterial | <5 % Hemolysis at 64 μM | Human | Chbac3.4 Full-Lenght Variants | NA | Low hemolytic | ||
| 33194795 | 2020 | RFRLPFRRIHPPPFVRIHPPPFYRRFL | ChBac3.4-1-COOH | Free | Free | Linear | L | None | 27 | Antitumor, Antibacterial | <5 % Hemolysis at 64 μM | Human | Chbac3.4 Full-Lenght Variants | NA | Low hemolytic | ||
| 33194795 | 2020 | RFRRFRLPFRRIHPPPFVRIHPPPFYRRFL{ct:Amid} | RFR-ChBac3.4-1-NH2 | Amidation | Free | Linear | L | None | 30 | Antibacterial, Antibiofilm | <5 % Hemolysis at 64 μM | Human | Chbac3.4 Full-Lenght Variants | NA | Low hemolytic | ||
| 33194795 | 2020 | RFRLPFRRPWPIRIHPPPFYPWPFRRFL | ChBac3.4-2-COOH | Free | Free | Linear | L | None | 28 | Antibacterial | <5 % Hemolysis at 64 μM | Human | Chbac3.4 Full-Lenght Variants | NA | Low hemolytic | ||
| 33194795 | 2020 | RFRLPFRRPPIRIPPPFYPPFRRFL{ct:Amid} | ChBac3.4(Н-) | Amidation | Free | Linear | L | None | 25 | Antibacterial | <5 % Hemolysis at 64 μM | Human | Chbac3.4 Full-Lenght Variants | NA | Low hemolytic | ||
| 33092132 | 2020 | GLLDLLKGAGKGLLTHLASQI{ct:Amid} | Ocellatin-1I | Amidation | Free | Linear | L | None | 21 | Antibacterial | 50 % Hemolysis at > 250 μg/ml | Mouse | Ocellatins Frog Leptodactylus Insularum | α-Helical at 2–9, 13–19 | Low hemolytic | ||
| 33092132 | 2020 | GLLDFFKGAGKELLTHLASQI{ct:Amid} | Ocellatin-2I | Amidation | Free | Linear | L | None | 21 | Antibacterial | 50 % Hemolysis at > 250 μg/ml | Mouse | Ocellatins Frog Leptodactylus Insularum | α-Helical at 11–19 | Low hemolytic | ||
| 33092132 | 2020 | GAVVDILKGAGKNLLSLALNKLSEKVA{ct:Amid} | Ocellatin-1N | Amidation | Free | Linear | L | None | 26 | Antibacterial | 50 % Hemolysis at >500 μg/ml | Mouse | Ocellatins Frog Leptodactylus Nesiotus | α-Helical at 3–10, 12–24 | Non-hemolytic | ||
| 32776410 | 2020 | AIGSILGALAKGLPTLISWIKNR{ct:Amid} | AR‐23 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 101.3 % Hemolysis at 10 μM (pH 7.4) | Human | Frog Skin‐Derived Amp From Rana Tagoi | 50% TFE = α-Helix | NA | ||
| 32776410 | 2020 | AIGSILGALAEGLPTLISWIKNR{ct:Amid} | aAR1 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 79.9 % Hemolysis at 10 μM (pH 7.4) | Human | Ar-23 Analogs | 50% TFE = α-Helix | NA | ||
| 32776410 | 2020 | AIGSILGALAEGLPTLISWIENR{ct:Amid} | aAR2 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 14.6 % Hemolysis at 10 μM (pH 7.4) | Human | Ar-23 Analogs | 50% TFE = α-Helix | NA | ||
| 32776410 | 2020 | AIGSILGALAEGLPTLISWIENE{ct:Amid} | aAR3 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 0.1 % Hemolysis at 10 μM (pH 7.4) | Human | Ar-23 Analogs | 50% TFE = α-Helix | Non-hemolytic | ||
| 32776410 | 2020 | AIGSILGALAEGLPTLISWIENE{ct:Amid} | aAR3 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 3.8 % Hemolysis at 40 μM (pH 7.4) | Human | Ar-23 Analogs | 50% TFE = α-Helix | Non-hemolytic | ||
| 32776410 | 2020 | AIGSILGALAKGLPTLISWIKNR{ct:Amid} | AR‐23 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 42.7 % Hemolysis at 20 μM (pH 5.2) | Human | Frog Skin‐Derived Amp From Rana Tagoi | 50% TFE = α-Helix | NA | ||
| 32776410 | 2020 | AIGSILGALAEGLPTLISWIKNR{ct:Amid} | aAR1 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 79.7 % Hemolysis at 20 μM (pH 5.2) | Human | Ar-23 Analogs | 50% TFE = α-Helix | NA | ||
| 32776410 | 2020 | AIGSILGALAEGLPTLISWIENR{ct:Amid} | aAR2 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 61.4 % Hemolysis at 20 μM (pH 5.2) | Human | Ar-23 Analogs | 50% TFE = α-Helix | NA | ||
| 32776410 | 2020 | AIGSILGALAEGLPTLISWIENE{ct:Amid} | aAR3 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 56 % Hemolysis at 20 μM (pH 5.2) | Human | Ar-23 Analogs | 50% TFE = α-Helix | NA | ||
| 32776410 | 2020 | AIGSILGALAEGLPTLISWIENE{ct:Amid} | aAR3 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 80.3 % Hemolysis at 40 μM (pH 7.4) | Human | Ar-23 Analogs | 50% TFE = α-Helix | NA | ||
| 33218175 | 2020 | LVDIYTHVYNCTSSEKHTHCYEIRKSIS | OrR214 | Free | Free | Linear | L | None | 28 | Antibacterial | 0.142 % Hemolysis at 150 μM | Goat | Plant Oryza Rufipogon Griff | α-Helix Random coil | Non-hemolytic | ||
| 33218175 | 2020 | LGVPVSSTLRLNNTTMNPCLPS | OrR935 | Free | Free | Linear | L | None | 22 | Antibacterial | 0.306 % Hemolysis at 150 μM | Goat | Plant Oryza Rufipogon Griff | Random coil | Non-hemolytic | ||
| 33233541 | 2020 | FFGSLLSLGSKLLPSVFKLFQRKKE{ct:Amid} | Css54 | Amidation | Free | Linear | L | None | 25 | Antibacterial, Antibiofilm | 40 % Hemolysis at 16 μM | Sheep | Scorpion Venom Of Centruroides Suffusus | aqueous(10mM sodium phosphate) = Random coil, TFE and SDS = α-Helix | NA | ||
| 32445120 | 2020 | DFFRKSKEKIGKEFKRIVQRIKDFLR | Human CAP18 | Free | Free | Linear | L | None | 26 | Antibacterial | ≥20 % Hemolysis at 1000 μg/mL | Human | Human Cap18 Peptide | NA | Low hemolytic | ||
| 33369262 | 2020 | KLLKKAGKLLKKAGKLLKKAG | Stripe | Free | Free | Linear | L | None | 21 | Antibacterial | No Hemolysis at >100 μM | Human | Synthetic Rationally Designed Amphipathic Amp | 20mM PBS (PH7.5) with 1%SDS at 202-222nm = α-Helical | Non-hemolytic | ||
| 33369262 | 2020 | KLLKKGGKLLKKGGKLLKKGG | 1 | Free | Free | Linear | L | None | 21 | Antibacterial | No Hemolysis at >100 μM | Human | Stripe Side-Chain Stapling Analogue Peptide | 20mM PBS (PH7.5) with 1%SDS at 202-222nm = Helical | Non-hemolytic | ||
| 33369262 | 2020 | KLLKK{nnr:X}GKLLKK{nnr:X}GKLLKK{nnr:X}G | 2 | Free | Free | Linear | L | X = Aib (2-aminoisobutyric acid) | 21 | Antibacterial | No Hemolysis at >100 μM | Human | Stripe Side-Chain Stapling Analogue Peptide | 20mM PBS (PH7.5) with 1%SDS at 202-222nm = α-Helical | Non-hemolytic | ||
| 33369262 | 2020 | KLLKK{nnr:Z}GKLLKK{nnr:Z}GKLLKK{nnr:Z}G | 3 | Free | Free | Linear | L | Z = Ac6c(1-aminocyclohexanecarboxylic acid) | 21 | Antibacterial | Hemolysis at 1.56 μM | Human | Stripe Side-Chain Stapling Analogue Peptide | 20mM PBS (PH7.5) with 1%SDS at 202-222nm = α-Helical | NA | ||
| 33369262 | 2020 | KLLKKAGKLLKK{nnr:R}GKLLKK{nnr:S}G | 4 | Free | Free | Linear | L | R8 = (R)-(7-octenyl)alanine, S5 = (S)-(4-pentenyl)alanine, R8 and S5 in peptides 4 and 5 denote side-stapling produced by (R)-(7-octenyl)alanine and (S)-(4-pentenyl)alanine. | 21 | Antibacterial | Hemolysis at 0.78 μM | Human | Stripe Side-Chain Stapling Analogue Peptide | 20mM PBS (PH7.5) with 1%SDS at 202-222nm = α-Helical | NA | ||
| 33369262 | 2020 | KLLKK{nnr:R}GKLLKK{nnr:S}GKLLKKAG | 5 | Free | Free | Linear | L | R8 = (R)-(7-octenyl)alanine, S5 = (S)-(4-pentenyl)alanine, R8 and S5 in peptides 4 and 5 denote side-stapling produced by (R)-(7-octenyl)alanine and (S)-(4-pentenyl)alanine. | 21 | Antibacterial | Hemolysis at 1.56 μM | Human | Stripe Side-Chain Stapling Analogue Peptide | 20mM PBS (PH7.5) with 1%SDS at 202-222nm = α-Helical | NA | ||
| 33321960 | 2020 | RWCVYAYVRVRGVLVRYRRCW | Ar-1 | Free | Free | Linear | L | None | 21 | Antibacterial | 10 % Hemolysis at 2.9 ± 1.2 μM | Human | Sea Polychaete Arenicola Marina | Aqueous = right-twisted and kinked β-Hairpin, SDS = β-Sheet | NA | ||
| 33321960 | 2020 | RWCVYAYVRIRGVLVRYRRCW | Ar-2 | Free | Free | Linear | L | None | 21 | Antibacterial | 10 % Hemolysis at 1.8 ± 0.9 μM | Human | Sea Polychaete Arenicola Marina | Aqueous = right-twisted and kinked β-Hairpin, SDS = β-Sheet | NA | ||
| 33321960 | 2020 | RWAVYAYVRVRGVLVRYRRAW | Ar-1-(C/A) | Free | Free | Linear | L | None | 21 | Antibacterial | 10 % Hemolysis at 11.1 ± 2.3 μM | Human | Synthetic Derivative Of Ar-1 | Aqueous = right-twisted antiparallel β-Sheet, SDS = relaxed antiparallel and parallel β-Sheets | NA | ||
| 33348729 | 2020 | GFAWNVCVYRNGVRVCHRRAN{ct:Amid} | N6NH2 | Amidation | Free | Linear | L | None | 21 | Antibacterial | 0.19 % Hemolysis at 256 μg/mL | Mouse | Marine Peptide-N6 | ddH2O = coil and antiparallel Strand or β-Turn, SDS solution = α-Helix and antiparallel Strand, 50% TFE = β-Turn, coil and antiparallel Sheet | Non-hemolytic | ||
| 33348729 | 2020 | GFAWNVCVYRNGVRVCHRRAN | N6 | Free | Free | Linear | L | None | 21 | Antibacterial | 1.9 % Hemolysis at 256 μg/mL | Mouse | N6 Anaog Amidated | ddH2O = coil and antiparallel Strand or β-Turn, SDS solution = α-Helix and antiparallel Strand, 50% TFE = β-Turn, coil and antiparallel Sheet | Non-hemolytic | ||
| 33374458 | 2020 | GSKKPVPIIYCNRRSGKCQRM | TS | Free | Free | Linear | L | None | 21 | Antibacterial | <10 % Hemolysis at 160 μM | Human | Modified From Thanatin (Hemipteran Insect Podisus Maculiventris) | β-Helix | Non-hemolytic | ||
| 33352972 | 2020 | GLNALKKVFQGIHEAIKLINNHVQ{ct:Amid} | Pseudin-2 | Amidation | Free | Linear | L | None | 24 | Antiyeast | Hemolysis at 64 μM | Mouse | Paradox Frog Pseudis Paradoxa | α-Helical | NA | ||
| 33352972 | 2020 | GLNAAKKVFQGAHEAIKLINNHVQ{ct:Amid} | P2-LZ1 | Amidation | Free | Linear | L | None | 24 | Antiyeast | Hemolysis at 64 μM | Mouse | Synthetic Analogous Peptide | α-Helical | NA | ||
| 33352972 | 2020 | GANALKKVAQGIHEAIKLINNHVQ{ct:Amid} | P2-LZ2 | Amidation | Free | Linear | L | None | 24 | Antiyeast | Hemolysis at 64 μM | Mouse | Synthetic Analogous Peptide | α-Helical | NA | ||
| 33352972 | 2020 | GLNALKKVFQGAHEAIKLANNHVQ{ct:Amid} | P2-LZ3 | Amidation | Free | Linear | L | None | 24 | Antiyeast | Hemolysis at 64 μM | Mouse | Synthetic Analogous Peptide | α-Helical | NA | ||
| 33352972 | 2020 | GLNALKKVAQGIHEAAKLINNHVQ{ct:Amid} | P2-LZ4 | Amidation | Free | Linear | L | None | 24 | Antiyeast | Hemolysis at 64 μM | Mouse | Synthetic Analogous Peptide | α-Helical | NA | ||
| 33352972 | 2020 | GLNALKKVKQGKHEAIKLINNHVQ{ct:Amid} | P2-LZ5 | Amidation | Free | Linear | L | None | 24 | Antiyeast | Hemolysis at 64 μM | Mouse | Synthetic Analogous Peptide | α-Helical | NA | ||
| 33049300 | 2021 | RRGFFKPYGKKPKKVAKKPYYH | Gj-CATH3-(1–22)-peptide | Free | Free | Linear | L | None | 22 | NA | 9.54 ± 6.08 % Hemolysis at 80 μM | Sheep | Gj-Cath3 Analogues | NA | NA | ||
| 32666297 | 2021 | RIIDLLWRVRRPQKPKFVTVWVR | PMAP-23 | Free | Free | Linear | L | None | 23 | Antibacterial | <4 % Hemolysis at 1000 μg/mL | Mouse | Synthetic Peptide | two α-Helix regions | Non-hemolytic | ||
| 32666297 | 2021 | RIIDRLWRVRRPQKPKFVTVWVR | PMAP-23R | Free | Free | Linear | L | None | 23 | Antibacterial | <4 % Hemolysis at 1000 μg/mL | Mouse | Pmap-23 Analogs | NA | Non-hemolytic | ||
| 32666297 | 2021 | RIIDLLWRVRRPQKPKFVIVWVR | PMAP-23I | Free | Free | Linear | L | None | 23 | Antibacterial | <4 % Hemolysis at 1000 μg/mL | Mouse | Pmap-23 Analogs | NA | Non-hemolytic | ||
| 32666297 | 2021 | RIIDRLWRVRRPQKPKFVIVWVR | PMAP-23RI | Free | Free | Linear | L | None | 23 | Antibacterial | <4 % Hemolysis at 1000 μg/mL | Mouse | Pmap-23 Analogs | NA | Non-hemolytic | ||
| 32812694 | 2021 | FALGAVTKVLPKLFCLITRKC | Brevinin-1H | Free | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm, Antifungal | >20 % Hemolysis at 32 µM | Horse | Frog Amolops Hainanensis | Helix | NA | ||
| 32812694 | 2021 | FALGAVTKVLPKLFCLITRKC | Brevinin-1H | Free | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm, Antifungal | 50 % Hemolysis at 53.12 µM | Horse | Frog Amolops Hainanensis | Helix | NA | ||
| 32812694 | 2021 | FALGAVTKVLPKLFCLITRKC | Brevinin-1H | Free | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm, Antifungal | 9.49 % Hemolysis at 4 µM | Horse | Frog Amolops Hainanensis | Helix | NA | ||
| 32812694 | 2021 | FALGAVTCLIRTKCKVLPKLF | Brevinin-1Ha | Free | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm | 22.1 % Hemolysis at 128 µM | Horse | Brevinin-1H Analogues | NA | NA | ||
| 32812694 | 2021 | FALGAVTKVLYKLFCLITRKC | Brevinin-1HY | Free | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm | 28.48 % Hemolysis at 4 µM | Horse | Brevinin-1H Analogues | Helix | NA | ||
| 33141035 | 2021 | RIIDLLWRVRRPQKPKFVTVWVR | PMAP-23 | Free | Free | Linear | L | None | 23 | Antibacterial, Antibiofilm | ≤4 % Hemolysis at 1280 μg/mL | Mouse | Porcine Myeloid | two α-Helical | Non-hemolytic | ||
| 33141035 | 2021 | RIIDRLWRVRRPQKPKFVIVWVR | PMAP-23R | Free | Free | Linear | L | None | 23 | Antibacterial, Antibiofilm | ≤4 % Hemolysis at 1280 μg/mL | Mouse | Pmap-23 Analogs | NA | Non-hemolytic | ||
| 33141035 | 2021 | RIIDRLWRVRRPQKPKFVIVWVR-K-{nnr:Dec}{ct:Dec} | PMAP-23RI-Dec | Dec | Free | Linear | L | Dec = Decanoic acid | 24 | Antibacterial, Antibiofilm | ≤4 % Hemolysis at 1280 μg/mL | Mouse | Pmap-23 Analogs With Decanoic Acid | NA | Non-hemolytic | ||
| 33175610 | 2021 | IWLTALKFLGKNLGKHLAKQQLAKL{nt:H}{ct:Amid} | LyeTx I | Amidation | H | Linear | L | None | 25 | Antibacterial, Antifungal | 50 % Hemolysis at 32.35 µM | Rabbit | Spider Lycosa Erythrognatha | water = Random coil, TFE = α-Helix | NA | ||
| 33175610 | 2021 | IWLTALKFLGKNLGKHLAKQQLAKL{nt:H}{ct:Amid} | LyeTx I | Amidation | H | Linear | L | None | 25 | Antibacterial, Antifungal | 1 % Hemolysis at 5.06 µM | Rabbit | Spider Lycosa Erythrognatha | water = Random coil, TFE = α-Helix | NA | ||
| 33242568 | 2021 | EGCNILCLLKRKVKAVKNVVKNVVKSVVG | PN-CATH2 | Free | Free | Linear | L | None | 29 | Antibacterial, Antifungal, Antibiofilm, Anti-inflammatory, anitoxidant | 7.5 % Hemolysis at 200 μg/mL | Mouse | Black-Spotted Frog, Pelophylax Nigromaculata | SDS = α-Helical | Low hemolytic | ||
| 33582221 | 2021 | ALWKDLLKNVGIAAGKAALNKVTDMVNQ{ct:Amid} | DRS-TO | Amidation | Free | Linear | L | None | 28 | Anticancer, Antimicrobial | 50 % Hemolysis at 436.7 µM | Horse | Leaf Frog Phyllomedusa Tomopterna | Helical | Low hemolytic | ||
| 33582221 | 2021 | ALWKTLLKNVGKAAGKAVLNAVTDMVNQ{ct:Amid} | DRS-PS2 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 50 % Hemolysis at 210.7 µM | Horse | Waxy Monkey Tree Frog Phyllomedusa Sauvagii | Helical | Low hemolytic | ||
| 33981626 | 2021 | GIGKFLHSAKKFGKAFVGEIMNS | MAG2 | Free | Free | Linear | L | None | 23 | Antibacterial | 10 % Hemolysis at >100 μM | Human | Frog Xenopus Laevis | NA | Low hemolytic | ||
| 33981626 | 2021 | GMASKAGAIAGKIAKVALKAL{ct:Amid} | PGLa | Amidation | Free | Linear | L | None | 21 | Antibacterial | 10 % Hemolysis at 16 μM | Human | Frog Xenopus Laevis | NA | NA | ||
| 33981626 | 2021 | KIAGKIAKIAGKIAKIAGKIA{ct:Amid} | MSI-103 | Amidation | Free | Linear | L | None | 21 | Antibacterial | 10 % Hemolysis at 9 μM | Human | Pgla Analog | α-Helix | NA | ||
| 33798688 | 2021 | CLELLEELLELLEELLELLEEL | LZEP | Free | Free | Linear | L | None | 22 | NA | ~2.5 % Hemolysis at ~20 μM at pH 7.4 | Human | Synthetic Peptide | α-Helical | Low hemolytic | ||
| 33798688 | 2021 | CLELLEELLELLEELLELLEEL | LZEP | Free | Free | Linear | L | None | 22 | NA | 40 % Hemolysis at ~20 μM at pH 5 | Human | Synthetic Peptide | α-Helical | NA | ||
| 33942149 | 2021 | GFLDVLKGVGKAALGAVTHLINQ{ct:Amid} | cruzioseptin-16 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antifungal | 0.1 % Hemolysis at 1.7 µM | Human | Leaf Frog Cruziohyla Calcarifer | α-Helical | NA | ||
| 33942149 | 2021 | GFLDVLKGVGKAALGAVTHLINQ{ct:Amid} | cruzioseptin-16 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antifungal | 1.1 % Hemolysis at 3.4 µM | Human | Leaf Frog Cruziohyla Calcarifer | α-Helical | NA | ||
| 33942149 | 2021 | GFLDVLKGVGKAALGAVTHLINQ{ct:Amid} | cruzioseptin-16 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antifungal | 1.2 % Hemolysis at 6.9 µM | Human | Leaf Frog Cruziohyla Calcarifer | α-Helical | NA | ||
| 33942149 | 2021 | GFLDVLKGVGKAALGAVTHLINQ{ct:Amid} | cruzioseptin-16 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antifungal | 2.8 % Hemolysis at 13.7 µM | Human | Leaf Frog Cruziohyla Calcarifer | α-Helical | NA | ||
| 33942149 | 2021 | GFLDVLKGVGKAALGAVTHLINQ{ct:Amid} | cruzioseptin-16 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antifungal | 6.3 % Hemolysis at 27.5 µM | Human | Leaf Frog Cruziohyla Calcarifer | α-Helical | NA | ||
| 33942149 | 2021 | GFLDVLKGVGKAALGAVTHLINQ{ct:Amid} | cruzioseptin-16 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antifungal | 9.7 % Hemolysis at 55.1 µM | Human | Leaf Frog Cruziohyla Calcarifer | α-Helical | NA | ||
| 33942149 | 2021 | GFLDVLKGVGKAALGAVTHLINQ{ct:Amid} | cruzioseptin-16 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antifungal | 21.8 % Hemolysis at 110.3 µM | Human | Leaf Frog Cruziohyla Calcarifer | α-Helical | NA | ||
| 33942149 | 2021 | GFLDVLKGVGKAALGAVTHLINQ{ct:Amid} | cruzioseptin-16 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antifungal | 55.2 % Hemolysis at 220.6 µM | Human | Leaf Frog Cruziohyla Calcarifer | α-Helical | NA | ||
| 33942149 | 2021 | GFLDVVKGVGKAALGAVTHLINQ{ct:Amid} | cruzioseptin-17 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antifungal | 0 % Hemolysis at 0.8 µM | Human | Leaf Frog Cruziohyla Calcarifer | α-Helical | Non-hemolytic | ||
| 33942149 | 2021 | GFLDVVKGVGKAALGAVTHLINQ{ct:Amid} | cruzioseptin-17 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antifungal | 0 % Hemolysis at 1.7 µM | Human | Leaf Frog Cruziohyla Calcarifer | α-Helical | Non-hemolytic | ||
| 33942149 | 2021 | GFLDVVKGVGKAALGAVTHLINQ{ct:Amid} | cruzioseptin-17 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antifungal | 0 % Hemolysis at 3.4 µM | Human | Leaf Frog Cruziohyla Calcarifer | α-Helical | Non-hemolytic | ||
| 33942149 | 2021 | GFLDVVKGVGKAALGAVTHLINQ{ct:Amid} | cruzioseptin-17 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antifungal | 0 % Hemolysis at 6.9 µM | Human | Leaf Frog Cruziohyla Calcarifer | α-Helical | Non-hemolytic | ||
| 33942149 | 2021 | GFLDVVKGVGKAALGAVTHLINQ{ct:Amid} | cruzioseptin-17 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antifungal | 0 % Hemolysis at 13.8 µM | Human | Leaf Frog Cruziohyla Calcarifer | α-Helical | Non-hemolytic | ||
| 33942149 | 2021 | GFLDVVKGVGKAALGAVTHLINQ{ct:Amid} | cruzioseptin-17 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antifungal | 0.1 % Hemolysis at 27.7 µM | Human | Leaf Frog Cruziohyla Calcarifer | α-Helical | Non-hemolytic | ||
| 33942149 | 2021 | GFLDVVKGVGKAALGAVTHLINQ{ct:Amid} | cruzioseptin-17 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antifungal | 0.7 % Hemolysis at 55.5 µM | Human | Leaf Frog Cruziohyla Calcarifer | α-Helical | Non-hemolytic | ||
| 33942149 | 2021 | GFLDVVKGVGKAALGAVTHLINQ{ct:Amid} | cruzioseptin-17 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antifungal | 4.3 % Hemolysis at 111 µM | Human | Leaf Frog Cruziohyla Calcarifer | α-Helical | Low hemolytic | ||
| 33942149 | 2021 | GFLDVVKGVGKAALGAVTHLINQ{ct:Amid} | cruzioseptin-17 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Antifungal | 11.6 % Hemolysis at 222 µM | Human | Leaf Frog Cruziohyla Calcarifer | α-Helical | Low hemolytic | ||
| 34158805 | 2021 | PSAWQITKCAGSIAWALGSGIF | CBP22 | Free | Free | Linear | L | None | 22 | Antibacterial | <10 % Hemolysis at 256 μg/ml | Human | Bacteriocin Clostridium Butyricum Zju-F1 | NA | Low hemolytic | ||
| 34198776 | 2021 | RINSAKDDAAGLQIA-KKLFKKILKKL{ct:Amid} | BP358 (flg15-BP16) | Amidation | Free | Linear | L | None | 26 | Antibacterial | 5 ± 0.2 % Hemolysis at 375 μM | Horse | Combination Of Flg15 And Bp16 | NA | Low hemolytic | ||
| 34198776 | 2021 | KKLFKKILKKL-RINSAKDDAAGLQIA{ct:OH} | BP359 (BP16-flg15) | OH | Free | Linear | L | None | 26 | Antibacterial | 0.8 ± 0.5 % Hemolysis at 375 μM | Horse | Combination Of Bp16 And Flg15 | NA | Non-hemolytic | ||
| 33972716 | 2021 | IWLTALKFLGKNLGKHLAKQQLAKL{nt:H}{ct:Amid} | LyeTx I | Amidation | H | Linear | L | None | 25 | Antibacterial, Antifungal | 50 % Hemolysis at 32.35 μM | Human | Lycosa Erythrognatha Spider Venom | NA | NA | ||
| 34301247 | 2021 | FKRIVQRIKRFLRFKRIVQRIKRFLR | (FR)2 | Free | Free | Linear | L | None | 26 | Antibacterial | 20 % Hemolysis at 16 μM | Human | Synthetic Peptide | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLVGANA | DS4 (1–28) dermaseptin S4 (DS4) | Free | Free | Linear | L | None | 28 | Antibacterial, Anti-proliferative on SW620 colon cancer | 54.2±5.43 % Hemolysis at 8 μg/mL | Human | Frog Skin Of Phyllomedusa Sauvagii | lipid bilayers = amphipathic α-Helical | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLVGANA | DS4 (1–28) dermaseptin S4 (DS4) | Free | Free | Linear | L | None | 28 | Antibacterial, Anti-proliferative on SW620 colon cancer | 60±3.94 % Hemolysis at 16 μg/mL | Human | Frog Skin Of Phyllomedusa Sauvagii | lipid bilayers = amphipathic α-Helical | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLVGANA | DS4 (1–28) dermaseptin S4 (DS4) | Free | Free | Linear | L | None | 28 | Antibacterial, Anti-proliferative on SW620 colon cancer | 65.7±4.57 % Hemolysis at 32 μg/mL | Human | Frog Skin Of Phyllomedusa Sauvagii | lipid bilayers = amphipathic α-Helical | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLVGANA | DS4 (1–28) dermaseptin S4 (DS4) | Free | Free | Linear | L | None | 28 | Antibacterial, Anti-proliferative on SW620 colon cancer | 85.7±7.6 % Hemolysis at 64 μg/mL | Human | Frog Skin Of Phyllomedusa Sauvagii | lipid bilayers = amphipathic α-Helical | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLVGANA | DS4 (1–28) dermaseptin S4 (DS4) | Free | Free | Linear | L | None | 28 | Antibacterial, Anti-proliferative on SW620 colon cancer | 85.7±9.28 % Hemolysis at 128 μg/mL | Human | Frog Skin Of Phyllomedusa Sauvagii | lipid bilayers = amphipathic α-Helical | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLVGANA | DS4 (1–28) dermaseptin S4 (DS4) | Free | Free | Linear | L | None | 28 | Antibacterial, Anti-proliferative on SW620 colon cancer | 80±3.32 % Hemolysis at 256 μg/mL | Human | Frog Skin Of Phyllomedusa Sauvagii | lipid bilayers = amphipathic α-Helical | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (1–28)a | Amidation | Free | Linear | L | None | 28 | Antibacterial, Anti-proliferative on SW620 colon cancer | 0 % Hemolysis at 8 μg/mL | Human | Analogs Of Ds4 | NA | Non-hemolytic | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (1–28)a | Amidation | Free | Linear | L | None | 28 | Antibacterial, Anti-proliferative on SW620 colon cancer | 2.8±0.86 % Hemolysis at 16 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (1–28)a | Amidation | Free | Linear | L | None | 28 | Antibacterial, Anti-proliferative on SW620 colon cancer | 22.8±4.88 % Hemolysis at 32 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (1–28)a | Amidation | Free | Linear | L | None | 28 | Antibacterial, Anti-proliferative on SW620 colon cancer | 31.4±4.28 % Hemolysis at 64 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (1–28)a | Amidation | Free | Linear | L | None | 28 | Antibacterial, Anti-proliferative on SW620 colon cancer | 51.4±6.05 % Hemolysis at 128 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (1–28)a | Amidation | Free | Linear | L | None | 28 | Antibacterial, Anti-proliferative on SW620 colon cancer | 68.5±10.83 % Hemolysis at 256 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLVGA{ct:Amid} | DS4 (1–26)a | Amidation | Free | Linear | L | None | 26 | Antibacterial, Anti-proliferative on SW620 colon cancer | 28.5±5.01 % Hemolysis at 8 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLVGA{ct:Amid} | DS4 (1–26)a | Amidation | Free | Linear | L | None | 26 | Antibacterial, Anti-proliferative on SW620 colon cancer | 31.4±5.98 % Hemolysis at 16 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLVGA{ct:Amid} | DS4 (1–26)a | Amidation | Free | Linear | L | None | 26 | Antibacterial, Anti-proliferative on SW620 colon cancer | 54.2±6.91 % Hemolysis at 32 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLVGA{ct:Amid} | DS4 (1–26)a | Amidation | Free | Linear | L | None | 26 | Antibacterial, Anti-proliferative on SW620 colon cancer | 65.7±7.01 % Hemolysis at 64 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLVGA{ct:Amid} | DS4 (1–26)a | Amidation | Free | Linear | L | None | 26 | Antibacterial, Anti-proliferative on SW620 colon cancer | 68.5±5.1 % Hemolysis at 128 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLVGA{ct:Amid} | DS4 (1–26)a | Amidation | Free | Linear | L | None | 26 | Antibacterial, Anti-proliferative on SW620 colon cancer | 74.2±5.82 % Hemolysis at 256 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLV{ct:Amid} | DS4 (1–24)a | Amidation | Free | Linear | L | None | 24 | Antibacterial, Anti-proliferative on SW620 colon cancer | 2.8±1.03 % Hemolysis at 8 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLV{ct:Amid} | DS4 (1–24)a | Amidation | Free | Linear | L | None | 24 | Antibacterial, Anti-proliferative on SW620 colon cancer | 11.4±2.8 % Hemolysis at 16 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLV{ct:Amid} | DS4 (1–24)a | Amidation | Free | Linear | L | None | 24 | Antibacterial, Anti-proliferative on SW620 colon cancer | 31.4±3.83 % Hemolysis at 32 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLV{ct:Amid} | DS4 (1–24)a | Amidation | Free | Linear | L | None | 24 | Antibacterial, Anti-proliferative on SW620 colon cancer | 40±3.5 % Hemolysis at 64 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLV{ct:Amid} | DS4 (1–24)a | Amidation | Free | Linear | L | None | 24 | Antibacterial, Anti-proliferative on SW620 colon cancer | 51.4±8.1 % Hemolysis at 128 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAVLV{ct:Amid} | DS4 (1–24)a | Amidation | Free | Linear | L | None | 24 | Antibacterial, Anti-proliferative on SW620 colon cancer | 57.1±6.34 % Hemolysis at 256 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAV{ct:Amid} | DS4 (1–22)a | Amidation | Free | Linear | L | None | 24 | Antibacterial, Anti-proliferative on SW620 colon cancer | 5.7±1.21 % Hemolysis at 8 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAV{ct:Amid} | DS4 (1–22)a | Amidation | Free | Linear | L | None | 22 | Antibacterial, Anti-proliferative on SW620 colon cancer | 31.4±3.8 % Hemolysis at 16 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAV{ct:Amid} | DS4 (1–22)a | Amidation | Free | Linear | L | None | 22 | Antibacterial, Anti-proliferative on SW620 colon cancer | 40±5.06 % Hemolysis at 32 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAV{ct:Amid} | DS4 (1–22)a | Amidation | Free | Linear | L | None | 22 | Antibacterial, Anti-proliferative on SW620 colon cancer | 54.2±4.41 % Hemolysis at 64 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAV{ct:Amid} | DS4 (1–22)a | Amidation | Free | Linear | L | None | 22 | Antibacterial, Anti-proliferative on SW620 colon cancer | 68.5±7.85 % Hemolysis at 128 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | ALWMTLLKKVLKAAAKAALNAV{ct:Amid} | DS4 (1–22)a | Amidation | Free | Linear | L | None | 22 | Antibacterial, Anti-proliferative on SW620 colon cancer | 80±1.12 % Hemolysis at 256 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | WMTLLKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (3–28)a | Amidation | Free | Linear | L | None | 26 | Antibacterial, Anti-proliferative on SW620 colon cancer | 0 % Hemolysis at 8 μg/mL | Human | Analogs Of Ds4 | NA | Non-hemolytic | ||
| 33774792 | 2021 | WMTLLKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (3–28)a | Amidation | Free | Linear | L | None | 26 | Antibacterial, Anti-proliferative on SW620 colon cancer | 25.7±5.81 % Hemolysis at 16 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | WMTLLKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (3–28)a | Amidation | Free | Linear | L | None | 26 | Antibacterial, Anti-proliferative on SW620 colon cancer | 40±5.25 % Hemolysis at 32 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | WMTLLKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (3–28)a | Amidation | Free | Linear | L | None | 26 | Antibacterial, Anti-proliferative on SW620 colon cancer | 48.5±9.3 % Hemolysis at 64 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | WMTLLKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (3–28)a | Amidation | Free | Linear | L | None | 26 | Antibacterial, Anti-proliferative on SW620 colon cancer | 57.1±7.45 % Hemolysis at 128 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | WMTLLKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (3–28)a | Amidation | Free | Linear | L | None | 26 | Antibacterial, Anti-proliferative on SW620 colon cancer | 68.5±7.58 % Hemolysis at 256 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | TLLKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (5–28)a | Amidation | Free | Linear | L | None | 24 | Antibacterial, Anti-proliferative on SW620 colon cancer | 0 % Hemolysis at 8 μg/mL | Human | Analogs Of Ds4 | NA | Non-hemolytic | ||
| 33774792 | 2021 | TLLKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (5–28)a | Amidation | Free | Linear | L | None | 24 | Antibacterial, Anti-proliferative on SW620 colon cancer | 5.7±3.14 % Hemolysis at 16 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | TLLKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (5–28)a | Amidation | Free | Linear | L | None | 24 | Antibacterial, Anti-proliferative on SW620 colon cancer | 8.5±2.79 % Hemolysis at 32 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | TLLKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (5–28)a | Amidation | Free | Linear | L | None | 24 | Antibacterial, Anti-proliferative on SW620 colon cancer | 34.2±4.43 % Hemolysis at 64 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | TLLKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (5–28)a | Amidation | Free | Linear | L | None | 24 | Antibacterial, Anti-proliferative on SW620 colon cancer | 54.2±6.9 % Hemolysis at 128 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | TLLKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (5–28)a | Amidation | Free | Linear | L | None | 24 | Antibacterial, Anti-proliferative on SW620 colon cancer | 57.1±7.64 % Hemolysis at 256 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | LKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (7–28)a | Amidation | Free | Linear | L | None | 22 | Antibacterial, Anti-proliferative on SW620 colon cancer | 0 % Hemolysis at 8 μg/mL | Human | Analogs Of Ds4 | NA | Non-hemolytic | ||
| 33774792 | 2021 | LKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (7–28)a | Amidation | Free | Linear | L | None | 22 | Antibacterial, Anti-proliferative on SW620 colon cancer | 0 % Hemolysis at 16 μg/mL | Human | Analogs Of Ds4 | NA | Non-hemolytic | ||
| 33774792 | 2021 | LKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (7–28)a | Amidation | Free | Linear | L | None | 22 | Antibacterial, Anti-proliferative on SW620 colon cancer | 3.2±0.62 % Hemolysis at 32 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | LKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (7–28)a | Amidation | Free | Linear | L | None | 22 | Antibacterial, Anti-proliferative on SW620 colon cancer | 6.4±1.74 % Hemolysis at 64 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | LKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (7–28)a | Amidation | Free | Linear | L | None | 22 | Antibacterial, Anti-proliferative on SW620 colon cancer | 6.4±2.88 % Hemolysis at 128 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 33774792 | 2021 | LKKVLKAAAKAALNAVLVGANA{ct:Amid} | DS4 (7–28)a | Amidation | Free | Linear | L | None | 22 | Antibacterial, Anti-proliferative on SW620 colon cancer | 35.4±6.28 % Hemolysis at 256 μg/mL | Human | Analogs Of Ds4 | NA | NA | ||
| 34022355 | 2021 | FLGSLFSIGSKLLPGVIKLFQRKKQ | Im5 | Free | Free | Linear | L | None | 25 | Anti-Acinetobacter baumannii | 10 % Hemolysis at 2.7 μM | Human | Scorpion Isometrus Maculatus | NA | NA | ||
| 34058259 | 2021 | LPYITADATGPKHMNIKVTRAKLESLVE | DP2 | Free | Free | Linear | L | None | 28 | Anti-Salmonella | 1 % Hemolysis at 100 µg/ml | Human | Synthetic Multi-Epitope Dnak Peptides | NA | Non-hemolytic | ||
| 34058259 | 2021 | AEDNQSAVTIHVLQGERKRASDNKSLG | DP3 | Free | Free | Linear | L | None | 27 | Anti-Salmonella | 1 % Hemolysis at 100 µg/ml | Human | Synthetic Multi-Epitope Dnak Peptides | NA | Non-hemolytic | ||
| 34058259 | 2021 | ETALKGEDKAAIEAKMQELAQVSQKLMEIA | DP6 | Free | Free | Linear | L | None | 30 | Anti-Salmonella | 1 % Hemolysis at 100 µg/ml | Human | Synthetic Multi-Epitope Dnak Peptides | NA | Non-hemolytic | ||
| 34342438 | 2021 | RPFTRAQWFAIQHISPRTIAMRAINNYRWR | hECP30 | Free | Free | Linear | L | None | 30 | Antimicrobial, Antibiofilm | 44 ± 4 % Hemolysis at 250 μM | Horse | Human Rnase 3 Eosinophil Cationic Protein (Ecp) Fragment | aqueous = Random coil, SDS micelles (1 mM) = α-Helical | NA | ||
| 34342438 | 2021 | {nnr:O}PFT{nnr:O}AQWFAIQHISP{nnr:O}TIAM{nnr:O}AINNY{nnr:O}W{nnr:O} | Orn analog | Free | Free | Linear | L | O = L-Ornithine | 30 | Antibacterial | 10 ± 2 % Hemolysis at 250 μM | Horse | Hecp30 Analogs | aqueous = Random coil, SDS micelles (1 mM) = α-Helical | NA | ||
| 34342438 | 2021 | {nnr:X}PFT{nnr:X}AQWFAIQHISP{nnr:X}TIAM{nnr:X}AINNY{nnr:X}W{nnr:X} | Dab analog | Free | Free | Linear | L | X = L-2,4-diaminobutyric acid | 30 | Antibacterial | 14 ± 6 % Hemolysis at 250 μM | Horse | Hecp30 Analogs | NA | NA | ||
| 34342438 | 2021 | {nnr:Z}PFT{nnr:Z}AQWFAIQHISP{nnr:Z}TIAM{nnr:Z}AINNY{nnr:Z}W{nnr:Z} | Har analog | Free | Free | Linear | L | Z = L-homoarginine | 30 | Antibacterial | 43 ± 1 % Hemolysis at 250 μM | Horse | Hecp30 Analogs | NA | NA | ||
| 34342438 | 2021 | FT{nnr:O}AQWFAIQHISP{nnr:O}TIAM{nnr:O}AINNY{nnr:O}W{nnr:O} | Des[Orn1-Pro2] analog | Free | Free | Linear | L | O = L-Ornithine | 28 | Antibacterial | 11 ± 4 % Hemolysis at 250 μM | Horse | Hecp30 Analogs | NA | NA | ||
| 34342438 | 2021 | {nnr:O}P{d}FT{nnr:O}AQWFAIQHISP{nnr:O}TIAM{nnr:O}AINNY{nnr:O}W{nnr:O} | [Orn,1D-Pro2] analog | Free | Free | Linear | Mix | O = L-Ornithine, p = D-Proline | 30 | Antibacterial | 1.1 ± 0.9 % Hemolysis at 250 μM | Horse | Hecp30 Analogs | aqueous = Random coil, SDS micelles (1 mM) = α-Helical | Low hemolytic | ||
| 34342438 | 2021 | {nnr:o}P{d}FT{nnr:O}AQWFAIQHISP{nnr:O}TIAM{nnr:O}AINNY{nnr:O}W{nnr:O} | [D-Orn,1D-Pro2] analog | Free | Free | Linear | Mix | o = D-Ornithine, p = D-Proline | 30 | Antibacterial | 3.6 ± 0.7 % Hemolysis at 250 μM | Horse | Hecp30 Analogs | aqueous = Random coil, SDS micelles (1 mM) = α-Helical | Low hemolytic | ||
| 34282895 | 2021 | KYEITTIHNLFRKLTHRLFRRNFGYTLR | KYE28 | Free | Free | Linear | L | None | 28 | Anti-inflammatory, Antimicrobial | ~20 % Hemolysis at 25 μM | Human | Heparin Cofactor Ii (Hcii)-Derived Peptide | α-Helical | NA | ||
| 34423969 | 2021 | WLGSALKIGAKLLPSVVGLFKKKKQ{nt:NH3}{ct:Amid} | Ponericin W1 | Amidation | NH3 | Linear | L | None | 25 | Antibacterial | 80 % Hemolysis at 50 µM | Human | Ants Pachycondyla Goeldii | negatively charged liposomes = α-Helix | NA | ||
| 34423969 | 2021 | WLKKALKIGAKLLPSVVKLFKGSGQ{nt:NH3}{ct:Amid} | PonAmp | Amidation | NH3 | Linear | L | None | 25 | Antibacterial | 70 % Hemolysis at 100 µM | Human | Ponericin W1 Analogues | NA | NA | ||
| 34423969 | 2021 | KKKKKKWLGSALIGALLPSVVGLFQ{nt:NH3}{ct:Amid} | PonN | Amidation | NH3 | Linear | L | None | 25 | Antibacterial | 20 % Hemolysis at 100 µM | Human | Ponericin W1 Analogues | NA | NA | ||
| 34423969 | 2021 | WLGSALIGALLPSVVGLFQKKKKKK{nt:NH3}{ct:Amid} | PonC | Amidation | NH3 | Linear | L | None | 25 | Antibacterial | 90 % Hemolysis at 100 µM | Human | Ponericin W1 Analogues | Helical and unstructured | NA | ||
| 34423969 | 2021 | WAKKAAKIGAKLLPSVVKLFKGSGQ{nt:NH3}{ct:Amid} | PonAmp 2A | Amidation | NH3 | Linear | L | None | 25 | Antibacterial | 0 % Hemolysis at 100 µM | Human | Ponericin W1 Analogues | NA | Non-hemolytic | ||
| 34423969 | 2021 | KKKKKKWAGSAAIGALLPSVVGLFQ{nt:NH3}{ct:Amid} | PonN 2A | Amidation | NH3 | Linear | L | None | 25 | Antibacterial | 0 % Hemolysis at 100 µM | Human | Ponericin W1 Analogues | NA | Non-hemolytic | ||
| 34423969 | 2021 | WAGSAAIGALLPSVVGLFQKKKKKK{nt:NH3}{ct:Amid} | PonC 2A | Amidation | NH3 | Linear | L | None | 25 | Antibacterial | 0 % Hemolysis at 100 µM | Human | Ponericin W1 Analogues | NA | Non-hemolytic | ||
| 34576320 | 2021 | SMWSGMWRRKLKKLRNALKKKLKGE | Ltc1 | Free | Free | Linear | L | None | 25 | Antibacterial | 100 % Hemolysis at 256 μg/ml | Human | Spider Lachesana Tarabaevi | vesicles composed of DMPC/DMPG (7/3) = α-Helix | NA | ||
| 34576320 | 2021 | GLFGKLIKKFGRKAISYAVKKARGKH | Ltc2a | Free | Free | Linear | L | None | 26 | Antibacterial | 36 % Hemolysis at 256 μg/ml | Human | Spider Lachesana Tarabaevi | vesicles composed of DMPC/DMPG (7/3) = α-Helix | NA | ||
| 34576320 | 2021 | GLKDKFKSMGEKLKQYIQTWKAKF{ct:Amid} | Ltc4a | Amidation | Free | Linear | L | None | 24 | Antibacterial | 12 % Hemolysis at 256 μg/ml | Human | Spider Lachesana Tarabaevi | vesicles composed of DMPC/DMPG (7/3) = α-Helix | Low hemolytic | ||
| 34576320 | 2021 | GFFGKMKEYFKKFGASFKRRFANLKKRL{ct:Amid} | Ltc5 | Amidation | Free | Linear | L | None | 28 | Antibacterial | 27 % Hemolysis at 256 μg/ml | Human | Spider Lachesana Tarabaevi | vesicles composed of DMPC/DMPG (7/3) = α-Helix | Low hemolytic | ||
| 34037941 | 2021 | KRNGFRKFMRRLKKFFAGGGSSIAHIKLH{ct:Amid} | CATHPb2 | Amidation | Free | Linear | L | None | 29 | Antibacterial, Antifungal | <5 % Hemolysis at 512 μg/ml | Sheep | Cathelicidin In Snake Python Bivittatus | α-Helical | Non-hemolytic | ||
| 34302796 | 2021 | FLGALLKIGAKLLPSVVGLFKKKQQ | M-PONTX–Na1b | Free | Free | Linear | L | None | 25 | Antimicrobial, anthelmintic, Insecticidal | 50 % Hemolysis at 39.9–61.5 μM | Human | Ant Neoponera Apicalis | aqueous = Disordered, 20% TFE or 20 mM SOS = α-Helical | NA | ||
| 34302796 | 2021 | FWGAAAKMLGKALPGLISMFQKN | M-PONTX–Nc1a | Free | Free | Linear | L | None | 23 | Antimicrobial, anthelmintic, Insecticidal | 50 % Hemolysis at 28.6–48.2 μM | Human | Ant Neoponera Commutata | aqueous = Disordered, 20% TFE or 20 mM SOS = α-Helical | NA | ||
| 34302796 | 2021 | FVKELWDKVKKMGSAAWSAAKGAFA | M-PONTX–Nc2a | Free | Free | Linear | L | None | 25 | Antimicrobial, anthelmintic, Insecticidal | 50 % Hemolysis at >250 μM | Human | Ant Neoponera Commutata | aqueous = Disordered, 20% TFE or 20 mM SOS = α-Helical | Low hemolytic | ||
| 34302796 | 2021 | GWKDWLNKAKDFIKEKGPEILRAAANAAIN | M-PONTX–Nc3a | Free | Free | Linear | L | None | 30 | Antimicrobial, anthelmintic, Insecticidal | 50 % Hemolysis at >100 μM | Human | Ant Neoponera Commutata | aqueous = Disordered, 20% TFE or 20 mM SOS = α-Helical | NA | ||
| 34461456 | 2021 | G{d}I{d}G{d}A{d}V{d}L{d}K{d}V{d}L{d}T{d}T{d}G{d}L{d}P{d}A{d}L{d}I{d}S{d}W{d}I{d}K{d}R{d}K{d}R{d}Q{d}Q{d}C{d} | D-melittin | Free | Free | Linear | L | None | 27 | Antitumor | 50 % Hemolysis at 14.8 μM (pH 5.4) | Human | Honeybee Venom | NA | NA | ||
| 34461456 | 2021 | G{d}I{d}G{d}A{d}V{d}L{d}K{d}V{d}L{d}T{d}T{d}G{d}L{d}P{d}A{d}L{d}I{d}S{d}W{d}I{d}K{d}R{d}K{d}R{d}Q{d}Q{d}C{d} | D-melittin | Free | Free | Linear | L | None | 27 | Antitumor | 50 % Hemolysis at 8.5 μM (pH 6.4) | Human | Honeybee Venom | NA | NA | ||
| 34461456 | 2021 | G{d}I{d}G{d}A{d}V{d}L{d}K{d}V{d}L{d}T{d}T{d}G{d}L{d}P{d}A{d}L{d}I{d}S{d}W{d}I{d}K{d}R{d}K{d}R{d}Q{d}Q{d}C{d} | D-melittin | Free | Free | Linear | L | None | 27 | Antitumor | 50 % Hemolysis at 3.3 μM (pH 7.4) | Human | Honeybee Venom | NA | NA | ||
| 34721331 | 2021 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antibacterial | 5 % Hemolysis at 1 μM | Human | Honeybee Venom | α-Helical | Low hemolytic | ||
| 34819923 | 2021 | GIGKFLHSAKKFGKAFVGEIMNS{ct:Amid} | Magainin 2 | Amidation | Free | Linear | L | None | 26 | Antimicrobial, Antibiofilm | 35.2 ± 1.1 % Hemolysis at 150 μM | Horse | Synthetic Amp | NA | NA | ||
| 34819923 | 2021 | GIGKFLHSAKKFGKAFVGEIMNS{ct:Amid} | Magainin 2 | Amidation | Free | Linear | L | None | 26 | Antimicrobial, Antibiofilm | 54.5 ± 3.7 % Hemolysis at 250 μM | Horse | Synthetic Amp | NA | NA | ||
| 34819923 | 2021 | GIGKFLHSAKKFGKAFVGEIMNS{ct:Amid} | Magainin 2 | Amidation | Free | Linear | L | None | 26 | Antimicrobial, Antibiofilm | 71.1 ± 6.0 % Hemolysis at 375 μM | Horse | Synthetic Amp | NA | NA | ||
| 34508563 | 2021 | FLGALFKVASKLVPAAICSISKKC | Brevinin-1HL | Free | Free | Linear | L | None | 24 | Antimicrobial, Anticancer, Antibiofilm | 50 % Hemolysis at 11.5 ± 0.2 μM | Horse | Broad-Folded Frog, Hylarana Latouchii | aqueous = Random coil, 50% TFE = α-Helical | NA | ||
| 34867843 | 2021 | GVVDIIKGAGKKFAKGLAGKIANKK | PHNX-7 | Free | Free | Linear | L | None | 25 | Antibacterial | ~10 % Hemolysis at 100 μg/ml | Human | Synthetic Peptide | Helical | NA | ||
| 34867843 | 2021 | GLMDTVKNAAKNLAGQLLDKIKCKITG | PHNX-8 | Free | Free | Linear | L | None | 27 | Antibacterial | ~10 % Hemolysis at 100 μg/ml | Human | Synthetic Peptide | Helical | NA | ||
| 34959645 | 2021 | SKEKIGKEFKRIVQRIKDFLRNLV{ct:Amid} | SK-24 | Amidation | Free | Linear | L | None | 24 | Antibacterial, Antibiofilm | <25 % Hemolysis at 200 μM | Human | Ll-37 Derived Peptide | PBS, 60mMSDS = Helical | Low hemolytic | ||
| 34164880 | 2021 | KLLKKAGKLLKKAGKLLKKAG{nt:H}{ct:Amid} | Stripe | Amidation | H | Linear | L | None | 21 | Antibacterial | 0 % Hemolysis at 100 μM | Human | Synthetic Amp | phosphate buffer solution (pH 7.4) contain 1%SDS = right-handed Helical | Non-hemolytic | ||
| 34164880 | 2021 | KLLKKA{nnr:X}KLLKKA{nnr:X}KLLKKA{nnr:X}{nt:H}{ct:Amid} | Stripe1 | Amidation | H | Linear | L | X = sarcosine | 21 | Antibacterial | 0 % Hemolysis at 100 μM | Human | Stripe Modification With Sarcosine | phosphate buffer solution (pH 7.4) contain 1%SDS = Random coil | Non-hemolytic | ||
| 34164880 | 2021 | KLLKK{nnr:X}GKLLKK{nnr:X}GKLLKK{nnr:X}G{nt:H}{ct:Amid} | Stripe2 | Amidation | H | Linear | L | X = sarcosine | 21 | Antibacterial | 0 % Hemolysis at 100 μM | Human | Stripe Modification With Sarcosine | phosphate buffer solution (pH 7.4) contain 1%SDS = Random coil | Non-hemolytic | ||
| 34164880 | 2021 | KLLKK{nnr:X}{nnr:X}KLLKK{nnr:X}{nnr:X}KLLKK{nnr:X}{nnr:X}{nt:H}{ct:Amid} | Stripe3 | Amidation | H | Linear | L | X = sarcosine | 21 | Antibacterial | 0 % Hemolysis at 100 μM | Human | Stripe Modification With Sarcosine | phosphate buffer solution (pH 7.4) contain 1%SDS = Random coil | Non-hemolytic | ||
| 34164880 | 2021 | KL{nnr:X}KK{nnr:X}{nnr:X}KL{nnr:X}KK{nnr:X}{nnr:X}KL{nnr:X}KK{nnr:X}{nnr:X}{nt:H}{ct:Amid} | Stripe4 | Amidation | H | Linear | L | X = sarcosine | 21 | NA | 0 % Hemolysis at 100 μM | Human | Stripe Modification With Sarcosine | phosphate buffer solution (pH 7.4) contain 1%SDS = Random coil | Non-hemolytic | ||
| 34164880 | 2021 | K{nnr:X}{nnr:X}KK{nnr:X}{nnr:X}K{nnr:X}{nnr:X}KK{nnr:X}{nnr:X}K{nnr:X}{nnr:X}KK{nnr:X}{nnr:X}{nt:H}{ct:Amid} | Stripe5 | Amidation | H | Linear | L | X = sarcosine | 21 | NA | 0 % Hemolysis at 100 μM | Human | Stripe Modification With Sarcosine | phosphate buffer solution (pH 7.4) contain 1%SDS = Random coil | Non-hemolytic | ||
| 34338123 | 2021 | KKKKKRFSFKKSFKLSGFSFKKNKK | peptide P1 | Free | Free | Linear | L | None | 25 | Cell penetrating peptides, interact with plasmid DNA | <0.5 % Hemolysis at 10 μM | Mouse | Synthetic Peptide | NA | Low hemolytic | ||
| 34966279 | 2021 | KIILRIRWRGGGVRKPPYLPRPRPRPL{ct:Amid} | hyP1CoG1 | Amidation | Free | Linear | L | None | 27 | Antibacterial | 50 % Hemolysis at >157 μM | Human | Hybrid Peptide With Gly Linker, Optp1 C-Terminal | NA | Low hemolytic | ||
| 34966279 | 2021 | VRKPPYLPRPRPRPLGGGKIILRIRWR{ct:Amid} | hyP1CoG2 | Amidation | Free | Linear | L | None | 27 | Antibacterial | 50 % Hemolysis at >157 μM | Human | Hybrid Peptide With Gly Linker, Optp1 C-Terminal | NA | Low hemolytic | ||
| 34966279 | 2021 | VRKPPYLPRPRPRPLGGGKRRVRWIIW{ct:Amid} | hyP7CoG1 | Amidation | Free | Linear | L | None | 27 | Antibacterial | 50 % Hemolysis at >154 μM | Human | Hybrid Peptide With Gly Linker, Optp7 C-Terminal | NA | Low hemolytic | ||
| 34966279 | 2021 | KRRVRWIIWGGGVRKPPYLPRPRPRPL{ct:Amid} | hyP7CoG2 | Amidation | Free | Linear | L | None | 27 | Antibacterial | 50 % Hemolysis at >154 μM | Human | Hybrid Peptide With Gly Linker, Optp7 N-Terminal | NA | Low hemolytic | ||
| 34966279 | 2021 | RWRRPIRRRPIRPPFWRGGGKRRVRWIIW{ct:Amid} | hyP7B5G | Amidation | Free | Linear | L | None | 29 | Antibacterial | 50 % Hemolysis at 102 μM | Human | Hybrid Peptide With Gly Linker, Optp7 C-Terminal | NA | NA | ||
| 34966279 | 2021 | RWRRPIRRRPIRPPFWRKKKKRRVRWIIW{ct:Amid} | hyP7B5K | Amidation | Free | Linear | L | None | 29 | Antibacterial | 50 % Hemolysis at 82 μM | Human | Hybrid Peptide With Lys Linker, Optp7 C-Terminal | NA | NA | ||
| 34941705 | 2021 | ASIGALIQKAIALIKAKAA{nt:CH3-(CH2)16CONH}{ct:Amid} | LVTX-9-C18 | Amidation | CH3-(CH2)16CONH | Linear | L | CH3-(CH2)16 = N-Terminal Fatty acid | 23 | Anticancer | 10 % Hemolysis at 25 μM | Human | Lvtx-9, Fatty Acid Modification | ultrapure water = α-Helical, SDS = α-Helical | NA | ||
| 34908502 | 2021 | GMFTNMLKGIGKLAGKAALGAVKTLA{ct:Amid} | Dermaseptin-AC | Amidation | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 50 % Hemolysis at 76.55 μM | Horse | Frog Agalychnis Callidryas | 50% TFE-10 mM NH4Ac solution = α-Helix | NA | ||
| 34908502 | 2021 | GMFTNMLKGIGKLAGKAALGAVKTLA{ct:Amid} | Dermaseptin-AC | Amidation | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 2.73 % Hemolysis at 2 μM | Horse | Frog Agalychnis Callidryas | 50% TFE-10 mM NH4Ac solution = α-Helix | NA | ||
| 34908502 | 2021 | GMFTNMLKGIGKLAGKAALGAVKTLA{ct:Amid} | Dermaseptin-AC | Amidation | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 4.31 % Hemolysis at 4 μM | Horse | Frog Agalychnis Callidryas | 50% TFE-10 mM NH4Ac solution = α-Helix | NA | ||
| 34908502 | 2021 | GMFTNMLKGIGKLAGKAALGAVKTLA{ct:Amid} | Dermaseptin-AC | Amidation | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 7.47 % Hemolysis at 8 μM | Horse | Frog Agalychnis Callidryas | 50% TFE-10 mM NH4Ac solution = α-Helix | NA | ||
| 34506798 | 2022 | VWLSALKFIGKHLAKHQLSKL{ct:Amid} | Lycosin-II | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm | 1 % Hemolysis at 2 μM | Sheep | Venom Of The Spider Lycosa Singoriensis | 30 mM SDS and 50% TFE = α-Helical | Low hemolytic | ||
| 34506798 | 2022 | VWLSALKFIGKHLAKHQLSKL{ct:Amid} | Lycosin-II | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm | <5 % Hemolysis at 16 μM | Sheep | Venom Of The Spider Lycosa Singoriensis | 30 mM SDS and 50% TFE = α-Helical | Low hemolytic | ||
| 35792128 | 2022 | GLKSLGRKILRAWRKAVRIVQRI | MAA-41 | Free | Free | Linear | L | None | 23 | Antibacterial, Antibiofilm | 0.6 % Hemolysis at 5 μM | Human | Hybrid Of (Bamp-28/Ll37) | α-Helical | NA | ||
| 35792128 | 2022 | GLKSLGRKILRAWRKAVRIVQRI | MAA-41 | Free | Free | Linear | L | None | 23 | Antibacterial, Antibiofilm | 0.8 % Hemolysis at 10 μM | Human | Hybrid Of (Bamp-28/Ll37) | α-Helical | NA | ||
| 35792128 | 2022 | GLKSLGRKILRAWRKAVRIVQRI | MAA-41 | Free | Free | Linear | L | None | 23 | Antibacterial, Antibiofilm | 2.5 % Hemolysis at 20 μM | Human | Hybrid Of (Bamp-28/Ll37) | α-Helical | NA | ||
| 35792128 | 2022 | GLKSLGRKILRAWRKAVRIVQRI | MAA-41 | Free | Free | Linear | L | None | 23 | Antibacterial, Antibiofilm | 8.7 % Hemolysis at 40 μM | Human | Hybrid Of (Bamp-28/Ll37) | α-Helical | NA | ||
| 35792128 | 2022 | GLKSLGRKILRAWRKAVRIVQRI | MAA-41 | Free | Free | Linear | L | None | 23 | Antibacterial, Antibiofilm | 10.1 % Hemolysis at 60 μM | Human | Hybrid Of (Bamp-28/Ll37) | α-Helical | NA | ||
| 35792128 | 2022 | GLKSLGRKILRAWRKAVRIVQRI | MAA-41 | Free | Free | Linear | L | None | 23 | Antibacterial, Antibiofilm | 14.8 % Hemolysis at 80 μM | Human | Hybrid Of (Bamp-28/Ll37) | α-Helical | NA | ||
| 35792128 | 2022 | GLKSLGRKILRAWRKAVRIVQRI | MAA-41 | Free | Free | Linear | L | None | 23 | Antibacterial, Antibiofilm | 37.2 % Hemolysis at 100 μM | Human | Hybrid Of (Bamp-28/Ll37) | α-Helical | NA | ||
| 36465844 | 2022 | GVKFAKRFWRFAKKAFKRFEK{nt:Amid} | HAZ | Free | Amidation | Linear | L | None | 21 | Antibacterial, Antibiofilm, Anticancer | 20 % Hemolysis at 120 μM | Human | Synthetic Hybride (Palustrin-1D And Hp(2–20)) Peptide | α-Helical | NA | ||
| 36350889 | 2022 | GRKSAKIGKRAKRIVQRIKDFLR{ct:Amid} | LL37-1 | Amidation | Free | Linear | L | None | 23 | Antibiofilm | ≤5 % Hemolysis at 1.5 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36350889 | 2022 | RKSKEKIGKEFKRIVQRIKDFLR{nt:Acet}{ct:Amid} | ACLL37-1 | Amidation | Acetylation | Linear | L | None | 23 | Antibacterial | ≤5 % Hemolysis at 1.5 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36350889 | 2022 | GRKSAKIGKRAKRIVQRIKDFLR{nt:Acet}{ct:Amid} | ACLL37-2 | Amidation | Acetylation | Linear | L | None | 23 | Antibacterial | ≤5 % Hemolysis at 1.5 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36350889 | 2022 | GRKSAKIGKRAKRIVQRIKDF{d}LR{nt:Acet}{ct:Amid} | DLL37-1 | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acid | 23 | Antibacterial, Antibiofilm | ≤5 % Hemolysis at 1.5 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36350889 | 2022 | GRKSAKIGKRAKRIVQRIKDFLR{ct:Amid} | LL37-1 | Amidation | Free | Linear | L | None | 23 | Antibiofilm | ≤5 % Hemolysis at 2.5 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36350889 | 2022 | RKSKEKIGKEFKRIVQRIKDFLR{nt:Acet}{ct:Amid} | ACLL37-1 | Amidation | Acetylation | Linear | L | None | 23 | Antibacterial | ≤5 % Hemolysis at 2.5 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36350889 | 2022 | GRKSAKIGKRAKRIVQRIKDFLR{nt:Acet}{ct:Amid} | ACLL37-2 | Amidation | Acetylation | Linear | L | None | 23 | Antibacterial | ≤5 % Hemolysis at 2.5 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36350889 | 2022 | GRKSAKIGKRAKRIVQRIKDF{d}LR{nt:Acet}{ct:Amid} | DLL37-1 | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acid | 23 | Antibacterial, Antibiofilm | ≤5 % Hemolysis at 2.5 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36350889 | 2022 | GRKSAKIGKRAKRIVQRIKDFLR{ct:Amid} | LL37-1 | Amidation | Free | Linear | L | None | 23 | Antibiofilm | ≤5 % Hemolysis at 5 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36350889 | 2022 | RKSKEKIGKEFKRIVQRIKDFLR{nt:Acet}{ct:Amid} | ACLL37-1 | Amidation | Acetylation | Linear | L | None | 23 | Antibacterial | ≤5 % Hemolysis at 5 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36350889 | 2022 | GRKSAKIGKRAKRIVQRIKDFLR{nt:Acet}{ct:Amid} | ACLL37-2 | Amidation | Acetylation | Linear | L | None | 23 | Antibacterial | ≤5 % Hemolysis at 5 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36350889 | 2022 | GRKSAKIGKRAKRIVQRIKDF{d}LR{nt:Acet}{ct:Amid} | DLL37-1 | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acid | 23 | Antibacterial, Antibiofilm | ≤5 % Hemolysis at 5 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36350889 | 2022 | GRKSAKIGKRAKRIVQRIKDFLR{ct:Amid} | LL37-1 | Amidation | Free | Linear | L | None | 23 | Antibiofilm | ≤20 % Hemolysis at 10 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36350889 | 2022 | RKSKEKIGKEFKRIVQRIKDFLR{nt:Acet}{ct:Amid} | ACLL37-1 | Amidation | Acetylation | Linear | L | None | 23 | Antibacterial | ≤20 % Hemolysis at 10 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36350889 | 2022 | GRKSAKIGKRAKRIVQRIKDFLR{nt:Acet}{ct:Amid} | ACLL37-2 | Amidation | Acetylation | Linear | L | None | 23 | Antibacterial | ≤20 % Hemolysis at 10 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36350889 | 2022 | GRKSAKIGKRAKRIVQRIKDF{d}LR{nt:Acet}{ct:Amid} | DLL37-1 | Amidation | Acetylation | Linear | Mix | lowercase letters correspond to D-amino acid | 23 | Antibacterial, Antibiofilm | ≤20 % Hemolysis at 10 μM | Human | Ll37 Analogous | α-Helical | NA | ||
| 36548751 | 2022 | MVWLLPLKFLASHVAMEQLSKLGSKIATKL{ct:Amid} | M-lycotoxin-Lp1a | Amidation | Free | Linear | L | None | 30 | Antibacterial | 50 % Hemolysis at >100 μM | Sheep | Spider Lycosa Poonaensis | 50% TFE in a 0.2 M phosphate buffer (pH 7.0) = α-Helix | Non-hemolytic | ||
| 36548751 | 2022 | VIWLPALKFLASHIAMEQLSKL{ct:Amid} | M-lycotoxin-Lp1b | Amidation | Free | Linear | L | None | 22 | Antibacterial | 50 % Hemolysis at >100 μM | Sheep | Spider Lycosa Poonaensis | 50% TFE in a 0.2 M phosphate buffer (pH 7.0) = α-Helix | Non-hemolytic | ||
| 36548751 | 2022 | IWLTALKFIGKNLGKHFAKQQLSKL{ct:Amid} | M-lycotoxin-Lp3a | Amidation | Free | Linear | L | None | 25 | Antibacterial | 50 % Hemolysis at >100 μM | Sheep | Spider Lycosa Poonaensis | 50% TFE in a 0.2 M phosphate buffer (pH 7.0) = α-Helix | Non-hemolytic | ||
| 36548751 | 2022 | KIKWFKAMKSIAKVAKKQLKKHLGGEN{ct:Amid} | M-lycotoxin-Lp4 | Amidation | Free | Linear | L | None | 27 | Antibacterial | 50 % Hemolysis at >100 μM | Sheep | Spider Lycosa Poonaensis | 50% TFE in a 0.2 M phosphate buffer (pH 7.0) = α-Helix | Non-hemolytic | ||
| 36551443 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | AM-mel | Free | Free | Linear | L | None | 26 | Antimycobacterial | 100 % Hemolysis at 1000 µg/mL | Human | Apis Mellifera | NA | NA | ||
| 36555393 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ{nt:(FITC)-Ahx = Fluorescein isothiocyanate} | FITC-melittin | Free | (FITC)-Ahx = Fluorescein isothiocyanate | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 40 μM | Mouse | Honeybee Venom | NA | NA | ||
| 36769243 | 2023 | MNLVDRAILIRKRRRAALQLRDKVLRYLK | AMP 1 | Free | Free | Linear | L | None | 29 | Antibacterial | 29.2 ± 32 % Hemolysis at 100 µM | Mouse | Synthetic Peptide | NA | NA | ||
| 36769243 | 2023 | MTDGRYLIKRVKKKKKAVLQLILKFL | AMP 3 | Free | Free | Linear | L | None | 26 | Antibacterial | 50.1 ± 14.4 % Hemolysis at 100 µM | Mouse | Synthetic Peptide | NA | NA | ||
| 36769243 | 2023 | MNLVDRAILIRKRRRAALQLRDKVLRYLK | AMP 1 | Free | Free | Linear | L | None | 29 | Antibacterial | 12.9 ± 1.7 % Hemolysis at 100 µM | Rat | Synthetic Peptide | NA | NA | ||
| 36769243 | 2023 | MTDGRYLIKRVKKKKKAVLQLILKFL | AMP 3 | Free | Free | Linear | L | None | 26 | Antibacterial | 29.5 ± 8.2 % Hemolysis at 100 µM | Rat | Synthetic Peptide | NA | NA | ||
| 36769243 | 2023 | MNLVDRAILIRKRRRAALQLRDKVLRYLK | AMP 1 | Free | Free | Linear | L | None | 29 | Antibacterial | 7.1 ± 1.1 % Hemolysis at 100 µM | Rabbit | Synthetic Peptide | NA | NA | ||
| 36769243 | 2023 | MTDGRYLIKRVKKKKKAVLQLILKFL | AMP 3 | Free | Free | Linear | L | None | 26 | Antibacterial | 53.2 ± 7.4 % Hemolysis at 100 µM | Rabbit | Synthetic Peptide | NA | NA | ||
| 36769243 | 2023 | MNLVDRAILIRKRRRAALQLRDKVLRYLK | AMP 1 | Free | Free | Linear | L | None | 29 | Antibacterial | 22.3 ± 4 % Hemolysis at 100 µM | Human | Synthetic Peptide | NA | NA | ||
| 36769243 | 2023 | MTDGRYLIKRVKKKKKAVLQLILKFL | AMP 3 | Free | Free | Linear | L | None | 26 | Antibacterial | 37 ± 5.1 % Hemolysis at 100 µM | Human | Synthetic Peptide | NA | NA | ||
| 36908510 | 2023 | RFRPPIRRPPIRPPFRPPFRPPVR | OaBac5mini | Free | Free | Linear | L | None | 24 | Antibacterial | −1.26 to 1.59 % Hemolysis at 400 μg/mL | Rabbit | Active Fragment Of The Sheep-Derived | Random coil | Non-hemolytic | ||
| 36910465 | 2023 | RFFVPLFLVGILFPAILAKQFTK | ALA‐A1 | Free | Free | Linear | L | None | 23 | NA | 5.6 ± 0.6 % Hemolysis at 200 µM | Human | Synthetic Peptide Sequence Of Alphalactalbumin | coil–Helix–coil–Helix | Low hemolytic | ||
| 36910465 | 2023 | RFFVPLFLVGILFPAILAKQFTKC | ALA‐A3 | Free | Free | Linear | L | None | 24 | NA | 1.3± 1.2 % Hemolysis at 200 µM | Human | Synthetic Peptide Sequence Of Alphalactalbumin | Helix–coil–Helix | Low hemolytic | ||
| 36910465 | 2023 | FKCRRWQWRMKKLGAPSITCVR | BMP‐S6 (positive control)[ 5 , 10 ] | Free | Free | Linear | L | None | 22 | Anticancer | 6.0± 9.2 % Hemolysis at 200 µM | Human | Bovine-Derived Acp | coil–Helix | Low hemolytic | ||
| 36979510 | 2023 | AWLDKLKSIGKVVGKVAIGVAKNLLNPQ | Raniseptins-3 | Free | Free | Linear | L | None | 28 | Antibacterial, Antifungal | ≤20 % Hemolysis at 128 µM | Human | Frog Boana Raniceps Skin Secretion | SDS = α-Helix | NA | ||
| 36979510 | 2023 | ALLDKLKSLGKVVGKVALGVVQNYLNPRQ | Raniseptins-6 | Free | Free | Linear | L | None | 29 | Antibacterial, Antifungal | ≤20 % Hemolysis at 128 µM | Human | Frog Boana Raniceps Skin Secretion | SDS = α-Helix | NA | ||
| 37251186 | 2023 | GIGKFLKKAKKFGKAFVKILKK{ct:Amid} | MSI-78 | Amidation | Free | Linear | L | None | 22 | Antimicrobial, Anti-inflammatory | 15.2 ± 1.1 % Hemolysis at 100 µM | Pig | Derived From Magainin | LPC and LPS = α-Helical | NA | ||
| 37251186 | 2023 | KKKKKGIGFLAFGAFVILKKKK{ct:Amid} | MSI-Seg | Amidation | Free | Linear | L | None | 22 | Antibacterial | 16.6 ± 4.2 % Hemolysis at 100 µM | Pig | Msi-78 Analogues | LPC = α-Helical | NA | ||
| 37251186 | 2023 | KKKKKFIGLFAGGIVLAFKKKK{ct:Amid} | MSI-Seg-Scr | Amidation | Free | Linear | L | None | 22 | Antibacterial | 3.9 ± 1.4 % Hemolysis at 100 µM | Pig | Msi-78 Analogues | LPC = α-Helical | NA | ||
| 37251186 | 2023 | KKKKKGIGGLAGGAFVILKKKK{ct:Amid} | MSI-Seg-F2G | Amidation | Free | Linear | L | None | 22 | Antibacterial | 1.2 ± 30.2 % Hemolysis at 100 µM | Pig | Msi-78 Analogues | LPC = Random coil | NA | ||
| 37251186 | 2023 | KKKKKGIGF{d}LAF{d}GAFVILKKKK{ct:Amid} | MSI-Seg-F2F | Amidation | Free | Linear | Mix | None | 22 | Antibacterial | 8.1 ± 3.2 % Hemolysis at 100 µM | Pig | Msi-78 Analogues | LPC and LPS = β-Sheet | NA | ||
| 37251186 | 2023 | KKKKKKKGIGFLAFGAFVKILK{ct:Amid} | MSI-N7K | Amidation | Free | Linear | L | None | 22 | Antibacterial | 10 ± 5.6 % Hemolysis at 100 µM | Pig | Msi-78 Analogues | LPC and LPS = Random coil | NA | ||
| 36868141 | 2023 | FLPLIAGVAAKVLPKIFCAISKKC | Brevinin-1PMa | Free | Free | Linear | L | None | 24 | Antibacterial | 50 % Hemolysis at 4 µM | Mouse | Amazon River Frog Lithobates Palmipes | NA | NA | ||
| 37365421 | 2023 | VPTTPFLCTNDPQCKVNYEDGHCFDILSK | CaCDef-like | Free | Free | Linear | L | None | 29 | Antifungal, Anti‑Candida | 0 % Hemolysis at 400 μg/mL | Sheep | Sweet And Chili Pepper Plant Capsicum Annuum Leaves | Disordered, β-Sheet and α-Helix | Non-hemolytic | ||
| 37310533 | 2023 | RIIDLLWRVRRPQKPKFVTVWVR | PMAP-23 | Free | Free | Linear | L | None | 23 | Antibacterial | <10 % Hemolysis at 100 µM | Human | Cathelicidin-Derived Amp | aqueous bufer = unordered structure, membrane-mimetic environments = Helix–hinge–Helix | Low hemolytic | ||
| 37310533 | 2023 | RIIDRLWLVRRPQKPKFVLVWVL | PMAP-NC | Free | Free | Linear | L | None | 23 | Antibacterial, Anticancer | 20 % Hemolysis at 64 µM | Human | Pmap-23 Analogs | Helix–hinge–Helix | NA | ||
| 37686259 | 2023 | RKYKEKKDKSQNKKKKRKCMIL | RK22 | Free | Free | Linear | L | None | 22 | Antibacterial, Antibiofilm | 0 % Hemolysis at 400 μg/mL | Mouse | Leech Hirudinaria Manillensis | NA | Non-hemolytic | ||
| 36907048 | 2023 | IWLTALKFLGKNLGKHLAKQQLSKL{nt:H}{ct:Amid} | LVTX-8 | Amidation | H | Linear | L | None | 25 | Anticancer | 66.7 % Hemolysis at >5 µM | Human | Spider Lycosa Vittata | PBS buffer = α-Helical | NA | ||
| 36907048 | 2023 | IWLTALKFLGKNLGKHLAKQQLSKL{nt:hydrazide = NHNH2}{ct:Acet} | 825 | Acetylation | hydrazide = NHNH2 | Linear | L | None | 25 | Anticancer | 16.7 % Hemolysis at >5 µM | Human | Lvtx-8-Analogs | PBS buffer = α-Helical | Low hemolytic | ||
| 36907048 | 2023 | GFLG-IWLTALKFLGKNLGKHLAKQQLSKL{nt:MTX}{ct:Amid} | 827 | Amidation | MTX | Linear | L | MTX = methotrexate | 29 | Anticancer | 35.8 % Hemolysis at >5 µM | Human | Lvtx-8-Analogs | PBS buffer = α-Helical | NA | ||
| 34971943 | 2022 | FIHHIIGGLFSAGKAIHRLIRRRRR | Oreoch-2 | Free | Free | Linear | L | None | 25 | Antibacterial | 40.33 % Hemolysis at 64 µg/mL | Mouse | Synthetic | α-Helix | Low hemolytic | ||
| 34971943 | 2022 | FIHHIIGGLFSAGKAIHRLIRRRRR | Oreoch-2 | Free | Free | Linear | L | None | 25 | Antibacterial | ∼10 % Hemolysis at 32 µg/mL | Mouse | Synthetic | α-Helix | NA | ||
| 34971943 | 2022 | FIIGGLFSAGKAIHRLIRRRRR | ZN-5 | Free | Free | Linear | L | None | 22 | Antibacterial | 4.84 % Hemolysis at 64 µg/mL | Mouse | Synthetic | α-Helix | Non-hemolytic | ||
| 35323465 | 2022 | RSPRVCIRVCRNGVCYRRCWG | CT2 | Free | Free | Linear | L | None | 21 | Antibacterial | >5 % Hemolysis at 128 µM | Human | Synthetic | NA | Non-hemolytic | ||
| 35123230 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 96 ± 2.1 % Hemolysis at 5 µg/mL | Human | Synthetic | NA | NA | ||
| 35123230 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 80.5 ± 2.3 % Hemolysis at 2.5 µg/mL | Human | Synthetic | NA | NA | ||
| 35123230 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 74.2 ± 2.2 % Hemolysis at 1.25 µg/mL | Human | Synthetic | NA | NA | ||
| 35123230 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 59.5 ± 1.8 % Hemolysis at 0.625 µg/mL | Human | Synthetic | NA | NA | ||
| 35123230 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 25 ± 1.2 % Hemolysis at 0.312 µg/mL | Human | Synthetic | NA | NA | ||
| 35123230 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 6 ± 0.8 % Hemolysis at 0.156 µg/mL | Human | Synthetic | NA | NA | ||
| 35123230 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.078 µg/mL | Human | Synthetic | NA | Non-hemolytic | ||
| 35123230 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 0 % Hemolysis at 0.039 µg/mL | Human | Synthetic | NA | Non-hemolytic | ||
| 35606468 | 2022 | GLLGKILGAGKKVLCGVSGLC | Nigrocin-PN | Free | Free | Linear | L | None | 21 | Antimicrobial, Anticancer | 0 % Hemolysis at 10 µM | Horse | Pelophylax Nigromaculatus | Random coil | Non-hemolytic | ||
| 35606468 | 2022 | GLLGKILGAGKKVLCGVSGLC | Nigrocin-PN | Free | Free | Linear | L | None | 21 | Antimicrobial, Anticancer | <5 % Hemolysis at 100 µM | Horse | Pelophylax Nigromaculatus | Random coil | Non-hemolytic | ||
| 35606468 | 2022 | GLLGKILGAGKKVLLGVSGLL | Nigrocin-M1 | Free | Free | Linear | L | None | 21 | Antimicrobial, Anticancer | 0 % Hemolysis at 10 µM | Horse | Pelophylax Nigromaculatus | Random coil | Non-hemolytic | ||
| 35606468 | 2022 | GLLGKILGAGKKVLLGVSGLL | Nigrocin-M1 | Free | Free | Linear | L | None | 21 | Antimicrobial, Anticancer | <20 % Hemolysis at 100 µM | Horse | Pelophylax Nigromaculatus | Random coil | Non-hemolytic | ||
| 35740895 | 2022 | FLSGIVGMLA{d}KLFK-FLSGIVGMLDAKLF{ct:Amid} | [G10a]2 SHa | Amidation | Free | Linear | Mix | a = D-alanine, Linked b/w Phe26 and Lys40 and Lys41 and Phe39 | 27 | Antimicrobial, Antiproliferative | 50 % Hemolysis at 11.55 ± 0.38 µM | Human | Dendrimeric Analog Of Temporin-Sha | α-Helix | NA | ||
| 35740895 | 2022 | FLSGIVGMLA{d}KLF-FLSGIVGMLDAKLF{ct:Amid} | Jeff-[G10a2 SHa conjugate | Amidation | Free | Linear | Mix | Jeffamine linker b/w Phe13 and Phe26 | 26 | Antimicrobial, Antiproliferative | 50 % Hemolysis at 1926 ± 242 µM | Human | Dendrimeric Analog Of Temporin-Sha | Triple Helical | Non-hemolytic | ||
| 35740895 | 2022 | FLSGIVGMLA{d}KLFK-FLSGIVGMLDAKLF{ct:Amid} | [G10a]2 SHa | Amidation | Free | Linear | Mix | a = D-alanine, Linked b/w Phe26 and Lys40 and Lys41 and Phe39 | 27 | Antimicrobial, Antiproliferative | 100 % Hemolysis at 100 µM | Human | Dendrimeric Analog Of Temporin-Sha | α-Helix | NA | ||
| 35740895 | 2022 | FLSGIVGMLA{d}KLF-FLSGIVGMLDAKLF{ct:Amid} | Jeff-[G10a2 SHa conjugate | Amidation | Free | Linear | Mix | a = D-alanine, Jeffamine linker b/w Phe13 and Phe26 | 26 | Antimicrobial, Antiproliferative | 24.01 ± 5.06 % Hemolysis at 100 µM | Human | Dendrimeric Analog Of Temporin-Sha | Triple Helical | Non-hemolytic | ||
| 35878166 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial, Cytotoxic | 50 % Hemolysis at 3.03 ± 0.02 µg/mL | Rabbit | Apis Mellifera | α-Helix | NA | ||
| 35878166 | 2022 | GIGAVLKVLTTGLPALIS({nnr:DapAMCA})IKRKRQQ | MELFL | Free | Free | Linear | L | DapAMCA = noncanonical fluorescent amino acid, MELFL = labeled melittin | 25 | Antimicrobial, Cytotoxic | 50 % Hemolysis at 40.30 ± 0.04 µg/mL | Rabbit | Analog Of Melittin | α-Helix | Low hemolytic | ||
| 35814659 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial, Cytotoxic | 6 % Hemolysis at 0.156 µg/mL | Human | Apis Mellifera | α-Helix | NA | ||
| 35814659 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial, Cytotoxic | 0 % Hemolysis at 0.039 µg/mL | Human | Apis Mellifera | α-Helix | NA | ||
| 35814659 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial, Cytotoxic | 0 % Hemolysis at 0.019 µg/mL | Human | Apis Mellifera | α-Helix | NA | ||
| 35814659 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial, Cytotoxic | 0 % Hemolysis at 0.009 µg/mL | Human | Apis Mellifera | α-Helix | NA | ||
| 35814659 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial, Cytotoxic | 0 % Hemolysis at 0.004 µg/mL | Human | Apis Mellifera | α-Helix | NA | ||
| 35814659 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial, Cytotoxic | 50 % Hemolysis at 1.48 µg/mL | Human | Apis Mellifera | α-Helix | NA | ||
| 35814659 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial, Cytotoxic | 91.6 % Hemolysis at 5 µg/mL | Human | Apis Mellifera | α-Helix | NA | ||
| 35814659 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antimicrobial, Cytotoxic | 80.5 % Hemolysis at 45327 µg/mL | Human | Apis Mellifera | α-Helix | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLFKKILKKL{ct:Amid} | flg15-BP16 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 2 ± 0.1 % Hemolysis at 50 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKLRINSAKDDAAGLQIA{ct:OH} | BP16-flg15 | OH | Free | Linear | L | None | 26 | Antimicrobial | 0 ± 0.3 % Hemolysis at 50 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLFKKILKYL{ct:Amid} | flg15-BP100 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 48 ± 4.1 % Hemolysis at 50 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYLRINSAKDDAAGLQIA{ct:OH} | BP100-flg15 | OH | Free | Linear | L | None | 26 | Antimicrobial | 1 ± 0.9 % Hemolysis at 50 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLFKKIK{conj:COC3H7}KYL{nt:Acet}{ct:Amid} | flg15-BP387 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 26 | Antimicrobial | 5 ± 0.4 % Hemolysis at 50 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKIK{conj:COC3H7}KYLRINSAKDDAAGLQIA{nt:Acet}{ct:OH} | BP387-flg15 | OH | Acetylation | Linear | L | COC3H7 = butanoyl | 26 | Antimicrobial | 3 ± 0.3 % Hemolysis at 50 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid} | flg15-BP475 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 26 | Antimicrobial | 7 ± 0.6 % Hemolysis at 50 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKK{conj:COC3H7}LRINSAKDDAAGLQIA{nt:Acet}{ct:OH} | BP475-flg15 | OH | Acetylation | Linear | Mix | COC3H7 = butanoyl | 26 | Antimicrobial | 1 ± 1.0 % Hemolysis at 50 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKVVFWVKFK{ct:Amid} | flg15-KSLW | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 0 ± 0.6 % Hemolysis at 50 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFKRINSAKDDAAGLQIA{ct:OH} | KSLW-flg15 | OH | Free | Linear | L | None | 25 | Antimicrobial | 4 ± 1.9 % Hemolysis at 50 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKLFKKILKKL{ct:Amid} | BP13-BP16 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 86 ± 13.2 % Hemolysis at 50 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKLFKLFKKILKVL{ct:Amid} | BP16-BP13 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 100 ± 4.0 % Hemolysis at 50 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKLFKKILKYL{ct:Amid} | BP13-BP100 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 100 ± 8.3 % Hemolysis at 50 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYLFKLFKKILKVL{ct:Amid} | BP100-BP13 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 100 ± 9.4 % Hemolysis at 50 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKLF{d}KKILKYL{ct:Amid} | BP13-BP143 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 22 | Antimicrobial | 100 ± 0.6 % Hemolysis at 50 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKYLFKLFKKILKVL{ct:Amid} | BP143-BP13 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 22 | Antimicrobial | 100 ± 6.1 % Hemolysis at 50 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKVVFWVKFK{ct:Amid} | BP13-KSLW | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 80 ± 11.2 % Hemolysis at 50 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFKFKLFKKILKVL{ct:Amid} | KSLW-BP13 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 62 ± 8.2 % Hemolysis at 50 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKLFKKILKKL{ct:Amid} | Pep13-BP16 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 2 ± 0.6 % Hemolysis at 50 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKLVWNQPVRGFKVYE{ct:OH} | BP16-Pep13 | OH | Free | Linear | L | None | 24 | Antimicrobial | 1 ± 0.4 % Hemolysis at 50 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKLFKKILKYL{ct:Amid} | Pep13-BP100 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 9 ± 1.0 % Hemolysis at 50 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYLVWNQPVRGFKVYE{ct:OH} | BP100-Pep13 | OH | Free | Linear | L | None | 24 | Antimicrobial | 5 ± 0.3 % Hemolysis at 50 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKLF{d}KKILKYL{ct:Amid} | Pep13-BP143 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 24 | Antimicrobial | 5 ± 0.5 % Hemolysis at 50 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKYLVWNQPVRGFKVYE{ct:OH} | BP143-Pep13 | OH | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 24 | Antimicrobial | 5 ± 1.9 % Hemolysis at 50 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKVVFWVKFK{ct:Amid} | Pep13-KSLW | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 9 ± 2.3 % Hemolysis at 50 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFKVWNQPVRGFKVYE{ct:OH} | KSLW-Pep13 | OH | Free | Linear | L | None | 23 | Antimicrobial | 0 ± 0.3 % Hemolysis at 50 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLFKKILKKL{ct:Amid} | flg15-BP16 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 3 ± 0.2 % Hemolysis at 150 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKLRINSAKDDAAGLQIA{ct:OH} | BP16-flg15 | OH | Free | Linear | L | None | 26 | Antimicrobial | 1 ± 0.1 % Hemolysis at 150 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLFKKILKYL{ct:Amid} | flg15-BP100 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 52 ± 4.3 % Hemolysis at 150 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYLRINSAKDDAAGLQIA{ct:OH} | BP100-flg15 | OH | Free | Linear | L | None | 26 | Antimicrobial | 1 ± 0.8 % Hemolysis at 150 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLFKKIK{conj:COC3H7}KYL{nt:Acet}{ct:Amid} | flg15-BP387 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 26 | Antimicrobial | 15 ± 1.6 % Hemolysis at 150 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKIK{conj:COC3H7}KYLRINSAKDDAAGLQIA{nt:Acet}{ct:OH} | BP387-flg15 | OH | Acetylation | Linear | L | COC3H7 = butanoyl | 26 | Antimicrobial | 5 ± 0.9 % Hemolysis at 150 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid} | flg15-BP475 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 26 | Antimicrobial | 28 ± 2.3 % Hemolysis at 150 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKK{conj:COC3H7}LRINSAKDDAAGLQIA{nt:Acet}{ct:OH} | BP475-flg15 | OH | Acetylation | Linear | Mix | COC3H7 = butanoyl | 26 | Antimicrobial | 0 ± 0.2 % Hemolysis at 150 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKVVFWVKFK{ct:Amid} | flg15-KSLW | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 1 ± 0.4 % Hemolysis at 150 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFK-RINSAKDDAAGLQIA{ct:OH} | KSLW-flg15 | OH | Free | Linear | L | None | 25 | Antimicrobial | 7 ± 3.4 % Hemolysis at 150 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKLFKKILKKL{ct:Amid} | BP13-BP16 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 86 ± 1.6 % Hemolysis at 150 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKLFKLFKKILKVL{ct:Amid} | BP16-BP13 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 100 ± 2.3 % Hemolysis at 150 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKLFKKILKYL{ct:Amid} | BP13-BP100 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 100 ± 5.9 % Hemolysis at 150 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYLFKLFKKILKVL{ct:Amid} | BP100-BP13 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 100 ± 5.5 % Hemolysis at 150 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKLF{d}KKILKYL{ct:Amid} | BP13-BP143 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 22 | Antimicrobial | 100 ± 3.7 % Hemolysis at 150 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKYLFKLFKKILKVL{ct:Amid} | BP143-BP13 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 22 | Antimicrobial | 100 ± 3.6 % Hemolysis at 150 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKVVFWVKFK{ct:Amid} | BP13-KSLW | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 90 ± 7.3 % Hemolysis at 150 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFKFKLFKKILKVL{ct:Amid} | KSLW-BP13 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 65 ± 5.9 % Hemolysis at 150 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKLFKKILKKL{ct:Amid} | Pep13-BP16 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 3 ± 0.2 % Hemolysis at 150 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKLVWNQPVRGFKVYE{ct:OH} | BP16-Pep13 | OH | Free | Linear | L | None | 24 | Antimicrobial | 1 ± 0.3 % Hemolysis at 150 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKLFKKILKYL{ct:Amid} | Pep13-BP100 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 25 ± 2.4 % Hemolysis at 150 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYLVWNQPVRGFKVYE{ct:Amid} | BP100-Pep13 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 12 ± 1.1 % Hemolysis at 150 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKLF{d}KKILKYL{ct:Amid} | Pep13-BP143 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 24 | Antimicrobial | 8 ± 0.3 % Hemolysis at 150 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKYLVWNQPVRGFKVYE{ct:OH} | BP143-Pep13 | OH | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 24 | Antimicrobial | 9 ± 0.4 % Hemolysis at 150 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKVVFWVKFK{ct:Amid} | Pep13-KSLW | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 31 ± 3.7 % Hemolysis at 150 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFK-VWNQPVRGFKVYE{ct:OH} | KSLW-Pep13 | OH | Free | Linear | L | None | 23 | Antimicrobial | 2 ± 1.0 % Hemolysis at 150 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLFKKILKKL{ct:Amid} | flg15-BP16 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 4 ± 0.9 % Hemolysis at 250 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKLRINSAKDDAAGLQIA{ct:OH} | BP16-flg15 | OH | Free | Linear | L | None | 26 | Antimicrobial | 0 ± 0.6 % Hemolysis at 250 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIA-KKLFKKILKYL{ct:Amid} | flg15-BP100 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 63 ± 2.4 % Hemolysis at 250 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYLRINSAKDDAAGLQIA{ct:OH} | BP100-flg15 | OH | Free | Linear | L | None | 26 | Antimicrobial | 3 ± 0.0 % Hemolysis at 250 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLFKKIK{conj:COC3H7}KYL{nt:Acet}{ct:Amid} | flg15-BP387 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 26 | Antimicrobial | 26 ± 3.5 % Hemolysis at 250 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKIK{conj:COC3H7}KYLRINSAKDDAAGLQIA{nt:Acet}{ct:OH} | BP387-flg15 | OH | Acetylation | Linear | L | COC3H7 = butanoyl | 26 | Antimicrobial | 7 ± 0.2 % Hemolysis at 250 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid} | flg15-BP475 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 26 | Antimicrobial | 43 ± 2.7 % Hemolysis at 250 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKK{conj:COC3H7}LRINSAKDDAAGLQIA{nt:Acet}{ct:OH} | BP475-flg15 | OH | Acetylation | Linear | Mix | COC3H7 = butanoyl | 26 | Antimicrobial | 1 ± 0.3 % Hemolysis at 250 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKVVFWVKFK{ct:Amid} | flg15-KSLW | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 1 ± 0.4 % Hemolysis at 250 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFKRINSAKDDAAGLQIA{ct:OH} | KSLW-flg15 | OH | Free | Linear | L | None | 25 | Antimicrobial | 8 ± 0.9 % Hemolysis at 250 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKLFKKILKKL{ct:Amid} | BP13-BP16 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 87 ± 1.2 % Hemolysis at 250 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKLFKLFKKILKVL{ct:Amid} | BP16-BP13 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 100 ± 8.5 % Hemolysis at 250 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKLFKKILKYL{ct:Amid} | BP13-BP100 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 99 ± 7.1 % Hemolysis at 250 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYLFKLFKKILKVL{ct:Amid} | BP100-BP13 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 98 ± 3.3 % Hemolysis at 250 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKLF{d}KKILKYL{ct:Amid} | BP13-BP143 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 22 | Antimicrobial | 100 ± 3.2 % Hemolysis at 250 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKYLFKLFKKILKVL{ct:Amid} | BP143-BP13 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 22 | Antimicrobial | 100 ± 7.1 % Hemolysis at 250 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKVVFWVKFK{ct:Amid} | BP13-KSLW | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 100 ± 8.4 % Hemolysis at 250 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFKFKLFKKILKVL{ct:Amid} | KSLW-BP13 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 77 ± 12.9 % Hemolysis at 250 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKLFKKILKKL{ct:Amid} | Pep13-BP16 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 4 ± 0.3 % Hemolysis at 250 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKLVWNQPVRGFKVYE{ct:OH} | BP16-Pep13 | OH | Free | Linear | L | None | 24 | Antimicrobial | 1 ± 0.5 % Hemolysis at 250 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKLFKKILKYL{ct:Amid} | Pep13-BP100 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 45 ± 9.0 % Hemolysis at 250 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYLVWNQPVRGFKVYE{ct:OH} | BP100-Pep13 | OH | Free | Linear | L | None | 24 | Antimicrobial | 20 ± 2.4 % Hemolysis at 250 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKLF{d}KKILKYL{ct:Amid} | Pep13-BP143 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 24 | Antimicrobial | 10 ± 0.6 % Hemolysis at 250 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKYLVWNQPVRGFKVYE{ct:OH} | BP143-Pep13 | OH | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 24 | Antimicrobial | 16 ± 1.9 % Hemolysis at 250 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYE-KKVVFWVKFK{ct:Amid} | Pep13-KSLW | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 48 ± 3.8 % Hemolysis at 250 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFK-VWNQPVRGFKVYE{ct:OH} | KSLW-Pep13 | OH | Free | Linear | L | None | 23 | Antimicrobial | 3 ± 0.3 % Hemolysis at 250 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLFKKILKKL{ct:Amid} | flg15-BP16 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 5 ± 0.3 % Hemolysis at 375 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKLRINSAKDDAAGLQIA{ct:OH} | BP16-flg15 | OH | Free | Linear | L | None | 26 | Antimicrobial | 1 ± 0.5 % Hemolysis at 375 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLFKKILKYL{ct:Amid} | flg15-BP100 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 66 ± 9.2 % Hemolysis at 375 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYLRINSAKDDAAGLQIA{ct:OH} | BP100-flg15 | OH | Free | Linear | L | None | 26 | Antimicrobial | 6 ± 1.6 % Hemolysis at 375 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLFKKIK{conj:COC3H7}KYL{nt:Acet}{ct:Amid} | flg15-BP387 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 26 | Antimicrobial | 39 ± 2.1 % Hemolysis at 375 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKIK{conj:COC3H7}KYLRINSAKDDAAGLQIA{nt:Acet}{ct:OH} | BP387-flg15 | OH | Acetylation | Linear | L | COC3H7 = butanoyl | 26 | Antimicrobial | 9 ± 2.5 % Hemolysis at 375 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid} | flg15-BP475 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 26 | Antimicrobial | 46 ± 3.6 % Hemolysis at 375 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKK{conj:COC3H7}LRINSAKDDAAGLQIA{nt:Acet}{ct:OH} | BP475-flg15 | OH | Acetylation | Linear | Mix | COC3H7 = butanoyl | 26 | Antimicrobial | 1 ± 0.3 % Hemolysis at 375 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIA-KKVVFWVKFK{ct:Amid} | flg15-KSLW | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 0 ± 0.3 % Hemolysis at 375 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFK-RINSAKDDAAGLQIA{ct:OH} | KSLW-flg15 | OH | Free | Linear | L | None | 25 | Antimicrobial | 8 ± 2.7 % Hemolysis at 375 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKLFKKILKKL{ct:Amid} | BP13-BP16 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 93 ± 2.3 % Hemolysis at 375 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKLFKLFKKILKVL{ct:Amid} | BP16-BP13 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 100 ± 2.1 % Hemolysis at 375 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKLFKKILKYL{ct:Amid} | BP13-BP100 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 100 ± 4.8 % Hemolysis at 375 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYLFKLFKKILKVL{ct:Amid} | BP100-BP13 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 99 ± 3.7 % Hemolysis at 375 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKLF{d}KKILKYL{ct:Amid} | BP13-BP143 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 22 | Antimicrobial | 100 ± 10.6 % Hemolysis at 375 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKYLFKLFKKILKVL{ct:Amid} | BP143-BP13 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 22 | Antimicrobial | 100 ± 7.0 % Hemolysis at 375 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKVVFWVKFK{ct:Amid} | BP13-KSLW | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 99 ± 8.4 % Hemolysis at 375 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFKFKLFKKILKVL{ct:Amid} | KSLW-BP13 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 82 ± 10.4 % Hemolysis at 375 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKLFKKILKKL{ct:Amid} | Pep13-BP16 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 4 ± 0.2 % Hemolysis at 375 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKLVWNQPVRGFKVYE{ct:OH} | BP16-Pep13 | OH | Free | Linear | L | None | 24 | Antimicrobial | 2 ± 0.4 % Hemolysis at 375 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKLFKKILKYL{ct:Amid} | Pep13-BP100 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 49 ± 9.2 % Hemolysis at 375 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYLVWNQPVRGFKVYE{ct:OH} | BP100-Pep13 | OH | Free | Linear | L | None | 24 | Antimicrobial | 30 ± 3.2 % Hemolysis at 375 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKLF{d}KKILKYL{ct:Amid} | Pep13-BP143 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 24 | Antimicrobial | 17 ± 0.4 % Hemolysis at 375 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKYLVWNQPVRGFKVYE{ct:OH} | BP143-Pep13 | OH | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 24 | Antimicrobial | 29 ± 0.9 % Hemolysis at 375 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKVVFWVKFK{ct:Amid} | Pep13-KSLW | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 60 ± 1.5 % Hemolysis at 375 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFKVWNQPVRGFKVYE{ct:OH} | KSLW-Pep13 | OH | Free | Linear | L | None | 23 | Antimicrobial | 5 ± 1.0 % Hemolysis at 375 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35616397 | 2022 | AHPKVKRKLKRMQRKKDGKQKRH | omCCL28-like-23 | Free | Free | Linear | L | None | 23 | Antibacterial, Antibiofilm | <1 % Hemolysis at 250 µg/mL | Human | Synthetic; Omck11 Analogues | α-Helix | NA | ||
| 35616397 | 2022 | ATPKMEQFLQKLMKRMARLKASAV | drCCL27b-24 | Free | Free | Linear | L | None | 24 | Antibacterial, Antibiofilm | <1 % Hemolysis at 250 µg/mL | Human | Synthetic; Omck11 Analogues | α-Helix | NA | ||
| 35616397 | 2022 | AHPKWMEVRSRQRKKKHNKRRATY | IcCCL28-25 | Free | Free | Linear | L | None | 24 | Antibacterial, Antibiofilm | <1 % Hemolysis at 250 µg/mL | Human | Synthetic; Omck11 Analogues | α-Helix | NA | ||
| 35616397 | 2022 | APLKMKAILEIVHRRMKQNKMKAAF | smCCL27b-25 | Free | Free | Linear | L | None | 25 | Antibacterial, Antibiofilm | <1 % Hemolysis at 250 µg/mL | Human | Synthetic; Omck11 Analogues | α-Helix | NA | ||
| 35616397 | 2022 | VDQTVFKDIWWRMKQWKQRVKKRAAKYNV | trCCL28-29 | Free | Free | Linear | L | None | 29 | Antibacterial, Antibiofilm | <1 % Hemolysis at 250 µg/mL | Human | Synthetic; Omck11 Analogues | α-Helix | NA | ||
| 35616397 | 2022 | AHPRIKKHLDLLMKKKRHLAMKIAAP | chCCL27a-26 | Free | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | <1 % Hemolysis at 250 µg/mL | Human | Synthetic; Omck11 Analogues | α-Helix | NA | ||
| 35367840 | 2022 | RAGLQFPVGRLLRRLLRRLLR | α-pep | Free | Free | Linear | L | None | 21 | Antimicrobial | 100 % Hemolysis at 50 µM | Mouse | Synthetic | α-Helix | NA | ||
| 35283164 | 2022 | FWASLGHAAGHFAKGFLGDRKMD | Ss-piscidins3 | Free | Free | Linear | L | None | 23 | Antimicrobial | No Hemolysis | Fish | Sebastes Schlegelii | α-Helix | Non-hemolytic | ||
| 35834028 | 2022 | GLLSVFKGVLKTAGKNVAKNVAGSLL | B2CE-N26 | Free | Free | Linear | L | None | 26 | Antimicrobial | 50 % Hemolysis at >150 µM | Human | B2Ce Analogs | α-Helix | Low hemolytic | ||
| 35834028 | 2022 | GLLSKFKGVLKTAGKNVAKNVAGSLL | B2CE-N26-V5K | Free | Free | Linear | L | None | 26 | Antimicrobial | 50 % Hemolysis at >150 µM | Human | B2Ce Analogs | α-Helix | Low hemolytic | ||
| 35834028 | 2022 | GLLSVFKGVLKTAGKWVKKNVAKSLL | B2CE-N26- N16WA18KG23K | Free | Free | Linear | L | None | 26 | Antimicrobial | 50 % Hemolysis at 30.68 µM | Human | B2Ce Analogs | α-Helix | NA | ||
| 35700987 | 2022 | {nnr:Tyr(oMe)}-W-W-{nnr:Orn}-N-{nnr:Nva}-{nnr:Aib}-R-W-W-{nnr:Dpr}-N-{nnr:Tyr(oMe)}-W-W-{nnr:Orn}-N-{nnr:Nva}-{nnr:Aib}-R-W-W-{nnr:Dpr}-N | [LBF127]×2 | Free | Free | Linear | L | Tyr(OMe) = Tyrosine (O-Methylated), Orn = Ornithine, Nva = Norvaline, Dpr = Dap (2,3-Diaminopropionic acid), Aib = Alpha-Amino isobutyric acid | 24 | Antifungal | Hemolysis at 6.25 µM | mouse | Synthetic; Lbf127 Analog | NA | NA | ||
| 35910608 | 2022 | RVKRVWPLVIRTVIAGYNLYRAIKKK | CATH-1 | Free | Free | Linear | L | None | 26 | Antimicrobial | <20 % Hemolysis | mouse | Synthetic | NA | Low hemolytic | ||
| 35910608 | 2022 | RVKRFWPLVPVAINTVAAGINLYKAIRRK | CATH-3 | Free | Free | Linear | L | None | 29 | Antimicrobial | <20 % Hemolysis | mouse | Synthetic | NA | Low hemolytic | ||
| 35887325 | 2022 | IWSFLIKAATKLLPSLFGGGKKDS | Smp24 | Free | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolysis at 76 µg/mL | Sheep | Scorpio Maurus Palmatus | α-Helix | NA | ||
| 35887325 | 2022 | IASFLIKAATKLLPSLFGGGKKDS | Smp24 W2A | Free | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolysis at >512 µg/mL | Sheep | Synthetic; Smp24 Analogs | α-Helix | NA | ||
| 35887325 | 2022 | IWFFLIKAATKLLPSLFGGGKKDS | Smp24 S3F | Free | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolysis at 52 µg/mL | Sheep | Synthetic; Smp24 Analogs | α-Helix | NA | ||
| 35887325 | 2022 | IWKFLIKAATKLLPSLFGGGKKDS | Smp24 S3K | Free | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolysis at 11 µg/mL | Sheep | Synthetic; Smp24 Analogs | α-Helix | NA | ||
| 35887325 | 2022 | IWKFLIKAATKLLPKLFGGGKKDS | Smp24 S3K/S15K | Free | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolysis at 23 µg/mL | Sheep | Synthetic; Smp24 Analogs | α-Helix | NA | ||
| 35887325 | 2022 | IWSALIKAATKLLPSLFGGGKKDS | Smp24 F4A | Free | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolysis at 423 µg/mL | Sheep | Synthetic; Smp24 Analogs | α-Helix | NA | ||
| 35887325 | 2022 | IWSFLISAATKLLPSLFGGGKKDS | Smp24 K7S | Free | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolysis at 36 µg/mL | Sheep | Synthetic; Smp24 Analogs | α-Helix | NA | ||
| 35887325 | 2022 | IWSFLIFAATKLLPSLFGGGKKDS | Smp24 K7F | Free | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolysis at 442 µg/mL | Sheep | Synthetic; Smp24 Analogs | α-Helix | NA | ||
| 35887325 | 2022 | IWSFLIKAATKLLPKLFGGGKKDS | Smp24 S15K | Free | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolysis at 26 µg/mL | Sheep | Synthetic; Smp24 Analogs | α-Helix | NA | ||
| 35887325 | 2022 | IWSFLIKAATKLLPSLFGGGKKFS | Smp24 D23F | Free | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolysis at 33 µg/mL | Sheep | Synthetic; Smp24 Analogs | α-Helix | NA | ||
| 35887325 | 2022 | IWSFLIKAATKLLPSLFGGGKKDK | Smp24 S24K | Free | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolysis at 15 µg/mL | Sheep | Synthetic; Smp24 Analogs | α-Helix | NA | ||
| 36015076 | 2022 | WRVCKQSEKVILNPFWKKKKKKKFRV | Octoprohibitin | Free | Free | Linear | L | None | 26 | Antimicrobial | 26.89 % Hemolysis at 600 µg/mL | Mouse | Synthetic | α-Helix | NA | ||
| 36015076 | 2022 | WRVCKQSEKVILNPFWKKKKKKKFRV | Octoprohibitin | Free | Free | Linear | L | None | 26 | Antimicrobial | 92.35 % Hemolysis at 800 µg/mL | Mouse | Synthetic | α-Helix | NA | ||
| 36009917 | 2022 | GLWNSIKIAGKKLFVNVLDKIRCKVAGGC | GL-29 | Free | Free | Linear | L | None | 29 | Antimicrobial | 10 % Hemolysis at 5.86 μM | Horse | Synthetic | α-Helix | NA | ||
| 36009917 | 2022 | GLWNSIKIAGKKLFVNVLDKIRCKVAGGC | GL-29 | Free | Free | Linear | L | None | 29 | Antimicrobial | 50 % Hemolysis at 32 μM | Horse | Synthetic | α-Helix | NA | ||
| 36009917 | 2022 | GLWNSIKIAGKKLFVNVLDKIR{ct:Amid} | GL-22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 10 % Hemolysis at 87.304 μM | Horse | Synthetic | α-Helix | NA | ||
| 36009917 | 2022 | GLWNSIKIAGKKLFVNVLDKIR{ct:Amid} | GL-22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | ∼6 % Hemolysis at 32 μM | Horse | Synthetic | α-Helix | NA | ||
| 36009917 | 2022 | GLWNSIKIAGKKLFVNVLDKIRCKVAGGC | GL-29 | Free | Free | Linear | L | None | 29 | Antimicrobial | 100 % Hemolysis at 512 μM | Horse | Synthetic | α-Helix | NA | ||
| 36009917 | 2022 | GLWNSIKIAGKKLFVNVLDKIR{ct:Amid} | GL-22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | >80 % Hemolysis at 512 μM | Horse | Synthetic | α-Helix | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at <1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL24 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolysis at <1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 50 % Hemolysis at <1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 57 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL24 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 0 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 52 % Hemolysis at 1 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 94 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL24 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 0 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 71 % Hemolysis at 2 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 94 % Hemolysis at 4 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL24 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 0 % Hemolysis at 4 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 72 % Hemolysis at 4 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 92 % Hemolysis at 8 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL24 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 0 % Hemolysis at 8 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 72 % Hemolysis at 8 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 81 % Hemolysis at 16 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL24 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 0 % Hemolysis at 16 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 50 % Hemolysis at 16 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 81 % Hemolysis at 32 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL24 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 0 % Hemolysis at 32 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 47 % Hemolysis at 32 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 82 % Hemolysis at 64 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL24 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 0 % Hemolysis at 64 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 47 % Hemolysis at 64 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 84 % Hemolysis at 128 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL24 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 0 % Hemolysis at 128 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 42 % Hemolysis at 128 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 87 % Hemolysis at 256 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL24 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 0 % Hemolysis at 256 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 36140173 | 2022 | KLKLKLKLKLKLKLKLKLKLKLKLKL{ct:Amid} | KL26 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 39 % Hemolysis at 256 μg/mL | Human | Synthetic | β-Sheets | NA | ||
| 35779173 | 2022 | GIGAVLKVLTTGLPALIKRKRQQ{ct:Amid} | MDP1 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 50 % Hemolysis at 30 µg/mL | Human | Synthetic | α-Helix | NA | ||
| 35779173 | 2022 | GIGAVLKVLTTGLPALIKRKRQQ{ct:Amid} | MDP2 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 50 % Hemolysis at 24 µg/mL | Human | Synthetic | α-Helix | NA | ||
| 35779173 | 2022 | GIGAVLKVLTTGLPALISWIKRKRQQ{nt:H}{ct:Amid} | melittin | Amidation | H | Linear | L | None | 26 | Antimicrobial | 50 % Hemolysis at 0.47 µg/mL | Human | Snake | α-Helix | NA | ||
| 35852614 | 2022 | FLGAVLKVAGKLVPAAICKISKKC | BR-1GHa | Free | Free | Linear | L | None | 24 | Antimicrobial | 16 % Hemolysis at 1 μM | Human | Hylarana Guentheri | α-Helix | NA | ||
| 35852614 | 2022 | FLGAVLKVAGKLVPAAICKISKKC | BR-1GHa | Free | Free | Linear | L | None | 24 | Antimicrobial | 100 % Hemolysis at 8 μM | Human | Synthetic; Br-1Gha Analogue | α-Helix | NA | ||
| 35640793 | 2022 | GVFKDALKQLGAALLDKAANALKPK{nt:H}{ct:OH} | Picturin-1 | OH | H | Linear | L | None | 25 | Antimicrobial | 8.8 % Hemolysis at 198.37 (512) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GVFKDALKQFGAALLDKAANALKPK{nt:H}{ct:OH} | Picturin-2 | OH | H | Linear | L | None | 25 | Antimicrobial | 4.5 % Hemolysis at 195.79 (512) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GVFKDALKQFGAALLDQAANALKPK{nt:H}{ct:OH} | Picturin-3 | OH | H | Linear | L | None | 25 | Antimicrobial | 88.1 % Hemolysis at 195.91 (512) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GFLDTLKNIGKTVGRIALNVLT{nt:H}{ct:Amid} | Pictuseptin-1 | Amidation | H | Linear | L | None | 22 | Antimicrobial | 61.6 % Hemolysis at 218.54 (512) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GFLDTLKNIGKTVGGIALNVLT{nt:H}{ct:Amid} | Pictuseptin-2 | Amidation | H | Linear | L | None | 22 | Antimicrobial | 33 % Hemolysis at 228.20 (512) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GFLDTLKNIGKTVGKVALDVAKNVLT{nt:H}{ct:Amid} | Pictuseptin-3 | Amidation | H | Linear | L | None | 26 | Antimicrobial | 22.3 % Hemolysis at 188.64 (512) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GVFKDALKQLGAALLDKAANALKPK{nt:H}{ct:OH} | Picturin-1 | OH | H | Linear | L | None | 25 | Antimicrobial | 3.88 % Hemolysis at 99.19 (256) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GVFKDALKQFGAALLDKAANALKPK{nt:H}{ct:OH} | Picturin-2 | OH | H | Linear | L | None | 25 | Antimicrobial | 2.8 % Hemolysis at 97.89 (256) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GVFKDALKQFGAALLDQAANALKPK{nt:H}{ct:OH} | Picturin-3 | OH | H | Linear | L | None | 25 | Antimicrobial | 28.3 % Hemolysis at 97.85 (256) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GFLDTLKNIGKTVGRIALNVLT{nt:H}{ct:Amid} | Pictuseptin-1 | Amidation | H | Linear | L | None | 22 | Antimicrobial | 54.9 % Hemolysis at 209.27 (256) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GFLDTLKNIGKTVGGIALNVLT{nt:H}{ct:Amid} | Pictuseptin-2 | Amidation | H | Linear | L | None | 22 | Antimicrobial | 15 % Hemolysis at 114.1 (256) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GFLDTLKNIGKTVGKVALDVAKNVLT{nt:H}{ct:Amid} | Pictuseptin-3 | Amidation | H | Linear | L | None | 26 | Antimicrobial | 8.3 % Hemolysis at 94.32 (256) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GVFKDALKQLGAALLDKAANALKPK{nt:H}{ct:OH} | Picturin-1 | OH | H | Linear | L | None | 25 | Antimicrobial | 0.67 % Hemolysis at 49.59 (128) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GVFKDALKQFGAALLDKAANALKPK{nt:H}{ct:OH} | Picturin-2 | OH | H | Linear | L | None | 25 | Antimicrobial | 1.4 % Hemolysis at 48.95 (128) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GVFKDALKQFGAALLDQAANALKPK{nt:H}{ct:OH} | Picturin-3 | OH | H | Linear | L | None | 25 | Antimicrobial | 0 % Hemolysis at 48.98 (128) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GFLDTLKNIGKTVGRIALNVLT{nt:H}{ct:Amid} | Pictuseptin-1 | Amidation | H | Linear | L | None | 22 | Antimicrobial | 29.2 % Hemolysis at 54.64 (128) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GFLDTLKNIGKTVGGIALNVLT{nt:H}{ct:Amid} | Pictuseptin-2 | Amidation | H | Linear | L | None | 22 | Antimicrobial | 8 % Hemolysis at 57.05 (128) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GFLDTLKNIGKTVGKVALDVAKNVLT{nt:H}{ct:Amid} | Pictuseptin-3 | Amidation | H | Linear | L | None | 26 | Antimicrobial | 4.1 % Hemolysis at 47.16 (128) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GFLDTLKNIGKTVGRIALNVLT{nt:H}{ct:Amid} | Pictuseptin-1 | Amidation | H | Linear | L | None | 22 | Antimicrobial | 12 % Hemolysis at 27.32 (64) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GFLDTLKNIGKTVGGIALNVLT{nt:H}{ct:Amid} | Pictuseptin-2 | Amidation | H | Linear | L | None | 22 | Antimicrobial | 3 % Hemolysis at 28.52 (64) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GFLDTLKNIGKTVGKVALDVAKNVLT{nt:H}{ct:Amid} | Pictuseptin-3 | Amidation | H | Linear | L | None | 26 | Antimicrobial | 1.2 % Hemolysis at 23.58 (64) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GFLDTLKNIGKTVGRIALNVLT{nt:H}{ct:Amid} | Pictuseptin-1 | Amidation | H | Linear | L | None | 22 | Antimicrobial | 5.3 % Hemolysis at 13.66 (32) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GFLDTLKNIGKTVGGIALNVLT{nt:H}{ct:Amid} | Pictuseptin-2 | Amidation | H | Linear | L | None | 22 | Antimicrobial | 1 % Hemolysis at 14.26 (32) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GFLDTLKNIGKTVGKVALDVAKNVLT{nt:H}{ct:Amid} | Pictuseptin-3 | Amidation | H | Linear | L | None | 26 | Antimicrobial | 0.1 % Hemolysis at 11.79 (32) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 35640793 | 2022 | GFLDTLKNIGKTVGRIALNVLT{nt:H}{ct:Amid} | Pictuseptin-1 | Amidation | H | Linear | L | None | 22 | Antimicrobial | 1.7 % Hemolysis at 6.83 (16) μM (mg/L) | Human | Boana Picturata | α-Helix | NA | ||
| 36109567 | 2022 | LLKELWTKMKGAGKAVLGKIKGLL | Bm-ponericin-L1 | Free | Free | Linear | L | None | 24 | Antimicrobial | 0.2 % Hemolysis | Bovine | Bombyx Mori | α-Helix | Non-hemolytic | ||
| 36094301 | 2022 | KNLLRRIRRKLRNKFSRSDVIKTPKIVEVN | P30 | Free | Free | Linear | L | None | 30 | Antimicrobial | 5.7 ± 0.4 % Hemolysis at 50 μM | Sheep | Clostridium Intestinale | NA | NA | ||
| 36094301 | 2022 | KNLLRRIRRKLRNKFSRSDVIKTPKIVEVN | P30 | Free | Free | Linear | L | None | 30 | Antimicrobial | <2.2 % Hemolysis at ≤25 μM | Sheep | Clostridium Intestinale | NA | NA | ||
| 35543330 | 2022 | IWLTALKFLGKNGKHLAKQQLAKL{ct:Amid} | LyeTxI | Amidation | Free | Linear | L | None | 24 | Antimicrobial | ~97.39 ± 7.40 % Hemolysis at 160 μM | Rabbit | Lycosa Erythrognatha | α-Helix | NA | ||
| 32828795 | 2020 | WPKWWKWKRRWGRKKAKKRRG | Peptide 1 | Free | Free | Linear | L | None | 21 | Antibacterial | 3.4 % Hemolysis at 100μM | Human | Synthetic Construct | NA | Low hemolytic | ||
| 19113844 | 2009 | GLWSKIKEVGKEAAKAAAKAAGK | Dermaseptin B2 (1-23) | Free | Free | Linear | L | None | 23 | Antibacterial | 0 % Hemolysis at 50μM | Rat | Synthetic Construct | NA | Non-hemolytic | ||
| 28433718 | 2017 | IFGLLLHGAIHVGKLIHGLVRRH | Piscidin-3 (1-23), ecPis-3 (1-23) | Free | Free | Linear | L | None | 23 | Antibacterial, Antiparasitic, Antifungal | 0.22±0.06 % Hemolysis at 1.25μM | Rabbit | Synthetic Construct | α-Helix | NA | ||
| 24495783 | 2014 | TQQAFQKFLAAVTSALGKQYH{ct:Amid} | SHbetaAP-NH2 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 0 % Hemolysis at 100μg/mL | Human | C-Terminus Of Katsuwonus Pelamis Hemoglobin Beta Synthetic Construct | α-Helix Random coil | Non-hemolytic | ||
| 24495783 | 2014 | TQQAFQKFLAAVTSALGKQYH{ct:OH} | SHbetaAP-OH | OH | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 0 % Hemolysis at 100μg/mL | Human | Synthetic Construct | α-Helix Random coil | Non-hemolytic | ||
| 8223491 | 1993 | IIGPVLGMVGSALGGLLKKI{ct:Amid} | Peptide B Bombinin H1 | Amidation | Free | Linear | L | None | 21 | Antibacterial, hemolytic | Hemolysis at 17μM | Human | Yellow-Bellied Toad, Bombina Variegata L, Europe | NA | NA | ||
| 11835991 | 2002 | GIGTKILGGVKTALKGALKELASTYAN{ct:Amid} | Maximin 1 | Amidation | Free | Linear | L | None | 27 | Antibacterial, Antiviral, Antifungal, candidacidal, Spermicidal, Anti-HIV, Hemolytic, Anticancer | Low Hemolysis at 50μg/mL | Rabbit | Chinese Red Belly Toad, Bombina Maxima | Helix | Low hemolytic | ||
| 8353519 | 1993 | SIGSAFKKALPVAKKIGKAALPIAKAALP | Ceratotoxin B | Free | Free | Linear | L | None | 29 | Antibacterial Gram-, Hemolytic | Hemolytic | Human | Female Reproductive Accessory Glands, Medfly, Ceratitis Capitata | Helix | NA | ||
| 15648972 | 2004 | GVVDILKGAGKDLLAHLVGKISEKV{ct:Amid} | Ocellatin-1 | Amidation | Free | Linear | L | None | 25 | Antibacterial Gram-, Hemolytic | Hemolytic | Human | Frog Skin South American Leptodactylus Ocellatus | NA | NA | ||
| 15648972 | 2004 | GVLDIFKDAAKQILAHAAEKQI{ct:Amid} | Ocellatin-2 | Amidation | Free | Linear | L | None | 22 | Antibacterial Gram-, Hemolytic | Hemolytic | Human | Frog Skin South American Leptodactylus Ocellatus | NA | NA | ||
| 15648972 | 2004 | GVLDILKNAAKNILAHAAEQI{ct:Amid} | Ocellatin-3 | Amidation | Free | Linear | L | None | 21 | Antibacterial Gram-, Hemolytic | Hemolytic | Human | South American Frog Leptodactylus Ocellatus | NA | NA | ||
| 10477123 | 1999 | ALWKTLLKNVGKAAGKAALNAVTDMVNQ | Dermaseptin-DI2 (Dermaseptin DI2, DRS-DI2, DD L) | Free | Free | Linear | L | None | 28 | Antibacterial, Antiparasitic, Hemolytic | Hemolytic at 12.5µM | Human | Brazilian Frog, Phyllomedusa Distincta, South America | NA | NA | ||
| 16872274 | 2006 | GLPTCGETCFGGTCNTPGCTCDPWPVCTHN{cyc:N-C} | Cycloviolacin O24 | Free | Free | Cyclic | L | None | 30 | Antiviral, Anti-HIV, Hemolytic | 75 % Hemolytic at 25µg/ml | Human | Plant Viola Odorata | Bridge | NA | ||
| 17272268 | 2007 | GFMDTAKNVAKNVAVTLIDNLKCKITKAC | Odorranain-F1 | Free | Free | Linear | L | None | 29 | Antibacterial, Antifungal, candidacidal, Hemolytic | 15.4 % Hemolytic at 50µg/ml | Rabbit | Frog Skin, Odorrana Grahami, China, Asia | Helix | NA | ||
| 17272268 | 2007 | GIFGKILGVGKKVLCGLSGWC | Odorranain-H1 | Free | Free | Linear | L | None | 21 | Antibacterial, Antifungal, candidacidal, Hemolytic | 21.6 % Hemolytic at 50µg/ml | Rabbit | Frog Skin, Odorrana Grahami, China, Asia | Helix | NA | ||
| 17272268 | 2007 | VIPFVASVAAEMMQHVYCAASKKC | Odorranain-P1a (OdP1a) | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, candidacidal, Hemolytic | 11.2 % Hemolytic at 50µg/ml | Rabbit | Frog Skin, Odorrana Grahami, China, Asia | NA | NA | ||
| 17272268 | 2007 | GLFGKSSVVGRKYYVDLAGCAKA | Odorranain-W1 | Free | Free | Linear | L | None | 23 | Antibacterial, Antifungal, candidacidal, Hemolytic | 17.6 % Hemolytic at 50µg/ml | Rabbit | Frog Skin, Odorrana Grahami, China, Asia | NA | NA | ||
| 17272268 | 2007 | GLLSGVLGVGKKVDCGLSGLC | Nigrocin-OG21 | Free | Free | Linear | L | None | 21 | Antibacterial, Antifungal, candidacidal, Hemolytic | 100 % Hemolytic at 50µg/ml | Rabbit | Frog Skin, Odorrana Grahami, China, Asia | NA | NA | ||
| 19022312 | 2009 | FFGTALKIAANVLPTAICKILKKC | Brevinin-1LTa | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, candidacidal, Hemolytic | 50 % Hemolytic at 1.5µg/ml | Rabbit | Chinese Broad-Folded Frog, Hylarana Latouchii (Anura:Ranidae), China, Asia | NA | NA | ||
| 19254736 | 2009 | FLPAIVGAAAKFLPKIFCAISKKC | Brevinin-1BLa | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, candidacidal, Hemolytic, Anticancer | 50 % Hemolytic at 14µM | Human | Leopard Frog, Lithobates Yavapaiensis, North America | NA | NA | ||
| 19254736 | 2009 | FLPIIAGVAAKVLPKIFCAISKKC | Brevinin-1BLb | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, Hemolytic, Anticancer | Hemolytic | Human | Leopard Frog, Lithobates Yavapaiensis, North America | NA | NA | ||
| 19254736 | 2009 | FLPIIAGIAAKFLPKIFCTISKKC | Brevinin-1BLc | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, candidacidal, Hemolytic, Anticancer | 50 % Hemolytic at 9µM | Human | Leopard Frog, Lithobates Yavapaiensis, North America | NA | NA | ||
| 19254736 | 2009 | FLPVIAGVAANFLPKLFCAISKKC | Brevinin-1Ya | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, candidacidal, Hemolytic, Anticancer | 50 % Hemolytic at 18µM | Human | Leopard Frog, Lithobates Yavapaiensis, North America | NA | NA | ||
| 19254736 | 2009 | FLPIIAGAAAKVVEKIFCAISKKC | Brevinin-1Yc | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, candidacidal, Hemolytic, Anticancer | 50 % Hemolytic at 13µM | Human | Leopard Frog, Lithobates Yavapaiensis, North America | NA | NA | ||
| 15556063 | 2004 | FFPIIAGMAAKLIPSLFCKITKKC | Brevinin-1SPa | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, candidacidal, Hemolytic | 50 % Hemolytic at 7µM | Human | Frog Rana Septentrionalis , North America | NA | NA | ||
| 21295070 | 2011 | FLPVLTGLTPSIVPKLVCLLTKKC | Brevinin-1PRa | Free | Free | Linear | L | None | 24 | Antibacterial Gram+, Antifungal, candidacidal, Hemolytic | 50 % Hemolytic at 7µM | Human | Frog North America, The Oregon Spotted Rana Pretiosa | NA | NA | ||
| 21596752 | 2011 | GIPCGESCVFIPCITGAIGCSCKSKVCYRN{cyc:N-C} | Cliotide T1 | Free | Free | Cyclic | L | None | 30 | Antibacterial, Hemolytic, Anticancer | 50 % Hemolytic at 7.1µM | Human | Plant Clitoria Ternatea | NA | NA | ||
| 21596752 | 2011 | GLPTCGETCTLGTCYVPDCSCSWPICMKN{cyc:N-C} | Cliotide T3 | Free | Free | Cyclic | L | None | 29 | Hemolytic, Anticancer | 50 % Hemolytic at 13.1µM | Human | Plant Clitoria Ternatea | NA | NA | ||
| 21596752 | 2011 | GIPCGESCVFIPCITAAIGCSCKSKVCYRN{cyc:N-C} | Cliotide T4 | Free | Free | Cyclic | L | None | 30 | Antibacterial, Hemolytic, Anticancer | 50 % Hemolytic at 8.4µM | Human | Plant Clitoria Ternatea | NA | NA | ||
| 22306820 | 2012 | FALGAVTKLLPSLLCMITRKC | Hainanenin 1 | Free | Free | Linear | L | None | 21 | Antibacterial, Antifungal, hemolytic, candidacidal | 20.72 % Hemolytic at 25µg/ml | Human | Skin Secretions, Hainan Cascade-Frog, Amolops Hainanensis; China, Asia | NA | NA | ||
| 22306820 | 2012 | FALGAVTKLLPSLLCMITRKC | Hainanenin 1 | Free | Free | Linear | L | None | 21 | Antibacterial, Antifungal, hemolytic, candidacidal | 42.34 % Hemolytic at 50µg/ml | Human | Skin Secretions, Hainan Cascade-Frog, Amolops Hainanensis; China, Asia | NA | NA | ||
| 22306820 | 2012 | FALGAVTKRLPSLFCLITRKC | Hainanenin 5 | Free | Free | Linear | L | None | 21 | Antibacterial, Antifungal, hemolytic, candidacidal | 23.31 % Hemolytic at 25µg/ml | Human | Skin Secretions, Hainan Cascade-Frog, Amolops Hainanensis; China, Asia | NA | NA | ||
| 22306820 | 2012 | FALGAVTKRLPSLFCLITRKC | Hainanenin 5 | Free | Free | Linear | L | None | 21 | Antibacterial, Antifungal, hemolytic, candidacidal | 49.14 % Hemolytic at 50µg/ml | Human | Skin Secretions, Hainan Cascade-Frog, Amolops Hainanensis; China, Asia | NA | NA | ||
| 22467870 | 2012 | GDACGETCFTGICFTAGCSCNPWPTCTRN{cyc:N-C} | ChaC1 (chassatide C1) | Free | Free | Cyclic | L | None | 29 | Hemolytic, Anticancer | Hemolytic | Human | Hybrid Peptide | Bridge | NA | ||
| 22467870 | 2012 | GASCGETCFTGICFTAGCSCNPWPTCTRN{cyc:N-C} | ChaC4 (chassatide C4) | Free | Free | Cyclic | L | None | 29 | Hemolytic, Anticancer | Hemolytic | Human | Plant Chassalia Chartacea (Or Chassalia Curviflora) | Bridge | NA | ||
| 22467870 | 2012 | IPCGESCVWIPCITAIAGCSCKNKVCYT | ChaC7 (chassatide C7) | Free | Free | Linear | L | None | 28 | Antibacterial, Hemolytic, Anticancer | 50 % Hemolytic at 11.6µM | Human | Plant Chassalia Chartacea (Or Chassalia Curviflora) | Bridge | NA | ||
| 22467870 | 2012 | AIPCGESCVWIPCISTVIGCSCSNKVCYR | ChaC8 (chassatide C8) | Free | Free | Linear | L | None | 29 | Antibacterial, Hemolytic, Anticancer | 50 % Hemolytic at 25.5µM | Human | Plant Chassalia Chartacea (Or Chassalia Curviflora) | Bridge | NA | ||
| 22467870 | 2012 | IPCGESCVWIPCISGMFGCSCKDKVCYS | ChaC11 (chassatide C11) | Free | Free | Linear | L | None | 28 | Antibacterial, Hemolytic, Anticancer | 50 % Hemolytic at 13.3µM | Human | Plant Chassalia Chartacea (Or Chassalia Curviflora) | Bridge | NA | ||
| 22828809 | 2013 | FLSTLLKVAFKVVPTLFCPITKKC | Brevinin-1-AJ1 | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, hemolytic, candidacidal | 50 % Hemolytic at 50-100µM | Rabbit | Skin, The Torrent Frog, Amolops Jingdongensis, South China, Asia | NA | NA | ||
| 22828809 | 2013 | FLSTLLKVAFKVVPTLFCPITKKC | Brevinin-1-AJ1 | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, hemolytic, candidacidal | 83.05 % Hemolytic at 100µM | Rabbit | Skin, The Torrent Frog, Amolops Jingdongensis, South China, Asia | NA | NA | ||
| 22828809 | 2013 | FLSTLLKVAFKVVPTLFCPITKKC | Brevinin-1-AJ1 | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, hemolytic, candidacidal | 24.58 % Hemolytic at 50µM | Rabbit | Skin, The Torrent Frog, Amolops Jingdongensis, South China, Asia | NA | NA | ||
| 22951323 | 2012 | FLPIVAGLAANFLPKIVCKITKKC | Brevinin-1CG2 | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, hemolytic | 50 % Hemolytic at 19µM | Human | Frog Skin Secretions, Amolops Chunganensis, China, Asia | NA | NA | ||
| 22951323 | 2012 | FLSTLLNVASNVVPTLICKITKKC | Brevinin-1CG3 | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, hemolytic | 50 % Hemolytic at 19µM | Human | Frog Skin Secretions, Amolops Chunganensis, China, Asia | NA | NA | ||
| 22951323 | 2012 | FLSTLLNVASKVVPTLFCKITKKC | Brevinin-1CG4 | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, hemolytic | 50 % Hemolytic at 37.5µM | Human | Frog Skin Secretions, Amolops Chunganensis, China, Asia | NA | NA | ||
| 22951323 | 2012 | FLPMLAGLAANFLPKIVCKITKKC | Brevinin-1CG5 | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, hemolytic, candidacidal | 50 % Hemolytic at 19µM | Human | Frog Skin Secretions, Amolops Chunganensis, China, Asia | NA | NA | ||
| 23000095 | 2012 | SGTSEKERESGRLLGVVKRLIVCFRSPFP{ct:Amid} | HsAp1 | Amidation | Free | Linear | L | None | 29 | Antibacterial, Antifungal, hemolytic | 95 % Hemolytic at 3.2µM | Human | Scorpions Venom, Heterometrus Spinifer, Asia | NA | NA | ||
| 23000095 | 2012 | SGTSEKERESGRLLGVVKRLIVCFRSPFP{ct:Amid} | HsAp1 | Amidation | Free | Linear | L | None | 29 | Antibacterial, Antifungal, hemolytic | 100 % Hemolytic at 6.4µM | Human | Scorpions Venom, Heterometrus Spinifer, Asia | NA | NA | ||
| 23000095 | 2012 | SGTSEKERESGRLLGVVKRLIVCFRSPFP{ct:Amid} | HsAp1 | Amidation | Free | Linear | L | None | 29 | Antibacterial, Antifungal, hemolytic | 35 % Hemolytic at 1.6µM | Human | Scorpions Venom, Heterometrus Spinifer, Asia | NA | NA | ||
| 18339450 | 2008 | MAADIISTIGDLVKLIINTVKKFQK | delta-lysin I | Free | Free | Linear | L | None | 25 | Antibacterial, hemolytic | 50 % Hemolytic at ~12.5µM | Human | Bacteria Staphylococcus Warneri Rk | NA | NA | ||
| 21262304 | 2011 | FLPIIAGVAAKVLPKLFCAITKKC | Brevinin-1CHa | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, candidacidal, Hemolytic | 50 % Hemolytic at 5µM | Human | Skin Secretions, Chiricahua Leopard Frog, Lithobates Chiricahuensis, Arizona, Usa, North America | NA | NA | ||
| 21262304 | 2011 | FLPVIAGLAAKVLPKLFCAITKKC | Brevinin-1CHb | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, candidacidal, Hemolytic | 50 % Hemolytic at 5µM | Human | Skin Secretions, Chiricahua Leopard Frog, Lithobates Chiricahuensis, Arizona, Usa, North America | NA | NA | ||
| 23935531 | 2013 | SLFGTFAKMALKGASKLIPHLLPSRQQ | CPF-St4 | Free | Free | Linear | L | None | 27 | Antibacterial, Antifungal, Antiparasitic, Hemolytic | 50 % Hemolytic at 64µM | Mouse | African Clawed Frog Silurana Tropicalis | NA | NA | ||
| 23935531 | 2013 | GVFGLLAKAALKGASKLIPHLLPSRQQ | CPF-St5 | Free | Free | Linear | L | None | 27 | Antibacterial, Antifungal, Antiparasitic, Hemolytic | 50 % Hemolytic at 64µM | Mouse | African Clawed Frog Silurana Tropicalis | NA | NA | ||
| 23935531 | 2013 | GVWSTILGGLKKFAKGGLDAIVNPK | XPF-St6 | Free | Free | Linear | L | None | 25 | Antibacterial, Antifungal, Antiparasitic, Hemolytic | 50 % Hemolytic at 64µM | Mouse | African Clawed Frog Silurana Tropicalis | NA | NA | ||
| 23935531 | 2013 | GFMSKVANFAKKFAKGGVNAIMNQK | XPF-St8 | Free | Free | Linear | L | None | 25 | Antibacterial, Antifungal, Antiparasitic, Hemolytic | 50 % Hemolytic at 64µM | Mouse | African Clawed Frog Silurana Tropicalis | NA | NA | ||
| 25066917 | 2014 | FLPGLIKAAVGVGSTILCKITKKC | Brevinin-1TP1 | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, Antioxidant, Hemolytic | 50 % Hemolytic at 44.4µM | Human | Frog Skin Secretions, Hylarana Taipehensis, China, Asia | NA | NA | ||
| 25066917 | 2014 | FLPGLIKAAVGIGSTIFCKISKKC | Brevinin-1TP2 | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, candidacidal, Antioxidant, Hemolytic | 50 % Hemolytic at 43.1µM | Human | Frog Skin Secretions, Hylarana Taipehensis, China, Asia | NA | NA | ||
| 25066917 | 2014 | FLPGLIKVAVGVGSTILCKITKKC | Brevinin-1TP3 | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, Antioxidant, Hemolytic | 50 % Hemolytic at 65.4µM | Human | Frog Skin Secretions, Hylarana Taipehensis, China, Asia | NA | NA | ||
| 25066917 | 2014 | FLPGLIKAAVGIGSTIFCKISRKC | Brevinin-1TP4 | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, candidacidal, Hemolytic | 50 % Hemolytic at 82µM | Human | Frog Skin Secretions, Hylarana Taipehensis, China, Asia | NA | NA | ||
| 25066917 | 2014 | FLPMLAGLAANFLPKIICKITKKC | Brevinin-1LF1 | Free | Free | Linear | L | None | 24 | Antibacterial Gram+, Antifungal, Antioxidant, Hemolytic | 50 % Hemolytic at 100µM | Human | Frog Skin Secretions, Amolops Lifanensis, China, Asia | NA | NA | ||
| 25066917 | 2014 | FLPIVASLAANFLPKIICKITKKC | Brevinin-1LF2 | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, candidacidal, Hemolytic | 50 % Hemolytic at 68µM | Human | Frog Skin Secretions, Amolops Lifanensis, China, Asia | NA | NA | ||
| 25066917 | 2014 | GILDTLKQLGKAAAQSLLSKAACKLAKTC | Palustrin-2GN3 | Free | Free | Linear | L | None | 29 | Antibacterial, Antifungal, Hemolytic | 50 % Hemolytic at 52.2µM | Human | Frog Skin Secretions, Amolops Granulosus, China, Asia | NA | NA | ||
| 37228702 | 2023 | FLPLLAGLAANFLPQIICKIARKC | Brevinin-1-AW | Free | Free | Linear | L | None | 24 | Antibacterial, Anti-MRSA, Hemolytic, Antibiofilm, Anticance | 50 % Hemolytic at 23.96µM | Horse | Skin Secretion, The Wuyi Torrent Frog, Amolops Wuyiensis, China, Asia | Helix | NA | ||
| 37228702 | 2023 | FLPLLAGLAANFLPKIICKIARKC | B1AW-K | Free | Free | Linear | L | None | 24 | Antibacterial, Anti-MRSA, Hemolytic, Antibiofilm, Anticance | 50 % Hemolytic at 10.6µM | Horse | Synthetic Peptide | Helix | NA | ||
| 33508505 | 2021 | RIRIRIWRIRIRICTKSIPPIC | RI3 | Free | Free | Linear | L | None | 22 | Antibacterial, Anti-MRSA, Hemolytic | 10 % Hemolytic at 8µM | Human | Synthetic Peptide | NA | NA | ||
| 37516110 | 2023 | GSKPWWWSYFTSLSTHRPRWLLKY | CBPZ-GSK24 | Free | Free | Linear | L | None | 24 | Antibacterial Gram-, Hemolytic | 50 % Hemolytic at 19.42µM | Human | Synthetic Peptide | NA | NA | ||
| 38074470 | 2023 | FLGTVLKVAAKVLPAALCQIFKKC | Brevinin-1LTe | Free | Free | Linear | L | None | 24 | Antibacterial, Anti-MRSA, Hemolytic, Antibiofilm | 50 % Hemolytic at 6.4µM | Human | Skin Secretion, The Broad-Folded Frog, Hylarana Latouchii | NA | NA | ||
| 38611812 | 2024 | FLPLLAGLAASFLPTIFCKISRKC{ct:C-terminus contains a Rana box: one disulfide bond.} | Brevinin-1BW | C-terminus contains a Rana box: one disulfide bond. | Free | Linear | L | None | 24 | Antibacterial, Anti-inflammatory, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer | 50 % Hemolytic at 35.8µg/ml | Sheep | Skin, Pelophylax Nigromaculatus, East Asia | NA | NA | ||
| 38988311 | 2024 | HLLSLLKKAAKKLLKKLLKKLAKKL | DeNo1011 | Free | Free | Linear | L | None | 25 | Antibacterial Gram-, Hemolytic | 50 % Hemolytic at 32µg/ml | Porcine | Synthetic Peptide | NA | NA | ||
| 38988311 | 2024 | KIFGKILKKLLKKLLKKLLKKL | DeNo1013 | Free | Free | Linear | L | None | 22 | Antibacterial Gram-, Hemolytic | 50 % Hemolytic at 64µg/ml | Porcine | Synthetic Peptide | NA | NA | ||
| 38988311 | 2024 | FLPIIAGLAAKLLPKLFCKITKKC | DeNo1017 | Free | Free | Linear | L | None | 24 | Antibacterial, Hemolytic | 50 % Hemolytic at 16µg/ml | Porcine | Synthetic Peptide | NA | NA | ||
| 38988311 | 2024 | FLPIIAGLAAKFLPKIFCKITKKC | DeNo1016 | Free | Free | Linear | L | None | 24 | Antibacterial, Hemolytic | 50 % Hemolytic at 4-8 µg/ml | Porcine | Synthetic Peptide | NA | NA | ||
| 39345903 | 2024 | FFPIVAGVAAKVLKKIFCTISKKC | Brevinin-1pl (natural AMPs; frog, amphibians, animals; XXU; 1S=S, UCSS1a; BBL) | Free | Free | Linear | L | None | 24 | Antibacterial, Anticancer, Anti-MRSA, Hemolytic | 50 % Hemolytic at 37.64µM | Horse | Skin Secretions, The Northern Leopard Frog, Rana Pipiens, North America | Helix | NA | ||
| 39345903 | 2024 | FFPKVAGVAAKVLKKIFCTISKKC | [Lys4] brevinine-1pl (brevinine-1pl I4K analog, Synthetic AMPs, XXU; 1S=S, UCSS1a) | Free | Free | Linear | L | None | 24 | Antibacterial, Anti-MRSA, Hemolytic | 50 % Hemolytic at 80.77µM | Horse | Synthetic Peptide | Helix | NA | ||
| 39345903 | 2024 | FFPKVAGVAAKVAKKIFCTISKKC | [Lys4, Ala13] brevinine-1pl (brevinine-1pl I4K,L13A analog, Synthetic AMPs, XXU; 1S=S, UCSS1a) | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic | 50 % Hemolytic at 41.34µM | Horse | Synthetic Peptide | Helix | NA | ||
| 39345903 | 2024 | FFPKVAGVAAKVLKKAFCTISKKC | [Lys4, Ala16] brevinine-1pl (brevinine-1pl I4K,I16A analog, Synthetic AMPs, XXU; 1S=S, UCSS1a | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic | 50 % Hemolytic at 84.86µM | Horse | Synthetic Peptide | Helix | NA | ||
| 32414842 | 2020 | GFPCGESCVYIPCFTAAIGCSCKSKVCYKN | Hyen D | Free | Free | Linear | L | None | 30 | Anticancer, Hemolytic | 50 % Hemolytic at 24.56µM | Human | Hybanthus Enneaspermus | NA | NA | ||
| 21624426 | 2011 | FIKELLPHLSGIIDSVANAIK{ct:Amid} | Kasstasin | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 12.8 % Hemolytic at 128µM | Horse | Phlyctimantis Maculatus (Red-Legged Running Frog) (Hylambates Maculatus) | NA | Low hemolytic | ||
| 21816202 | 2012 | DSMGAVKLAKLLIDKMKCEVTKAC | Jindongenin-1a (Jindongenin-1) | Free | Free | Linear | L | None | 24 | Antimicrobial | IC50 % Hemolytic at 150µM | Rabbit | Amolops Jingdongensis (Chinese Torrent Frog) | NA | Low hemolytic | ||
| 21816202 | 2012 | GFMDTAKNVAKNVAVTLIDKLRCKVTGGC | Palustrin-2AJ1 | Free | Free | Linear | L | None | 29 | Antimicrobial | IC50 % Hemolytic at 135µM | Rabbit | Amolops Jingdongensis (Chinese Torrent Frog) | NA | Low hemolytic | ||
| 21816202 | 2012 | DSMGAVKLAKLLIDKMKCEVTKAC | Jindongenin-1a (Jindongenin-1) | Free | Free | Linear | L | None | 24 | Antimicrobial | IC50 % Hemolytic at 150µM | Human | Amolops Jingdongensis (Chinese Torrent Frog) | NA | Low hemolytic | ||
| 21816202 | 2012 | GFMDTAKNVAKNVAVTLIDKLRCKVTGGC | Palustrin-2AJ1 | Free | Free | Linear | L | None | 29 | Antimicrobial | IC50 % Hemolytic at 135µM | Human | Amolops Jingdongensis (Chinese Torrent Frog) | NA | Low hemolytic | ||
| 22917879 | 2012 | GIFGKILGAGKKVLCGLSGLC{ct:OH} | Nigrocin-2JDa | OH | Free | Linear | L | None | 21 | Antimicrobial | 80.3 ± 5.5 % Hemolytic at 128µg/ml | Rabbit | Odorrana Jingdongensis (Jingdong Frog) (Rana Jingdongensis) | α-Helical | NA | ||
| 22917879 | 2012 | GIFGKILGVGKKVLCGLSGMC{ct:OH} | Nigrocin-2JDb | OH | Free | Linear | L | None | 21 | Antimicrobial | 88.4 ± 4.2 % Hemolytic at 128µg/ml | Rabbit | Odorrana Jingdongensis (Jingdong Frog) (Rana Jingdongensis) | α-Helical | NA | ||
| 28513074 | 2017 | LIGLVSKGTCVLVKTVCKKVLKQ | M-myrmeciitoxin-Mp2b (M-MIITX-Mp2b) (DELTA-myrtoxin-Mp1a B chain) (Mp1a B chain) (Pilosin-3 subunit b) (Pilosulin-3b) | Free | Free | Linear | L | None | 23 | Antimicrobial | 50 % Hemolytic at 2.18µM | Human | Myrmecia Pilosula (Jack Jumper Ant) (Australian Jumper Ant) | β-Turn | NA | ||
| 10484737 | 1999 | GLLPKVKLVPEQISFILSTRENR | Phospholipase A1 verutoxin-1 (PLA1) (VT-1) (EC 3.1.1.32) (EC 3.1.1.5) | Free | Free | Linear | L | None | 23 | Catalytic | 3 % Hemolytic at 3ug/ml | mouse | Vespa Velutina (Asian Yellow-Legged Hornet) | NA | NA | ||
| 10484737 | 1999 | FNPCPYSDDTVKMIILTRENKKHDF | Phospholipase A1 verutoxin-2a (PLA1) (VT-2a) (EC 3.1.1.32) (EC 3.1.1.5) | Free | Free | Linear | L | None | 25 | Catalytic | 98.8 % Hemolytic at 3ug/ml | mouse | Vespa Velutina (Asian Yellow-Legged Hornet) | NA | NA | ||
| 10484737 | 1999 | FNPCPYSDDTVKMIILTRENKKHDF | Phospholipase A1 verutoxin-2b (PLA1) (VT-2b) (EC 3.1.1.32) (EC 3.1.1.5) | Free | Free | Linear | L | None | 25 | Catalytic | 99.3 % Hemolytic at 3ug/ml | mouse | Vespa Velutina (Asian Yellow-Legged Hornet) | NA | NA | ||
| 29885399 | 2018 | NLYQFKNMVQCVGTQLCVAYVKYGCYCGPG | Non-toxic phospholipase A2 (WaPLA2) (svPLA2) (Phosphatidylcholine 2-acylhydrolase) (EC 3.1.1.4) | Free | Free | Linear | L | None | 30 | Antimicrobial | 100 % Hemolytic at 3ug | Human | Walterinnesia Aegyptia (Desert Black Snake) | NA | NA | ||
| 18098329 | 2007 | IWLTALKFLGKHAAKHLAKQQLSKL{ct:Amid} | M-lycotoxin-Hc1a (M-LCTX-Hc1a) (Lycotoxin I) (Lycotoxin-1) | Amidation | Free | Linear | L | None | 25 | Antimicrobial | Hemolytic at 20µM | Sheep | Hogna Carolinensis (Carolina Wolf Spider) (Lycosa Carolinensis) | α-Helix | NA | ||
| 18098329 | 2007 | IWLTALKFLGKHAAKHLAKQQLSKL{ct:Amid} | M-lycotoxin-Hc1a (M-LCTX-Hc1a) (Lycotoxin I) (Lycotoxin-1) | Amidation | Free | Linear | L | None | 25 | Antimicrobial | Hemolytic at 20µM | Rabbit | Hogna Carolinensis (Carolina Wolf Spider) (Lycosa Carolinensis) | α-Helix | NA | ||
| 31671555 | 2019 | ASWKVFLKNIGKAAGKAVLNSVTDMVNQ{ct:Amid} | Dermaseptin-SP2 (DRS-SP2) | Amidation | Free | Linear | L | None | 28 | Antimicrobial | >20 % Hemolytic at 512mg/L | Human | Agalychnis Spurrelli (Gliding Leaf Frog) (Agalychnis Litodryas) | α-Helix | Non-hemolytic | ||
| 24523715 | 2014 | VRDICKKEAERQDLSSCENYITQRRGY | Trypsin inhibitor 1 (JcTI-I) | Free | Free | Linear | L | None | 27 | Antimicrobial | 0 % Hemolytic at 25µM | Human | Jatropha Curcas (Barbados Nut) | NA | Non-hemolytic | ||
| 16401077 | 2005 | GLRSKIWLWVLLMIWQESNKFKKM | Atypical cationic antimicrobial peptide (Dermaseptin-S9) (DRS-S9) | Free | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolytic at 175µM | Rat | Phyllomedusa Sauvagei (Sauvage'S Leaf Frog) | Alphα-Helical | NA | ||
| 16872274 | 2006 | GIPCGESCVWIPCISSAIGCSCKSKVCYRN{cyc:N-C} | Cycloviolacin-O2 | Free | Free | Cyclic | L | None | 30 | Antimicrobial | HD50 % Hemolytic at 36µM | Human | Viola Odorata (Sweet Violet) | NA | NA | ||
| 16872274 | 2006 | GIPCGESCVWIPCISAAIGCSCKSKVCYRN{cyc:N-C} | Cycloviolacin-O13 (Cyclotide c3) | Free | Free | Cyclic | L | None | 30 | Antimicrobial | HD50 % Hemolytic at 11µM | Human | Viola Odorata (Sweet Violet) | NA | NA | ||
| 19946788 | 2010 | IWLTALKFLGKNLGKHLAKQQLAKL{nt:H}{ct:Amid} | Toxin LyeTx 1 | Amidation | H | Linear | L | None | 25 | Antibacterial | 50 % Hemolytic at 1.3*10^-4M | Rabbit | Lycosa Erythrognatha (Wolf Spider) (Scaptocosa Raptoria) | α-Helix | Low hemolytic | ||
| 26322745 | 2015 | GKYTCGETCFKGKCYTPGCTCSYPICKKD{cyc:N-C} | Cyclotide mela-1 | Free | Free | Cyclic | L | None | 29 | Antibacterial | 50 % Hemolytic at >64µM | Human | Melicytus Latifolius (Norfolk Island Mahoe) (Hymenanthera Latifolia) | NA | Non-hemolytic | ||
| 26322745 | 2015 | GKPTCGETCFKGKCYTPGCTCSYPLCKKD{cyc:N-C} | Cyclotide mela-2 | Free | Free | Cyclic | L | None | 29 | Antibacterial | 50 % Hemolytic at >64µM | Human | Melicytus Latifolius (Norfolk Island Mahoe) (Hymenanthera Latifolia) | NA | Non-hemolytic | ||
| 26322745 | 2015 | GLPTCGETCFKGKCYTPGCSCSYPICKKD{cyc:N-C} | Cyclotide mela-6 | Free | Free | Cyclic | L | None | 29 | Antibacterial | 50 % Hemolytic at >64µM | Human | Melicytus Latifolius (Norfolk Island Mahoe) (Hymenanthera Latifolia) | NA | Non-hemolytic | ||
| 26322745 | 2015 | GLPTCGETCFKGKCYTPGCSCSYPICKKN{cyc:N-C} | Cyclotide mela-7 | Free | Free | Cyclic | L | None | 29 | Antibacterial | 50 % Hemolytic at >64µM | Human | Melicytus Latifolius (Norfolk Island Mahoe) (Hymenanthera Latifolia) | NA | Non-hemolytic | ||
| 26322745 | 2015 | GLPTCGETCTLGKCNTPKCTCNWPICYKD{cyc:N-C} | Cyclotide mech-2 | Free | Free | Cyclic | L | None | 29 | cytotoxicity | 50 % Hemolytic at >64µM | Human | Melicytus Chathamicus (Chatham Island Mahoe) (Hymenanthera Latifolia Var. Chathamica) | NA | Non-hemolytic | ||
| 26322745 | 2015 | GLPTCGETCTLGKCNTPKCTCNWPICYKN{cyc:N-C} | Cyclotide mech-3 | Free | Free | Cyclic | L | None | 29 | cytotoxicity | 50 % Hemolytic at >64µM | Human | Melicytus Chathamicus (Chatham Island Mahoe) (Hymenanthera Latifolia Var. Chathamica) | NA | Non-hemolytic | ||
| 25220871 | 2014 | FWGAVWKILSKVLPHIPGTVKWLQEKV | M-ectatotoxin-Eb2a (M-ECTX-Eb2a) (Ponericin-Q42) | Free | Free | Linear | L | None | 27 | Antibacterial | 50 % Hemolytic at 2.5+-0.1µM | Human | Ectatomma Brunneum (Ant) (Ectatomma Quadridens) | NA | NA | ||
| 22467870 | 2012 | GEYCGESCYLIPCFTPGCYCVSRQCVNKN{cyc:N-C} | Chassatide C10 (Cyclotide chaC10) | Free | Free | Cyclic | L | None | 29 | NA | 50 % Hemolytic at >25µM | Human | Chassalia Chartacea | NA | Non-hemolytic | ||
| 30734396 | 2019 | GLVSGLLNSVTGLLGNLAGGGL | Plasticin-TR (PTC-TR) | Free | Free | Linear | L | None | 22 | Anti-inflammatory | 50 % Hemolytic at >500µM | Mouse | Phyllomedusa Trinitatis (Trinidad Leaf Frog) | Helical | Non-hemolytic | ||
| 32414842 | 2020 | GVPCGESCVYIPCFTGIINCSCRDKVCYNN{cyc:N-C} | Cyclotide hyen-E | Free | Free | Cyclic | L | None | 30 | cytotoxicity | 50 % Hemolytic at >50µM | Human | Pigea Enneasperma (Spade Flower) (Hybanthus Enneaspermus) | NA | NA | ||
| 32414842 | 2020 | GIPCAESCVYIPCTVTALLGCSCSDKVCYN{cyc:N-C} | Cyclotide hyen-L | Free | Free | Cyclic | L | None | 30 | cytotoxicity | 50 % Hemolytic at >50µM | Human | Pigea Enneasperma (Spade Flower) (Hybanthus Enneaspermus) | NA | NA | ||
| 22450466 | 2012 | FLPLIASVAANLVPKIFCKITKKC | Brevinin-1V | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal | 50 % Hemolytic at 75µM | Human | Odorrana Hainanensis (Odor Frog) (Rana Hainanensis) | Helical | NA | ||
| 22450466 | 2012 | FLPLIASLAANFVPKIFCKITKKC | Brevinin-1HN1 | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal | 50 % Hemolytic at 75µM | Human | Odorrana Hainanensis (Odor Frog) (Rana Hainanensis) | Helical | NA | ||
| 17277458 | 2007 | DCCHNTQLPFIYKTCPEGCNL | Cardiotoxin-like basic polypeptide ah (CLBPah) | Free | Free | Linear | L | None | 21 | Anticancer | Hemolytic | Rabbit | Naja Atra (Chinese Cobra) | NA | NA | ||
| 19716842 | 2010 | FLPKMSTKLRVPYRRGTKDYH | Antimicrobial peptide scolopin-1 | Free | Free | Linear | L | None | 21 | Antibacterial, Antiyeast | 25±2 % Hemolytic at 50μg/mL | Human | Scolopendra Mutilans (Chinese Red-Headed Centipede) (Scolopendra Subspinipes Mutilans) | NA | NA | ||
| 19716842 | 2010 | GILKKFMLHRGTKVYKMRTLSKRSH | Antimicrobial peptide scolopin-2 | Free | Free | Linear | L | None | 25 | Antibacterial, Antiyeast | 32±7 % Hemolytic at 50μg/mL | Human | Scolopendra Mutilans (Chinese Red-Headed Centipede) (Scolopendra Subspinipes Mutilans) | NA | NA | ||
| 19716842 | 2010 | FLPKMSTKLRVPYRRGTKDYH | Antimicrobial peptide scolopin-1 | Free | Free | Linear | L | None | 21 | Antibacterial, Antiyeast | 21±5 % Hemolytic at 50μg/mL | Rabbit | Scolopendra Mutilans (Chinese Red-Headed Centipede) (Scolopendra Subspinipes Mutilans) | NA | NA | ||
| 19716842 | 2010 | GILKKFMLHRGTKVYKMRTLSKRSH | Antimicrobial peptide scolopin-2 | Free | Free | Linear | L | None | 25 | Antibacterial, Antiyeast | 37±6 % Hemolytic at 50μg/mL | Rabbit | Scolopendra Mutilans (Chinese Red-Headed Centipede) (Scolopendra Subspinipes Mutilans) | NA | NA | ||
| 15207717 | 2004 | GFRDVLKGAAKAFVKTVAGHIAN{ct:Amid} | Ascaphin-1 | Amidation | Free | Linear | L | None | 23 | Antibacterial | 50 % Hemolytic at >200µM | Human | Ascaphus Truei (Coastal Tailed Frog) | NA | NA | ||
| 15207717 | 2004 | GFRDVLKGAAKAFVKTVAGHIANI | Ascaphin-3 | Free | Free | Linear | L | None | 24 | Antibacterial | 50 % Hemolytic at >200µM | Human | Ascaphus Truei (Coastal Tailed Frog) | NA | NA | ||
| 15207717 | 2004 | GIKDWIKGAAKKLIKTVASHIANQ | Ascaphin-5 | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal | 50 % Hemolytic at >200µM | Human | Ascaphus Truei (Coastal Tailed Frog) | NA | NA | ||
| 15207717 | 2004 | GFKDWIKGAAKKLIKTVASAIANQ | Ascaphin-7 | Free | Free | Linear | L | None | 24 | Antibacterial | 50 % Hemolytic at >200µM | Human | Ascaphus Truei (Coastal Tailed Frog) | NA | NA | ||
| 15556063 | 2004 | GIWDTIKSMGKVFAGKILQNL{ct:Amid} | Brevinin-2-related peptide | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antifungal, Anti-HIV | 50 % Hemolytic at 70µM | Human | Lithobates Septentrionalis (Mink Frog) (Rana Septentrionalis) | NA | NA | ||
| 19463738 | 2009 | GLKDIFKAGLGSLVKGIAAHVAN{ct:Amid} | Alyteserin-1a | Amidation | Free | Linear | L | None | 23 | Antibacterial Gram- | 50 % Hemolytic at >100µM | Human | Alytes Obstetricans (Common Midwife Toad) (Bufo Obstetricans) | Alphα-Helical | NA | ||
| 19463738 | 2009 | GLKEIFKAGLGSLVKGIAAHVAN{ct:Amid} | Alyteserin-1b | Amidation | Free | Linear | L | None | 23 | Antibacterial Gram- | 50 % Hemolytic at 210µM | Human | Alytes Obstetricans (Common Midwife Toad) (Bufo Obstetricans) | Alphα-Helical | NA | ||
| 38110035 | 2024 | GIFSALKTLGKILLPVILPTVAEKIKEKV{ct:Amid} | Myrmicitoxin(1)-Pm6a (MYRTX(1)-Pm6a) | Amidation | Free | Linear | L | None | 29 | NA | 50 % Hemolytic at 614±148nm | Human | Pogonomyrmex Maricopa (Maricopa Harvester Ant) | NA | NA | ||
| 19428765 | 2009 | GLVNGLLSSVLGGGQGGGGLLGGIL | Plasticin-L1 (PTC-L1) | Free | Free | Linear | L | None | 25 | NA | Hemolytic at 500µM | Human | Leptodactylus Laticeps (Santa Fe Frog) | NA | Non-hemolytic | ||
| 16087274 | 2006 | GLHKVMREVLGYERNSYKKFFLR | Ixosin | Free | Free | Linear | L | None | 23 | Antibacterial, Antifungal | Hemolytic at 50μg/mL | Rabbit | Ixodes Sinensis (Hard Tick) | NA | Non-hemolytic | ||
| 11682065 | 2001 | GLLSKVLGVGKKVLCGVSGLC | Nigrocin-2 | Free | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 0.9 % Hemolytic at 100μg/mL | Human | Pelophylax Nigromaculatus (Black-Spotted Frog) (Rana Nigromaculata) | α-Helical | Non-hemolytic | ||
| 26930596 | 2016 | AVAGEKLWLLPHLLKMLLTPTP | Polydim-I | Free | Free | Linear | L | None | 22 | Antibacterial | <2.6 % Hemolytic at 121.6μg/mL | Human | Polybia Dimorpha (Neotropical Wasp) | NA | Non-hemolytic | ||
| 15777955 | 2005 | WWRELLKKLAFTAAGHLGSVLAAKQSGW | Grammistin Gs A | Free | Free | Linear | L | None | 28 | Antibacterial | Hemolytic at <10HU/mg | Horse | Grammistes Sexlineatus (Goldenstriped Soapfish) (Perca Sexlineata) | NA | Non-hemolytic | ||
| 15777955 | 2005 | NWRKILGKIAKVAAGLLGSMLAGYQV | Grammistin Gs C | Free | Free | Linear | L | None | 26 | Antibacterial | Hemolytic at <10HU/mg | Horse | Grammistes Sexlineatus (Goldenstriped Soapfish) (Perca Sexlineata) | NA | Non-hemolytic | ||
| 9784389 | 1998 | SMLSVLKNLGKVGLGFVACKINKQC | Ranatuerin-1 | Free | Free | Linear | L | None | 25 | Antibacterial | 0 % Hemolytic at 20μg/mL | Human | Aquarana Catesbeiana (American Bullfrog) (Rana Catesbeiana) | NA | Non-hemolytic | ||
| 9784389 | 1998 | FLPFIARLAAKVFPSIICSVTKKC | Ranatuerin-4 | Free | Free | Linear | L | None | 24 | Antibacterial | 0 % Hemolytic at 20μg/mL | Human | Aquarana Catesbeiana (American Bullfrog) (Rana Catesbeiana) | NA | Non-hemolytic | ||
| 19298834 | 2009 | GLLGGLLGPLLGGGGGGGGGLL | Leptoglycin | Free | Free | Linear | L | None | 22 | Antibacterial | 0 % Hemolytic at 2-200µM | Human | Leptodactylus Pentadactylus (Smokey Jungle Frog) (Rana Pentadactyla) | NA | Non-hemolytic |